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Abstract 
 
Diabetes is a rapidly growing health concern in the developed world. Hypoglycaemia is 
a major risk factor in people with diabetes. Each year, about 7000 calls relating to 
hypoglycaemia are made to the Scottish Ambulance Service (SAS), including a 
considerable number of repeat callers. Very little is known about people’s experiences 
and explanations of recurrent hypoglycaemia; in particular, why some individuals 
manage their recurrent hypoglycaemic episodes independently, while others require 
more direct healthcare support. 
This thesis investigated participants’ experiences and individual explanations of 
recurrent hypoglycaemic episodes, in order to understand their health help-seeking 
behaviour. To do this, it compared the experiences of people who had called the 
emergency services within one month prior to recruitment (SAS participants), with 
those people who had not done so (non-SAS participants). The study employed a 
multiple methods longitudinal approach to prospectively capture participants’ 
experiences of hypoglycaemic episodes, using qualitative semi-structured interviews, 
hypoglycaemia and blood glucose diaries and follow-up telephone interviews over a 
six month period. Thirty participants were involved in the study, recruited through the 
Scottish Ambulance Service, Diabetes UK (Scotland), and the University of Stirling. All 
participants resided in the central belt of Scotland. Qualitative data was analysed using 
the framework method, and quantitative data was analysed using descriptive 
statistics. 
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This study found that hypoglycaemic episodes had a wide ranging impact on people’s 
everyday life. It was not only the actual hypoglycaemic episode that affected 
participants’ everyday life, but also fears and worries about future hypoglycaemic 
episodes, the preparations that participants engaged in, and the process of recovery.  
Hypoglycaemia unawareness was found to be a major problem for many people living 
with diabetes. It appeared to be associated with the likelihood of needing external 
help. There were differences between participant groups with regard to management 
of hypoglycaemia unawareness. Non-SAS participants adopted strategies to prepare 
for future hypoglycaemic episodes, and appeared to be more knowledgeable about 
their diabetes and its management, resulting in needing less external help. SAS 
participants experienced more severe hypoglycaemic episodes. Consequently, they 
relied more on external help.  
Findings of this study call for a re-conceptualisation of the previously recognised 
‘balancing act’ of managing diabetes and hypoglycaemic episodes. This study 
introduces the concept of a hypoglycaemic episode balancing continuum (HEBC) which 
enables a deeper understanding of the factors involved in this balancing act: it 
demonstrates that people balance the various risks differently, depending on whether 
they prioritised their fear of hypoglycaemia over fears of long-term complications. 
People’s position on the continuum directly affected their management strategies for 
hypoglycaemic episodes.  
Most hypoglycaemic episodes were managed by the individual without requiring any 
external help. However, participants’ ability to self-care differed and deficits occurred, 
resulting in participants being more likely to need involvement of others 
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(family/friends). When the capacity of others to help broke down, participants’ were 
more likely to need SAS emergency care. In order to explain how hypoglycaemic 
episodes are managed, this thesis has developed a hypoglycaemic episode help-
seeking network (HEHS network), which helps to identify the various agents involved 
in helping to manage hypoglycaemic episodes. 
Findings from this study have implications for clinical practice. For example, looking at 
hypoglycaemia unawareness, this study has shown that current understanding may fail 
to take account of participants’ real experiences, which show hypoglycaemia 
unawareness to be a fluid phenomenon that can affect people at various times. If 
blood glucose levels can fail to predict onset of hypoglycaemic episodes, healthcare 
professionals may need to broaden the range of blood glucose readings that might 
indicate a hypoglycaemic episode and tailor specific advice to individual patients. 
To reduce the use of emergency services, more attention must be paid to 
hypoglycaemia unawareness and better advice provided about this condition. Also, 
more education should be provided for family members/carers, given the crucial role 
they play in the management of diabetes and hypoglycaemic episodes, and being a 
link in the process leading to increased use of emergency services. 
The HEBC could be developed into a useful ‘screening tool’ to help healthcare 
professionals identify those at greater risk of hypoglycaemic episodes and those at 
greater risk of long-term complications, and to target advice more specifically to these 
patient groups. Further research could explore family member/carer knowledge in 
more detail to better understand their role in helping to manage hypoglycaemic 
episodes.  
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Chapter 1 - Introduction 
This thesis is an applied piece of health research which has been informed by 
sociological thinking. Applied health research has been defined as “research that has 
potential to improve health or quality of life” (Fathalla 2004:27). The sociological lens 
was selected because diabetes is not just an illness affecting the physical body, but 
also a condition that is managed within the context of people’s social life. The 
sociological approach underlines prevention, health promotion and the social 
construction of health and illness, rather than focussing on medical treatment alone 
(Freund et al. 2003).  
1.1 Personal interest 
The main motivation for this study is personal. My younger brother was diagnosed 
with diabetes when he was just four years old. So throughout my childhood, I have 
experienced what it meant for a close family member to live with diabetes and 
manage hypoglycaemic episodes. I saw how many aspects of everyday life had to be 
adjusted to accommodate his diabetes, both by him and the family.  
Diabetes and its complications are ever present in the lives of people living with the 
condition. For example, several times my brother was shaky and needed to eat 
something, no matter what time of day it was. From this experience, I have always 
wanted to learn more about diabetes. In this sense, I could relate to the subject 
matter.  
Beyond personal reasons, the research area also captured my interest, particularly 
looking at how people cope with long-term conditions. I wanted to hear from people, 
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to understand how they make sense of their condition. This is in part because my 
research interests are in the dynamics of sociology, illness experience and health. But 
also, I saw there was a lack of studies looking at people’s experiences and individual 
explanations for hypoglycaemia; despite hypoglycaemia being a reality for people 
living with diabetes.  
1.2 Rationale for thesis 
Diabetes is a rapidly growing health concern in the developed world with an alarming 
global incidence rate (WHO 2009; International Diabetes Federation 2012). 
Hypoglycaemia is a major risk factor in people with diabetes (Briscoe and Davis 2006; 
Frier 2008). Many people who experience hypoglycaemic episodes self-manage these 
events; others do not (The Scottish Government 2010). Very little is known about 
people’s experiences and explanations of recurrent hypoglycaemia. In particular, very 
little is known about why some individuals manage their recurrent hypoglycaemic 
episodes independently, while others require more direct healthcare support. 
To date, diabetes research has paid little attention to people’s experiences of 
hypoglycaemia. Although hypoglycaemia has been mentioned in the literature in the 
context of diabetes complications, there are few studies that focus on people’s 
experiences of hypoglycaemia in particular. Much of the research about 
hypoglycaemia has used a quantitative approach, and clusters around ‘fear of 
hypoglycaemia’ and its impact on diabetes self-management (e.g. Shiu and Wong 
2000; Leiter et al. 2005; Currie et al. 2006; Belendez and Hernandez-Mijares 2009; 
Anderbro et al. 2010), see section 3.3.4.1. 
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Most people manage hypoglycaemic episodes independently, though some need 
external support from family members, their wider support network or emergency 
services. A proportion of this support is delivered by the Scottish Ambulance Service 
(SAS). Each year, about 7000 calls relating to diabetes are made to the SAS, which 
includes a considerable number of repeat callers (The Scottish Government 2010).  
The recurrence of hypoglycaemic episodes, especially severe hypoglycaemic episodes, 
is a major interest of the Scottish Ambulance Service (SAS), who are partly funding this 
study. The SAS aims to find out more about underlying reasons for repeat call-out of 
emergency services. This appears to be a novel and important area of research, since 
the structured review did not find any studies looking at recurrent hypoglycaemic 
episodes in the context of people’s experiences of hypoglycaemia (see section 3.3).  
The Scottish Government (2010) Diabetes Action Plan aims to reduce diabetes 
emergencies. The Diabetes Action Plan also indicates that the SAS wants to reduce 
episodes of recurrent severe hypoglycaemia. Understanding the underlying reasons 
and people’s experiences of hypoglycaemic episodes could help to address the 
problem of recurrent hypoglycaemia, as well as designing appropriate policy 
responses. Therefore, it is important to investigate why some people repeatedly rely 
on emergency services in response to hypoglycaemia and others appeared to self-
manage or engage the help and support of others (see section 2.10.1). This may help 
offer insights into how the management of hypoglycaemic episodes or their impact 
can be better supported (by healthcare professionals or others) to enable better self-
care practices. 
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Given the findings of the literature review (see chapter 3) and the quality of existing 
research, there is a need for good quality research to investigate people’s experiences 
of hypoglycaemia more specifically within their overall experience of diabetes. This 
study explored the perspectives of people living with diabetes to address: participants’ 
experiences of hypoglycaemic episodes; including the experience of hypoglycaemic 
emergencies (i.e. when an ambulance is called to attend a person experiencing a 
hypoglycaemic emergency). It investigated participants’ perspectives regarding why 
hypoglycaemic episodes occur, how they are avoided and how they are managed.  This 
study adopted a sample that allowed for comparison of two groups of people with 
diabetes: those who had recently used emergency services to manage a 
hypoglycaemic episode (Scottish Ambulance Service (SAS) participants), and a group of 
people primarily recruited via Diabetes UK who self-identified as not having recently 
used emergency services (non-SAS participants).  
This study used a longitudinal approach to explore participants’ perspectives and 
experiences of recurrent hypoglycaemia over time. This approach also enabled 
prospective data collection, allowing access to actual hypoglycaemic episodes (Polit 
and Beck 2003). The study employed a multiple methods approach, with qualitative 
semi-structured interviews forming the basis of the investigation, and quantitative 
data being collected on participants’ daily blood glucose readings and recording of 
hypoglycaemic episodes. This design allowed capturing actual hypoglycaemic episodes 
and understanding how participants’ responses to (low) blood glucose levels may vary. 
It also helped to explore participants’ experiences of living with diabetes and 
hypoglycaemia, thus giving an insight into people’s everyday life (‘life worlds’) 
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managing a chronic condition (Hawkes et al. 2009). It also helped understand people’s 
individual explanations for hypoglycaemic episodes as they happened, and their 
coping strategies, as well as how hypoglycaemic episodes affected their everyday life. 
1.3 Structure of thesis 
The following chapter of this thesis (chapter 2) provides background information 
about diabetes and hypoglycaemia; the clinical conditions of interest to this study. It 
discusses complications and health-related risks of diabetes, including risks relating to 
hyperglycaemia and hypoglycaemia. This study focussed on hypoglycaemia. The 
challenges of defining hypoglycaemia were also considered. The final sections of 
chapter 2 describe the symptoms, management of hypoglycaemia, use of emergency 
services, risk factors and the differences between type 1 and type 2 diabetes relating 
to hypoglycaemia. 
Chapter 3 presents the findings of the literature review investigating people’s 
experiences and perspectives of living with diabetes and hypoglycaemia. The chapter 
is in two parts, covering both the experience of living with diabetes, as well as 
hypoglycaemia. It highlights that hypoglycaemia can have a considerable impact on 
the well-being of people living with diabetes, potentially affecting them in two ways: 
one, directly through the effects of a hypoglycaemic episode, and two, indirectly 
through fears and worries about recurrent hypoglycaemic episodes happening 
(Lundkvist et al. 2005). Chapter 3 also includes a detailed rationale for this study. 
Chapter 4 then introduces theoretical perspectives concerning illness experience. This 
includes a discussion of potentially relevant theories from the fields of chronic illness 
6 
 
experience and help-seeking behaviour.  The chapter also considers the usefulness of 
theories to this study.  
Chapter 5 describes in detail the methods used to conduct this study, including study 
aims, research questions, study design, sampling strategy and recruitment issues. It 
also highlights ethical implications and provides an overview of the schedule for data 
collection. The chapter finally considers how the data were analysed.  
In chapter 6, characteristics of the study population as well as results from the 
hypoglycaemia and blood glucose diary are presented. Chapters 7 and 8 present study 
findings and describe the hypoglycaemic episode balancing continuum (HEBC) and the 
hypoglycaemic episode help-seeking network (HEHS network), which were both 
developed from the analysis of study data.  
Chapter 9 discusses the findings with reference to the wider literature. The chapter 
also discusses the strengths and limitations of this study. In particular, it emphasises 
that the longitudinal design combining qualitative semi-structured interviews with 
blood glucose and hypoglycaemia diaries helped to obtain a rich and in-depth 
understanding of participants’ experiences of recurrent hypoglycaemic episodes. 
Finally, chapter 9 considers the implications of study findings for clinical practice and 
future research. 
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Chapter 2 - Background 
2.1 Introduction 
Diabetes has become one of the major health threats of the 21st century. Despite the 
condition having an age long history, recent prevalence figures show that numbers 
have increased exponentially. The World Health Organization (WHO) estimated that in 
2009, about 220 million people had diabetes globally, predicting that these numbers 
would rise to about 366 million by 2030 (WHO 2009). However, a more recent figure 
from the International Diabetes Federation (2012) has shown that there were already 
about 371 million people living with diabetes worldwide. 
In the United Kingdom, four key factors have been highlighted to be responsible for 
this increase in prevalence, namely: the ageing population, which has resulted from 
increases in life expectancy due to advances in medical treatment, and the ageing of 
the ‘baby boom’ generation; increases in diabetes incidence driven primarily by 
increases in obesity; decreases in mortality in those with diabetes; and immigration 
from countries with higher diabetes prevalence rates (Wild et al. 2004).  
This chapter briefly explains what diabetes is, how it is diagnosed, as well as potential 
complications of the condition. It also provides information relating to incidence and 
prevalence of diabetes worldwide. The second part of the chapter (starting from 
section 2.6.2) focusses on hypoglycaemia (definition, symptoms, risk factors, etc.), 
thus providing relevant background information for this study. 
8 
 
2.2 What is diabetes? 
Diabetes is a chronic condition characterised by high blood glucose levels. It is caused 
by a lack of insulin or a resistance to its action. The clinical term ‘diabetes mellitus’ 
derives from two words: ‘Diabetes’ comes from the Greek word ‘siphon’ which refers 
to disorders removing liquids from the body, while ‘mellitus’ has its origin from the 
Latin word ‘sweet, honeyed’. Hence, ‘diabetes mellitus’ describes a condition that 
causes ‘sweet urine’ (Banks 2005). Diabetes mellitus has been known for thousands of 
years, however, over time, more and more has been discovered about diabetes 
mellitus, and the way it is diagnosed has been refined. 
There are two forms of diabetes, diabetes insipidus and diabetes mellitus, of which 
diabetes mellitus is the much more prevalent. Diabetes insipidus is a rare condition 
caused by the deficiency of a hormone required to concentrate urine (Banks 2005). 
Diabetes insipidus shares the name ‘diabetes’ as it also results in the production of 
large quantities of urine, but it has no relationship to how the body manages glucose 
(Banks 2005). This study is concerned with diabetes mellitus. The term diabetes will 
therefore be used to refer to diabetes mellitus. 
There are two main types of diabetes, commonly referred to as type 1 and type 2 
diabetes. Type 1 diabetes results from the pancreatic beta cells not producing any 
insulin, while type 2 is consequential to either insulin not being used effectively by the 
body or its amount not being sufficient to regulate blood glucose levels (Williams and 
Pickup 2004; Polonsky 2012). Type 1 diabetes is more common in younger individuals, 
while type 2 is more likely to develop in older populations (Watkins et al. 2003). The 
two types of diabetes are explained in more detail in section 2.4.1 and 2.4.2. 
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2.3 Diagnosis 
In 1965, the World Health Organization (WHO) began publishing guidelines for the 
diagnosis and classification of diabetes, which has resulted in better and more 
accurate diagnostic information becoming available (WHO 1999). Following on, in 
2003, the WHO Expert Committee on the Diagnosis and Classification of Diabetes 
Mellitus reviewed its diagnostic criteria, thus paving the way for future 
recommendations.  
WHO (2006) recommends the following diagnostic criteria for diabetes: either a 
fasting plasma glucose level of 7.0 mmol/l (or higher) or a plasma glucose value of 11.1 
mmol/l (or higher) two hours after ingesting 75g oral glucose, and the presence of 
diabetes symptoms. The main symptoms of diabetes include increased thirst and 
appetite, the frequent need to pass urine, fatigue and blurred vision (Watkins 2003). If 
diabetes symptoms are absent, the individual should be tested at least twice on 
different days.  
Following a WHO expert consultation in 2009, the WHO published a report which 
concluded that people’s HbA1c (glycated haemoglobin) value can be used to diagnose 
diabetes. The HbA1c value provides an index of average blood glucose values for the 
previous eight to twelve weeks, (WHO 2011). The cut off point for diagnosing diabetes 
is an HbA1c of 6.5%. However, an HbA1c below 6.5% does not necessarily exclude 
diabetes, if it has been diagnosed using glucose tests (as described above; WHO 2011). 
Clinically diagnosed diabetes needs to be distinguished from impaired glucose 
tolerance (IGT) and impaired fasting glycaemia (IFG). IGT is a term used to describe 
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higher blood glucose levels than those of a healthy individual, but below the level of a 
person with diabetes. This could be a result of impaired insulin secretion and/or insulin 
resistance (IDF 2009). This phenomenon is also known as ‘pre-diabetes’ (American 
Diabetes Association 2012). IGT is identified by conducting an oral glucose tolerance 
test (OGTT), while IFG diagnosis follows a fasting plasma glucose test (FPG). These 
tests are also used to diagnose diabetes. Both IGT and IFG would be classed as pre-
diabetic conditions (NIH 2008).  
2.4 Types of diabetes 
There are two main types of diabetes: type 1 and type 2 diabetes. A third form of 
diabetes, called gestational diabetes will be explained briefly at the end of this section. 
2.4.1 Type 1 diabetes 
Type 1 diabetes, which is also referred to as insulin dependent diabetes is more 
commonly first diagnosed in children and younger adults, though not limited to these 
age groups. Insulin is vital for human survival as it helps to keep blood glucose levels 
within a healthy range. However, in people with type 1 diabetes, their body cannot 
produce insulin, due to destruction of pancreatic beta cells (Daneman 2006).   
It is not entirely known what causes type 1 diabetes, but genetic factors seem to play 
some part; and in many cases an autoimmune reaction, which can be triggered by 
environmental factors, is responsible for the destruction of beta cells (Daneman 2006).  
Weight loss, the frequent need to pass urine, and excessive thirst are some of the 
symptoms of type 1 diabetes (Watkins et al. 2003). An additional indicator for type 1 
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diabetes is rapid development of symptoms, as opposed to a gradual development of 
symptoms in type 2 diabetes (Watkins et al. 2003; Banks 2005). 
2.4.2 Type 2 diabetes 
Type 2 diabetes is caused by a combination of insulin resistance and insulin deficiency. 
After the onset of type 2 diabetes, there is usually still some amount of insulin present 
in the body, but this might either be insufficient and/or the body cells are resistant to 
its action (insulin resistance). Type 2 diabetes tends to be further exacerbated by 
obesity and physical inactivity (Stumvoll et al. 2005). 
Additionally, type 2 diabetes is a progressive condition, getting worse over time. As a 
result, initial treatment could be comprised of diet-controlled intervention, weight 
management and physical exercise, but as the condition progresses, oral 
hypoglycaemic agents and later on insulin injections may become necessary (Watkins 
et al. 2003).   
Since the condition develops gradually and people have few symptoms initially, it can 
go unnoticed for years before a diagnosis is established. Treatment of type 2 diabetes 
can be multifaceted, and needs to take into account other underlying medical 
conditions, which patients, particularly older patients, might have, e.g. obesity, 
dementia, high blood pressure, etc. (Watkins et al. 2003; Murata et al. 2004). Barnett 
et al. (2012) have investigated the distribution of multimorbidity in a large sample in 
Scotland (N=1,751,841) and found that 23.2% of the sample had two or more 
morbidities. They recommended that the presence of multimorbidities should be 
taken into account when designing healthcare/treatment strategies.  
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2.4.3 Gestational diabetes 
A third form of diabetes, gestational diabetes, first occurs in women during pregnancy. 
In most cases, this type of diabetes resolves after the baby has been born. However, 
women who have experienced gestational diabetes have an increased risk of 
developing type 2 diabetes later in life (NIH 2008). 
2.5 Incidence and prevalence of diabetes worldwide 
Diabetes continues to pose a significant public health risk globally, impacting on the 
health and well-being of the world population. International estimates have continued 
to rise. For example, the WHO estimated that in 2009, over 220 million people were 
living with diabetes worldwide, and that these numbers were expected to rise to 
about 366 million by 2030 (WHO 2009). One decade later, figures had increased to 
about 285 million (Diabetes UK 2010). However, a more recent estimate from the 
International Diabetes Federation (2012) has shown that there were about 371 million 
people living with diabetes worldwide. 
In tandem with the burden of diabetes on the health of the population (prevalence), 
the numbers of newly diagnosed cases of diabetes (incidence) remain high, as more 
and more people have been diagnosed with the condition since 2000. For example, 
the incidence for type 1 and type 2 diabetes in Scotland was 52 cases/100,000/year 
(Scottish Diabetes Survey 2010). According to Banks (2005), 90% of people diagnosed 
with diabetes globally are diagnosed with type 2, with approximately 10% being 
diagnosed with type 1. 
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Although global figures have continued to rise, considerable variations exist in terms 
of national prevalence. For example, 2012 figures by the International Diabetes 
Federation (IDF) show that the three countries with the largest number of people with 
diabetes were China, India and the United States. China in particular, accounts for over 
92 million of the global population of people living with diabetes, with a prevalence 
rate of 8.82%. In India, 43 million people live with diabetes, with a prevalence rate of 
9.01%. Figures for the USA were 24 million, with a prevalence rate of 9.35% (IDF 2012).  
In terms of the UK, approximately 2.9 million people were diagnosed with diabetes, of 
which 237,468 were in Scotland (Scottish Diabetes Survey 2010). A more recent figure 
has put the UK in the region of 3.3 million (IDF 2012). Explanations for these variations 
usually range from environmental influences to ethnic and genetic predispositions 
(Dorman and Bunker 2000; Agency for Healthcare Research and Quality 2001; 
Feltbower et al. 2002).  
A recent study by Ujcic-Voortman et al. (2009) in Amsterdam found that the 
prevalence of diabetes among Turkish and Moroccan migrants was significantly higher 
compared to that of the indigenous population, which would support ethnic and 
genetic predisposition. Williams and Pickup (2004) also compared the incidence of 
type 1 diabetes in various European countries and found that Finland had the highest 
incidence level with 48.5 cases/100,000/year, while the lowest was in the Ukraine with 
only 1.3 cases/100,000/year (Williams and Pickup 2004). Looking at Scotland, recent 
figures show an incidence rate of 18 cases/100,000/year (Scottish Diabetes Survey 
2010). The Scottish figures are the highest in the UK (Watkins et al. 2003). 
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2.6 Complications and health-related risks 
The main complications of diabetes relate to glycaemic instability, namely 
hyperglycaemia (where blood glucose levels stay too high) and hypoglycaemia (where 
blood glucose levels drop too low; Williams and Pickup 2004). The following sections 
explain risks and complications relating to hyperglycaemia and hypoglycaemia.  
2.6.1 Hyperglycaemia 
Hyperglycaemia is indicated when a person’s blood glucose level exceeds 11 mmol/l 
(Lowth 2012). Risks relating to hyperglycaemia fall into one of two categories:  
• Acute risk of ketoacidosis, and  
• Risk of developing long-term complications 
Ketoacidosis (also known as diabetic ketoacidosis/DKA) happens as a result of lack of 
insulin in the body, which is much more common in type 1 diabetes. Due to insulin 
deficiency, glucose cannot enter cells to provide energy. Therefore, the blood glucose 
level increases (hyperglycaemia) and as it gets higher, glucose is passed out of the 
body with urine (Watkins et al. 2003). Consequently, the cells do not receive the 
energy they need and the body starts breaking down fat and protein to provide 
energy. A by-product of this response is the production of ketones, an acid, which 
remains when the body breaks down fatty acids in the liver. This process can lead to 
ketoacidosis, a severe condition characterised by hyperglycaemia, hyperketonaemia 
and metabolic acidosis (low blood pH; Williams and Pickup 2004). If DKA is not treated 
appropriately, it can cause the person to go into a diabetic coma which can be fatal. 
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Treatment for ketoacidosis usually consists of a combination of fluid replacement and 
insulin injection (Watkins et al. 2003). 
The most common long-term complication of hyperglycaemia relates to damage to the 
blood vessels, which can cause cardiovascular disease, eventually leading to stroke or 
heart attack. Further long-term complications are eye problems (diabetic retinopathy), 
foot problems due to restricted circulation, erectile dysfunction in men, kidney and 
nerve damage (nephropathy and neuropathy respectively; American Diabetes 
Association 2012). These complications are particularly common if diabetes is left 
undiagnosed for a number of years (mainly in type 2 diabetes; Watkins 2003). 
2.6.2 Hypoglycaemia 
This study focussed on hypoglycaemia, which will be discussed in subsequent sections. 
Hypoglycaemia occurs when blood glucose levels drop below normal values (see 
‘definition’ in section 2.7 below). In people with diabetes, hypoglycaemia arises as a 
side-effect of treatment with insulin and some sulphonylurea oral medications 
(Barnett et al. 2010). These are usually required to keep blood glucose levels within a 
healthy range. However, inappropriately high insulin levels (hyperinsulinaemia) lead to 
very low blood glucose levels (Williams and Pickup 2004). Elevated insulin levels are a 
result of either administering too much medication or a reduced need for insulin 
which can be due to physical exercise, delayed or missed meals or snacks, diminishing 
insulin requirements following impaired renal function or alcohol consumption (Alwan 
1994). 
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Hypoglycaemia is the most common adverse reaction in insulin-treated type 1 and 
type 2 diabetes (Wild et al. 2007).  In type 1 diabetes, the annual incidence of severe 
hypoglycaemia is between 1 and 2 cases per individual, which can further increase 
when other risk factors are present (Frier 2008; see section 2.11). Mild and usually 
self-treated hypoglycaemia is even more common, occurring on average about twice a 
week (Frier 2008). In people with type 2 diabetes, severe hypoglycaemia is less 
common than in type 1 diabetes (UKPDS 1998). However, people with insulin-treated 
type 2 diabetes experience similar rates of severe hypoglycaemia compared to those 
with type 1 diabetes, particularly when the duration of insulin treatment is 5 years or 
more (Heller 2008). 
The Diabetes Control and Complications trial (DCCT 1993; focussed on type 1 diabetes) 
and the UK Prospective Diabetes Study (UKPDS 1998; focussed on type 2 diabetes) 
have both shown evidence of a reduced risk for long-term complications if blood 
glucose levels are strictly monitored and near normal. This has brought with it 
recommendations for tighter glycaemic control, which in turn increases the 
occurrence of hypoglycaemia (Heller 2008).  
Given that hypoglycaemia does not only pose a serious health risk, but it is also 
accompanied with unpleasant symptoms and often negative experiences, some 
people develop an associated fear of hypoglycaemia (Wild et al. 2007; see section 
3.3.4.1). 
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2.7 Definition of hypoglycaemia 
It is important to define hypoglycaemia, in order to be able to identify and measure its 
frequency and to give guidelines for treatment. However, there has been some 
difficulty in agreeing on a commonly accepted blood glucose value to define 
hypoglycaemia. First, there are two different unit descriptors currently in use; millimol 
per litre (mmol/l) and milligram per decilitre (mg/dl; see Briscoe and Davis 2006; 
Diabetes UK 2008). 
In the United Kingdom, a commonly accepted threshold for hypoglycaemia is defined 
as blood glucose values below 4.0 mmol/l (JRCALC 2006; Diabetes UK 2008). But this 
varies across different authors and has changed over time. Watkins et al. (2003) for 
example set the threshold for hypoglycaemia at 3.5 mmol/l of plasma glucose 
concentration (as opposed to blood glucose), while Williams and Pickup (2004) argue 
for a limit of 3.6 to 3.8 mmol/l. Part of these differences may be due to the fact that 
plasma glucose is assessed in laboratory testing and gives a slightly different 
measurement compared to whole blood glucose (Briscoe and Davis 2006). 
Another important factor in the definition of hypoglycaemia is the occurrence of 
symptoms (see section 2.8). There are individual differences regarding the level of 
blood glucose at which symptoms of hypoglycaemia begin to show. Additionally, 
people can have different symptoms when they experience a hypoglycaemic episode 
(Deary 2007). Therefore, the presence of symptoms is significant as is the 
measurement of blood glucose concentration to clearly establish whether a person 
with diabetes is experiencing a hypoglycaemic episode. This would help to avoid 
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unwanted hyperglycaemia (by ingesting more glucose than necessary) as well as 
treating hypoglycaemia in a timely and appropriate manner. 
Strachan (2007) suggests that hypoglycaemia can be defined as “an episode in which 
typical symptoms occur and the symptoms are reversed by appropriate treatment to 
raise blood glucose” (p.50). Even though this definition covers the existence of 
symptoms and action to increase blood glucose levels, it does not feature the 
measurement and classification of a blood glucose value. Also, the phenomenon of 
hypoglycaemia unawareness is not included in Strachan’s definition (see section 2.9). 
The Diabetes Control and Complications Trial Research Group (DCCT) introduced a 
definition for severe hypoglycaemia, which has achieved widespread acceptance. It 
states that severe hypoglycaemia is indicated when assistance from another person is 
needed to effect treatment and blood glucose concentration is below 50 mg/dl (~2.8 
mmol/l; DCCT 1997). Graveling and Frier (2009) concur with this definition, adding that 
mild hypoglycaemia would be indicated when an individual is able to self-treat. 
For the purpose of this study, the definition of hypoglycaemia as blood glucose values 
below 4.0 mmol/l was used, since this threshold is commonly accepted in clinical 
practice, and participants would be familiar with this value (see for example JRCALC 
2006; Craigie and Lamb 2008; Diabetes UK 2008). Furthermore, the presence (or 
absence) of symptoms was taken into consideration.  
2.8 Symptoms of hypoglycaemia 
Symptoms of hypoglycaemia usually start with mild signs like sweating and headache 
and get progressively worse as blood glucose levels continue to drop (Watkins et al. 
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2003). According to Williams and Pickup (2004), the brain requires a continuous 
glucose supply, and if this is not provided, it can lead to central nervous system 
dysfunction, impaired cognition and in severe cases coma. It is important to recognise 
that symptoms can differ between individuals (Williams and Pickup 2004). 
Symptoms of hypoglycaemia are classed into autonomic and neuroglycopenic 
symptoms. When blood glucose levels fall below 4 mmol/l, autonomic (mild) 
symptoms begin to occur. These include sweating, palpitation, shaking, hunger, 
tingling of lips/tongue and anxiousness. As the hypoglycaemic episode worsens, 
neuroglycopenic symptoms like difficulty in concentrating, confusion, drowsiness, 
change of behaviour and loss of consciousness develop (Diebel 1999; Banks 2005). 
These symptoms reflect classic textbook expressions. 
In reality, people’s symptom experience of hypoglycaemia can be highly subjective. 
Using the blood glucose level of an individual to determine whether someone has a 
hypoglycaemic episode does not necessarily manifest itself with the same symptoms. 
For example, some people with a high average blood glucose level may experience 
symptoms at a much higher blood glucose level compared to people who are on a 
strictly controlled insulin treatment regime. People on strictly controlled insulin 
treatment may experience symptoms at a much lower blood glucose level, or in fact 
no symptoms at all (‘hypoglycaemia unawareness’, see section 2.9; Briscoe and Davis 
2006; Frier 2007a). This phenomenon is also known as ‘relative hypoglycaemia’, due to 
the brain’s adjustment to certain levels of blood glucose and subsequent action of 
‘counterregulatory’ hormones; that is hormones which have a protective effect against 
hypoglycaemia (Briscoe and Davis 2006). 
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2.9 Hypoglycaemia unawareness 
Hypoglycaemia unawareness, which is also known as impaired hypoglycaemia 
awareness, is a risk factor for severe hypoglycaemia. It is defined as the inability to 
recognise the onset of hypoglycaemia due to an absence or reduced intensity of (mild) 
symptoms (Clarke et al. 1995, Frier 2007a; Graveling and Frier 2010; Elliott and Heller 
2011). This phenomenon seems to be caused by repeat mild hypoglycaemia, which in 
turn can trigger a readjustment of the threshold of sensitivity of a glucose sensor in 
the central nervous system (Amiel 1994). Hence, people who are affected by 
hypoglycaemia unawareness can find themselves in a situation in which they may not 
recognise impending hypoglycaemia until it is too late to be prevented (Diebel 1999; 
Gerich 2000).   
Hypoglycaemia unawareness has been associated with (a long duration of) insulin 
treatment, which is mostly the case with type 1 diabetes (Frier 2007a). However, 
people with type 2 diabetes who are treated with insulin also experience 
hypoglycaemia unawareness, as shown in a study by Henderson et al. (2003). 
Henderson and colleagues found a prevalence rate of 8%, but as their data was based 
on self-report, actual prevalence may be higher. Schopman et al. (2010) used both 
questionnaires and blood glucose monitoring to investigate hypoglycaemia 
unawareness in insulin-treated type 2 diabetes, and found a slightly higher prevalence 
rate of 9.8%. A reduction or gradual loss of warning signs (i.e. mild symptoms) affects 
about 25% of all people treated with insulin (Frier 2007a), rising to almost 50% after 25 
years or more of insulin-treated diabetes (Pramming et al. 1991). Treatment strategies 
for hypoglycaemia unawareness include frequent blood glucose monitoring, taking 
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regular snacks and avoidance of hypoglycaemic episodes for a period of time 
(Graveling and Frier 2010).  
2.10  Management of hypoglycaemia 
The majority of hypoglycaemic episodes are managed within the community, by the 
individual and/or family members, friends and colleagues, as most hypoglycaemic 
episodes occur within the home environment, workplace or during leisure activities 
(Strachan 2007). Recommendations for treatment of hypoglycaemia depend on 
whether the individual is conscious or unconscious. For mild and usually self-treated 
hypoglycaemic episodes (individual is conscious), treatment consists of ingesting 15-
20g fast-acting carbohydrates (e.g. glucose tablets, fruit juice, sugary soft drinks) 
followed by eating 10-20g slow-acting carbohydrates (e.g. a slice of bread or a few 
biscuits), depending on when the next meal will be taken (Watkins et al. 2003).  
If the person with diabetes is unconscious or unable to swallow, which is usually the 
case during a severe hypoglycaemic episode, an intramuscular glucagon injection or 
intravenous glucose should be administered (Williams and Pickup 2004). The 
intramuscular glucagon injection can be given by a family member/carer (glucagon 
injection kits are available upon prescription) if they have been taught how to do this. 
Paramedics or medical staff in the hospital can also administer the intramuscular 
glucagon injection as well as giving intravenous glucose treatment, if emergency 
services are called (Watkins et al. 2003). Once the person regains consciousness, 
he/she should be given a drink containing glucose and a snack rich in carbohydrate. 
Additionally, the individual’s blood glucose level should be monitored to ensure full 
recovery (Watkins et al. 2003; JRCALC Guidelines 2006).  
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Since hypoglycaemia can occur quite unpredictably, people with diabetes are advised 
to always carry some fast-acting carbohydrates (glucose) with them, in case a 
hypoglycaemic emergency occurs (Craigie and Lamb 2008). 
2.10.1  Use of emergency services 
Most hypoglycaemic episodes occur outwith a medical/hospital setting (Strachan 
2007; also see previous section). When hypoglycaemic episodes get to the severe 
stage (where external help is indicated, see section 2.7), ambulance or hospital 
services may be required. Interestingly, only a small proportion of people experiencing 
hypoglycaemic episodes are treated by emergency and/or hospital services (Frier 
1993; Leese et al. 2003). Leese and colleagues analysed routinely collected datasets 
within NHS Tayside in Scotland to investigate the incidence of severe hypoglycaemia 
requiring medical, emergency or hospital assistance (including primary care, inpatient 
care, accident and emergency services, and ambulance services). They found that 7.1% 
of people with type 1 diabetes and 7.3% of people with type 2 diabetes, who were 
treated with insulin required emergency assistance due to a severe hypoglycaemic 
episode (Leese et al. 2003).  
Although the proportion of people who require emergency services is relatively small 
(237,468 people with diabetes living in Scotland, compared to approximately 7000 
calls made to the SAS per year, which are categorised as hypoglycaemic emergencies), 
within the group of people who use emergency services there is a significant number 
of repeat callers (The Scottish Government 2010; Scottish Diabetes Survey 2010).  
Considering the incidence of severe hypoglycaemia (between one and two cases per 
individual per year (Frier 2008)), Strachan (2007) observed that “the distribution is 
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heavily skewed, such that many individuals are unaffected […], while a small number 
experience recurrent episodes (p.75). 
A study conducted by Brackenridge et al. (2006) investigated the use of emergency 
services due to hypoglycaemia in two general hospitals in Surrey. They confirmed the 
finding that a minority of people with diabetes require emergency services. However, 
within the group of people using emergency services, 20% do not receive any 
treatment suggesting that they may call the emergency services inappropriately 
(Brackenridge et al. 2006). Brackenridge and colleagues conclude that the ambulance 
service is used as a ‘lifeline’ by some people, who would call out the ambulance before 
taking any treatment themselves. However, explanations for use and non-use of 
emergency services have not been explored from the patient’s perspective. 
2.11  Risk factors for hypoglycaemia 
A study conducted by the Diabetes Control and Complications Trial Research Group 
(DCCT 1997) found that people with diabetes who receive intensive insulin treatment 
as opposed to conventional therapy have a threefold increase in the risk of 
experiencing a severe hypoglycaemic episode. Intensive insulin treatment 
encompasses flexible multiple daily injections of insulin or use of an insulin pump and 
frequent blood glucose testing in order to achieve tight blood glucose control 
(Jermendy 2012; Switzer et al. 2012). Conventional therapy involves up to three daily 
insulin injections at set times and much less blood glucose testing (DCCT 1997, Meetoo 
et al. 2012). 
24 
 
There is also evidence that tight glycaemic control can reduce the risk for diabetes-
related long-term complications (Diebel 1999). As Amiel (1994) pointed out, there is 
need to balance priorities: on the one hand minimising the risk of long-term 
complications, while on the other hand not underestimating the immediate impact of 
hypoglycaemia. Therefore, strict glycaemic control is a risk factor for hypoglycaemia 
and needs to be taken into consideration when prescribing treatment. 
A further risk factor for hypoglycaemia is recurrent hypoglycaemic episodes in the 
past, and the age of the person. The risk for hypoglycaemia increases with the 
duration of diabetes, older age, severity, and frequency of previous hypoglycaemic 
episodes (Briscoe and Davis 2006; Frier 2008; Graveling and Frier 2009). Physical 
exercise, nutrition and alcohol consumption also influence the incidence of 
hypoglycaemia. Physical exercise affects blood glucose levels in two ways; one, insulin 
absorption can be increased and two, the need for insulin diminishes as the body uses 
more glucose during exercise (Diebel 1999). This links closely with nutrition since an 
increased carbohydrate intake can counteract the lowering effects of exercise on 
blood glucose levels (Frier 2008). Additionally, (excessive) alcohol consumption can 
contribute to causing hypoglycaemia as ethanol, a component of alcoholic drinks, 
blocks the release of glucose from the liver (Diebel 1999).  
Hypoglycaemia unawareness is another risk factor for developing severe 
hypoglycaemia (section 2.9). It is defined as the inability to recognise the onset of 
hypoglycaemia due to an absence or reduced intensity of (mild) symptoms (Clarke et 
al. 1995, Frier 2007a; Graveling and Frier 2010; Elliott and Heller 2011). Therefore, 
people who are affected by hypoglycaemia unawareness can find themselves in a 
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situation in which they might not identify impending hypoglycaemia until it is too late 
to be prevented (Diebel 1999; Gerich 2000).  
Nocturnal hypoglycaemia or hypoglycaemia during sleep is a very common 
complication in insulin-treated diabetes, and sleep has been identified as a risk factor 
for hypoglycaemia (Frier 2008). Nocturnal hypoglycaemia is particularly dangerous 
because it often goes without symptoms, can cause cognitive impairment and ‘sudden 
death’ (especially in young people with type 1 diabetes). ‘Sudden death’ or ‘dead in 
bed’ syndrome happens as a result of a fatal hypoglycaemic episode during sleep 
(Tattersall and Gill 1991). 
There is also a high risk for nocturnal hypoglycaemia to develop into severe 
hypoglycaemia; this is because the body’s normal release of anti-insulin hormones 
when blood glucose levels fall is impaired during sleep and while lying down (Heller 
2007). A further concern regarding nocturnal hypoglycaemia is its contribution to the 
development of hypoglycaemia unawareness – in other words; someone who 
experienced a hypoglycaemic episode during the night is less likely to have early 
warning symptoms of hypoglycaemia during the day (Heller 2007). 
Yale (2004) has pointed out that nocturnal hypoglycaemia is caused by the inadequacy 
of externally administered insulin to imitate the body’s own insulin secretion during 
the night. Another important aspect is the effort to reduce morning hyperglycaemia by 
increasing the evening dose of insulin. As a result of this and intensive insulin therapy, 
the risk for nocturnal hypoglycaemia increases (DCCT 1997). 
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2.12  Hypoglycaemia in type 1 and type 2 diabetes 
There are a number of differences relating to frequency and severity of hypoglycaemic 
episodes when comparing type 1 and type 2 diabetes. For example, severe 
hypoglycaemia tends to be more common in type 1 diabetes, compared to type 2 
diabetes. This seems to be as a result of intensive insulin treatment in type 1 diabetes 
and also different physiological responses to falling blood glucose levels (Gerich 2000). 
In type 2 diabetes, people’s (physiological) responses range from increasing release of 
anti-insulin hormones to developing an awareness of warning symptoms and taking 
preventive action. Additionally, people with type 2 diabetes often show some degree 
of insulin resistance and decreasing personal insulin secretion as blood glucose levels 
fall, which can act as a buffer to prevent severe hypoglycaemia (Gerich 2000; Barnett 
et al. 2010).  
In contrast, people with type 1 diabetes tend to have an impaired anti-insulin 
hormone response to hypoglycaemia: for example, the release of the hormone 
glucagon from the pancreas no longer occurs. This hormone counteracts the effects of 
insulin by stimulating glucose release from the liver and muscle tissues (Watkins et al. 
2003). Furthermore, recurrent mild, symptomless hypoglycaemia can damage the 
body’s own protective mechanism to release glucose, which also can lead to 
hypoglycaemia unawareness (see section 2.9). 
Hypoglycaemia is less common among people with type 2 diabetes. However, as the 
condition progresses and insulin treatment may become necessary, incidence and 
severity of hypoglycaemia increases and appears to be similar to that of people with 
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type 1 diabetes. Thus, longer duration of diabetes and intensive insulin treatment 
seem to have an influence on hypoglycaemia rates (Heller 2008). 
2.13  Conclusion 
This chapter has provided background information about diabetes and hypoglycaemia; 
the clinical conditions of interest in this study. The first section gave an overview of 
diabetes; definition, diagnosis and prevalence. Two main types of diabetes were 
discussed; namely type 1 and type 2 diabetes.  
This was followed by a section that discussed complications and health-related risks of 
diabetes, with a particular focus on hypoglycaemia. The chapter also considered the 
challenges of defining hypoglycaemia. The final sections described the symptoms, 
management of hypoglycaemia, use of emergency services, risk factors and the 
differences between type 1 and type 2 diabetes relating to hypoglycaemia.  
The next chapter will review literature, focussing specifically on people’s experiences 
of diabetes and hypoglycaemia. People with diabetes have to manage their condition 
for 24 hours each day throughout the year. This creates a substantial self-care burden 
which impacts on their everyday life. Exploring people’s perspectives and experiences 
can contribute to better understanding of self-care processes, as well as personal 
explanations and coping strategies for hypoglycaemia. This might offer explanations 
for differences in self-care processes that lead some people with diabetes to rely more 
on emergency services than others. The purpose of the literature review was to 
explore what is known about people’s experiences of diabetes and hypoglycaemic 
episodes. It was also to explore what is known about self-care processes, personal 
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explanations and coping strategies for hypoglycaemic episodes, and to determine 
whether they offer any explanation for the use of emergency services. 
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Chapter 3 - Literature Review 
3.1 Introduction 
This chapter reviews literature relating to people’s experiences of living with diabetes 
and hypoglycaemia. The chapter is in two parts, the first part presents a general 
overview of literature about living with diabetes, the second focusses more specifically 
on people’s experiences of hypoglycaemia.  
3.2 People’s experiences of living with diabetes 
People living with diabetes have to manage their condition constantly. The 
management of diabetes includes regular monitoring of the individual’s blood glucose 
level, taking diabetes medications (e.g. insulin injections), as well as balancing 
carbohydrate intake and activity status. This section presents a structured review of 
published literature relating to people’s experiences of living with diabetes. The 
methods used in the review are described; key themes from the literature are 
presented and discussed. The aim of the review was to gain a general overview of key 
themes in the literature around people’s experiences of diabetes and to explore how 
hypoglycaemia has been explored within this literature. 
3.2.1 Methods 
A systematic search of online databases CINAHL (Cumulative Index for Nursing and 
Allied Health Literature), PsycINFO and MEDLINE was carried out. Additionally, reviews 
from the Cochrane Library’s Consumer and Communication Group and Metabolic and 
Endocrine Disorders Group were searched for relevance. Two facets were developed: 
Patients’ point of view: (patient*, client*, people*, man*, men*, male*, woman*, 
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women*, female*, consumer*, subject*, participant* or person*) and experience: 
(well*being, quality of life, self*care, self*management, experience*, perspective*, 
fear*, affect* or impact*) and illness (diabet*). Subject headings and text words within 
each facet were combined using the Boolean operator “OR” and the resultant facets 
were then combined using the Boolean operator “AND”. These facets were then 
applied to publication titles. 
After limiting search results to English language publications in the 10 years (March 
2000 - March 2010), the search yielded 3186 results. These were screened for 
relevance and whether they were directly related to people’s perspectives of living 
with diabetes, including experience of hypoglycaemia. Papers that reported primary or 
secondary research or reviewed literature were included, while publications focussing 
on interventions were excluded. This was because the focus of the current review was 
on people’s experiences of living with diabetes rather than the effectiveness of 
interventions. 122 papers met the inclusion criteria during initial screening and were 
retrieved for full text assessment.  
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Figure 3.1: Flow diagram of structured search process (experiences of diabetes)  
 
3.2.2 Results 
After reviewing the full text version of potentially relevant papers, 44 primary research 
studies and five reviews were identified as relevant. In keeping with good review 
methods (Popay et al. 2006), twenty percent of papers (n=9) were checked for 
inclusion/exclusion criteria with the supervisory team, and agreements were high 
(agreements for n=7, two papers were further discussed regarding inclusion/exclusion 
(Green et al. 2000; Persson et al. 2009)). Following discussion, both these papers were 
included as they had some relevance to the aim of this review. Of the 44 primary 
3064 papers excluded after review of titles and 
abstracts 
122 papers retained for full text 
assessment 
64 MEDLINE 
45 CINAHL 
10 PSYCINFO 
 
3186 papers overall: 
1389 MEDLINE 
1349 CINAHL 
347 PSYCINFO 
101 Cochrane Library 
 
18 duplicate papers removed 
55 papers excluded after full text review 
49 papers included in the review 
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research studies, 30 studies used qualitative methods, 11 studies applied a 
quantitative approach, while the remaining three were multi-method studies.  In 
terms of the included reviews, there were some limitations relating to quality (see 
section 3.2.3). 
Following the identification of relevant papers, key data (e.g. authors, study design, 
study aim and key findings) were extracted into a summary table (see table 3.1 below). 
Papers were analysed in-depth to identify key findings and these were compared 
across included papers. This process generated a set of abstract themes which were 
further refined and synthesized through critical discussion with the supervisory team. 
These are presented in section 3.2.3. Salience of extracted information was reached by 
independent assessment of ten percent of papers (n=5) regarding identified themes. 
In terms of quality, most of the included papers provided a wide ranging overview of 
people’s experiences of living with diabetes; however, several gave only limited 
information on their methodological processes. For example, in a study by 
Koopmanschap (2002), which looked at the impact of diabetes from the perspective of 
people living with type 2 diabetes, other than the criteria of having been diagnosed 
with type 2 diabetes, there was limited information on sample characteristics. It is 
important to note that despite its limitations the study brought to the fore people’s 
perspectives of the effect of type 2 diabetes. Another key strength of the study was its 
ability to draw on data from a large sample (n=4189) cutting across five European 
Countries (Koopmanschap 2002). 
A study conducted by Peel et al. (2004) in Scotland investigated participants’ views of 
blood glucose monitoring. While the study highlighted a range of positive and negative 
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aspects of blood glucose monitoring, it also had a few limitations. For example, the 
study sample was drawn from adults who were newly diagnosed with type 2 diabetes. 
The study further excluded people who were treated with insulin. These limitations 
could mean that this study may have missed out on aspects affecting people’s blood 
glucose monitoring in the longer term, as well as issues impacting on blood glucose 
monitoring in people treated with insulin/those with type 1 diabetes. 
There was a broad scope of issues considered within the literature that related to 
living with diabetes; ranging from issues around self-care experiences, dealing with 
complications, having an ‘invisible’ illness to more specific problems such as regular 
monitoring of blood glucose levels. Hypoglycaemia was only mentioned in the context 
of diabetes complications (Frier 2008) and challenges of diabetes management 
(Debono and Cachia 2007). There was no in-depth exploration of people’s experiences 
of living with hypoglycaemia, and the impact of hypoglycaemia on people’s everyday 
life. Other reviews did not detail their search protocol, quality appraisal methods and 
overview of included papers (Debono and Cachia 2007; Wild et al. 2007; Frier 2008). 
As a result, criteria of transparency and reproducibility could not be fully met in many 
of the included reviews. 
Two of the included reviews (Spenceley and Williams 2006; Pun et al. 2009) focussed 
on people’s experiences of self-care. Spenceley and Williams (2006) explored barriers 
and facilitators of self-care from the patients’ perspective, but limited their review to 
type 2 diabetes. While their focus on self-care and treatment adherence provided 
details about the demand of diabetes care; for example, fears relating to injections, it 
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may have missed out on issues around the wider impact diabetes can have on 
everyday life.  
Pun et al. (2009) reviewed literature relating to barriers to diabetes self-care from 
both patients’ and health professionals’ perspectives; however, the focus of this 
review was also limited to type 2 diabetes and only investigated barriers to diabetes 
self-care. It did not cover the range of people’s experiences of living with diabetes.
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Table 3.1: Overview of included papers (experiences of diabetes) 
 
Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
Aalto et al. (2000),  Disease-related 
distress among insulin-treated 
diabetic patients: Associations with 
health status, psychosocial factors 
and self-care practices, Finland 
Quantitative (questionnaire incl. ATT 
39(measures emotional adjustment 
to diabetes) ), 423 participants, 20-
64 years, 53% male 
Measuring diabetes-related distress 
among insulin-treated persons with 
diabetes 
No scale for measurement of fear of 
hypoglycaemia was included 
Currie et al. (2006),  Multivariate 
models of health-related utility and 
the fear of hypoglycaemia in people 
with diabetes, UK 
Quantitative (postal surveys) using 
HFS (hypoglycaemia fear survey) and 
EQ5D (measures health-related 
utility), 1305 participants, type 1 and 
type 2 diabetes 
Measuring the impact of 
hypoglycaemia on patients’ health-
related utility, investigating how 
severity, frequency and fear of 
hypoglycaemia affect patients’ health 
status 
Difficulty of recall of hypoglycaemic 
events 
Di Battista et al. (2009), Type 1 
diabetes among adolescents: 
Reduced diabetes self-care caused by 
social fear and fear of hypoglycemia.  
Australia (Fieldwork in USA/Canada) 
Quantitative (Survey incl.DQoL 
(Diabetes Quality of Life Measure) 
and HFS (Hypoglycaemia Fear 
Survey)), 76 adolescent (13-18 years) 
participants, type 1 diabetes, 33 
boys/43 girls 
Investigating the association between 
social anxiety, fear of hypoglycaemia, 
adherence to diabetes treatment 
regimen and perceived quality of life 
Small sample size (acknowledged by 
authors). 
Sample limited to adolescents  
Hanberger et al. (2009),  Health-
related quality of life in intensively 
treated young patients with type 1 
diabetes, Sweden 
Quantitative (DISABKIDS 
questionnaire, EQ-5D), 400 children 
and adolescents (191 girls; mean age 
13.2 years)  and their parents 
Investigating the impact of type 1 
diabetes on health-related quality of 
life in intensively treated young 
patients 
No controls without diabetes 
Huang and Hung (2007),  Quality of 
life and its predictors for middle-
aged and elderly patients with type 2 
diabetes mellitus, Taiwan 
Quantitative (cross-sectional design), 
131 participants (57.3% male), 41-88 
years, type 2 Diabetes 
Exploring quality of life and its 
predictors among adults (>40 years of 
age) with type 2 diabetes 
Participants recruited from only one 
medical centre 
 
Kalda et al. (2008),  Predictors of 
quality of life of patients with type 2 
diabetes, Estonia 
Quantitative (questionnaire including 
SF-36), 200 participants (69% female, 
31% male), mean age 64.7 years, 
Investigating the factors which have 
most influence on quality of life of 
people with type 2 diabetes 
Results influenced by using a special 
questionnaire designed by authors 
which included multiple choice 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
type 2 diabetes questions about knowledge and 
awareness about diabetes, its risk 
factors and complications 
Koopmanschap (2002),  Coping with 
Type II diabetes: the patient's 
perspective, Netherlands 
Quantitative (EQ-5D scale), 4189 
participants with type 2 diabetes in 5 
European Countries 
Exploring the impact of type 2 diabetes 
from the patients’ perspective 
Limited information about participants 
(other than diagnosed with type 2 
diabetes)  
Lloyd et al. (2001),  Impact of long-
term complications on quality of life 
in patients with type 2 diabetes not 
using insulin, UK 
 
Quantitative (questionnaire including 
SF-36), 1233 patients with type 2 
diabetes (709 male/524 female), 
aged over 35, type 2 diabetes, not 
treated with insulin 
Assessing the impact of diabetic 
complications on health-related 
quality of life in patients with type 2 
diabetes  
Exclusion of patients treated with insulin 
(who may experience more 
complications) 
Paddison et al. (2008), Psychological 
Factors Account for Variation in 
Metabolic Control and perceived 
Quality of Life Among People with 
Type 2 Diabetes in New Zealand, 
New Zealand/UK 
Quantitative (survey), 615 
participants, 27-90 years/mean age 
63 years, 47% female, type 2 
diabetes 
Examining the association between 
psychological variables, metabolic 
control and quality of life among 
adults with type 2 diabetes in New 
Zealand 
Use of a single item from the ADDQoL 
(Audit of Diabetes-Dependent Quality of 
Life) to measure QoL 
Shiu and Wong (2000),  Fear of 
hypoglycaemia among insulin-
treated Hong Kong Chinese patients: 
Implications for diabetes patient 
education, China 
Quantitative (structured interviews), 
120 participants, adults, insulin-
treated type 1 and type 2 diabetes, 
1st phase study 
Identifying the extent of fear of 
hypoglycaemia and its impact on 
diabetes self-management 
Participants were recruited from 
patients who attended a diabetes clinic 
(misses out on those who did not 
attend) 
 
Tierney et al. (2008),  Living with 
cystic fibrosis-related diabetes or 
type 1 diabetes mellitus: A 
comparative study exploring health-
related quality of life and patients' 
reported experiences of 
hypoglycaemia, UK 
 
Quantitative (cross-sectional 
comparative study)using 
questionnaires incl. EHS (Edinburgh 
Hypoglycaemia Scale) and DQoL 
(Diabetes Quality of Life Measure), 
107 participants (55 with type 1 
diabetes (T1DM)/52 with cystic 
fibrosis-related diabetes (CFRD)) 
Gaining an insight into the experience 
of hypoglycaemia and the impact of 
diabetes on health-related quality of 
life. Comparing perceptions of people 
with T1DM and CFRD 
Low response rate 
T1DM patients were older than CFRD 
patients and had a longer duration of 
diabetes. This may increase 
occurrence/severity of hypoglycaemia. 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
Abdoli et al. (2008), The 
empowerment process in people 
with diabetes: An Iranian 
perspective,  Iran 
Qualitative (in-depth interviews), 16 
participants, (11 people with 
diabetes and 5 healthcare 
professionals), aged 21-73 years 
Exploring the concept of 
empowerment process (from diagnosis 
to learning to live with diabetes) 
among Iranian diabetes patients  
Details about type of diabetes were not 
given. 
Assumption that every diabetes patient 
will go through the same phases. 
Barton et al. (2005),  The diabetes 
experiences of aboriginal people 
living in a rural Canadian community, 
Canada 
Qualitative (interviews), 8 
participants (5 female/3 male), type 
2 diabetes, Aboriginal background 
Exploring experiences of living with 
type 2 diabetes from Aboriginal 
people’s perspective 
Very specific population group 
Carbone et al. (2007), Diabetes self-
management: Perspectives of Latino 
patients and their healthcare 
providers, USA 
 
 
Qualitative (focus groups), 37 
migrant Latino patients with type 2 
diabetes, 15 healthcare practitioners 
Exploring experiences and attitudes of 
Latino patients and their healthcare 
practitioners regarding diabetes self-
management. Refining culturally 
appropriate self-management 
interventions. 
Highly specific sample population might 
limit relevance of findings to other 
populations  
Sample was drawn from only one 
medical centre 
Choe et. al (2001),  Quality of life for 
patients with diabetes in Korea--I: 
The meaning of health-related 
quality of life, South Korea 
 
 
Qualitative (interviews), 22 
participants (11 male/11 female), 
type 2 diabetes 
Exploring the meaning of HRQoL and 
factors affecting it from the 
perspective of diabetes patients in 
Korea 
Potential misinterpretation of meaning 
due to translations (interviews 
conducted in Korean, analysis carried 
out in English) 
Interviews were conducted in hospital 
waiting room (possible privacy issues) 
Coyne et al. (2004), The impact of 
diabetic retinopathy: Perspectives 
from patient focus groups, USA 
Qualitative (focus groups), 15 
participants with diabetic 
retinopathy 
Exploring symptom experience, impact 
on everyday life and HRQoL of patients 
with diabetic retinopathy 
Focus on only one diabetes complication 
Dickinson and O’Reilly (2004), The 
lived experience of adolescent 
females with type 1 diabetes, USA 
 
Qualitative (interviews), 10 
participants, type 1 diabetes, aged 
16-17 years, all female 
Exploring female adolescents’ 
perspectives of living with type 1 
diabetes 
Participants were recruited from a 
diabetes training camp, which may have 
influenced findings 
Everett (2001),  Qualitative study of 
the impact of type 1 diabetes on 
everyday life, UK 
Qualitative (Interview), 21 
participants, 18-40 years, type 1 
Diabetes 
Exploring impact of type 1 diabetes on 
everyday life 
 
Limited to people with type 1 diabetes 
Frandsen and Kristensen (2002),  Qualitative (focus groups), 123 Identifying barriers relating to Exclusion of insulin-treated patients 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
Diet and lifestyle in type 2 diabetes: 
The patient's perspective, Denmark 
 
 
participants, 45-60 years, type 2 
diabetes, treated with oral 
hypoglycaemic agents (groups were 
conducted in Germany, France, 
Spain, UK and USA) 
adherence to diabetes treatment (diet, 
lifestyle, medication) and gaining an 
insight into the patients’ perspective 
Garcia de Alba et al. (2007), 
"Diabetes is my companion": lifestyle 
and self-management among good 
and poor control Mexican diabetic 
patients, Mexico 
 
Qualitative (interviews), 62 
participants (31 good diabetes 
control/31 poor control patients) 
Comparison of poor and good 
glycaemic control patients 
(determined by HbA1c values) 
regarding attitudes towards lifestyle 
and self-management activities. 
Identification of views associated with 
better glycaemic control 
Participants recruited from only one 
clinic setting 
Gazmararian et al. (2009), Perception 
of barriers to self-care management 
among diabetic patients, USA 
Qualitative (focus groups), 35 
participants, African Americans 
Exploring individual, educational and 
system barriers to low income 
diabetes patients’ self-care 
management 
Limited generalisability of findings due 
to very specific group of participants 
Hayes et al. (2006),  Understanding 
diabetes medications from the 
perspective of patients with type 2 
diabetes: Prerequisite to medication 
concordance, USA 
Qualitative (focus groups), 138 
participants, type 2 diabetes 
Investigating patients’ perspectives 
and experiences with diabetes 
medications 
Limited description of data analysis 
process 
Kay et al. (2009), An exploration of 
the experiences of young women 
living with type 1 diabetes, UK 
 
 
Qualitative (semi-structured 
interviews), 9 female participants, 
18-24 years, type 1 diabetes 
Exploring young female adults’ 
perspectives of living with type 1 
diabetes 
Sample limited to one diabetes clinic, no 
inclusion criteria relating to 
socioeconomic or educational 
background 
Keeratiyutawong et al. (2003), Self-
care experiences of Thai patients 
with type 2 diabetes, Thailand 
 
Qualitative (in-depth interview), 8 
participants (5 female/3 male), 38-75 
years, type 2 diabetes 
Gain an understanding of self-care 
experiences of Thai patients with type 
2 diabetes who have difficulty 
controlling their blood glucose 
Focus was only on patients who have 
difficulty controlling their blood glucose 
level 
Small sample size 
Lin et al. (2008),  Diabetes self- Qualitative (focus groups), 41 Gain an understanding of self- Authors provide limited information 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
management experience: A focus 
group study of Taiwanese patients 
with type 2 diabetes, Taiwan 
participants with type 2 diabetes (19 
female, 22 male), 42-81 years 
management experiences of 
Taiwanese patients with type 2 
diabetes 
about sampling strategy, age/gender 
within different focus groups 
Moser et al. (2008),  Self-
management of type 2 diabetes 
mellitus: A qualitative investigation 
from the perspective of participants 
in a nurse-led, shared-care 
programme in the Netherlands, 
Netherlands 
Qualitative (in-depth interviews),15 
patients with type 2 diabetes over 55 
years 
Exploring patients’ understanding of 
self-management processes in type 2 
diabetes and relating this to concept of 
autonomy 
Participants were selected by nurse. 
Patients who did not attend follow-up 
meetings/did not adhere to prescribed 
treatment were not included in sample 
Mulvaney et al. (2008),  Self-
management in type 2 diabetes: The 
adolescent perspective, USA 
Qualitative (focus groups), 24 
adolescents with type 2 diabetes, 13-
19 years 
Exploring barriers and facilitators of 
diabetes self-management from the 
patients’ perspective 
Limited generalisability due to 
participants recruited from only one 
paediatric clinic   
Nafees et al. (2006), How diabetes 
and insulin therapy affects the lives 
of people with type 1 diabetes, UK 
 
 
Qualitative (focus groups), 11 
participants, type 1 diabetes, adults 
Exploring patients’ experiences of 
living with diabetes and being on 
insulin therapy. Further topics 
discussed were hypoglycaemia, 
understanding of blood glucose 
control and treatment preferences. 
Small sample size (acknowledged by 
authors), recruitment method 
(responding to newspaper 
advertisement) was self-selected   
Peel et al. (2004),  Blood glucose self-
monitoring in non-insulin-treated 
type 2 diabetes: A qualitative study 
of patients' perspectives, 
Scotland/UK 
Qualitative (repeat interviews), 40 
adults newly diagnosed with type 2 
diabetes who were not treated with 
insulin 
Investigating positive and negative 
aspects of blood glucose monitoring as 
perceived by newly diagnosed patients 
with type 2 diabetes 
Focus of study was limited to newly 
diagnosed patients and excluded those 
being treated with insulin 
 
Peel et al. (2007),  Self-monitoring of 
blood glucose in type 2 diabetes: 
longitudinal qualitative study of 
patients' perspectives, Scotland/UK 
Longitudinal qualitative study (in-
depth interviews), 18 adults with 
type 2 diabetes 
Gain an insight into patients’ attitudes 
to blood glucose self-monitoring over 
time 
Patients’ medical records/HbA1c values 
not available to researchers  
Penckofer et al. (2007),  The 
psychological impact of living with 
diabetes: Women's day-to-day 
Qualitative (focus groups), 41 female 
participants, 41-68 years, type 2 
diabetes, 42% of sample African 
Exploring women’s everyday 
experiences of living with type 2 
diabetes and psychological impact of 
Discussion guide for focus groups was 
specifically addressing particular 
emotions  
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
experiences, USA Americans, 58% white Americans the condition 
Persson et al. (2009), 'From stun to 
gradual balance'- women's 
experiences of living with gestational 
diabetes mellitus, Sweden 
Qualitative (interviews), 10 pregnant 
women living with gestational 
diabetes mellitus (GDM) 
Exploring women’s experiences of 
living with GDM 
In contrast to type 1 and type 2 
diabetes, GDM is a temporary 
experience  
Phillips (2007), Experiences of 
patients with type 2 diabetes starting 
insulin therapy, UK 
Qualitative (in-depth interviews), 4 
men and 4 women with type 2 
diabetes, aged 49-72 
 
Exploring the experience of patients 
with type 2 diabetes changing to 
insulin therapy 
Small sample size (acknowledged by 
author) 
Rayman and Ellison (2004), Home 
alone: The experience of women 
with type 2 diabetes who are new to 
intensive control, USA 
Qualitative (interviews), 14 women, 
type 2 diabetes, 35- 75 years 
Gaining an understanding of women’s 
experiences of daily diabetes self-
management. Focus on women who 
were new to intensive control.  
Focus was only on women who were 
new to intensive diabetes control 
Shiu and Wong (2002),  Fears and 
worries associated with 
hypoglycaemia and diabetes 
complications: Perceptions and 
experience of Hong Kong Chinese 
clients, China 
Qualitative (semi-structured 
interviews), 13 participants, insulin-
treated type 1 & type 2 diabetes, 
adults, 2nd phase study, using a sub-
sample of 1st phase (quantitative) 
study 
Investigating patients’ (Hong Kong 
Chinese) perspectives of living with 
hypoglycaemia, fear of hypoglycaemia 
(and other complications) as well as 
coping strategies 
Sampling strategy focussed on particular 
sub-group of patients who expressed 
higher level of fear and worry relating to 
hypoglycaemia and other diabetes 
complications. 
Utz et al. (2006), "Working hard with 
it": Self-management of type 2 
diabetes by rural African Americans, 
USA 
Qualitative (focus groups), 73 African 
Americans (42 female/31 male) with 
type 2 diabetes 
Exploring the experience (barriers and 
facilitators) of self-management 
among African Americans with type 2 
diabetes living in rural areas 
Sample limited to participants who 
actively sought to discuss their 
experience of diabetes self-management 
Vermeire et al. (2003),  The 
adherence of type 2 diabetes 
patients to their therapeutic 
regimens: A qualitative study from 
the patient's perspective, Belgium 
Qualitative (focus groups), 46 
participants (21 male/25 female), 
over 40 years old, type 2 diabetes 
Examining type 2 diabetes patients’ 
health beliefs, communication with 
healthcare providers and problems 
related to treatment adherence 
Patients were selected for participation, 
potential bias towards more conversant 
patients with fewer complications 
Weiler and Crist (2009),  Diabetes 
self-management in a Latino social 
environment, USA 
Qualitative (semi-structured 
interviews) with 10 migrant Latino 
adults, type 2 diabetes 
Exploring the social context and 
sociocultural influences among 
migrant Latino adults 
Specific sample may limit generalisability 
of findings to other populations 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
Yamakawa and Makimoto (2008), 
Positive experiences of type 2 
diabetes in Japanese patients: An 
exploratory qualitative study, Japan 
Qualitative (interviews), 17 
participants, 50-78 years, type 2 
diabetes 
Exploring positive experiences of living 
with diabetes from the patients 
perspective 
Limited focus on positive experiences 
    
Everett and Kerr (2005), Measuring 
the impact of type 1 diabetes from 
the patient's perspective, UK 
Multi-method: first phase qualitative 
(semi-structured interviews), 31 
participants, quantitative BIDS scale 
(Bournemouth Impact of Diabetes), 
237 participants, type 1 diabetes 
Developing a tool to measure impact 
of type 1 diabetes on lifestyle 
Sample consisted of many well 
motivated and self-managing patients, 
less patients with complications and 
difficulty controlling their diabetes 
Puavilai and Stuifbergen (2000),  
Quality of life for Thai women with 
diabetes, Thailand 
 
 
Multi-method (1st phase 
quantitative/Self-Anchoring Striving 
Scale, 57 participants; 2nd phase 
qualitative/18 participants) aged 20-
59 years 
Exploring aspects affecting quality of 
life among Thai women living with 
diabetes 
Small sample size for quantitative part 
of the study (lack of justification) 
Limited information provided about 
response rate 
West and McDowell (2002), The 
distress experienced by people with 
type 2 diabetes, Scotland/UK 
 
 
 
Multi-method, quantitative (using 
PAID (problem areas in diabetes) 
questionnaire), 57 participants (35 
female/22 male), qualitative (focus 
groups), subsample of 10 
participants (5 female/5 male) 
Investigating distress related to type 2 
diabetes, potential gender differences 
in the impact of type 2 diabetes and 
views regarding dietary management 
Small sample size 
Green et al. (2000),  Fears and 
phobias in people with diabetes, UK 
Case study, 35 year old male with 
type 1 diabetes (since 15 years) 
Investigating how fear of 
hypoglycaemia and phobic disorders 
affect people with diabetes 
 
Limited generalisability 
Descriptive (rather than exploratory) 
methodology 
    
Debono and Cachia (2007), The 
impact of diabetes on psychological 
well-being and quality of life. The 
role of patient education, UK 
Review, search Strategy not given/no 
information about number of 
included papers /50 references in 
bibliography, not a systematic review 
 
Reviewing evidence of impact of 
diabetes on psychological well-being 
and quality of life of people living with 
diabetes 
Search strategy and overview of 
included papers are not provided; 
quality assessment of included studies 
was not carried out 
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Author/s, date, title, country Study design/Sample size Study Aim/Focus Limitations/Weaknesses 
Frier (2008),  How hypoglycaemia 
can affect the life of a person with 
diabetes, Scotland 
 
 
Search Strategy not given/no 
information about number of 
included papers/28 references in 
bibliography, not a systematic review 
Investigating how hypoglycaemia 
affects the everyday life of people 
living with diabetes 
Search strategy and overview of 
included papers were not provided; 
quality assessment of included studies 
was not carried out  
Pun et al. (2009), Barriers to the self-
care of type 2 diabetes from both 
patients’ and 
providers’ perspectives: literature 
review, China 
 
 
 
Searching Ovid Medline, CINAHL, 
Cochrane Library and British Nursing 
Index, search terms: type 2 diabetes 
mellitus, self-care, patient 
compliance, patient adherence and 
barriers to diabetes self-care,  
published between 1986 and 2007, 
16 studies included 
Reviewing the literature about barriers 
to diabetes self-care from patients’ 
and health professionals’ perspectives, 
focus on type 2 diabetes 
Good quality review that included 
details of search strategy and overview 
of included papers. Quality assessment 
of included papers was not carried out. 
Spenceley and Williams (2006), Self-
Care from the Perspective 
of People Living with Diabetes, 
Canada 
 
Focus on self-care experience, 
patients’ perspective, English 
language, published between 1993 
and 2003, 16 studies included 
Gaining an understanding of self-care 
experience (identifying barriers and 
facilitators) from the patients’ 
perspective 
Broad search strategy included studies 
about both type 1 and type 2 diabetes, 
thematic focus on self-care did not allow 
to explore the impact diabetes can have 
on everyday life 
Wild et al. (2007),  A critical review of 
the literature on fear of 
hypoglycemia in diabetes: 
Implications for diabetes 
management and patient education 
Reviewing research on fear of 
hypoglycaemia, English language, 
published between 1985 and 2007, 
34 papers included 
Gaining an overview of existing 
research into fear of hypoglycaemia 
and analyse its impact on diabetes 
management and patient education 
Overview/table of included papers was 
not included, not much information 
about included papers given (e.g. 
grouping, methodology,etc.)  
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3.2.3 Identified themes: Experience of living with diabetes 
3.2.3.1 Constant presence of diabetes 
Diabetes is a ‘constant presence’ in people’s lives (Hayes et al. 2006; Moser et al. 
2008). The theme of ‘constant attention’ of diabetes care was frequently apparent in 
the literature: diabetes care is not just a complex balancing act of managing 
medication/blood glucose monitoring, diet and exercise, but this has to be done on an 
on-going basis (Frandsen and Kristensen 2002). It is therefore not surprising that some 
studies reported that people felt overwhelmed by their diabetes care (Everett 2001; 
West and McDowell 2002; and Nafees et al. 2006). For example, participants in a 
number of studies reported feelings of stress and hopelessness and not being able to 
control their diabetes (Aalto et al. 2000; Choe et al. 2001; Everett 2001; Nafees et al. 
2006; Huang and Hung 2007; Gazmararian et al. 2009).   
Taking a temporary ‘break’ from all self-care activities was found to be a coping 
strategy in response to the constant demand of diabetes care (Penckofer et al. 2007). 
Some papers report that people with diabetes want to take a holiday from their 
condition (Shiu and Wong 2002; Rayman and Ellison 2004). This could range from 
intentionally omitting medication, eating any choice of food without worrying about 
the effect on blood glucose level, or completely ‘forgetting about’ diabetes for some 
time (Shiu and Wong 2002; Rayman and Ellison 2004). 
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3.2.3.2 Conflict of perspectives 
Another theme that was evident within the literature is the ‘conflict of perspectives’ 
between patients and health professionals, their family and the wider society (Debono 
and Cachia 2007).  
Keeratiyutawong et al. (2003) conducted qualitative in-depth interviews with 8 people 
with type 2 diabetes in Thailand looking at self-care experiences. In this study, 
participants reported that if they felt fine, they might not adhere to their prescribed 
treatment regime. Also, some participants admitted to having personal goals for their 
diabetes care, which might not necessarily reflect those of their healthcare providers. 
Additionally, patients felt misunderstood by health professionals; while they have to 
live with and manage their diabetes 24 hours a day throughout the year, health 
professionals (those with expert knowledge) spend only a short time with patients 
during consultations (Keeratiyutawong et al. 2003). This is also reflected in the findings 
of an ethnographic study conducted by Hinder and Greenhalgh (2012), who concluded 
that people with diabetes spend 99% of their time managing their diabetes on their 
own. 
There are however a few limitations to Keeratiyutawong et al. (2003). For example, 
their study only included people with type 2 diabetes who had difficulty controlling 
their blood glucose level. While this provides useful insight about this particular 
sample, it could mean that the experiences of other people with diabetes may have 
been missed. Another limitation relates to the small sample size. Keeratiyutawong et 
al. (2003) findings are based on data from only 8 participants.  
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Keeratiyutawong et al. (2003) also noted conflicting priorities between health 
professionals’ and patients’ perspectives in relation to diabetes care. In their study, 
health professionals tended to be more concerned about meeting treatment targets 
and reducing long-term complications of diabetes, while patients were more focussed 
on the immediate impact of their condition as well as their quality of life.  
Similarly, Vermeire et al. (2003) reported that patients placed much higher importance 
on immediate effects of diabetes treatment as opposed to potential long-term 
complications. This finding was also evident in relation to fear of hypoglycaemia where 
patients were more concerned about immediate, rather than long-term effects (Wild 
et al. 2007). 
Two qualitative studies highlighted another aspect of conflicting perspectives between 
patients and health professionals: treatment adherence. One of the studies was 
carried out in Taiwan (Lin et al. 2008) and the other in Canada (Barton et al. 2005). 
They both found that participants tended to try alternative therapies/traditional 
medicine first, before accepting to take their diabetes medication. For example, Lin et 
al. (2008) conducted focus groups with 41 participants with type 2 diabetes 
investigating self-care experiences, while Barton et al. (2005) used qualitative 
interviews with 8 participants to explore participants’ experiences of living with type 2 
diabetes. The Barton et al. (2005) study only included people with type 2 diabetes 
from an Aboriginal background, which may not reflect the experiences of other people 
with diabetes. 
Further qualitative studies from the USA and Canada conducted with minority ethnic 
groups have shown that conflicts can extend to members of the community, family 
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relations and social occasions (Carbone et al. 2007; Weiler and Crist 2009). For 
example, Weiler and Crist (2009) carried out semi-structured interviews with 10 Latino 
adults. They found that a major cause for conflict was people’s negative perception of 
diabetes, a reluctance to openly talk about a diabetes diagnosis and difficulties when 
attending social events (also see Mulvaney et al. 2008). These difficulties included 
performing diabetes self-care activities in public and the sharing of (traditional) foods, 
which could impact on diabetes care, e.g. diet recommendations (Barton et al. 2005; 
Garcia de Alba et al. 2007; Mulvaney et al. 2008).  
3.2.3.3 Invisibility of diabetes 
Diabetes is an invisible illness. Its presence may not be apparent to others, unless an 
obvious complication is present or a (hypoglycaemic) emergency arises. A number of 
studies report that revealing one is diabetic can be challenging, given the stigma and 
embarrassment that can be attached to a diagnosis of diabetes, as well as the 
awkward social environment an emergency can create (see Utz et al. 2006; Abdoli et 
al. 2008; and also Lin et al. 2008). For example, a qualitative focus group study 
conducted by Lin et al. (2008) found that diabetes was perceived to be an infectious 
and self-inflicted condition caused by overeating. Another aspect of the stigma 
attached to diabetes relates to the need to inject insulin and carrying needles; this 
could be confused with illicit drug use (Shiu et al. 2003). 
Closely related to the difficulties in social environments is the question of whether 
someone with diabetes actually wishes to disclose their condition. For example, a 
qualitative study using focus groups with 24 adolescents found that for many 
participants, having diabetes makes them feel different from everyone else (Mulvaney 
47 
 
et al. 2008). According to Rayman and Ellison (2004), a person with diabetes can also 
feel a loss of their former lifestyle; or even feel alone with a condition that is not 
comprehended by society and people around them (Debono and Cachia 2007).  
The issue of invisibility of diabetes is particularly prominent among adolescents and 
young adults who express the desire to fit in with their peers and do not want to stand 
out (Dickinson and O’Reilly 2004; Kay et al. 2009). While people living with diabetes 
might perceive its invisibility as positive as it allows them to hide their condition, this 
approach can complicate an open discussion about a diagnosis of diabetes and might 
impact on an individual’s adherence to their diabetes treatment. The complexities 
arising from the invisible nature of diabetes have further been confirmed by a 
qualitative study investigating the experiences of women who were diagnosed with 
gestational diabetes (Persson et al. 2009). Persson and colleagues interviewed 10 
women with gestational diabetes and found that as diabetes is an invisible illness, 
many social situations can involve having to disclose that an individual has been 
diagnosed with diabetes and that this includes taking diabetes medication and possibly 
following a special diet. 
Another dimension of the invisibility of diabetes is the tangibility of diabetes to people 
living with it. A study underlining the complexity of having an ‘invisible illness’ has 
been conducted by Peel et al. (2004). They explored participants’ perspectives 
regarding blood glucose monitoring and found that they liked the visibility of their 
blood glucose values when measuring the same. Some of their findings included that 
low blood glucose values were associated with a feeling of success and being in 
control, while high readings could trigger an adjustment in diet/medication (Peel et al. 
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2004). This finding was confirmed by a study carried out by Shiu and Wong (2002). 
Also, these findings suggest that a diagnosis of diabetes might not even be tangible to 
people themselves unless there is a clear blood glucose reading or unequivocal 
symptoms of the condition. 
3.2.3.4 Multiple challenges of living with diabetes 
In addition to the three prominent themes of ‘constant presence of diabetes’, ‘conflict 
of perspectives’, and ‘invisibility of diabetes’, the review identified a variety of 
challenges that people living with diabetes face, and the wide ranging impact diabetes 
can have on different aspects of everyday life.  
Diabetes impacts on all aspects of life 
Puavilai and Stuifbergen (2000) conducted a multi-method study involving 57 Thai 
women to explore aspects affecting quality of life. The first phase (quantitative) 
included completing a life satisfaction survey and collecting personal information, and 
the second phase (qualitative) employed in-depth interviews with a sub-sample of 18 
women. The authors identified that many participants viewed their lives as a ‘holistic 
unit’. Hence, diabetes was seen as having an impact on all aspects of life (Puavilai and 
Stuifbergen 2000). For example, having diabetes can have an impact on people’s 
quality of life, on their physiological and psychological well-being, as well as on social 
relationships. It is not only the presence of diabetes complications that reduces 
individuals’ perceived quality of life, but also the demand and complexity of diabetes 
care (Aalto et al. 2000).  
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Everett (2001) carried out a qualitative study involving 21 participants with type 1 
diabetes in the UK. She investigated the impact of diabetes on everyday life, and found 
that many participants set themselves the target of controlling and normalising their 
diabetes. This was as a result of participants comparing themselves to what they 
perceived as the 'perfect diabetic’. In explaining the findings, Everett (2001) 
introduced a concept called ’cost of normalisation’, which was used to describe the 
effort required by people living with diabetes to maintain a near normal lifestyle. The 
cost of normalisation includes managing all aspects of diabetes on a daily basis (e.g. 
blood glucose monitoring, taking medication), as well as controlling hypoglycaemic 
episodes. 
Balancing Act 
According to Shiu and Wong (2002) and Moser et al. (2008), living with diabetes seems 
to be a balancing act between reducing the risk of long-term complications, avoiding 
short-term complications and emergencies, while aiming to achieve a good quality of 
life. For example, both Vermeire et al. (2003) and Nafees et al. (2006) found that in the 
bid to deal with the multiple challenges of managing diabetes, people often value the 
immediate effects of treatment on their well-being over the possibility of suffering 
some long-term complications in the future. This finding of balancing multiple 
challenges of living with diabetes is further supported by a review undertaken by 
Debono and Cachia (2007). 
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Fear of complications 
It was evident in the literature that people’s fears and worries about diabetes 
complications can have a massive effect on psychological well-being; even without the 
presence of any complications. This fear can be triggered by previous personal 
experiences, other people’s depiction or simply knowledge about potential 
complications (Puavilai and Stuifbergen 2000; Choe et al. 2001; Phillips 2007). A 
number of papers have shown that in many cases people’s fear about complications is 
an important driver in improving treatment adherence, as people learn to adopt a 
more positive and co-operative approach (Vermeire et al. 2003; Spenceley and 
Williams 2006; Kay et al. 2009). 
The DAWN study (Diabetes Attitudes, Wishes, and Needs), a large international study, 
investigated people’s perspectives about diabetes care (Funnell 2006), and found that 
psychosocial difficulties and worries were very common among people with diabetes, 
especially around the time of diagnosis. However, problems of living with diabetes 
seemed to continue even many years after diagnosis. This included complexity and 
burden of diabetes care, e.g. monitoring blood glucose level, taking diabetes 
medications, constant monitoring of carbohydrate intake (see section 3.2.3.1), as well 
as fears and worries about complications (Funnell 2006).  
Positive Outlook 
While this review identified that there are a number of studies focussing on the 
challenges of diabetes management (e.g. Hayes et al. 2006; Penckofer et al. 2007; 
Mulvaney et al. 2008; Gazmararian et al. 2009), it is important to note that a few other 
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studies have looked at positive aspects of living with diabetes (Abdoli et al. 2008; 
Yamakawa and Makimoto 2008). 
Yamakawa and Makimoto (2008) conducted a qualitative study in Japan that 
specifically investigated positive aspects of living with diabetes. They carried out 
interviews with 17 adults with type 2 diabetes. Participants identified a number of 
positive aspects of living with diabetes, including the privilege of regular medical 
checks and changing to a healthier lifestyle. Also, having diabetes meant an 
opportunity to gain new social networks (e.g. other people with diabetes, exercise 
groups) and to improve relationships through shared responsibility of diabetes care 
(Yamakawa and Makimoto 2008). Similarly, Abdoli et al. (2008) described the 
‘empowerment process’ of learning to live with and manage diabetes. They discovered 
that after overcoming initial challenges associated with a new diagnosis of diabetes, 
participants worked hard to achieve treatment targets and to develop the ability to 
control their diabetes (Abdoli et al. 2008). 
Misconceptions 
Paddison et al. (2008) carried out a quantitative survey in New Zealand, involving 615 
adults with type 2 diabetes. They examined the association between psychological 
factors/beliefs about diabetes, quality of life and metabolic control. Findings showed 
that despite the growth in research, education and prevalence of diabetes, 
misconceptions still persist (Paddison et al. 2008). There were generally negative 
representations and misconceptions about diabetes. These included a belief that 
diabetes is temporary, and a belief that it has immediate, serious health implications 
(i.e. it is uncontrollable). These misconceptions were associated with lower quality of 
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life and poorer metabolic control (Paddison et al. 2008). This shows the importance of 
self-confidence and attitude towards diabetes in the successful management of the 
condition.   
Social Dimension  
Another dimension that can be affected by diabetes is people’s social life. This extends 
from interactions with partners/family, friends and colleagues to social and 
recreational activities. A large quantitative study involving 4189 participants from five 
European countries (Belgium, Italy, The Netherlands, Sweden and Spain) has 
investigated the impact of type 2 diabetes from the participant’s perspective. It found 
a reduction in social functioning due to the impact of long-term complications, which 
can lead to feelings of social isolation (Koopmanschap 2002). 
An important aspect of how diabetes can influence people’s social life has been 
highlighted by some qualitative studies conducted in the USA (Samuel-Hodge et al. 
2000; Carbone et al. 2007; Penckofer et al. 2007). While Carbone and colleagues 
pointed out that participants in their study perceived family and social networks as a 
main source of support regarding diabetes self-management, the opposite was the 
case in the Samuel-Hodge et al. (2000) and Penckofer et al. (2007) studies. In these 
two studies the ‘multi caregiver’ role of many women and the responsibility and time 
implications of looking after their families impacted on the resources (e.g. motivation, 
energy, time and finances) they had left to look after themselves and their own 
diabetes care.  
53 
 
Interestingly, evidence from a qualitative study that focussed on a minority ethnic 
population in the USA highlighted that participants tended to seek advice and support 
relating to their diabetes management from family and their wider social network 
rather than health professionals (Weiler and Crist 2009). This further highlights the 
important role of people’s social network in supporting them in their diabetes 
management. The phenomenon of seeking advice and support from non-professional 
sources (e.g. family members/relatives, friends, acquaintances) is also known as ‘lay 
referral’ (Suls et al. 1997). The issue of ‘lay referral’ is further discussed in sections 4.4 
and 4.5. 
Impact of complications on diabetes self-care  
The literature showed that the ‘knock-on’ effect of diabetes complications can be very 
devastating for people living with diabetes. For example, diabetic retinopathy and 
neuropathy can have adverse effects on diabetes management (Coyne et al. 2004; 
Garcia de Alba et al. 2007). This can include impact on planning and performing of 
diabetes self-care activities (Coyne et al. 2004), and diet and physical exercise (Garcia 
de Alba et al. 2007). According to Coyne et al. (2004), reduced vision through diabetic 
retinopathy can complicate testing blood glucose levels, reading medication 
instructions and administering insulin injections (Coyne et al. 2004). 
Donald et al. (2012) carried out a 5-year cohort study involving 3951 participants, 
which focussed on the everyday experiences of people living with diabetes, in 
Queensland, Australia. They found that despite most participants being actively 
involved in the management of their illness, a significant number of the people; in fact, 
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two in every three reported having at least one complication linked to their illness, 
which impacts on their self-management abilities (Donald et al. 2012).  
Impact of hypoglycaemia 
Hypoglycaemia is one of the most serious diabetes complications. According to Shiu 
and Wong (2000), many people with diabetes have experienced at least one 
hypoglycaemic emergency since they were diagnosed. Moreover, the literature 
suggests that even the presence of mild complications can reduce people’s perceived 
quality of life (Lloyd et al. 2001; Hayes et al. 2006). As hypoglycaemic emergencies 
make diabetes publicly visible and frequently require the assistance of another person, 
the tendency towards avoidance of hypoglycaemic episodes by decreasing treatment 
adherence and intentionally keeping blood glucose levels high has been widely 
reported in the literature (Shiu and Wong 2000; Nafees et al. 2006; Di Battista et al. 
2009).  This strategy of avoiding hypoglycaemic episodes is further considered in 
section 3.3.4.2.  
Although the general literature about people’s experiences of living with diabetes does 
not consider the impact of hypoglycaemic episodes on people’s everyday life in detail, 
it is evident that hypoglycaemic episodes are one of the challenges people face in 
managing their diabetes. The literature that more specifically addresses the impact of 
hypoglycaemia and people’s experiences of living with hypoglycaemia are further 
considered in section 3.3. 
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3.2.4 Summary 
The first part of this chapter has emphasised that living with diabetes has far reaching 
consequences for the individual: diabetes is a chronic condition and its care is an on-
going and constant process. While this review focussed on people’s experiences of 
living with diabetes, identified themes highlighted various other factors, e.g. the 
invisibility of diabetes, as well as misconceptions and stigma about diabetes.  
In terms of diabetes treatment, there seems to be an underlying tension between 
patients’ perspectives and the perspective of health professionals, signalling different 
priorities. For example, a number of studies (Keeratiyutawong et al. 2003; Vermeire et 
al. 2003; Wild et al. 2007), indicate that while people with diabetes are much more 
concerned about the immediate impact of medication and maintaining a better quality 
of life, health professionals tend to place higher importance on longer-term treatment 
targets.   
Managing diabetes can be a complex task with the need to balance medication, diet, 
lifestyle and physical activity. The theme of ‘constant attention’/constant presence in 
the management of diabetes has also been well documented in the literature (Everett 
2001; Frandsen and Kristensen 2002; Hayes et al. 2006). For example, Moser et al. 
(2008) explored people’s understanding of self-management, and found that self-
management is perceived as a complex, on-going process involving routine tasks, 
managing ‘off-course’ events (e.g. hypoglycaemia) and taking preventative actions.  
This review highlighted that the invisible nature of diabetes is another challenge that 
people face in everyday life. This entails the reluctance of people to make their 
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condition noticeable whenever in a social environment (Mulvaney et al. 2008), which 
is further exacerbated by the complexity of diabetes care (Aalto et al. 2000). In a study 
by Utz et al. (2006) participants expressed unwillingness to discuss their diabetes 
condition as a result of perceived social stigma. Thus, there could be a danger that 
people feel socially excluded and may decline participation in social activities.  
Overall, diabetes impacts on people’s entire life. This includes: quality of life, 
relationships, psychological, and physiological well-being (Puavilai and Stuifbergen 
2000). Also, a person with diabetes requires a substantial amount of skill and effort to 
achieve a ‘near normal’ life (Everett 2001), as well as the problem of balancing 
seemingly conflicting interests (Campbell et al. 2003; Debono and Cachia 2007); all 
these emphasise the intricacies of living with diabetes and illustrate the challenges of 
successful diabetes self-management. 
Limitations of this review 
This review was challenging as it included papers that used a variety of research 
methods as well as publication types. This made synthesis of the results difficult. To 
address this challenge, a thematic analysis of findings was undertaken. However, 
looking at more recent research relating to the thematic area, there seems to be 
agreement with the findings of this review; that, living with diabetes has far reaching 
consequences for the individual (Donald et al. 2012); that managing diabetes is a 
complex and on-going process (American Diabetes Association 2012), and that many 
people with diabetes worry about possible complications (Ridge et al. 2012). 
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Search terms combined people’s perspectives; experience and diabetes (see section 
3.2.1). The search terms were applied to publication titles only due to the large 
number of results when including abstracts in the search. Limiting the search results 
this way might have missed out on some relevant papers. However, the purpose of 
this review was not to achieve a definitive review covering all research about living 
with diabetes; rather, to gain an understanding of the key themes in diabetes research 
relating to people’s lives and experiences. Another aim was to find out how much of 
the general diabetes literature has investigated people’s experiences of hypoglycaemic 
episodes. 
Wild and colleagues (2007) investigated research into fear of hypoglycaemia and 
possible implications this has for diabetes management. They provide a summary of 
negative outcomes associated with fear of hypoglycaemia, especially the impact it can 
have on the ‘balancing act’ of avoiding both acute complications of hypoglycaemic 
episodes, as well as long-term complications resulting from hyperglycaemia. However, 
Wild et al. (2007) fail to offer an overview of included papers. The limitations of the 
included reviews highlight that there is a need for good quality reviews looking at the 
impact of hypoglycaemia. 
The first part of this chapter has highlighted various challenges people face in the day 
to day management of their diabetes. It has shown that hypoglycaemia is a 
considerable problem for many people with diabetes (Shiu and Wong 2000). The next 
section provides an in-depth, structured review, specifically exploring the literature on 
people’s experiences of living with hypoglycaemia.  
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3.3 People’s experiences of living with hypoglycaemia 
Despite improvement in the treatment and management of diabetes over the years, 
hypoglycaemia is still one of the most feared complications in insulin-treated diabetes. 
Hypoglycaemia occurs as a potentially dangerous side effect of some diabetes 
medications. It is caused by inappropriately high insulin levels, which can lead to low 
blood glucose values (Hicks 2010). Symptoms of hypoglycaemia range from sweating, 
headache, difficulty in concentrating, to confusion, change of behaviour, and 
eventually loss of consciousness (Banks 2005; also see section 2.8).  
Beyond clinical implications, hypoglycaemia can have a huge impact on the well-being 
of people living with diabetes, impinging on their ability to perform ‘normal’ everyday 
activities, participate in employment, and even engage in social activities (Frier 2004). 
Lundkvist et al. (2005) summarise that “the effects of [...] hypoglycaemia are twofold. 
First, well-being may be affected in people with frequent hypoglycaemia, both directly 
from the effects of hypoglycaemia and indirectly from concern about recurrent events. 
Second, apart from the distressing acute symptoms, hypoglycaemia may also impair 
the person’s health in the long term; fear of an event may additionally prevent people 
from taking their anti-diabetic treatment” (p.197). 
As highlighted in chapter 2, hypoglycaemia is the most common complication in 
insulin-treated type 1 and type 2 diabetes (Wild et al. 2007). For example, in people 
with type 1 diabetes, the annual incidence for severe hypoglycaemia is between one 
and two cases per individual, which can further increase when other risk factors (e.g. 
intensive insulin treatment, exercise, past history of frequent and severe 
hypoglycaemic episodes, etc.) are present. However, mild and usually self-treated 
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hypoglycaemia is even more common, occurring on average about twice a week (Frier 
2008; see section 2.6.2). 
Severe hypoglycaemia is less common in people with type 2 diabetes than in those 
with type 1 (UKPDS 1998). Though, people with type 2 diabetes who are treated with 
insulin experience similar rates of severe hypoglycaemia compared to people with 
type 1 diabetes, particularly when the duration of insulin treatment was 5 years or 
more (Heller 2008). These further underline the impact hypoglycaemia has on people 
living with diabetes, but especially those treated with insulin. The initial review 
(section 3.2) revealed a lack of systematic literature reviews focussing on people’s 
experiences of living with hypoglycaemia. Therefore, the following section presents a 
review around people’s perspectives and experiences of living with hypoglycaemia. 
3.3.1 Methods 
The aim of this review was to gain an understanding of people’s experiences of living 
with hypoglycaemia. A systematic search of online databases CINAHL (Cumulative 
Index for Nursing and Allied Health Literature), PsycINFO and MEDLINE was carried 
out. Two facets were developed: Experience: (experience*, perspective*, perception*, 
well*being, quality of life, self*care, self*management, fear*, affect* or impact*) and 
illness: (hypoglyc*). Additionally, the facet ‘diabetes’ was applied in an all text search 
to ensure focus on hypoglycaemia in the context of diabetes. Subject headings and 
text words within each facet were combined using the Boolean operator “OR” and the 
resultant facets were then combined using the Boolean operator “AND”. These facets 
were then applied to publication titles and abstracts.  
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After excluding research carried out with animals, and limiting search results to English 
and German language publications (due to my language skills) within the last 20 years 
(since March 1991), the search yielded 3382 results. These were screened for 
relevance and whether they were directly related to people’s experience of 
hypoglycaemia. Papers that reported primary or secondary research, opinion pieces 
and literature reviews were included, while publications evaluating interventions were 
excluded. This was because the focus of the current review was on people’s 
experiences of living with hypoglycaemia rather than the effectiveness of 
interventions. 104 papers met the inclusion criteria during initial screening and were 
retrieved for full text assessment. A flow diagram of the structured search process is 
shown in figure 3.2 below. 
Following the identification of relevant papers, key data (e.g. authors, study design, 
study aims, and themes) were extracted into a summary table (see table 3.2 below). 
Papers were analysed in-depth to identify key findings and these were compared 
across included papers. This process generated a set of abstract themes which were 
further refined and synthesized through critical discussion with my supervisors. 
Salience of extracted information was reached by independent assessment of ten 
percent of papers regarding identified themes. 
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Figure 3.2: Flow diagram of structured search process (experiences of 
hypoglycaemia) 
 
3.3.2 Quality assessment 
Quality appraisal was conducted using adapted NICE public health guidance (2009) 
quality appraisal tools and checklists (also see Crombie 1996). Each included paper was 
assessed for relevance and quality and was given a score following quality appraisal. 
Papers were then independently checked with my supervisors, and their quality scores 
discussed.  
3278 papers excluded after review of titles and 
abstracts 
3382 papers overall:                                                         
2518 MEDLINE                                                                    
688 CINAHL                                                                         
176 PSYCINFO 
 
104 papers retained for full text assessment 
56 MEDLINE                                                         
37 CINAHL                                                            
11 PSYCINFO 
 
22 duplicate papers removed 
 58 papers excluded after full text review 
24 papers included in the review 
19 primary research studies 
1 opinion piece  
4 literature reviews 
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3.3.3 Results 
After reviewing the full text version of potentially relevant papers, 19 primary research 
studies, one opinion piece and four literature reviews were identified as relevant (see 
figure 3.2). Twenty percent of papers (n=5) were checked for inclusion/exclusion 
criteria with my supervisors, and agreements were high (agreements for n=4, one 
paper was further discussed regarding inclusion/exclusion (Crace 1991)). This process 
is well established and has been used previously by Popay et al. (2006) and 
Kolehmainen et al. (2010). Of the 19 primary research studies, four studies used 
qualitative methodology; two studies were based around a single case study, and 13 
studies applied a quantitative approach. An overview of included papers is presented 
in table 3.2 below, along with a list of key themes identified in each paper. 
This review faced a challenge of including papers that used a variety of research 
methods as well as publication types (reviews, primary research studies, etc.). This also 
brought with it a difficulty of comparing results. To address this challenge, a thematic 
analysis of findings was undertaken. The review may have missed out on some 
relevant papers as reference lists of relevant papers or relevant journals were not 
searched. 
The quality of reviews included was poor. For example, some reviews lacked detailed 
search protocols, overview of included papers and quality appraisal (Gold et al. 1997; 
Wild et al. 2007; Frier 2008). Frier’s review outlines possible implications of 
hypoglycaemia on people’s everyday lives; including travel, driving, physical activities, 
working life and relationships. But whilst this review gives an interesting and broad 
overview, it is unclear whether it reflects the perspective of people living with 
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diabetes. There was a lack of information on the research upon which these 
conclusions were reached and on the selection of included research studies. 
This review has identified only four studies using qualitative methods, with three of 
them being carried out in the nineties (Richmond 1996; Rajaram 1997; Ritholz and 
Jacobson 1998). This means that findings could be out of date with changes in 
treatment (e.g. different types of insulins) and diabetes management approaches. Two 
of the qualitative studies were conducted in the USA (Rajaram 1997; Ritholz and 
Jacobson 1998) and one in England (Richmond 1996). The fourth study was carried out 
in China (Shiu and Wong 2002). Studies which are not conducted in the United 
Kingdom may have limited relevance to the UK system. Richmond’s (1996) study was 
based on semi-structured interviews with only seven participants and was reported 16 
years ago. This suggests that there is a lack of recent, qualitative studies investigating 
people’s experiences of living with hypoglycaemia. In terms of the Scottish context, 
the literature searched to date has been unable to locate any qualitative studies that 
have looked at people’s experiences of living with hypoglycaemia. 
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Table 3.2: Overview of included papers (experiences of hypoglycaemia) 
 
 
Author/s, date, title, country 
 
Study Design/Sample Size (n) 
 
Study Aim/Focus 
Q
u
al
it
y 
sc
o
re
 
Th
e
m
e
(s
) 
Anderbro et al. (2010), Fear of 
hypoglycaemia in adults with type 1 
diabetes, Sweden 
Quantitative, Swe-HFS, using worry and aloneness 
subscales, 764 adults with type 1 diabetes, mean age 43.3 
years 
Investigating the associations between fear 
of hypoglycaemia and disease- 
specific/demographic variables 
++ 1 
Belendez and Hernandez- Mijares 
(2009), Beliefs about insulin as a 
predictor of fear of hypoglycaemia, 
Spain 
Quantitative, Beliefs about medicines questionnaire, fear 
of hypoglycaemia survey and other questionnaires, 81 
adults (18-58 years) type 1 diabetes, 56% female 
Investigating how concerns about insulin 
treatment influences fear of hypoglycaemia  
- 1 
Costea et al. (1993), Fear of 
hypoglycaemia in type 1 (insulin- 
dependent) diabetic patients, Romania 
 
Quantitative (interview and questionnaires) to measure 
frequency of hypos, evaluation of anxiety, 224 patients 
with type 1 diabetes, divided into 2 groups (frequent 
hypos vs. occasional hypos) 
To investigate the relationship between 
frequency and severity of hypoglycaemia, 
anxiety and compliance behaviours 
+ 1,2,3 
Currie et al. (2006), Multivariate models 
of health-related utility and the fear of 
hypoglycaemia in people with diabetes, 
UK 
Quantitative (postal surveys) using HFS (Hypoglycaemia 
Fear Survey) and EQ5D (measures health-related utility), 
1305 participants, type 1 and type 2 diabetes 
Measuring the impact of hypoglycaemia on 
patients’ health-related utility, investigating 
how severity, frequency and fear of 
hypoglycaemia affect patients’ health status 
++ 1,5 
Davis et al. (2005), Impact of 
hypoglycaemia on quality of life and 
productivity in type 1 and type 2 
diabetes, UK 
Quantitative (postal survey) using EQ-5D and SF-36, 861 
respondents (response rate= 28%) 
To investigate impact of hypos on quality of 
life, productivity, health related utility 
+ 2,5 
Di Battista et al. (2009), Type 1 Diabetes 
among adolescents- reduced diabetes 
self-care caused by social fear and fear 
of hypoglycaemia, Australia (Fieldwork 
in USA/Canada) 
Quantitative (Survey incl.DQoL (Diabetes Quality of Life 
Measure) and HFS), 76 adolescent (13-18 years) 
participants, type 1 diabetes, 33 boys/43 girls 
Investigating the association between social 
anxiety, fear of hypoglycaemia, adherence 
to diabetes treatment regimen and 
perceived quality of life 
+ 1,2,5 
Irvine et al. (1992), Fear of 
Hypoglycemia: Relationship to physical 
Quantitative, HFS and other questionnaires, 69 
participants with type 1 diabetes (41 female/28 male), 
Investigating the impact of hypoglycaemia 
on fear, self-care behaviour and 
+ 1,2 
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and psychological symptoms in patients 
with insulin-dependent diabetes 
mellitus, USA 
mean age 33.4 years psychological symptoms 
Leiter et al. (2005), Assessment of the 
impact of fear of hypoglycemic episodes 
on glycemic and hypoglycemia 
management, Canada 
Quantitative, HFS-98 and other questionnaire items, 235 
adults with type 1 and type 2 diabetes, insulin-treated, 
(171 male/164 female) 
Investigating the impact fear of 
hypoglycaemia has on glycaemic control, 
lifestyle and hypoglycaemia management 
+ 1,2 
Myers et al. (2007) Fear of 
hypoglycemia and self-reported 
posttraumatic stress in adults with type 
1 diabetes treated by intensive 
regimens, USA 
Quantitative (questionnaires incl. HFS, posttraumatic 
diagnostic scale (PDS), Beck Depression Inventory and 
other demographics questions, 90 participants (65 
female/25 male), adults with type 1 diabetes, intensive 
insulin treatment 
Investigating the relationship between fear 
of hypoglycaemia and posttraumatic stress 
in people with type 1 diabetes 
- 1 
Nordfeldt and Ludvigsson (2005), Fear 
and other disturbances of severe 
hypoglycaemia in children and 
adolescents with type 1 diabetes 
mellitus, Sweden 
Quantitative, 74 participants,  4-18 years, type 1 diabetes, 
person most in charge of treatment filled in questionnaire 
(incl. parents/carer), participants divided into 2 groups: 
those who experienced severe hypoglycaemic episodes 
with unconsciousness and those without unconsciousness 
Investigate the occurrence and extent of 
fear of hypoglycaemia in young people 
experiencing severe hypoglycaemic 
episodes  
+ 1,2,3 
Polonsky et al. (1992), Correlates of 
hypoglycaemic fear in type 1 and type 2 
diabetes mellitus, USA 
Quantitative, HFS and other anxiety and fear scales, 232 
participants, insulin-treated type 1 and type 2 diabetes, 
13-85 years old 
Investigating whether fear of 
hypoglycaemia is a response to prior 
experience of hypoglycaemic episodes, or 
associated with general anxiety levels? 
+ 1 
Shiu and Wong (2000), Fear of 
hypoglycaemia among insulin-treated 
Hong Kong Chinese patients: 
implications for diabetes patient 
education, China 
Quantitative (structured interviews), 120 participants, 
adults, insulin-treated type 1 and type 2 diabetes, 1st 
phase study 
Identifying the extent of fear of 
hypoglycaemia and its impact on diabetes 
self-management 
+ 1,2 
Tierney et al. (2008), Living with cystic 
fibrosis-related diabetes or type 1 
Quantitative (cross-sectional comparative study)using 
questionnaires incl. EHS (Edinburgh Hypoglycaemia Scale) 
Gaining an insight into the experience of 
hypoglycaemia and the impact of diabetes 
++ 5 
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diabetes mellitus: a comparative study 
exploring health-related quality of life 
and patients’ reported experiences of 
hypoglycaemia, UK 
and DQoL (Diabetes Quality of Life Measure), 107 
participants (55 with type 1 diabetes/52 with CFRD (Cystic 
Fibrosis-Related Diabetes) 
on health-related quality of life. Comparing 
perceptions of people with type 1 diabetes 
and CFRD 
     
Crace (1991), Experiences with 
hypoglycaemia, Sheffield/UK 
 
Opinion piece, experience report/story by patient with 
type 1 diabetes 
Describing personal experiences of living 
with hypoglycaemia 
N/A 2,3,4 
Green et al. (2000), Fears and phobias in 
people with diabetes, UK 
 
Case study, 35 year old male with type 1 diabetes (since 
15 years) 
Investigating how fear of hypoglycaemia 
and phobic disorders affect people with 
diabetes 
N/A 1,2 
Luthra and Donaldson (1997), Severe 
hypoglycaemia in insulin-dependent 
diabetes mellitus (IDDM)- living to tell 
the tale, USA 
Case study, 62 year old male with type 1 diabetes Giving a retrospect account of a severe 
nocturnal hypoglycaemic episode  
N/A 1,3 
     
Rajaram (1997), Experience of 
hypoglycemia among insulin dependent 
diabetics and its impact on the family, 
USA 
Qualitative (interviews with 23 people with type 1 
diabetes and their partners),  partners were interviewed 
separately 
To explore experience of hypoglycaemia, its 
management and impact on everyday life 
from both patients and partners’ points of 
view 
++ 3,4 
Richmond (1996), Effects of 
hypoglycaemia: patients’ perception 
and experience, UK 
Qualitative, semi-structured interviews, 7 participants (3 
males/4 females), adults (20-72 years) 
 
Exploring people’s experiences of insulin-
treated diabetes in relation to 
hypoglycaemia 
+ 2,3,5 
Ritholz and Jacobson (1998), Living with 
hypoglycaemia, USA 
 
Qualitative, in-depth, semi-structured interviews, 20 
participants (aged 21-30 years), type 1 diabetes,  
10 male/10 female 
Exploring young adults’ experiences of 
hypoglycaemia and its impact on everyday 
life 
+ 3,4 
Shiu and Wong (2002), Fears and 
worries associated with hypoglycaemia 
Qualitative (semi-structured interviews), 13 participants, 
insulin-treated type 1 and type 2 diabetes, adults, 2nd 
Investigating participants’ (Hong Kong 
Chinese) perspectives of living with 
++ 1,2,3 
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and diabetes complications: perceptions 
and experience of Hong Kong Chinese 
clients, China 
phase study (sub-sample of 1st phase (quantitative) study) hypoglycaemia, fear of hypoglycaemia (and 
other complications) as well as coping 
strategies 
     
Frier (2008), How hypoglycaemia can 
affect the life of a person with diabetes,  
Scotland/UK 
Review, Search Strategy not given/no information about 
number of included papers/28 references in 
bibliography not a systematic review 
Investigating how hypoglycaemia affects the 
everyday life of people living with diabetes 
- 1,2,3 
Gold et al. (1997), Hypoglycaemia and 
non-cognitive aspects of psychological 
function in insulin-dependent  diabetes 
mellitus (IDDM), UK 
Review, 35 references 3 main aims are review of: 
1- impact of acute hypoglycaemia on mood 
and behaviour 
2- investigation of fear of hypoglycaemia 
3- effects of recurrent hypoglycaemia on 
mood, behaviour and personality 
- 1,4 
Wild et al. (2007), A critical review of 
the literature on fear of hypoglycaemia 
in diabetes: Implications for diabetes 
management and patient education, UK 
Reviewing research on fear of hypoglycaemia, English 
language, published between 1985 and 2007, 34 papers 
included 
Gaining an overview of existing research 
into fear of hypoglycaemia and analyse its 
impact on diabetes management and 
patient education  
+ 1,2 
Zhang et al. (2010), The burden of 
hypoglycaemia in type 2 diabetes: a 
systematic review of patient and 
economic perspectives, UK 
 
Review of research investigating personal and economic 
impact of hypoglycaemia in people with type 2 diabetes 
treated with oral diabetes medications, included 17 
studies for economic review and 11 for patient reported 
outcomes 
Gaining an overview of literature focussing 
on personal and economic impact of 
hypoglycaemia in people with type 2 
diabetes treated with oral diabetes 
medications  
+ 1,2,5 
(Themes: 1= fear of hypoglycaemia, 2= balancing risk, 3= loss of control, 4= impact on identity, 5= impact on quality of life) 
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Many of the included papers focus on research around fear of hypoglycaemia. It is the 
most common theme in both reviews and quantitative studies; however, only one 
qualitative study mentions the ‘fear of hypoglycaemia’ theme. Among the included 
qualitative studies, the most frequent theme is the ‘loss of control’ theme. This 
suggests that fear of hypoglycaemia has generally been studied using quantitative 
methods.  
Even though the quantitative studies investigating fear of hypoglycaemia and factors 
influencing it gave an indication about the extent to which people with diabetes are 
affected by such fear, they tell us little about people’s perspectives and experiences of 
hypoglycaemia. The search strategy identified few qualitative studies (n=4) focussing 
on experience of hypoglycaemia. Only one qualitative study was conducted in the UK 
(Richmond 1996). However, this study had a very limited sample size (7 participants). 
None of the included studies used a longitudinal approach, which indicates a further 
gap in the literature exploring the impact of hypoglycaemia over time.  
The quality of included studies and reviews varied within and between study types. 
Among the quantitative studies, few were rated as very good quality papers (e.g. 
Tierney et al. 2008; Anderbro et al. 2010); however, the majority of quantitative 
studies (n=8) received an average quality score. The main limitations in these studies 
related to a low response rate (Davis et al. 2005) and a small sample size (e.g. Irvine et 
al. 1992; Nordfeldt and Ludvigsson 2005; Di Battista et al. 2009). In contrast, 
qualitative studies appeared to be of a higher quality, with half of the included studies 
(n=2) receiving a very good quality score. Quality rating of included reviews (n=4) was 
generally poor to average. One of the main shortcomings was not following a 
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transparent and rigorous process; for example, two of the reviews did not include an 
overview of their methodology (Gold et al. 1997; Frier 2008). 
3.3.4 Identified themes: Experience of living with hypoglycaemia 
Four main themes were identified in this review: fear of hypoglycaemia; balancing risk; 
impact on identity; and loss of control. These themes suggest that people living with 
diabetes carry a considerable burden as they have to constantly manage their 
condition, and directly experience the impact of their diabetes on everyday life. They 
also have the additional burden that hypoglycaemic episodes can bring and that this 
also requires substantial management, which may not always be within their control.  
3.3.4.1  Fear of hypoglycaemia 
18 papers examined this theme (11 quantitative studies, 1 qualitative study, 4 reviews 
and 2 case studies) 
With regard to quality of included papers looking at fear of hypoglycaemia, five were 
rated as very good. These were three quantitative papers (Currie et al. 2006, Tierney 
et al. 2008, and Anderbro et al. 2010); and two qualitative papers (Rajaram 1997; Shiu 
and Wong 2002). The rest of the papers, including the reviews, achieved either an 
average or poor quality score (see quality scores in table 3.2).  There was no study that 
looked at fear of hypoglycaemia in relation to concerns and worries relating to long-
term complications. 
The theme of ‘fear of hypoglycaemia’ frequently emerged within the literature. Many 
people with diabetes are afraid or worry about possible hypoglycaemic episodes. As 
hypoglycaemia is accompanied by unpleasant, frightening symptoms and can 
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potentially be life threatening, it is not surprising that many people with diabetes 
develop a fear of hypoglycaemia. Fear of hypoglycaemia is generally measured using 
the Hypoglycemia Fear Scale (HFS), which includes a behaviour and worry subscale. 
The behaviour subscale addresses diabetes self-care behaviours that are adopted to 
avoid hypoglycaemia, while the worry subscale assesses aspects of hypoglycaemia that 
cause anxiety (Wild et al. 2007). 
There is strong evidence that fear of hypoglycaemia can increase with more severe 
and more frequent episodes of hypoglycaemia (Gold et al. 1997; Shiu and Wong 2000; 
Currie et al. 2006; Hanberger et al. 2009). Severe hypoglycaemia occurs more often in 
people treated with insulin, which includes people with type 1 diabetes. Consequently, 
people with type 1 diabetes tend to have higher levels of fear of hypoglycaemia 
(Belendez and Hernandez-Mijares 2009). Interestingly, a study conducted by Tierney 
et al. (2008) found that frequency of hypoglycaemic episodes seems to have a lesser 
impact on health-related quality of life compared to severity of hypoglycaemic 
episodes. This suggests that more severe and disruptive symptoms can cause more 
distress and fear in people experiencing hypoglycaemia.   
Davis et al. (2005) examined associations between occurrence of hypoglycaemia, 
quality of life, productivity and primary care resource use. Not surprisingly, they found 
that with increasing frequency and severity of hypoglycaemic events, primary care 
resources were used more frequently, while both quality of life and productivity 
reduced. They conclude that “hypoglycaemia clearly has a major impact on people’s 
lives in terms of physical, mental and social functioning” (Davis et al. 2005:1483). 
These findings are very relevant as there is evidence that severity of hypoglycaemic 
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episodes in particular has a considerable effect on fear of hypoglycaemia (Anderbro et 
al. 2010). 
Many people with insulin-treated diabetes worry about possible hypoglycaemic 
emergencies. Fears and worries about hypoglycaemia seem to be associated with 
personality (general level of anxiety and self-efficacy), previous experience of (severe) 
hypoglycaemia and social environment (see Polonsky et al. 1992; Shiu and Wong 
2000). Even though it is not clear how many people with diabetes experience fear of 
hypoglycaemia, the literature suggests that where fears and worries about 
hypoglycaemia are present, they should be addressed by the diabetes care provider in 
the context of designing treatment options (Shiu and Wong 2002; Funnell and 
Anderson 2004). 
3.3.4.2  Balancing risk 
14 papers examined this theme (7 quantitative studies, 2 qualitative studies, 3 reviews,         
1 case study and 1 opinion piece) 
With the exception of one qualitative study (Shiu and Wong 2002), which received a 
very good quality score, the remainder of the included papers discussing this theme 
received an average quality score (see table 3.2). 
As a chronic condition, diabetes requires constant balancing and prioritising of 
medications, food intake, physical activities, and monitoring of blood glucose values. 
Many people living with diabetes feel caught in between the risk of hypoglycaemia 
and hyperglycaemia (high blood glucose levels), as well as potential long-term 
complications (Shiu and Wong 2002). When it comes to balancing these risks, there is 
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a tendency that immediate effects (e.g. hypoglycaemic episodes) are more salient for 
people living with diabetes.  
Wild et al. (2007) review of research on fear of hypoglycaemia confirms that for 
people living with diabetes the immediate effects of hypoglycaemia are often more 
important than longer term effects when trying to balance risks. This may lead to a 
higher priority of avoiding hypoglycaemia by keeping a higher blood glucose level. This 
does not seem surprising; given the huge impact hypoglycaemia can have on people’s 
lives, and also the range of negative emotions associated with hypoglycaemia, 
including feelings of losing control, anger and anxiety (Green et al. 2000; Everett 
2001). Unfortunately, this behaviour comes at the cost of worse glycaemic control and 
risk of potential long-term complications later in life (Richmond 1996).  
Overall, several factors influence how people balance risk. For example, risk avoidance 
behaviour can be linked to previous negative experience of hypoglycaemic episodes 
(Shiu and Wong 2000; Di Battista 2009). This does not just refer to individual 
experience and physical symptoms of hypoglycaemia, but also the perceived reaction 
of people present during hypoglycaemic episodes. There is a perceived stigma and 
embarrassment associated with a diagnosis of diabetes, and having hypoglycaemia is 
often considered as being incompetent in the self-management of diabetes, especially 
when in a public place (Rajaram 1997). Richmond (1996) illustrated this with the 
following quote from one of her study participants: “I can’t do exactly what I want. I 
feel trapped and people blame me for not getting it right” (p.1684).  
The research exemplified the need for people experiencing hypoglycaemia to balance 
risks. On the one hand, they need to manage their diabetes and hypoglycaemic 
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episodes when they occur, while on the other hand they also have to consider their 
‘public image’, (interaction with society/people around them). The possible impact of 
hypoglycaemia on people’s identities and interaction with society is discussed in the 
next section. 
3.3.4.3  Impact on identity 
4 papers examined this theme (2 qualitative studies, 1 review and 1 opinion piece) 
The theme ‘impact on identity’ was mentioned by only four papers, which were 
published either in the UK (Crace 1991; Gold et al. 1997) or in the USA (Rajaram 1997; 
Ritholz and Jacobson 1998). The two qualitative studies were rated as good (Rajaram 
1997) and average (Ritholz and Jacobson 1998), while the review (Gold et al. 1997) 
was rated as poor quality. 
Diabetes is an invisible illness. Unless an obvious complication is present or a 
(hypoglycaemic) emergency arises, other people would not know whether someone 
has been diagnosed with diabetes (Peel et al. 2004). This dilemma is further 
exacerbated by a perceived stigma and embarrassment to openly communicate about 
diabetes and the risk of hypoglycaemia (Rajaram 1997).  
A study conducted by Ritholz and Jacobson (1998) found that people feel different 
from their normal self when experiencing hypoglycaemia. One of their study 
participants is quoted as follows: “I think one thing that sort of bothers me about it 
[hypoglycaemia] is just how stupid I can feel, and it’s like losing a major part of your 
person” (p.801). There is a sense that some people with diabetes are worried about 
being defined by their illness.  
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Another dimension is added by Costea et al. (1993), who introduced the concept of 
“post-hypoglycaemic syndrome”. They claimed that even after a hypoglycaemic 
episode has been treated, feelings of depersonalisation and depression can remain for 
up to a couple of days. This illustrates that hypoglycaemia can also affect the identity 
and sense of self of the person experiencing it, (see section 4.8). 
3.3.4.4  Loss of control 
9 papers examined this theme (2 quantitative studies, 4 qualitative studies, 1 review,             
1 case study and 1 opinion piece) 
 
The quality of included papers within the ‘loss of control’ theme varied. For example, 
half of the qualitative studies (n=2) were rated as very good (Rajaram 1997; Shiu and 
Wong 2002), while the other two qualitative studies as well as the two quantitative 
studies received an average quality score (Costea et al. 1993; Richmond 1996; Ritholz 
and Jacobson 1998; Nordfeldt and Ludvigsson 2005). The review (Frier 2008) received 
a poor quality score. 
One major challenge of hypoglycaemia is its unpredictability. Hypoglycaemia often 
happens suddenly and unexpectedly. People with diabetes can find themselves in a 
risky situation, where they either need to take action or depend on someone else to 
take control (Rajaram 1997). A case study by Luthra and Donaldson (1997) describes 
the experience of a severe nocturnal hypoglycaemic episode of a man with type 1 
diabetes. It confirms the finding that hypoglycaemic episodes are frightening and 
distressing for the individuals involved, especially when it occurs suddenly without any 
prior warning signs. 
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Caroline Crace, who is living with type 1 diabetes, published an opinion paper 
elucidating her individual experiences of hypoglycaemia (1991). She explains that 
hypoglycaemia can have a considerable effect on diabetes self-management and 
confidence levels, as she may feel exhausted and low following a hypoglycaemic 
episode. 
In a review of the literature about how hypoglycaemia can impact on the everyday life 
of people with diabetes, Frier (2008) describes a range of areas hypoglycaemia can 
affect: from driving/travelling, to employment, personal relationships and leisure 
activities/exercise. Moreover, one theme overarches all these aspects, the feeling of 
‘powerlessness’ when hypoglycaemia occurs. This is particularly true for episodes of 
severe hypoglycaemia, which can cause major disruption (Frier 2008). 
3.3.4.5  Impact on quality of life 
6 papers examined this theme (4 quantitative studies, 1 qualitative study and 1 review) 
The quality of included papers within the ‘impact on quality of life’ theme was 
generally average, with two quantitative studies rated as very good (Currie et al. 2006; 
Tierney et al. 2008). Interestingly, all the papers that examined this theme had been 
conducted in the UK (with the exception of Di Battista et al. (2009), who carried out 
their study in the USA and Canada). The impact diabetes and hypoglycaemia can have 
on quality of life has mostly been investigated using a quantitative approach. This 
review identified only one qualitative study that did mention the impact on quality of 
life (Richmond 1996). 
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The literature has emphasised negative impacts of hypoglycaemia on people’s quality 
of life. For example, Richmond (1996) noted that worrying about possible 
hypoglycaemic episodes and avoiding social and physical activities for fear of 
embarrassment and loss of control all contribute to reduce quality of life among 
people with diabetes.  People’s situation is further worsened as a result of demands by 
healthcare providers for tight control of blood glucose levels, which may lead to an 
increased risk of hypoglycaemia (Diebel 1999). While a near-normal blood glucose 
level minimises the risk of long-term complications, a higher risk of hypoglycaemia can 
have potentially devastating impact on the person’s everyday life. Furthermore, using 
optimal glycaemic control as the only indicator to measure good self-management 
practices may overlook the impact of diabetes treatment regimen on emotional well-
being and quality of life (Shiu and Wong 2002; Debono and Cachia 2007). 
Davis et al. (2005) carried out a postal survey in the United Kingdom to investigate the 
impact of hypoglycaemia on quality of life, primary care resource use and productivity. 
They found a direct correlation between increase in frequency and severity of 
hypoglycaemia and a reduction in quality of life and productivity. Additionally, primary 
care resource use increased with more severe cases of hypoglycaemia. While this 
study had some limitations in terms of a low response rate and timeframe 
(hypoglycaemic episodes over a period of three months), it gave an indication of the 
huge impact hypoglycaemia can have on people with diabetes. In conclusion, the 
authors recommended that every effort should be geared towards achieving good 
glycaemic control, reducing the risk of hypoglycaemia and addressing the impact 
treatment has on people’s quality of life. 
77 
 
Another study which was conducted by Richmond (1996) explored the effects 
hypoglycaemia has on young people aged 16-30 years. Richmond described that 
people may find themselves in a ‘Catch-22’ (no-win) situation. That is, they either face 
an increased risk of hypoglycaemia by aiming at a tight blood glucose control, or they 
intentionally run higher blood glucose levels to avoid hypoglycaemia, which also 
carries with it the potential for future complications. According to Richmond (1996), 
people with diabetes constantly need to take action to manage their condition. They 
need to balance the risk of complications, decide whether to adhere to the prescribed 
treatment and weigh possible implications this decision has on their well-being and 
quality of everyday life. 
3.3.5 Summary 
Many people with diabetes have experienced a hypoglycaemic emergency since they 
were diagnosed (Shiu and Wong 2000). There is evidence that fear of hypoglycaemia, 
including nocturnal hypoglycaemia, increases with more severe and more frequent 
episodes of hypoglycaemia (Shiu and Wong 2000; Currie et al. 2006). Given the 
unpleasant symptoms of hypoglycaemia, it is not surprising that some people reveal a 
tendency towards avoidance of hypoglycaemia by decreasing their treatment 
adherence and intentionally keeping blood glucose levels high (Shiu and Wong 2000; 
Wild et al. 2007).   
As highlighted in the summary of the initial review (see section 3.2.4), people with 
diabetes face the challenge of living with an invisible condition. This includes the 
reluctance of people to discuss their diabetes whenever in a social situation (Mulvaney 
et al. 2008), due to perceived social stigma (Utz et al. 2006). Thus, there could be a 
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danger that people feel socially excluded. However, hypoglycaemic emergencies make 
diabetes publicly visible as they require the assistance of another person. In such a 
situation, the individual does not have a choice of whether to disclose their condition 
to people around. Rajaram (1997) conclude that “chronic illness is seldom a personal 
matter; the experience of the illness is shaped and transformed by the ill person’s 
interactions with others” (p.287). 
Overall, experiencing hypoglycaemia impacts the entirety of people’ lives. This 
includes impact on quality of life, relationships, psychological and physiological well-
being (Puavilai and Stuifbergen 2000). It also includes the problem of balancing risks of 
hypoglycaemia and hyperglycaemia, as well as managing various challenges of 
diabetes self-management (Wild et al. 2007). Some people with diabetes have 
expressed how hypoglycaemia affects their sense of self and causes fear of being 
defined by their diabetes (Ritholz and Jacobson 1998). All these challenges emphasise 
the intricacies of managing hypoglycaemic episodes and illustrate the challenges of 
successful diabetes self-care. 
Hypoglycaemia can have a devastating impact on everyday life. Therefore, a range of 
negative emotions are associated with hypoglycaemia, including feelings of losing 
control, anger and anxiety (Green et al. 2000). Even the thought of hypoglycaemia, as 
well as its actual occurrence can interfere with people’s independence and could 
trigger feelings of powerlessness. There is evidence that many people alter their 
treatment to avoid having a hypoglycaemic episode (Shiu and Wong 2000). Whilst 
avoiding the unpleasantness of a hypoglycaemic episode, such behaviour is likely to 
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compromise future quality of life due to the increased risk of long-term complications 
as a result of worse glycaemic control (Nordfeldt and Ludvigsson 2005).  
The impact of hypoglycaemia can be perceived in two ways: first, the actual 
hypoglycaemic episode with its physiological implications and impending threat to 
health and second, fears and worries about hypoglycaemia (see Nafees et al. 2006). 
The latter might even manifest itself with symptoms like anxiousness and avoidance 
behaviour, e.g. intentionally keeping a higher blood glucose level to avoid 
hypoglycaemia (Wild et al. 2007; Patton et al. 2008).  
More importantly, fears and worries about hypoglycaemia possibly affect the 
individual for a longer period of time than those particular instances during which 
hypoglycaemic episodes occur. Additionally, fears and worries about hypoglycaemia 
can pose a major barrier to achievement: they might even lead to avoidance of some 
social situations and life opportunities (Richmond 1996). 
Frier (2008) suggests that hypoglycaemia can impact on many aspects of life; including 
travel, driving, physical activities, working life and relationships. However, it is unclear 
whether Frier’s review reflects the perspective of people living with diabetes. There is 
a lack of information on the research upon which these conclusions are reached and 
the selection of included research studies. 
3.3.6 Rationale for this study 
To date, diabetes research has paid little attention to people’s experiences of 
hypoglycaemia. Although hypoglycaemia has been mentioned in the literature in the 
context of diabetes complications, there are few studies that focus on people’s 
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experiences of hypoglycaemia in particular. Much of the research about 
hypoglycaemia has used a quantitative approach, and clusters around ‘fear of 
hypoglycaemia’ and its impact on diabetes self-management (e.g. Shiu and Wong 
2000; Leiter et al. 2005; Currie et al. 2006; Belendez and Hernandez-Mijares 2009; 
Anderbro et al. 2010).  
The review looking at people’s experiences of living with hypoglycaemia has identified 
only four studies using qualitative methods, with three of them being carried out in 
the nineties (Richmond 1996; Rajaram 1997; Ritholz and Jacobson 1998). This means 
that findings could be out of date with changes in treatment (e.g. different types of 
insulins) and diabetes management approaches. Only one of the qualitative studies 
was conducted in the UK (England; Richmond 1996). Studies which are not conducted 
in the United Kingdom may have limited relevance to the UK system. This suggests 
that there is a lack of recent, qualitative studies investigating people’s experiences of 
living with hypoglycaemia. In terms of the Scottish context, the literature searched to 
date has been unable to locate any qualitative studies that have looked at people’s 
experiences of living with hypoglycaemia. It is therefore not possible to use current 
literature to explain differences relating to self-care processes that lead some people 
with diabetes to rely more on emergency services than others. 
There is some evidence in the literature that hypoglycaemia has potentially far 
reaching consequences for individuals with diabetes (Richmond 1996; Currie et al. 
2006; Wild et al. 2007). For example, impact on social life, future expectations (Frier 
2007b), driving, ability to perform ‘normal’ everyday activities (Frier 2004), 
psychological well-being (Everett 2001) and even diabetes care (Nafees et al. 2006). 
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However, the consequences and impact of living with hypoglycaemia have not been 
sufficiently investigated. In particular, the studies completed to date have focussed 
mainly on fear of hypoglycaemia as if this is a universal experience, and have been 
exclusively cross-sectional in design. This study explores the perspective of people 
living with diabetes and hypoglycaemia. 
None of the studies included in the review used a longitudinal approach, which 
suggests a gap in the literature exploring the impact of hypoglycaemia and how this 
might change over time or in relation to different episodes. As hypoglycaemia is a 
complication related to a long-term condition, it may be that people’s experiences 
change over time.  
On average, mild hypoglycaemia occurs about twice a week, while cases for severe 
hypoglycaemia range between one and two incidents per individual annually (Frier 
2008). However, some people living with diabetes experience hypoglycaemic episodes 
much more often, depending on circumstances and risk factors (e.g. strict glycaemic 
control, history of hypoglycaemia, physical exercise; Heller 2008). Many people 
manage hypoglycaemic episodes independently, though some need external support. 
A proportion of this support is delivered by the Scottish Ambulance Service (SAS). Each 
year, about 7000 calls relating to diabetes are made to the SAS, which includes a 
considerable number of repeat callers (The Scottish Government 2010).  
The Scottish Government published the ‘Diabetes Action Plan’ in 2010, which states 
“reducing diabetes emergencies” as one of its targets (p.44). The Diabetes Action Plan 
also indicates that the SAS aims to reduce episodes of repeat severe hypoglycaemia. 
Understanding the underlying reasons and people’s experiences of hypoglycaemic 
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episodes would help to address the problem of recurrent hypoglycaemia as well as 
designing appropriate policy responses. Therefore, it is important to investigate why 
some people repeatedly rely on emergency services in response to hypoglycaemia 
(SAS participants) and others appear to self-manage or engage the help and support of 
others (non-SAS participants; also see section 2.10.1). This may help offer insights into 
how the management of hypoglycaemic episodes or their impact can be better 
supported (by healthcare professionals or others) to enable better self-care practices. 
Given the findings of the review and the quality of existing research, there was a need 
for good quality research to investigate people’s experiences of hypoglycaemia within 
their overall experience of diabetes. This study explored the perspectives of people 
living with diabetes to address: participants’ experiences of hypoglycaemic episodes; 
including the experience of hypoglycaemic emergencies (i.e. when an ambulance is 
called to attend a person experiencing a hypoglycaemic episode). It investigated 
participants’ perspectives regarding why hypoglycaemic episodes occur, how they are 
avoided and how they are managed over time.  In this context, it was important to 
establish reasons why participants made use of emergency services, and also why 
some people did not. Therefore, this study adopted a sample that allowed for 
comparison of two groups of people with diabetes: those who had recently used 
emergency services to manage a hypoglycaemic episode (Scottish Ambulance Service 
(SAS) participants), and a group of people primarily recruited via Diabetes UK who self- 
identified as not having recently used the SAS.  
This study used a longitudinal approach to explore participants’ perspectives and 
experiences of recurrent hypoglycaemia over time. It employed a multiple methods 
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approach, with qualitative semi-structured interviews forming the basis of the 
investigation, and quantitative data being collected on participants’ daily blood 
glucose readings and recording of hypoglycaemic episodes to capture episodes and 
understand how participants’ responses to low blood glucose levels may vary. This 
approach helped to explore participants’ experiences of living with diabetes and 
hypoglycaemia, thus giving an insight into people’s life worlds (Hawkes et al. 2009). It 
also helped understand people’s individual explanations for hypoglycaemic episodes 
as they happened, and their coping strategies, as well as how hypoglycaemic episodes 
affected their everyday life. 
The research questions for this study were: 
1. What are the experiences of recurrent hypoglycaemia of those who were 
emergency service users (SAS participants) and those who were not (non-SAS 
participants)? 
a) How does hypoglycaemia affect participants’ everyday life? 
b) What is the impact of hypoglycaemia on participants’ family and wider 
social network? 
2. What are participants’ explanations for having recurrent hypoglycaemia?  
a) What coping strategies do participants adopt to deal with recurrent 
hypoglycaemia? 
b) How (if at all) does recurrent hypoglycaemia influence diabetes self-
management behaviours? 
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3. Are there any changes over time in relation to experience, possible 
explanations and management of recurrent hypoglycaemia? What influences 
these? Are there any differences between participant’s various hypoglycaemic 
episodes (within case)? 
4. Are there any similarities or differences between SAS participants and non-SAS 
participants?  
a) Are the SAS group having more severe hypoglycaemic episodes than those who 
do not use emergency services?   
3.4 Conclusion 
Diabetes is a chronic condition, and its care is an on-going process. This chapter has 
provided a review of existing literature investigating people’s experiences and 
perspectives of living with diabetes and hypoglycaemia. The literature was reviewed in 
two parts, covering experience of living with diabetes, as well as hypoglycaemia.  
Key themes from the first review showed that a substantial part of the burden of 
managing diabetes is borne by the people living with it; and that they face multiple 
challenges in trying to navigate their everyday life. Sometimes treatment goals 
between health professionals and patients can conflict.  
The second review emphasised the impact of hypoglycaemia on the everyday life of 
people living with diabetes, their quality of life, as well as issues around fear of 
hypoglycaemia, impact on identity and loss of control. The final sections discussed the 
review and concluded that there was a lack of research investigating people’s 
experiences of hypoglycaemic episodes, especially in the context of use/non-use of 
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emergency services. This then provided a rationale for the current study undertaken 
as part of this PhD. 
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Chapter 4 - Theoretical perspectives within illness 
experience 
4.1 Introduction 
This study is a piece of applied health research which has been informed by a number 
of sociological theories. According to Fathalla (2004), applied health research “has 
potential to improve health or quality of life” (p.27). This chapter discusses some 
sociological theories that could apply to this field of research. It highlights theories of 
illness experience, help-seeking and self-care, and discusses their potential relevance 
to this study. These theoretical perspectives are considered in relation to study 
findings in the final discussion chapter.  
4.2 The role of theory 
Theories of illness experience are concerned with how people interpret the social and 
psychological aspects of living with chronic illness. They contribute to a better 
understanding of health, help-seeking, and healthcare provision. Freund et al. (2003) 
state that the “interpretation of illness is an on-going process. People reinterpret their 
situation at various stages of their illness. They look back at earlier experiences and 
actions and reinterpret them to make sense of subsequent events and new beliefs” 
(p.173). This thesis focusses on the social aspects of illness experience. 
The role of theory in health research has been well documented (Alderson 1998; Brazil 
et. al 2005; Reeves et al. 2008; Kelly 2010). For example, Reeves et al. (2008) have 
suggested that using theories may “propose explanations of the underlying causes or 
influences of observed phenomena” (p.633). Therefore, in health research theory can 
help explain why a phenomenon happens and in interpreting data. This section 
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highlights a number of theories that are potentially useful for the interpretation of the 
study data. There is first a mention of biomedical and sociological models of health, 
given the nature of diabetes. 
4.3 Biomedical versus sociological model 
Illness can be viewed and defined from various perspectives, for example, biomedical 
and sociological. Between these two, the biomedical model has been the more 
dominant model of health and illness in western medicine (Freund et al. 2003).  
The foundation of the biomedical model is the belief that illness is confined to the 
body; that is, illness is understood as the presence of biological abnormality. Medical 
interventions and treatments are tools to halt or reverse the disease process 
(Armstrong 2000; Taylor 2007). The health of society is considered to be largely 
dependent on medical knowledge and medical resources, due to the narrow focus of 
the biomedical model (Freund et al. 2003).  
Helman (2007) suggests that to some extent, modern medicine has adopted a 
reductionist approach, moving beyond the individual, and concentrating only on 
specific ‘diseased’ parts of the body. This has resulted in many medical doctors 
specialising in a small area of medicine. Even though this reductionist approach has 
been useful in advancing medical knowledge, Freund et al. (2003) noted that it could 
miss out on the wider dimensions affecting people’s health status. 
Medical advancements have been remarkable, helping to achieve greater accuracy of 
diagnosis, as well as finding causes and targeting cures for diseases. However, a major 
limitation of the biomedical model is its exclusive focus on the physical body, ignoring 
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the social, emotional, cultural and psychological dimensions of ill health (Helman 
2007). 
In contrast to the biomedical model, the sociological model emphasises the 
environmental, social and economic causes of and/or ‘construction’ of illness. In terms 
of terminology, the sociological model uses ‘illness’ rather than ‘disease’, signalling 
wider implications, including people’s perspectives and interpretations of illness 
(Helman 2007). 
The sociological model underlines prevention, health promotion and the social 
construction of health and illness, rather than relying on medical treatment (Freund et 
al. 2003). It considers where the prevention or halting/reversing of illness might be at 
a societal level by looking at structural issues, as well as the individual level (Taylor 
2007).  
As highlighted above, the biomedical model has been dominant in modern medicine. 
This may have some implications for this study, for example, participants may be used 
to focussing on physical symptoms, and placing more emphasis on how they feel 
physically in relation to their diabetes and experiences of hypoglycaemic episodes. 
However, the biomedical world or ‘illness’ is only one part of people’s daily life and 
may not dominate.  
4.4 The sick role 
Parsons’ sick role theory is one of the most influential sociological theories of illness 
experience. Since its introduction in 1951, it has yielded volumes of research (see 
Freidson 1960; Twaddle 1973; Hahn 2001). The sick role theory defines illness 
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behaviour as a social role that disrupts normal, everyday life. Parsons views the sick 
role as temporary and deviant behaviour that is medically sanctioned (Cockerham 
2000). The sick person is exempt from normal social roles and everyday responsibilities 
during the period of illness. However, the legitimisation of being exempt from usual 
duties brings with it the expectation to view sickness as undesirable and to seek help.  
Further key characteristics of Parsons’ sick role theory include the assumption that 
patients are not responsible for their illness and that they are motivated to get well 
(Young 2004).  According to Parsons (1951) the ‘help’ would generally be in the form 
of professional medical help, and the patient would be compliant with the advice 
given. 
Despite the influence of Parsons’ sick role theory over the years, it has continued to 
divide academic opinions as well as receive criticism. One critic of Parsons’ work is 
Freidson (1960), who argues that Parsons overemphasised the consensus between the 
patient and the health professional. He points out that potential discrepancies 
between professional beliefs and lay perceptions could lead to conflicts between 
patients and professionals. Freidson (1960) introduces the ‘lay referral system’, that is 
a network of “potential consultants, from the intimate and informal confines of the 
nuclear family through successively more select, distant, and authoritative laymen, 
until the ‘professional’ is reached” (p.377). 
Further criticisms of Parsons sick role theory are in the works of Twaddle (1973) and 
Hahn (2001). Twaddle’s main criticism relates to the assumption that illness is viewed 
as deviant, while Hahn (2001) was concerned about the challenges arising in the 
doctor- patient relationship, and the part symptoms play in confirming the sick role. 
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More recently, Rier (2010) has highlighted a few grey areas of the sick role theory, e.g. 
when there is no official diagnosis (yet); or when the patient has an illness/symptoms 
that are not accepted by either the health professional or people around. 
Another major criticism relates to the applicability of Parson’s theory to long-term or 
chronic illness, given that the theory is based on acute, short-term illness (Taylor 
2007). Where someone is suffering from a long-term illness, the notion to get well and 
‘leave’ the sick role is difficult to achieve (Cockerham 2000). Parsons recognised this 
and modified his theory in 1975 to accommodate chronic illness, and the ‘getting well’ 
component of his original conceptualisation was considered equivalent to managing 
the chronic illness/following medical advice (Parsons 1975). 
The sick role theory views the patient as a passive recipient of care, rather than active 
participant, lacking autonomy. This passivity of the patient in the sick role theory limits 
its relevance to this study, as patients living with a chronic illness such as diabetes tend 
to play an active role in the management of their illness.  
4.5 Suchman’s illness experience model 
Suchman’s illness experience model is another sociological model that has been used 
in health research (Suchman 1965b; Andersen and Aday 1978; Pescosolido 1992; 
Cockerham 1995; Young 2004). It explains the different stages of illness experience, 
starting with symptom experience, response to symptoms, using self-care and lay 
advice to alleviate symptoms, through to interactions between the patient and health 
professional (Young 2004). In his model, Suchman (1965a) shows that in addition to 
physiological factors, cultural and social aspects play key roles in determining how 
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individuals respond to illness, and whether they seek medical help or not. Building on 
Parsons’ sick role theory, it goes further to explain delays in seeking medical care, 
highlights issues around self-care and lay referral, and interruptions of care (Young 
2004). 
According to Suchman (1965a), there are five stages of illness experience: 
• The first stage is symptom experience, where the patient recognises that 
something is wrong. If the symptoms are interpreted as indication of an illness, 
the patient assumes the sick role.  
• In the second stage, and within their sick role, patients seek symptom 
alleviation by consulting their social network for lay advice or by applying self-
care/self-medication.  
• When professional medical care is being sought, the person has moved to the 
third stage. At this stage, legitimisation for the sick role is being sought.  
• The fourth stage is acceptance of professional treatment and thereby assuming 
a dependent-patient role. 
• Finally the recovery and rehabilitation stage, which includes a return to normal 
function (Suchman 1965a; Cockerham 1995). 
At each stage of this experience, a decision has to be made, which determines either 
the continuation or interruption of the process. Suchman’s model is useful in 
understanding the “relationship between severity of symptoms, seriousness of 
symptoms, and degree of incapacitation with the level of concern and physician 
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contact; the greater the severity, seriousness, and incapacitation, the greater the level 
of contact with the physician” (Young 2004:12).  
Since the original work (Suchman 1965a), Suchman’s model has been widely applied. 
For example, in his survey study of social patterns of illness and medical care, Suchman 
(1965b) used his own model to investigate social group influences on individual 
medical responses within a multi-ethnic background. He found that an individual’s 
medical orientation can be highly influenced by the social organisation within which 
that individual associates. Some other works that have used and/or discussed 
Suchman’s illness experience model include: analysis of the influence of 
culture/ethnicity on symptom recognition and interpretation (Zola 1966), a critical re-
examination of Suchman’s model (Geertsen et al. 1975), benefits of self-help groups in 
the context of chronic illness (Trojan 1989) and social dimensions of help-seeking 
(Pescosolido 1992). 
Limitations of Suchman’s model are similar to those of Parsons’ sick role theory, even 
though Suchman’s model includes lay referral through people’s social network as well 
as self-care activities to treat symptoms (Young 2004). A key criticism relates to the 
fact that Suchman’s model is limited to the microsociological level, and does not 
consider environmental factors, population characteristics and the influence of 
healthcare institutions (Andersen and Aday 1978). 
Geertsen et al. (1975) re-analysed Suchman’s original data and compared it to new 
data. They concluded that Suchman did not include a number of aspects that may 
impact on the illness experience, e.g. cultural, structural and socio-economic aspects, 
as well as individual lifestyle characteristics.  
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4.6 Help-seeking theory 
Another theory that might be relevant for this study is Mechanic’s general theory of 
help-seeking (Mechanic 1966; Mechanic 1968; Mechanic 1995). Mechanic posits that 
illness behaviour is based on perception, recognition and interpretation of symptoms. 
That is, people’s response to symptoms can vary enormously. Mechanic (1995) claims 
that patients are more likely to seek medical help when symptoms interfere with their 
ability to carry out everyday activities. He adds that stress is also a factor that can 
trigger help-seeking. In explaining variations in patients’ responses to symptoms, 
Mechanic (1995) suggests that individual’s attitude, coping, use of medical care and 
social functioning are hugely dependent on perception of their health status. 
Mechanic further suggests that illness behaviour results from interaction of cultural 
assumptions, socially conditioned responses, and individual psychological factors (see 
Mechanic 1995; also Cockerham 1995). This interplay is illustrated in a study by 
Verbrugge and Ascione (1987), who used health diaries to investigate people’s 
responses to symptoms. The study found that professional medical care was only 
sought on five percent of days on which participants experienced symptoms. The 
authors conclude that “for most symptoms of daily life, people opt to do something on 
their own without medical help” (Verbrugge and Ascione 1987:549). 
On an everyday basis, people have to make a decision as to whether to treat 
themselves, consult family or friends – what Zola (1973) terms ‘lay referral’, or to seek 
medical help. In this context, the challenge is to interpret symptoms adequately; that 
is, to seek medical help where symptoms are serious and medically treatable, and not 
to bother medical professionals with unimportant ailments (Freund et al. 2003). This 
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highlights that help-seeking theory places more importance on patients’ agency and 
autonomy. 
Zola (1973) agrees with Mechanic that patients interpret symptoms variably, and that 
social factors play a major role in patients’ decision to seek medical help. Zola has 
devised a ‘help-seeking model’ (see below) that highlights five different ‘triggers’ or 
crises that can prompt patients to seek medical help.  
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Zola’s Help-Seeking Model (1973) 
According to this model, the first trigger is the occurrence of an inter-personal crisis, 
for example, losing a job or going through family breakdown. For Zola (1973) this can 
cause a person to consider their symptoms in a different light. Further prompts are the 
Perception of symptoms (i.e. physical, personal, social) 
Accommodation of symptoms 
Breakdown of accommodation due to:                             
1. Inter-personal crisis                                                          
2. Perceived interference with work activities                 
3. Perceived interference with social/leisure activities  
4. Sanctioning by others who insist help be sought        
5. Symptoms persist beyond arbitrary time limit  
Decision to seek help 
Lay referral Visit GP 
Self-medication   
Alternative therapies 
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perceived interference with work and social activities. For example, a painful back 
might prevent someone from taking part in social activities or might result in the 
person feeling unable to carry out daily work properly.  
Another trigger relates to ‘sanctioning’, which means that another person either 
legitimises the need to, or even insists on seeking medical help. Finally, if symptoms 
persist beyond an arbitrary time limit set by the individual, a decision to seek help 
might be facilitated. 
Interestingly, the decision to seek help does not necessarily lead to a visit to the GP; 
patients can also rely on what is termed a ‘lay referral’ system; that is other people 
around them including family and friends. In times of increasing availability of medical 
information, people also tend to engage in ‘self-medication’. For example, researching 
their symptoms on the internet and getting hold of drug treatments over the counter 
(Crinson 2007). Nettleton (2006) sums this up with the following words: “Seeking help 
is an on-going social process, rather than a straightforward response to physical 
symptoms” (p.77). 
4.7 Labelling theory 
Having an illness can often be stigmatising. Goffmann’s work (1968) has been 
fundamental in the context of stigma. His work is based on the assumptions of 
symbolic interactionism, that is, people act based on their interpretations of social 
situations, which takes place in the context of social interactions (Mead 1967).  
Goffmann describes stigma as reactions resulting from the discrepancy between 
people’s ‘virtual social identity’ (the way people should be if they did not have an 
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illness) and their ‘actual social identity’ (the way people are with an illness), referring 
to this as ‘spoiled identity’. If people’s illness or disability is visible, they are more likely 
to experience stigmatised reactions from others. This actual experience of being 
stigmatised is also known as ‘enacted stigma’ (Taylor 2007).  
In contrast, a different form of stigma, called ‘felt stigma’, considers people’s fear of 
being stigmatised. The distinction between enacted and felt stigma has been 
particularly coined by Scambler and Hopkins (1986), who conducted a study into the 
impact of epilepsy on patients’ lives, with a specific focus on stigmatising experiences. 
Interestingly, they found that felt stigma was much more disruptive to people’s lives 
than enacted stigma (Scambler and Hopkins 1986). 
The concept of legitimacy as discussed by Freidson links in well with labelling theory. 
He claims that there are three categories of legitimacy: conditional legitimacy, 
unconditional legitimacy and illegitimacy (Cockerham 1995). The difference between 
conditional and unconditional legitimacy is that the exemption from usual obligations 
is temporary or permanent, respectively. In contrast, illegitimacy frees individuals 
from some of their duties on a permanent basis, but this may come at a cost of 
stigmatisation (Freidson 1970). This is often the case with chronic illness. 
In the case of diabetes, illegitimacy could mean that people with diabetes may be 
expected to perform less well or take more time off work due to diabetes 
(complications), compared to people who do not have diabetes. According to 
Cockerham (1995), how people with a particular condition are viewed depends on the 
context and attitude of people around them (i.e. the concept of legitimacy is relative). 
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A major criticism of labelling theory is based on its limitation in relation to an 
explanatory stance. Labelling theory does not explain the reasons for illegitimacy; 
rather it focusses on the social reaction to it (Cockerham 2000). Another limitation of 
labelling theory relates to its variability/relativity as to what and who gets stigmatised. 
This depends on the societal, cultural and historic context (Young 2004). 
4.8 Biographical disruption 
Bury (1982) introduced the concept of ‘biographical disruption’, following a study with 
rheumatoid arthritis patients. His investigations focussed on the early stages of 
diagnosis and adjusting to the chronic illness. Bury claims that chronic illness disrupts 
everyday life in three ways:  
First, chronic illness interferes with everyday activities, it disorganises behaviours and 
routines that have been taken for granted. This impact on everyday life includes 
uncertainty in the face of fluctuating and unpredictable symptoms. 
Second, the disruption extends to people’s explanatory systems, which prompts a re-
thinking of identity and self-concept. Bury illustrates this point using the example of 
young women who were diagnosed with rheumatoid arthritis. Since this condition was 
perceived as an illness of ‘aging’ or older people, a diagnosis of rheumatoid arthritis 
for people in their twenties or thirties was upsetting in relation to their perceived 
‘normal trajectory’ (Bury 1982). 
The third point is concerned with people’s response to the disruption and the way 
they adjust to changing circumstances. This includes how people identify and use 
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resources (e.g. social network) as well as how they deal with the risk of social isolation 
and dependency (Bury 1982). 
There have been a number of criticisms of Bury’s concept of biographical disruption 
relating to timing/age and context of a chronic illness (Lawton 2009). Bury (1982) 
based his concept on findings that highlight the impact of chronic illness on a relatively 
healthy population (young women). However, the relevance of his concept is limited in 
older populations who may already have multiple health problems, and therefore may 
not perceive the onset of a new illness as biographically disruptive; instead, it may 
have been anticipated due to older age (Pound et al. 1998). 
Williams (2000) has published a paper reviewing Bury’s work. He pointed out that it is 
important to take the broader historical, social and political context into consideration 
when assessing the usefulness and relevance of the concept of ‘biographical 
disruption’. The criticisms levied against the biographical disruption concept highlight 
one major flaw of the concept: it is based on the assumption that a life has been free 
from illness and any other complexities when chronic illness occurs (Lawton 2009).   
4.9 Loss of self 
Charmaz (1983) looked at the ‘loss of self’ as a key feature in the management of 
chronic illness. Her study was based on data from a qualitative study that included 57 
chronically ill people. The ‘loss of self’ happened as a result of four dilemmas that 
people who have a chronic illness may face: the first dilemma was living a ‘restricted 
life’. The restrictions could either be a direct result of accommodating the chronic 
illness, or self-imposed in order to avoid embarrassment. Following these restrictions, 
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the second dilemma of social isolation may occur. For example, as people socialise less 
due to fear of embarrassment or unpredictability of symptoms, they risk becoming 
more isolated (Charmaz 1983).  
The third dilemma refers to ‘being discredited’. This is directly linked to people’s 
identity and sense of self, and takes place in the context of interaction with others. 
How people around view and act towards the person with a chronic illness has a direct 
impact on the person’s sense of self. The extent of the discrediting depends on the 
individual’s perception in terms of magnitude, who the gesture is coming from, and 
the specific situation.  
Interestingly, the discrediting or stigmatising includes those people with ‘invisible’ 
impairments like diabetes, resulting in decreased participation in the normal world 
(Charmaz 1983). Similarly, Field and Kelly (2007) argue that a chronic illness will always 
impact on a person’s identity, independent of whether or not others know about it, as 
it requires actions to manage the illness. 
Taylor (2007) supports this view as he points out the impact chronic illness can have 
on people’s identities: it can change people’s sense of self or self-image. Living with a 
chronic illness can affect people’s feelings of control over their lives as well as their 
sense of autonomy. Taylor shows that illness is not only an attack on the integrity of 
the body, but also on people’s identities. He states: “The sick person’s place in the 
world and sense of who they are can become compromised or even lost” (Taylor 
2007:39). 
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A final point Charmaz raises is that of ‘being a burden’ to others. This links in well with 
the ‘loss of control’ theme from the diabetes literature (e.g. Rajaram 1997). As people 
with a chronic illness lose their independence, they rely on others to support them 
(e.g. social network, healthcare system). Again, the feeling of ‘becoming a burden’ has 
an effect on the person’s sense of self, potentially limiting the role/s the person can 
fulfil. All four factors summarised here contribute to the loss of self. This brings with it 
the need to re-negotiate self-image and identity (Dewar and Lee 2000; Rasmussen et 
al. 2007). 
4.10 Theory of self-care 
Orem developed a theory of self-care, based on her definition of a universal human 
need for self-care. That is the “need for self-care action and the provision and 
management of it on a continuous basis in order to sustain life and health, recover 
from illness or injury, and cope with their effects" (Orem 1959:3). This quote shows 
that according to Orem, self-care does not just relate to treating illness, but also 
expands to activities required to maintain life and health. 
Orem (1991) defined self-care as “the practice of activities that individuals initiate and 
perform on their own behalf in maintaining life, health and well-being” (p.117). Every 
individual has the ability to perform self-care and take responsibility for their health 
(Masters 2011). Orem maintains that healthy adults would willingly care for 
themselves, while others such as children, the elderly, sick and disabled people would 
either require complete care or assistance with self-care activities. 
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In explaining how and why people care for themselves, Orem has developed a theory 
of self-care. This comprises of three composite theories: theory of self-care, theory of 
self-care deficit, and theory of nursing systems (Orem 1991; 1995).  
 
 
 
 
 
 
 
 
 
Figure 4.2: Orem’s self-care deficit theory of nursing (adapted from Orem 1995; 
2001) 
 
The theory of self-care outlines the care which an individual requires in order to stay 
healthy or get better from illness. The theory of self-care deficit goes a step further, 
explaining when medical care is required, that is, when patients and their family 
members/carers are not or no longer able to care for the individual. Finally, the theory 
of nursing systems refers to actions a nurse/medical professional undertakes to help 
meet a person’s self-care needs. It also describes the nurse’s responsibilities, roles of 
the nurse and the patient, as well as the nurse-patient relationship (George 1995).  
Given that this study investigated participant’s experiences, and not those of health 
professionals, or interactions between health professionals and patients, the first two 
composites of Orem’s theory (theory of self-care and theory of self-care deficit) may 
be potentially relevant, and will be further explored. 
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Theory of self-care 
 
 
Figure 4.3: Theory of self-care (adapted from Orem 1991; 1995) 
 
Orem’s theory of self-care includes four main components: self-care, self-care agency, 
self-care demand and self-care requisites. The purpose of self-care is to achieve 
human functioning and development. Self-care agency is the ability of the individual to 
engage in self-care activities (Orem 1991). Self-care demand is the self-care actions 
needed to meet an individual’s self-care requirements, while self-care requisites are 
actions required to provide self-care (Orem 1991).  
According to Orem (1991), there are three categories of self-care requisites, namely: 
universal, developmental and health deviation. Universal self-care requisites are 
common to all human beings varying with age, development and environment. They 
are linked to basic human functioning and well-being. Developmental requisites relate 
to processes and conditions that occur during various stages of the life cycle, e.g. 
pregnancy, adverse events, etc. Health deviation self-care requisites are concerned 
with genetic and constitutional defects, as well as human structural and functional 
deviations and their treatment (Orem 1991).  
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Theory of self-care deficit 
The theory of self-care deficit is a vital component of Orem’s theory as it helps to 
identify the reason why people require nursing, and also explains when nursing is 
needed. When patients are not able to meet self-care requisites due to limitations 
relating to their self-care agency/ability to carry out self-care activities, nursing may 
become necessary (Orem 2001). 
There are a few limitations to Orem’s theory of self-care and self-care deficit. Despite 
widespread use of Orem’s theories in nursing practice and research (Zarkowska and 
Clements 1994; Moore and Pichler 2000; Berbiglia 2002; Taylor 2002), it has been 
criticised for its use of terminology (Fitzpatrick and Whall 2004). The authors have 
noted that the multiple terms can be confusing, thus question the clarity of the theory. 
Orem’s theory is broad and comprehensive, touching important aspects of self-care 
(George 1995). However, according to Fitzpatrick and Whall (2004), it is not dynamic 
enough, potentially lacking to explain various levels of need. Despite these limitations, 
Orem’s theory may have some relevance for this study, as it could potentially help 
explain participants’ ability to perform self-care actions and the circumstances under 
which external help and intervention would be sought or needed. 
4.11  Conclusion 
This chapter has introduced some potentially relevant theories from the fields of 
chronic illness experience and help-seeking behaviour. For example, the biomedical 
model could be relevant to this study, given its emphasis on the physical body; that is, 
diabetes as a metabolic disorder that impacts on the functions of a healthy physical 
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body. Participants may be used to focussing on physical symptoms, and placing more 
emphasis on how they feel physically in relation to their diabetes and experiences of 
hypoglycaemic episodes. However, the medical management of illness is only one part 
of how people understand and cope with illness. The biomedical model tends to be 
reductionist, and may miss that people experience symptoms differently (Helman 
2007). 
Various aspects of theories introduced in this chapter may be relevant for this study, 
for example, the impact diabetes and the experience of hypoglycaemia can have on 
people’s identity and sense of self (Charmaz 1983). Charmaz highlights issues around 
being discredited or becoming a burden to others. This may be useful to explain the 
dynamics of seeking external help to treat hypoglycaemic episodes or to carry out 
diabetes self-care activities. 
Further, the concept of biographical disruption (Bury 1982) may be relevant for this 
study, as it could help to explain how participants respond to hypoglycaemic episodes, 
and adjust to living with diabetes. However, as highlighted in section 4.7, Bury’s 
concept focussed on the early stages of diagnosis and adjustment, which may limit its 
relevance to this study. Given that most participants in this study have lived with 
diabetes for many years, and therefore tend to be ‘expert patients’, that is, they have 
some experience of managing their diabetes and are used to hypoglycaemic episodes 
happening recurrently (Paterson and Thorne 2000). 
Help-seeking theory (Mechanic 1968; Mechanic 1995) could be relevant for the 
analysis and interpretation of data. This study looked at participants’ responses to 
symptoms of hypoglycaemia, as well as the phenomenon of hypoglycaemia 
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unawareness. In this context, Mechanic’s focus on perception, recognition and 
interpretation of symptoms could be very useful. Help-seeking theory affords more 
autonomy to the patient and may therefore be helpful for this thesis, since people 
living with a chronic illness tend to play an active role in the management of their 
illness, as opposed to being passive recipients of healthcare (Nettleton 2006). 
Also, labelling theory may have relevance to this study, in particular issues around the 
potential for people with diabetes to experience stigma (see section 4.7). Stigma may 
be an issue for people living with chronic illness. In terms of diabetes, the thought of 
hypoglycaemic episodes happening in public could cause embarrassment, fear or 
could lead to increased felt stigma. Labelling theory could therefore help to inform our 
understanding around the impact diabetes and the experience of hypoglycaemia could 
have on people’s sense of self and identity (Charmaz 1983; Taylor 2007).  
Another theoretical framework introduced in this study that could inform analysis and 
interpretation of findings is Orem’s theory of self-care and self-care deficit. It may help 
to explain participants’ ability to perform self-care actions, as well as highlight where 
people are not able to meet self-care demand and where external help is required. 
Orem’s theory may also help to explain how people with diabetes are required to 
modify their self-care activities in order to lead a normal life (‘maintain life and 
health’) and navigate the complexities of managing a long-term condition (Orem 1991; 
1995). 
In this context, diabetes self-management may be considered a health deviation self-
care requisite. For example, people with diabetes have to carry out a variety of self-
care activities (monitor blood glucose level, inject the appropriate amount of insulin at 
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regular intervals, etc.) to cope with their illness. In any situation when an individual is 
not able to meet these self-care requirements, external help may be required. This is 
usually the case when the person experiences a severe hypoglycaemic episode. 
This chapter has discussed theories with potential relevance and usefulness to this 
study. Theory is important in helping to understand why a phenomenon happens and 
in interpreting data (Kelly 2010). This thesis discusses the study findings in relation to 
these theoretical explanations (see section 9.3.1). 
The next chapter describes the primary research study undertaken for this PhD thesis. 
This includes a description of the aims and research questions, the study design and 
methods used. It also highlights challenges of the approaches employed as well as 
their operationalisation. 
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Chapter 5 - Methods 
5.1 Introduction 
The purpose of this research study was to explore participants’ perspectives and 
experiences of recurrent hypoglycaemia over time. The study employed a multiple 
methods approach, with qualitative semi-structured interviews forming the basis of 
the investigation. In terms of theoretical positioning, this study is a piece of applied 
health research which has been informed by a number of sociological theories. For 
example, this study explored participants’ social construction of illness (see Conrad 
and Barker 2010), and whether they had developed their own understanding of what 
hypoglycaemia is rather than relying on medical definitions (see section 7.2.4). 
This chapter aims to provide a detailed account of the development, design, methods, 
implementation and analysis of the study. The chapter begins with an overview of 
study aims and research questions, and gives a rationale for the methodological 
approach that was selected. It further presents details of the methods used in 
conducting the research, including sampling strategy, access to participants, 
recruitment process, ethical considerations, and practicalities around data collection. 
Finally, the chapter outlines the approach used for analysis of both qualitative and 
quantitative components, as well as synthesis of data.  
5.2 Aim of the study 
There was a scarcity of studies that focus on people’s experience of hypoglycaemic 
episodes, as well as a lack of research in this area using a longitudinal approach (see 
section 3.3.6). Therefore, the overall study aim was to investigate participants’ 
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experiences, possible explanations and management of recurrent hypoglycaemia over 
time (in the context of chronic illness experience). This was undertaken with two 
different participant groups: those who had recently used emergency services (SAS 
participants) and those who had not recently used emergency services (non-SAS 
participants, primarily recruited through Diabetes UK Scotland). 
5.3 Research questions 
The research questions were:  
1. What are SAS and non-SAS participants’ views of experiencing recurrent 
hypoglycaemia? 
a) How does hypoglycaemia affect participants’ everyday life? 
b) What is the impact of hypoglycaemia on participants’ family and wider 
social network? 
2. What are participants’ explanations for having recurrent hypoglycaemia?  
a) What coping strategies do participants adopt to deal with recurrent 
hypoglycaemia? 
b) How (if at all) does recurrent hypoglycaemia influence diabetes self-
management behaviours? 
3. Are there any changes over time in relation to experience, possible 
explanations and management of recurrent hypoglycaemia? What influences 
109 
 
these? Are there any differences between participant’s various hypoglycaemic 
episodes (within case)? 
4. Are there any similarities or differences between those who were emergency 
service users (SAS participants) and those who were not (non-SAS 
participants)? 
a) Are the SAS group having more severe hypoglycaemic episodes than those 
who do not use emergency services?  
Addressing the above questions will provide better understanding about the 
contributing factors to recurrent hypoglycaemia. It will also explore specific 
explanations for recurrent hypoglycaemia from the participants’ perspective, as well 
as highlight potential ways of reducing the number of emergency call-outs due to 
hypoglycaemia. 
5.4 Study design 
5.4.1 Multiple methods research 
Multiple methods research, also referred to as mixed methods research, has become 
increasingly popular within social and health science research (Johnson and 
Onwuegbuzie 2004; Greene 2007; Creswell et al. 2011). This can be attributed to the 
advancements in methodology, made possible by the various opportunities for 
training available to researchers using multiple methods approaches (Brannen 2005a). 
According to Tashakkori and Creswell (2007), mixed methods research has been 
defined as “research in which the investigator collects and analyses data, integrates 
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the findings, and draws inferences using both qualitative and quantitative approaches 
and methods in a single study or programme of inquiry” (p.3).  It has also been 
referred to as ‘multi-strategy research’ (Bryman 2001), which entails the application of 
different research strategies to the investigation of a complex set of research 
questions (Brannen 2005b).  
In terms of terminology, various terms have been used to describe mixed methods 
research (e.g. multi-method research, combined methods, mixed methods or multiple 
methods), and there has been some debate over the appropriate definition of each 
terminology (Gurtler et al.2007; Creswell 2011). Some authors have suggested using 
the term ‘multiple methods’ rather than ‘mixed methods’ when multiple sources of 
mainly one type of data (qualitative or quantitative) has been used (Morse and 
Niehaus 2009).  
This study used multiple methods to investigate people’s experiences and individual 
explanations of recurrent hypoglycaemic episodes. Greene (2007) has considered this 
approach as “multiple ways of seeing and hearing, multiple ways of making sense of 
the social world, and multiple standpoints on what is important and to be valued” 
(p.20). This type of combination and integration of findings also helps to investigate 
similarities and differences between various aspects of human behaviour (Bernardi et 
al. 2007).  
Additionally, there has also been much debate relating to theoretical perspectives. The 
debate has largely focussed on the different epistemological and ontological 
assumptions and paradigms associated with qualitative and quantitative research (Sale 
et al. 2002). Bryman (2007) argues that qualitative and quantitative research differs in 
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far more than the use of words or numbers; differences extend to the very 
foundations of each research approach: its epistemological, ontological and 
paradigmatic stance. 
Quantitative research approaches have traditionally been associated with ‘positivism’, 
which holds the position that there is an objective reality. This objective reality is 
considered independent of human perception and social interaction, and can be 
measured and reported as ‘facts’ (Sale et al. 2002; Bryman 2007). The positivist 
perspective originated from the natural sciences, using quantitative methods to 
measure phenomena and test hypotheses. Quantitative research typically adopts a 
deductive approach, where hypotheses are developed based on theory and then data 
is collected to test the hypotheses (Carr 1994; Buckingham and Saunders 2004). 
In contrast, qualitative research is usually based on an interpretivist paradigm which is 
concerned with meaning and action within the social world. It seeks to interpret how 
individuals experience and make sense of the world around them (Mason 1996; Sale et 
al. 2002; Bryman 2008). Rather than taking an objectivist view, qualitative research 
generally follows a constructionist ontological position which incorporates the 
assumption that realities are constructed by individuals, influenced by social 
interaction, and that there are multiple realities (Lincoln and Guba 2000). Another 
important aspect of the interpretivist epistemology is the role of interaction between 
the researcher and participants, which could influence the research process (Mason 
1996). Qualitative research is inductive in terms of how theory develops; it describes 
social phenomena as they occur naturally, and data is used to develop concepts and 
theories (Bradley et al. 2007; Lapan et al. 2011). 
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While the debate over philosophical stance continues (Bryman 2006; Creswell and 
Plano Clark 2007), the appropriateness of the different paradigms depends on the 
focus of the specific study design. For example, Howe (2004) has introduced the term 
‘mixed methods interpretivism’ in which qualitative research is the dominant method, 
and quantitative methods play a secondary role. This study was underpinned by such a 
‘mixed methods interpretivist’ paradigm, as its focus was on understanding people’s 
perspectives and their interpretations of the social world using qualitative methods as 
its dominant method (Snape and Spencer 2003).   
This study used multiple methods and multiple types of data collection to capture the 
depth and multiplicity of participants’ experiences of recurrent hypoglycaemic 
episodes.  While the qualitative method was the dominant method, quantitative data 
was used to record actual hypoglycaemic episodes and a range of blood glucose 
readings surrounding these episodes. The quantitative data added a precise measure 
of phenomena in the following ways: first, it helped to relate blood glucose readings to 
actual hypoglycaemic episodes collected via the hypoglycaemia diary. This was useful 
to establish whether actual blood glucose readings fell below the agreed threshold of 
hypoglycaemia (4.0 mmol/l, see section 2.7), and whether participants recorded a 
hypoglycaemic episode when their blood glucose reading did fall below 4.0 mmol/l. 
Therefore, quantitative data was also relevant in investigating hypoglycaemia 
unawareness, an important phenomenon that can contribute to the use of emergency 
services (see section 6.5.3).  
Second, quantitative data allowed for comparison of perceived severity scores of 
hypoglycaemic episodes across study groups (SAS and non-SAS participants). And 
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third, quantitative data provided an opportunity to compare the number of 
hypoglycaemic episodes across study groups. Hence, findings from quantitative data 
addressed the research question relating to similarities and differences between those 
who had recently used emergency services (SAS participants) and those who had not 
recently used emergency services (non-SAS participants, primarily recruited through 
Diabetes UK Scotland).  
The qualitative data was particularly useful to gain an understanding of participants’ 
experiences and explanations of recurrent hypoglycaemic episodes. It helped to 
address the impact hypoglycaemia can have on participants’ everyday life and their 
support network, as well as what coping strategies participants adopted. Further 
benefits of using qualitative semi-structured interviews and telephone interviews can 
be found in sections 5.7.3 and 5.7.5. Combining the findings from both quantitative 
and qualitative data helped to provide a fuller overall account of participants’ 
experiences of recurrent hypoglycaemia. Findings from qualitative data shed light on 
participants’ experiences of and possible explanations for recurrent hypoglycaemic 
episodes. The unique multiple methods, longitudinal design of this study used findings 
from quantitative data to inform findings from qualitative data.   
Table 5.1 below shows a summary of research questions and relevant data used to 
answer the research questions. 
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Research questions (RQ’s) Relevant data Data type 
1. What are SAS and non-SAS participants’ 
views of experiencing recurrent 
hypoglycaemia? 
Face to face interviews, 
follow-up telephone 
interviews 
Qualitative 
a) How does hypoglycaemia affect 
participants’ everyday life? 
Face to face interviews, 
hypoglycaemia diaries 
(narrative around 
hypoglycaemic episode) 
 
Qualitative 
b) What is the relationship between 
participants’ management of 
hypoglycaemia and their support network? 
Face to face interviews  
 
Qualitative 
2. What are participants’ explanations for 
having recurrent hypoglycaemia? 
Hypoglycaemia diaries 
(individual explanations), 
face to face interviews  
Qualitative 
a) What coping strategies do participants 
adopt to deal with recurrent 
hypoglycaemia? 
Face to face interviews, 
follow-up telephone 
interviews and 
hypoglycaemia diaries  
Qualitative 
b) How (if at all) does recurrent 
hypoglycaemia influence diabetes self-
management behaviours? 
Face to face interviews, 
follow-up telephone 
interviews, hypoglycaemia 
and blood glucose diaries  
Qualitative 
3. Are there any changes over time in 
relation to experience, possible 
explanations and management of recurrent 
hypoglycaemia? What influences these? 
Are there any differences between 
participant’s various hypoglycaemic 
episodes (within case)? 
Hypoglycaemia and blood 
glucose diaries, follow-up 
telephone interviews  
 
 
Qualitative 
4. Are there any similarities or differences 
between those who were emergency 
service users (SAS participants) and those 
who were not (non-SAS participants; more 
likely to engage in self-care)? 
Hypoglycaemia and blood 
glucose diaries (blood 
glucose readings and 
perceived severity score) 
Quantitative 
a) Are the SAS group having more severe 
hypoglycaemic episodes than those who 
do not use emergency services?  
Hypoglycaemia diaries 
(perceived severity score) 
Quantitative 
Table 5.1: Research questions and relevant data 
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5.4.2 Challenges of multiple methods research 
There are, however, a number of challenges in using a multiple methods approach. 
The major challenge relates to integration of qualitative and quantitative data due to 
the use of different data collection instruments, which generate different types of 
data. There has been an argument that the epistemological positions underlying 
qualitative and quantitative methods are conflicting (Bryman 2008) and cannot be 
merged. However, considering that there are huge variations within each research 
methodology, the position that there is a single epistemological and ontological stance 
attached to a research method is difficult to maintain (Bryman 2008).  
Onwuegbuzie and Leech (2005) recognise that there are overwhelming similarities 
between qualitative and quantitative perspectives, as both methodologies use 
observations to address research objectives, and attempt to develop explanations 
through the interpretation of their data. Hence, rather than being opposites, Newman 
and Benz (1998) consider qualitative and quantitative research as an ‘interactive 
continuum’, as neither tradition is fully independent of the other, nor can either 
approach cover the whole research process. Thus, using multiple method approaches 
can provide a more complete understanding of phenomena (Johnson and 
Onwuegbuzie 2004; Bryman 2007; Creswell et al. 2011). 
5.4.3 Longitudinal approach 
Ruspini (1999) claims that there are a number of potential benefits when using a 
longitudinal design: researchers may gain fuller information and a more complete 
picture of the issues under investigation. A longitudinal approach allows for 
investigating changes over time, since data collection is carried out at two or more 
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points in time over an extended period. This can range from a few weeks to many 
years, but is mainly constrained by resources and time available to researchers 
(Menard 2002). A longitudinal approach is considered particularly useful for a study 
using multiple methods as it can help to gain a more accurate picture of the 
phenomena under investigation (Mingione 1999).  
Previous research into experiences of living with diabetes and managing 
hypoglycaemic episodes has largely been cross-sectional (Richmond 1996; Rajaram 
1997; Ritholz and Jacobson 1998). While these studies provide a general insight into 
people’s experiences of hypoglycaemic episodes and impact on everyday life, they 
may miss out on issues relating to change over time, and in understanding potential 
differences between hypoglycaemic episodes, the context in which they occur and 
how they are subsequently managed. Considering that diabetes is a chronic condition, 
it is important to look at hypoglycaemic episodes over time.  
This study applied a longitudinal design to capture a variety of hypoglycaemic episodes 
over time. Participants were asked to keep a personal blood glucose and 
hypoglycaemia diary over a period of six months. The longitudinal approach facilitated 
the investigation of recurrent hypoglycaemia in a number of ways. First, it enabled 
prospective data collection, allowing access to actual hypoglycaemic episodes in the 
context of participants’ everyday life (Polit and Beck 2003). Second, the longitudinal 
approach also helped describe what happened in-between, in the run-up to, as well as 
following different hypoglycaemic episodes.  
Third, it explored whether there were differences between various hypoglycaemic 
episodes. And fourth, it investigated any changes (relating to the research questions) 
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that might have occurred over time (also see Menard 2002). Finally, the longitudinal 
approach can help to explore participants’ specific situations at various points in time 
and thus provide many options for analysis and inferences (Ruspini 2000).  
5.4.4 Challenges of longitudinal approach 
A major challenge in using a longitudinal approach is the issue of attrition; that is 
participants deciding to drop-out of the study at different time points (Polit and Beck 
2012). The main concern with attrition is that those who stay in the study may differ in 
important aspects from those who decide to leave the study (Bryman 2008), hence 
impacting on the representativeness of the sample and validity of study findings 
(Ruspini 2000; Polit and Beck 2012). It is therefore important to address this by 
identifying any differences between participants who leave the study and those who 
stay in the study. Details of this are discussed in section 5.8. 
Further consideration needs to be given to the time lag between data collection 
points, as a longer time lag can contribute to attrition (Robson 2011). In this study, 
data collection was on-going during the six month follow-up phase, and I kept in 
regular contact with participants. In order to make study participation as 
straightforward and easy as possible, participants were provided with clear 
information about the study and given the opportunity to ask questions both before 
and during the study. 
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5.5 Population 
5.5.1 Sampling strategy and sample size 
Developing a sampling strategy is a very important stage in the research design, and 
there are a number of approaches to sampling. A major distinction can be made 
between probability and non-probability sampling, which are associated with 
quantitative and qualitative research designs, respectively (Ritchie et al. 2003a; 
Bryman 2008). While probability sampling is mainly concerned with a statistically 
representative sample, non-probability sampling has traditionally been used in 
qualitative approaches. The choice of sampling strategy depends primarily on the 
research aim and research questions.  
As this study is guided by a qualitative approach to sampling, the two main approaches 
to sampling in qualitative research will briefly be outlined. First, theoretical sampling 
has been associated with grounded theory (Glaser and Strauss 1967), and, as the name 
suggests, is driven by the potential to develop theory. Theoretical sampling evolves in 
an iterative process: the researcher selects an initial sample, analyses the data, and 
decides on a further sample that helps to develop and refine emerging categories and 
theory (Charmaz 2000; Ritchie et al. 2003a; Hodkinson 2008).  
Another approach is purposive sampling, where participants are selected based on 
specific characteristics and criteria they possess (Mason 1996). This is also referred to 
as ‘symbolic representation’ by Ritchie et al. (2003a), because participants are chosen 
to both ‘represent’ and ‘symbolise’ certain features that are relevant to the study. As 
Gilbert (2008) put it, “the focus is on gaining insight and understanding by hearing 
from representatives from a target population” (p.512). The inclusion criteria are 
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strategically developed to ensure focus and relevance on research aim and research 
questions (Bryman 2008). The main difference between purposive and theoretical 
sampling is the stage at which criteria are defined: in purposive sampling the criteria 
are developed before data collection takes place, while within theoretical sampling the 
criteria evolve during the data collection period (Ritchie et al. 2003a). 
In sampling for qualitative research, consideration needs to be given to variety within 
the sample. This increases the chances to capture the full range of factors that are 
associated with a phenomenon, as well as allowing for comparison within the sample 
(Mason 1996; Ritchie et al. 2003a; Bryman 2008). 
A purposive approach to sampling was selected for this study as it was most 
appropriate in addressing the research aim and research questions. The study used a 
sample that allowed for comparison of recent emergency service users (SAS 
participants) and those who had not recently used emergency services (non-SAS 
participants, primarily recruited through Diabetes UK Scotland). It was assumed that 
both participant groups were likely to experience a number of hypoglycaemic 
episodes; however SAS participants were more likely to reflect the sub-set of the 
diabetes population who contacted emergency services (frequently). In order to get a 
clear classification of the two population groups, non-SAS participants who had called 
the SAS due to a hypoglycaemic episode in the three months prior to recruitment were 
excluded from participation (based on self-report).  
The sample included both male and female participants to investigate potential 
differences and similarities between genders. While some studies have focussed on 
specific population groups or only one gender (e.g. Kay et al. 2009; Weiler and Crist 
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2009), this study included both male and female participants as well as various age 
groups. This ensured a variety of people living with diabetes were included in the 
study.  
Inclusion criteria were: 
 adults (>18 years)  
 diagnosed with either type 1 or type 2 diabetes  
 residing in the central belt of Scotland 
 treated with insulin therapy 
 experience a hypoglycaemic episode at least once a month 
 
Exclusion criteria were: 
 individuals aged below 18 years 
 inability to communicate in English language 
 where participants lack capacity to consent 
 Indication of alerts (e.g. end of life issues, complications), particularly in the 
SAS group. 
These criteria were selected because the vast majority of people with diabetes who 
experience hypoglycaemia are treated with insulin (Wild et al. 2007). The lower age 
limit was 18, to ensure that only adults who can give consent were included in the 
study. The geographical limitation was a practical consideration. It covered the 
majority of the Scottish population and was affordable in terms of travel.  The 
experience of at least one hypoglycaemic episode per month had been chosen 
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because it captured individuals who experience hypoglycaemic episodes regularly and 
recurrently and therefore addresses the research aim. 
5.5.2 Sampling framework                                    
Sample group Non-SAS SAS 
 
Age group 
 
18 – 40 41 – 60 > 60 18 - 40 41 – 60 > 60 
 
Male 
 
4 4 4 4 4 4 
 
Female 
 
4 4 4 4 4 4 
Table 5.2: Target sampling framework 
 
For each cell of the table, the target was to recruit 4 individuals. The study adopted a 
naturalistic approach to sampling, and a record of geographical area (postcode) was 
kept. This was used to identify deprivation categories using the Scottish Index of 
Multiple Deprivation (SIMD) codes (The Scottish Government 2009). The number of 
participants per cell was set at four for the following reasons:  
 Trying to get variation/different perspectives within each cell 
 Collecting a manageable amount of data that is sufficient for the purpose and 
achievable within the time frame of the study 
 Minimising the impact of attrition over time. Due to the longitudinal nature of 
the study, keeping diaries and conducting follow-up telephone interviews, it 
was expected that a number of participants would drop out. 
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However, during the fieldwork, a number of factors contributed to a smaller sample 
size (see actual sample in table 5.3 overleaf). As mentioned above, high target 
numbers were set to allow for a degree of attrition. However, the major challenge 
during data collection was not attrition but recruitment. Overall, there was a limit to 
what could be achieved within the time frame. 
Once recruitment and operationalisation were under way, I realised that the effort 
required in keeping track of participants was more time consuming with repeated 
contacts during the follow-up period. During data collection, and especially during the 
recruitment phase, my workload was very high, given the number of people contacted 
(particularly in recruitment for the SAS group, see details below) and the amount of 
information collected. Participants wrote a lot more diary entries than initially 
expected. The inclusion criteria stated that participants should experience at least one 
hypoglycaemic episode a month (see section 5.5.1); however, some participants 
completed up to 62 diary entries over the six month follow-up period. There were a 
number of concurrent activities to manage during the data collection period, including; 
on-going recruitment of study participants, arranging and conducting initial semi-
structured interviews, staying in touch with existing participants, reading through diary 
entries, transcribing and reading interview transcripts in preparation for further 
telephone interviews and finally carrying out repeated follow-up telephone interviews.  
Delays in securing NHS ethical approval (detailed below) also reduced the time 
available to this study for recruitment. There were also some challenges during the 
recruitment process, mainly a slow response rate in the non-SAS group, and a time 
consuming method of recruiting SAS participants, which are described in more detail 
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in section 5.5.4.2. Despite these challenges, the actual sample achieved allowed for 
comparison between the two participant groups, as a total of 13 SAS and 17 non-SAS 
participants were involved in the study. These included 11 participants in the 18-40 
age group, 11 in the 41-60 age group and 8 in the over 60 age group; there were 14 
male and 16 female participants, which gave a good spread (see table 5.3 below). 
Overall, a total of 30 participants took part in the study with multiple data collection 
points. 
                                          
Sample group Non-SAS (n=17) SAS (n=13) 
 
Age group 
 
18 – 40 41 – 60 > 60 18 - 40 41 – 60 > 60 
 
Male 
 
4 3 1 1 3 2 
 
Female 
 
4 3 2 2 2 3 
Table 5.3: Actual sampling framework 
 
 
5.5.3 Inclusion of carer/family member 
Carers/family members have substantial knowledge about dealing with hypoglycaemic 
episodes. They play an important role in supporting the person living with diabetes 
(see Trief et al. 2003); they are also the first point of help/calling emergency services 
when hypoglycaemia occurs. Therefore, it was thought to be important to include 
carers/family members if requested. It was emphasised that carers and family 
members were only included when participants actively requested this, which 
suggested that participants were comfortable with their carer’s presence during the 
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interview. I knew from a previous study conducted in the NMAHP Research Unit that it 
was likely that participants would ask their carers to join them in the interview, and 
that carers would offer information during that process.  If such a request was made 
by the participant, I allowed their carer to attend the interview(s). During the data 
collection period, this was the case with 5 participants within the SAS group. 
Interestingly, there was no request made to include a carer/family member in the non-
SAS group. 
Separate consent forms were signed by carers as they contributed within the 
interview(s) and gave consent to their views and opinions being recorded and used 
anonymously in reports and publications. Consent was taken immediately prior to the 
interviews (see Appendix 6). There were not any specific questions for carers; 
however, if they had knowledge about participants’ hypoglycaemic episodes, they 
were invited to tell me about it. This meant that the focus of the study remained with 
the participant. 
5.5.4 Recruitment process 
5.5.4.1 Recruitment of non-SAS participants 
The recruitment strategy for non-SAS participants was discussed with key staff at the 
Diabetes UK (Scotland) office in Glasgow in the first instance. Colleagues there were 
very keen to support the study and agreed to send out study advert flyers (see 
Appendix 10) with the regular Diabetes UK newsletter, they also posted a study advert 
on both their Facebook page and Twitter account. This was re-posted regularly for a 
period of three months. Potential participants then got in touch with me. 
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Once potential participants got in touch, they were sent detailed information about 
the study (including participant information sheet (PIS), see Appendix 1). They were 
then asked to fill in a simple form with their contact information (see Appendix 9) and 
return it to me if they were still interested in taking part. Following this, a suitable date 
and time for the first interview was arranged. Immediately before the interview, 
participants were given the opportunity to ask further questions and asked to sign the 
consent form (see Appendix 4). 
Due to the low recruitment achieved by the above method, I also used snowball 
sampling techniques (Streeton et al. 2004; Denscombe 2007), which led to a post on a 
blog type website called “Shoot up or put up” including a written interview about my 
research study as well as an advertisement for the study. The snowball sampling 
technique also resulted in further distribution of study advert flyers within some 
Diabetes UK support groups. Overall, this technique generated another four 
participants. Despite the efforts to publicise the study advert both online and through 
flyers, the recruitment rate through Diabetes UK was quite slow and resulted in only 
21 enquiries, out of which 12 people eventually took part in the study.   
It was decided to seek an amendment to the initial ethical approval (which was 
granted through the School of Nursing Midwifery and Health Ethics Committee in 
November 2011) to advertise for the current study within the University of Stirling. 
People recruited through the University would likely be similar to participants 
recruited through Diabetes UK Scotland in terms of engagement in diabetes self-care. 
An advertisement on the University of Stirling internet portal generated another 14 
enquiries out of which 5 people finally took part in the study.  
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5.5.4.2 Recruitment of SAS participants 
SAS patients who had experienced a hypoglycaemic emergency in the preceding week 
were identified via the SAS electronic patient record system. SAS patients were initially 
contacted by phone and sent information about the study if they expressed an interest 
in knowing more about the study (this included participant information sheets and 
consent forms, see Appendices 2 and 5). Potential participants were then asked to 
confirm their interest in the study by returning a simple form or by phoning me. 
Similar procedures of identifying and contacting patients had been used successfully 
before in other SAS research within the NMAHP Research Unit. Caldicott Guardian 
approval was applied for and subsequently granted in order to access patient 
information for recruitment purposes. Further ethical issues that were relevant in the 
recruitment of SAS patients are discussed in more detail below (section 5.6). 
Once potential participants got in touch with me, a suitable date and time for the first 
interview was arranged. Before the interview, participants were given the opportunity 
to ask further questions and asked to sign the consent form (see Appendix 5).  
The process to gain access to SAS patients was lengthy since a number of permissions 
were required, including getting the appropriate Disclosure Certificate, Research 
Passport, Caldicott Guardian Approval, and setting up an NHS email account. Following 
this, a system was set up to be sent data relating to emergency call-outs due to a 
hypoglycaemic episode via a weekly email. 
Challenges in the recruitment of SAS patients included calling large numbers of 
patients (overall 248 patients were contacted) with very few people expressing an 
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interest in taking part in the study. At least two attempts (at different times) were 
often required to reach patients on the phone. Sending out study information and 
receiving participants’ expressions of interest forms through the post worked well, 
however, overall, the process was slow which led to delays in relation to the study 
timetable. Further details of the recruitment process through the SAS can be found in 
the flow diagram below (figure 5.1). It shows that there was no follow-up possible for 
many patients (n=162). This was because the telephone numbers available in the 
electronic patient record system were the telephone numbers that the emergency call 
was made from, which was not necessarily the patient’s telephone number (n=47). 
Another reason was that it was not possible to reach patients on the phone within two 
attempts (n=115). The slight discrepancy in numbers of patients who returned the 
form and those who finally took part in the study was either due to patients not 
meeting all inclusion criteria (n=2), or patients willing to take part, but not being well 
enough (n=2). 
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Figure 5.1: Recruitment process for SAS participants 
 
5.6 Ethical considerations 
This study was conducted in accordance with ethical approval received through both 
the School of Nursing, Midwifery and Health Research Ethics Committee, University of 
Stirling (in March 2011, see Appendix 20) and the NHS Fife and Forth Valley Research 
Ethics Committee (in August 2011, REC reference number 11/AL/0330, see Appendix 
21). Involvement in the study was on an opt-in basis and informed consent was 
ensured by providing participants with information sheets as well as giving them the 
opportunity to ask questions.  
Identify and call patients who fit 
inclusion criteria from SAS 
database, N= 248 
Contact possible, 
interested in study, 
recruitment pack was 
sent out, N= 60 
Patients where no 
follow-up was 
possible, N= 162 
Contact possible, not 
interested, N= 26 
Patients who returned 
form/expressed interest to 
take part, N= 17 
Patients who took part in the 
study, N= 13 
Patients declined to take part/no 
follow-up contact possible, N= 43 
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The main ethical concerns were about accessing confidential patient data (e.g. names, 
addresses, telephone numbers) and contacting SAS patients by telephone following 
their hypoglycaemic emergency episode without prior consent by the patient. 
Relevant permissions were obtained (see section 5.5.4.2), and I was granted limited 
access to the SAS electronic patient record system due to its sensitive and confidential 
nature. An NHS email account was set up, that allowed me to be sent data relating to 
emergency call-outs due to a hypoglycaemic episode via a weekly email. 
A few possible scenarios of contacting SAS patients were considered (see below); 
however, making contact by telephone was deemed the most appropriate option as it 
would best maintain patient confidentiality.  
Following advice from the Fife & Forth Valley Research Ethics Committee, a scripted 
telephone protocol (see Appendix 7) was devised to ensure patient confidentiality 
when making initial contact by telephone to confirm patients’ postal addresses.  The 
purpose of the telephone call was to ask if potential participants would be willing to 
receive information regarding the study and to ascertain the correct address to send 
this to. It was proposed that I would make the telephone call to potential participants, 
using the scripted telephone protocol (see Appendix 7). This approach was preferable 
to other options (discussed below) as it would best maintain patient confidentiality by 
ensuring that no information was divulged to anyone other than the patient. It is 
important to emphasise that I did not attempt to consent patients during this phone 
call. The aim was solely to ask if patients would be willing to receive information about 
the study, and if so, to record their postal address for this purpose. Similar calls to 
patients had been made in this manner before, and there were neither incidents 
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where I felt patient confidentiality was at risk, nor complaints about this procedure by 
any party.  
The following options were also considered following discussion with the Fife & Forth 
Valley Research Ethics Committee, but after lengthy consideration and consultation 
with other senior researchers and senior managers within the SAS, I came to the 
conclusion that they were unfeasible and/or unethical. The reasons for this are 
outlined in the following sections.  
The Fife & Forth Valley Research Ethics Committee suggested that the telephone call 
could be made by a SAS employee. Unfortunately, there were no funds to support this 
option. Furthermore, the SAS have limited capacity and were unlikely to be able to 
deliver this even if funds were available. Additionally, getting a SAS employee to make 
the telephone call would not in itself solve the challenge of patient confidentiality.  I 
did ensure however, that I had the appropriate permissions and disclosure to contact 
SAS patients for the purposes of this study. 
Another option that was considered was to ask ambulance clinicians to give study 
information leaflets to people when attending hypoglycaemic emergencies. This 
method would have significant ethical implications for the patient, as it would require 
paramedics to pass study information to people when they are in an emergency care 
situation and would potentially be unconscious or confused. Furthermore it would 
have been very challenging to ensure that all ambulance vehicles had the appropriate 
paperwork and paramedics would have been likely to forget to give out such leaflets 
when attending an emergency situation. If this method was used, it would be 
impossible to know who had actually received study information, and the likelihood of 
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achieving the study target numbers would dramatically reduce. For all these reasons, 
this method of distributing study information was considered to be both impractical 
and unethical.  
A further potential method of recruitment would be to send study information to 
addresses that are recorded in the SAS database (these are addresses where 
hypoglycaemic events occurred). However, the location of the hypoglycaemic 
emergency may well not have been the patient's own home address; and this method 
would therefore not address the issue of patient confidentiality. Further, this method 
of contacting people was also likely to decrease the response rate/number of potential 
recruits, and consequently lengthen the study time.  Due to these reasons this method 
was not considered to be either practical or ethical. 
5.6.1 Informed consent 
It was important to gain informed consent from all participants who took part in the 
study, as well as ensuring participants entered into the study freely and willingly, 
knowing and understanding what they agreed to. When people expressed an interest 
in participating in the study, they were provided with a copy of the participant 
information sheet (see Appendices 1 and 2). Information sheets were designed to 
outline the key points of the study, its overall purpose and to highlight potential risks 
and benefits of participation. They also included details about participants’ rights to 
withdraw from the study at any point (Mason 1996).  
If participants still expressed an interest to take part in the study once they had read 
the participant information sheet, a suitable time was arranged for the initial face to 
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face interview. Before commencing the interview, each participant was given the 
opportunity to ask any questions and then asked whether they were happy to take 
part in the study and, if so, to sign two copies of the consent form (see Appendices 4 
and 5), one copy of which they were given to keep. It was made clear to all 
participants (both verbally and in the information sheets and consent forms) that they 
were free to withdraw from the study at any time, without giving any reason and that 
their medical care or legal rights would not be affected by this. Participants were also 
informed how data would be used. 
5.6.2 Confidentiality and anonymity 
Each interview was audio recorded using a digital recorder. As soon as possible after 
each interview, the recording was uploaded onto a password protected computer and 
deleted from the hand-held digital recorder. Typed notes of interviews were assigned 
a participant number with no names or other identifiable information included in the 
notes. A list of names of participants and their numbers was kept electronically, 
separate from the interview notes themselves. Interviews were also anonymised, with 
personal and place names removed (see Bryman 2008). It was ensured that quotes 
were not attributable to participants. Anonymity was guaranteed to all participants 
with descriptors being carefully used to describe participants (e.g. female, SAS, age 
group 1). Only I had access to personal details of participants. Transcriptions of 
interviews (both face to face and telephone interviews) did not contain any 
identifiable information as they were all anonymised. The diaries were also 
anonymised before analysis. Completed consent forms were stored in a locked cabinet 
separate from all other data.  
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On completion of the study, all written data was securely archived. All paper data will 
be destroyed 6 months after completion of the PhD thesis. According to University of 
Stirling regulations, this data will then be held in electronic format for a period of 10 
years. Provision for electronic storage was made through the Nursing, Midwifery and 
Allied Health Professions Research Unit (NMAHP RU). All data was securely archived in 
keeping with the NMAHP RU guidelines.  
5.6.3 Potential risks and safeguarding against risk 
The research was carried out in accordance with the University of Stirling ‘Code of 
Good Research Practice’ (2009).  The rights, safety and well-being of participants were 
the primary concern throughout the study. 
The overall burden on participants was minimised by ensuring that telephone 
interviews and diary requirements were brief. In summary, each participant was asked 
to take part in one semi-structured interview (lasting about 60 minutes), keep a 
hypoglycaemia and blood glucose diary over a period of six months (recording blood 
glucose values no more or less often than they would usually do and writing diary 
entries about hypoglycaemic episodes as they occurred), as well as take part in six 
monthly telephone interviews each lasting about 15 minutes. The frequency of 
telephone interviews was later reduced to bi-monthly (see section 5.7.5). Overall, 
monthly participation time was about 30 minutes. 
There was no physical/medical risk to participants via participation in this study. 
However, I explored private worlds and experiences of study participants, which 
“might sometimes evoke strong emotional responses and sometimes pursuing 
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thoughts that might otherwise never be revealed” (Cowles 1988:163). Actual or 
potential distress may be revealed through interviews or diary entries; this could 
include emotional stress experienced through recounting hypoglycaemic events, as 
well as problematic diabetes self-care, etc. Consideration was given to the impact this 
might have on the participant and researcher. Risks were balanced with ensuring 
participant confidentiality and the limitations of the researcher role.  
Participants were able to stop the interview at any point. If participants were to 
become distressed, the interviewer would suggest a break or offer to terminate the 
interview. It was emphasised that participants had the right to withdraw from the 
study at any time. Given my training and experience in social work, I would have been 
able to sensitively deal with situations where participants were getting distressed.  
Additionally, I proposed to refer participants to their GP in the event that they became 
unduly distressed during the interview which might not necessarily have been related 
to the interview. If specialist counselling services were required, the GP could refer 
participants to this service. In case participants did not feel comfortable contacting 
their GP with any concerns they had, contact details of an alternative free service 
(Diabetes UK helpline, if Diabetes related; or Breathing Space, if mental health related) 
were provided on the participant information sheet (see Appendices 1 and 2). In this 
case, it was left to the participant to decide whether further action needed to be taken 
with regards to any concerns the interview may have raised. There were no incidents 
of participants becoming distressed or stopping the interview during data collection. 
Any issues arising for me were discussed with supervisors who offered support as 
required. 
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Due to the approach chosen to contact SAS patients, there was a risk that potential 
SAS participants might be unwell or might have died at the point of or following initial 
contact. Further exclusion criteria were imposed to limit the chances of this 
happening. SAS patients who resided in nursing homes were excluded, and where 
there was a clinical alert of end of life issues, the person was also excluded (clinical 
alerts were recorded in the SAS database). During the recruitment process, a small 
number of patients who I attempted to contact, were unwell or had died. In those 
cases, I tactfully apologised for calling and expressed my sympathy to the person who 
answered the telephone call. There was one person who got upset about being 
contacted, in which case I apologised and removed the person’s name from the list of 
potential study participants. 
I was working as a lone worker when conducting interviews. For this reason, I provided 
a contact person (either one of my supervisors, or the NMAHP Research Unit 
secretary) with the address of the interview location and prior to entering the 
location/beginning the interview, contacted the contact person. I then phoned the 
contact person immediately after leaving the interview location. If there had not been 
any communication after one and a half hour from commencement of the interview, 
the safety protocol was as follows:  
1. The contact person phoned me. 
2. If I was still with the participant, and in the event that I had concerns for my or 
the participants’ safety a code word (pre-arranged with the contact person) 
was used, after which the police would be called by the contact person who 
would raise their concerns and inform the police of my location. 
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3. If the contact person was unable to make contact with me when they called 
then the police were contacted as above. 
4. I would stop any interview in which I had concerns for my safety and inform 
the contact person that I had done so immediately upon leaving the interview. 
Additionally, during some of the interviews, I used a personal security device 
(‘GEMshield’) which was provided by a company called ‘Skyguard’. The main feature of 
the GEMshield device was the alarm function which could be activated by pressing the 
SOS button. Once activated, an alarm message containing the user’s identity and 
location would be sent to Skyguard’s Incident Management Centre (IMC) and a voice 
call would be initiated. Following this, Skyguard’s controllers would assess the incident 
and follow pre-arranged emergency procedures (i.e. contact the police and a named 
contact person). The GEMshield device used GPS tracking to ensure accurate location 
information (see http://www.skyguardgroup.com for further details, accessed 29th 
November 2012). 
5.6.4 Potential benefits for study participants 
There was no direct healthcare benefit to participants. However, it was hoped that, 
indirectly participants would be able to help shape future emergency care, improve 
the safety of current diabetes care and help people with diabetes by ensuring that 
they receive appropriate advice and care. At the end of the study, each participant 
received a £10.00 gift voucher to thank them for their participation, which they were 
not aware of at the point of recruitment. 
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5.7 Data collection 
During the data collection period, face to face semi-structured interviews, blood 
glucose and hypoglycaemia diaries and telephone interviews were used. Participants 
were asked a number of questions relating to the overall research aim (see section 
5.2). During this first meeting, participants were provided with a ‘Hypoglycaemia and 
blood glucose’ diary (see Appendices 13 and 14). The format of the diary was 
explained and any questions answered. Interviews were recorded using a digital voice 
recorder. During the period of diary keeping (six months), I stayed in regular contact 
with participants and conducted a brief telephone interview monthly (see Appendix 
15). The frequency of telephone interviews was later reduced to bi-monthly (see 
section 5.7.5). 
5.7.1 Schedule for data collection 
Data collection took place between July 2011 and July 2012. It consisted of four 
phases: the piloting phase, the recruitment phase, the data collection phase and the 
follow-up phase. Piloting for the current study was conducted in July 2011.  The 
recruitment phase was carried out from August 2011 until February 2012.  
The main phase of data collection using semi-structured face to face interviews was 
conducted from August 2011 until February 2012, and the follow-up phase was on-
going, starting after the first interview was conducted in August 2011, until the last 
participant finished with the blood glucose and hypoglycaemia diary, in July 2012.  
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5.7.2 Piloting 
Piloting is an important stage in any research project as it can help to fine-tune 
procedures and identify concerns, which need to be addressed in preparation for the 
main study (Robson 2002). This includes issues relating to data collection instruments, 
adequacy of instructions, and practicalities of daily management of the study during its 
conduct (Robson 2002; Bryman 2008). 
Participants’ views were sought in relation to acceptability and relevance of data 
collection tools, especially the interview guide (see Appendix 12), participant 
information sheet (see Appendix 1) and blood glucose and hypoglycaemia diary (see 
Appendices 13 and 14). The piloting was conducted with three volunteers recruited 
through the Diabetes UK (Scotland) Head office in Glasgow. While piloting was limited 
to participants recruited through Diabetes UK (Scotland), there was a range of age 
groups (from 24 to 67 years) and both genders represented (n=2 female, n=1 male). It 
was not possible to include participants recruited through the SAS in the piloting study 
because of delays in obtaining NHS Ethics Approval and in getting all appropriate 
permissions to access the target population. 
The participants in the piloting study gave very valuable and useful feedback that 
helped refine data collection tools. In particular, participants highlighted the 
phenomenon of overcompensating when having a hypoglycaemic episode, that is, 
taking more glucose or food than is required to bring blood glucose levels back to a 
normal range. Another interesting point was that there can be considerable variations 
when it comes to the blood glucose level people start feeling symptoms of 
hypoglycaemia, both on an individual level as well as between different people. These 
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themes were very relevant and were confirmed during the main data collection (see 
sections 7.2.4 and 8.2.5).  
Further, practical issues relating to the content of the interview guide and blood 
glucose and hypoglycaemia diary were emphasised during the piloting phase.  
Following feedback from participants, a space for recording the blood glucose value 
after a hypoglycaemic episode was included in the diary, and the number of pages to 
record hypoglycaemic episodes increased from 6 to 24 (as many people were 
experiencing more than one hypoglycaemic episode a month). Two of the questions 
on the ‘hypo diary’ page (see Appendix 13) focussed on the impact hypoglycaemic 
episodes can have on people; the question asking about how long the particular 
hypoglycaemic episode lasted and the question relating to perceived severity of 
hypoglycaemia episodes (‘From your perspective, how bad was the hypo?’). One of the 
participants in the piloting phase felt it was challenging to answer those two 
questions, as she did not like to focus on how hypoglycaemic episodes affected her 
everyday life. This was taken into consideration when introducing participants to the 
diary during the main data collection phase. 
The interview guide was also refined during the piloting phase. The question asking to 
describe a ‘typical day’ was removed, while the ‘Do hypos affect your daily activities?’ 
question was kept. As many people in the study have lived with diabetes for many 
years, they might not necessarily remember the first hypoglycaemic episode they have 
experienced; instead, very ‘bad’ hypoglycaemic episodes seemed to be more salient 
for people. Therefore, the initial question asking about first experience of 
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hypoglycaemic episodes was replaced by a question asking about particularly bad 
hypoglycaemic episodes people have had. 
Additionally a set of questions investigating how people felt after a hypoglycaemic 
episode, as well as how people managed (the risk of having) a hypoglycaemic episode 
in a work environment was included after taking into consideration feedback from 
participants during the piloting process, and further reflections and discussions with 
my supervisors.  
5.7.3 Qualitative semi-structured interviews 
The first stage of the main data collection for the current study used semi-structured 
interviews to gain understanding into participants’ perspectives of recurrent 
hypoglycaemia. Using qualitative interviews to collect data can provide a unique 
insight into participants’ life worlds; it gives the researcher an opportunity to explore 
participants’ perspectives and experiences. Interviews are ideal to gain an in-depth 
account, allowing the researcher to capture nuances within participants’ experiences 
(Arksey and Knight 1999).  
According to Patton (1990), “the purpose of interviewing is to find out what is in and 
on someone else’s mind […], to access the perspective of the person being interviewed 
[…], to find out from them those things we cannot directly observe” (p.278). Semi-
structured interviews are therefore appropriate in addressing some of the research 
questions, particularly the research questions relating to participants’ experiences of 
recurrent hypoglycaemia and impact on everyday life.   
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While qualitative semi-structured interviews can provide rich and in-depth data 
relating to the experience of participants, there are a number of drawbacks when 
using this approach. First, arranging and conducting semi-structured face to face 
interviews is both time consuming and costly (Opdenakker 2006; Flick 2009). In the 
current study, I interviewed participants at their home, which had cost and time 
implications in relation to travelling.  
Second, in order to collect good quality data, the researcher’s skillset is vital. This 
includes interpersonal skills that are important in developing rapport with research 
participants, e.g. creating a relaxed and friendly atmosphere, listening skills, 
interpreting body language, etc. (DiCicco-Bloom and Crabtree 2006). Another 
competency relates to research method. The researcher needs to have the ability to 
carry out a study within a flexible and adaptive qualitative research design, for 
example, asking the right questions, and constantly reflecting about and analysing 
data which may lead to creation of future questions or adaptation of existing ones. As 
Rubin and Rubin (2005) put it, “research design and questioning must remain flexible 
to accommodate new information, to adapt to the actual experiences that people 
have had, and to adjust to unexpected situations” (p.35).  
5.7.3.1 Interview guide 
The interview topic guide (see Appendix 12) was designed in a semi-structured format 
to allow for flexibility, while providing a general structure to ensure focus on the 
research questions (Flick 2009). The flexibility of the interview guide relates to time 
spent on each topic of discussion, wording of questions and the order questions were 
posed (Robson 2011).  The content of the interview guide was developed using 
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findings from the literature review, feedback obtained during piloting and focus on the 
research aims and research questions. 
In terms of topics, the interview guide covered participant’s individual history of 
diabetes, previous experiences of hypoglycaemic episodes as well as differences 
between various hypoglycaemic episodes. It also explored participants’ personal 
explanations for various hypoglycaemic episodes. The interview guide investigated the 
impact hypoglycaemic episodes have on participants’ everyday life (e.g. work, social 
life, family, driving) and how hypoglycaemic episodes might influence diabetes 
management. Further topics included coping strategies people adopted and individual 
views in relation to the future of living with hypoglycaemia. 
A few questions were added to the interview topic guide during the course of 
conducting the interviews. The issue of (having) children was introduced to the 
interview, this can be considered an extension to the initial question exploring the 
impact hypoglycaemic episodes can have on family. The discussion around children 
highlighted participants’ concerns about whether their children would inherit 
diabetes, whether they would be able to look after their children in case of 
complications (both long-term and short-term), their children caring for them (one 
participant’s daughter was registered his official carer) and issues around pregnancy.  
Participants recruited through the SAS were also asked whether they were a member 
of Diabetes UK. This helped to establish whether there was any overlap between the 
two groups of participants. During recruitment, I confirmed whether non-SAS 
participants had required the assistance of emergency services due to a 
hypoglycaemic episode recently (within the three months prior to recruitment). 
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5.7.4 Blood glucose and hypoglycaemia diaries 
In addition to semi-structured interviews, diaries were used to keep a record of 
hypoglycaemic episodes and blood glucose values over time. Participants were asked 
to keep a diary over a period of six months. This added another dimension to the data 
collection process; for example, participants could make notes of their reflections and 
generate further ideas in response to questions asked during the interview and cues 
given with the diary instructions (e.g. describing the different hypoglycaemic episodes 
as they occurred).  
The diary consisted of two parts: one section to keep a record of blood glucose 
readings and another section to describe experiences with hypoglycaemic episodes. 
Participants were instructed to carry out plotting of blood glucose values no more or 
less often than they would normally do; they were simply asked to keep a record of 
their blood glucose values when these were measured (this would usually be carried 
out on a daily basis). 
The frequency of filling in the hypoglycaemia diary varied depending on the number of 
hypoglycaemic episodes participants experienced during the diary time. Therefore, the 
hypoglycaemia diary was written intermittently rather than daily. 
5.7.4.1 Structure of diaries 
A brief description of every hypoglycaemic episode was written when they occurred. It 
was expected that keeping the diary would not take more than 30 minutes per month 
of participation time. Using diaries was beneficial for addressing the research 
questions in the following ways: it helped gain longitudinal insights into participants’ 
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lives, as well as exploring individual explanations for different hypoglycaemic events 
(Elliott 1997). Another advantage of using diaries is the “opportunity for the recording 
of events and emotions in their social context” (Hawkes et al. 2009:211). 
There are, however, a few potential drawbacks in using diaries. Keeping a diary 
requires some literacy skills and commitment from participants (see Hawkes et al. 
2009). To address this, the diary format was clearly explained and any questions 
addressed to support people keeping the diary and to minimise attrition rates. Diary 
entries were also brief and included a plotting of blood glucose levels (see Appendix 
14) and a section for participants to enter a brief narrative about the situational 
context (e.g. lifestyle, exercise, illness) surrounding their experiences of hypoglycaemia 
(see Appendix 13). The diaries were designed in a format that was attractive and easy 
to use. Additionally, pre-paid envelopes were provided to return completed diary 
entries, as this has been known to increase response rate (Hawkes et al. 2009). 
Looking at results from blood glucose diaries, there can be some inaccuracies, as 
highlighted in a study by Kazlauskaite et al. (2009). The authors suggest that the blood 
glucose meter memory (which usually saves a couple of months’ worth of blood 
glucose readings) should be checked and compared with participants’ written diary 
entries to increase reliability of results (Kazlauskaite et al. 2009). While it was not 
possible to access blood glucose meter memory in this study, limitations of self-
reported blood glucose diary entries should be taken into consideration when 
analysing diary results. 
In terms of the hypoglycaemia diaries, limitations were mainly related to its self-
reported nature. For example, participants had to make a decision on what they 
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identified as a hypoglycaemic episode, and whether to write a diary entry. Completion 
rates can be influenced by time participants had to complete the diary, commitment 
and literacy skills of participants (Burman 1995; Hawkes et al. 2009). Therefore, 
participants may not have written a diary entry every single time they experienced a 
hypoglycaemic episode. Also, some participants may fail to record sufficient detail of 
their hypoglycaemic episodes (Bryman 2008). However, I did not specify any expected 
number of hypoglycaemic episodes participants may experience, rather participants 
were asked to keep a record of all the hypoglycaemic episodes they had during the 
period they kept the diary. A major advantage of the hypoglycaemia diary was the fact 
that it enabled prospective recording of actual hypoglycaemic episodes as they 
happened, giving an insight into people’s life worlds (Hawkes et al. 2009).  
5.7.5 Semi-structured telephone interviews 
During the period of diary-keeping a short telephone interview was conducted 
monthly (later reduced to bi-monthly) to follow-up with participants to:  
1. Explore any changes that might have occurred in participants’ experiences of 
hypoglycaemia;  
2. Gain an understanding of different individual explanations for various 
hypoglycaemic episodes;  
3. Investigate whether participants perceived any link between hypoglycaemic 
events and variation of blood glucose levels; and  
4. Encourage participants to maintain their engagement in the study and 
completion of diary forms.  
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Telephone interviewing is a practical and time efficient way to collect data 
(Opdenakker 2006).  
During the course of the follow-up phase the frequency of follow-up telephone 
interviews was reduced from monthly to bi-monthly. This decision was made in 
consultation with the supervisory team following a few practical considerations. All 
participants returned their completed diaries via pre-paid envelopes in the post, which 
meant that there was a slight delay between the time participants completed their 
diaries, posted them to me and the time I received them. Further, arranging a suitable 
time for a telephone interview could take up to another week or more, depending on 
participants’ other commitments (e.g. work, family) and holidays/travel plans.  
Consideration was also given to the fact that after receiving the diaries, I needed time 
to study and review the entries, in order to prepare for the telephone interview. 
Finally, and very importantly, participants wanted to be able to feedback new 
information to me during follow-up telephone interviews, so reducing the frequency 
of telephone interviews from monthly to bi-monthly worked better, and provided 
enough time to explore and discuss the diary. 
Conducting telephone interviews bi-monthly was therefore deemed more practical 
and reduced the burden on both participants and researcher. Most importantly, 
reducing the number of telephone interviews from six to three per participant did not 
appear to adversely affect the collection of data required to answer the research 
questions. 
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In addition to the scheduled telephone interviews, I was still available for any 
questions or support in keeping the diary, as required by participants. I contacted 
participants when they returned their diaries (some did this every month while others 
preferred to send in their diaries every two months), or I got in touch when I did not 
hear anything from participants within 6 weeks. 
5.7.5.1  Structure of telephone interviews 
The structure of the telephone interviews was based on findings from the semi-
structured face to face interviews and literature (see Appendix 15). I asked 
participants to describe their experiences of writing the diary, and to discuss the 
hypoglycaemic episodes that had been recorded. The telephone interviews provided 
an opportunity to investigate issues around symptoms, individual explanations for 
hypoglycaemic episodes, perceived severity of hypoglycaemic episodes, as well as 
coping strategies, including whether participants required external or emergency help. 
During the regular telephone contacts, participants were also asked whether they 
needed any support in keeping the diary.  
Generally, where participants decided to stay in the study during the follow-up phase, 
they were very keen to share their experiences of hypoglycaemic episodes during the 
diary time. Some participants even claimed that keeping the hypoglycaemia and blood 
glucose diary for this study helped them to understand patterns and causes of 
hypoglycaemic episodes better, and helped to improve their diabetes control. 
The topic guide for the telephone interview was applied flexibly. On the one hand, I 
allowed participants to expand on their experiences of hypoglycaemic episodes freely 
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as long as there was a focus on the research questions. On the other hand, prompts 
and questions were used to investigate specific areas of interest. 
Some participants (n=2) who lived locally preferred to meet in person at the University 
of Stirling rather than being interviewed over the phone. I agreed to this, while making 
sure that the same structure for the follow-up/telephone interview was used with all 
participants. 
A small number of questions were added to the telephone interview topic guide 
during the follow-up phase, following interim analysis of data. These were in relation 
to coping strategies and people’s perceived severity of their hypoglycaemic episodes. 
Initial findings from face to face interviews and participants’ diaries showed that there 
were different views relating to the subjective, perceived severity of hypoglycaemic 
episodes. While for some participants, symptoms were the most important indicator in 
relation to severity, others tended to judge this purely based on blood glucose 
readings. Therefore, I included a question about the ‘perceived severity’ in the 
telephone interview topic guide.  
Another issue that came up during the face to face interviews was that of health 
literacy/health education. This seemed particularly relevant in the context of 
hypoglycaemia unawareness. For this reason, the topic of health education and 
training was included in the telephone interview topic guide.  
5.7.6 Managing data collection 
A number of issues were important in managing the data collection. First, I had to pay 
particular attention to minimise the burden of participation on participants. This was 
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achieved by clearly explaining what study participation involved and answering any 
questions participants had. Second, recruitment rates were monitored on a monthly 
basis and reviewed with my supervisors. Third, an accurate record of what stage in the 
study participants were at (e.g. dates of face to face interviews, progress with the 
blood glucose and hypoglycaemia diary, dates of follow-up telephone interviews) was 
kept throughout the data collection and follow-up phase. This was important to 
ensure that (telephone) interviews were conducted and diaries completed at the 
appropriate time. And finally, I attempted to keep a record of reasons why people 
either refused to take part in the study or decided to withdraw from the study at a 
later point. All these were important for establishing the accuracy and relevance of 
study findings as well as helping to inform the design of future research.  
Overall, the data collection yielded 30 interview recordings lasting between 15 and 72 
minutes (most interviews lasted 30-55 minutes/average 44 minutes), 20 personal 
diaries of participants covering between 1- 6 months (77 months of diary keeping) and 
48 telephone interviews.  
5.7.7 Rigour and quality of the qualitative data 
According to the Oxford Dictionary (2012), rigour is defined as the “quality of being 
extremely thorough and careful” (para.1). The issue of rigour is important when 
assessing quality of qualitative research. In order to convince the audience of 
trustworthiness and credibility of findings, it is vital that the research process is clearly 
described, and that methods, data analysis and presentation are transparent (Yardley 
2007).  
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Rigour allows reproducibility of a study based on accurate representation of the 
sample and good quality account of study design and method, ensuring consistency 
over time (Thomas and Magilvy 2011). Mays and Pope (1995) suggest that to 
guarantee rigour, researchers should “create an account of method and data which 
can stand independently so that another trained researcher could analyse the same 
data in the same way and come to essentially the same conclusions; and to produce a 
plausible and coherent explanation of the phenomenon under scrutiny” (p.110).  
Credibility can be achieved by presenting an accurate description and interpretation of 
participants’ experiences that is recognisable by people who share the same 
experience (Krefting 1991). Another aspect of credibility relates to the 
representativeness of data, which can be accomplished by reviewing interview 
transcripts to establish similarities across and within individual participants (Thomas 
and Magilvy 2011). 
Reflexivity of the researcher is an important quality criterion in the context of 
transparency of the research process, including data analysis and interpretation. 
Reflexivity means that the researcher considers how his/her personality and 
assumptions may influence the research outcomes (Thomas and Magilvy 2011). In 
order to address this, I wrote field notes immediately after each interview, including 
reflections on new insights and personal biases. During interviews, I attempted to stay 
neutral and not steer participants towards responses that they may not have 
previously thought about (see Thomas and Magilvy 2011). 
To ensure rigour, this study provides a detailed account of the processes through 
which the research was undertaken, as well as how the research questions were 
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developed, details of research design, sampling strategy, data collection, potential 
biases, etc. In terms of approach to data analysis, a link is established between the 
objectives of the study, choice of method, and the research findings, so that both the 
findings and processes are recognisable, transparent, and can be replicated.  
5.8 Potential for bias 
Bias may have been introduced into the study in a number of ways. For example, bias 
in relation to sampling can be a limitation (Groger et al. 1999). The non-SAS 
participants might not be entirely representative of people with diabetes who do not 
use emergency services. There might also be differences between those SAS patients 
who took part and those who refused to take part. This study only included people 
who resided in the central belt of Scotland, who might have different views and 
experiences of hypoglycaemic episodes compared to people who live outwith the 
region. However, the sample did cover two different groups (SAS and non-SAS 
participants), a good spread of ages (ranging from 21 to 82 years), as well as male and 
female participants (see section 5.5.2). 
Another factor that may influence participants’ responses is the way in which 
interviews and diaries are introduced. Participants’ require sufficient information 
about the study and what participation involves in order to make an informed decision 
about their willingness to participate. However, the information provided has to be 
carefully selected to minimise the level of bias in participants’ reporting.  
It is possible that participants decide to leave the study at various points (as 
highlighted in section 5.4.4), which can introduce bias to the study. It is therefore 
152 
 
important to investigate any differences between participants who stay in the study 
and those who decide to leave the study during the follow-up phase.  
Finally, the interviews and diaries may have revealed that some participants’ self-care 
activities or diabetes control were either problematic or inappropriate. I 
acknowledged the limitation of my role as a researcher, and only referred participants 
to seek medical advice and help when they expressed concern. Further limitations of 
this study are discussed in section 9.4. 
5.9 Data analysis 
There are a number of approaches in analysing qualitative data and their 
appropriateness is influenced by the stance of the researcher (participant or observer), 
data type and what research aims to achieve. This section briefly introduces a few 
ways of analysing qualitative data and gives details about the method of data analysis 
chosen for this study. 
Two similar approaches are conversation analysis (CA) and discourse analysis (DA), 
both of which place much importance on language. Bryman (2008) states that 
“language is depicted in discourse analysis as constituting or producing the social 
world” (p.500). Discourse analysis (DA) emphasises the way versions of the world, of 
society and events are produced in discourse; it is particularly interested in the use of 
language (Fairclough 2003; Bryman 2008). According to Morgan (2010), it represents 
the umbrella term for the many approaches used to analyse discourse.  
Discourse analysis can be useful in addressing key research questions and topics in 
health research and policy. For example, topics that emphasise promoting health, 
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reducing health inequalities, as well as improving health services (Morgan 2010). An 
example of a study that applied discourse analysis is O’Connor and Pearson (2005). 
They investigated the discourse used in palliative care for older adults living in 
Australia. Interestingly, their findings showed that there were two distinct approaches 
to palliative care: One stated that palliative care represented a highly specialised and 
complex practice. This was prominent in healthcare institutions and in the literature. 
The other discourse regarded palliative care as an addition to usual nursing practice, 
and did not associate it with any specialised knowledge. The latter view was primarily 
adopted within nursing homes (O’Connor and Pearson 2005). 
The emphasis of DA on language means that it could have been useful in looking at 
participants’ use of language in this study, for example to investigate whether all 
participants adopted a biomedical discourse of their illness. However, this study places 
less emphasis on participants’ use of language, as its main interest is about the 
content and themes of participants’ accounts of their experiences. 
Another approach is the ‘grounded theory’ method of data analysis, which was 
developed by Glaser and Strauss. The central feature of grounded theory is the 
“discovery of theory from data” (Glaser and Strauss 1967:2). This is achieved by an 
iterative and systematic process of data collection, data analysis and reflection (see 
Bryman 2008). Strauss and Corbin (1998) highlight that a grounded theory is one that 
is inductively derived from the study of the phenomenon it represents, while Creswell 
(1998) points out that the researcher has to set aside theoretical ideas to allow a 
‘substantive’ theory to emerge. According to Strauss and Corbin (1998), grounded 
theory is most appropriate in research areas where little or no theories exist.  
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Egan (2002) advises that although grounded theory research is commonly accepted to 
be holistic, naturalistic, and inductive in maintaining the traditional stages of research; 
that is, planning, data collection, analysis, and reporting, its creation is not wholly a 
linear process. For example, a key characteristic of grounded theory is theoretical 
sampling (Birks and Mills 2011), which means that further recruitment and data 
collection is based on emerging concepts from initial data analysis (Egan 2002). This 
study used a purposive sampling approach; with some pre-conceived assumptions of 
the study populations (see section 5.5.1). Thus, a pure grounded theory approach 
would not be appropriate. 
However, there are some less ‘purist’ ways of applying a grounded theory approach in 
data analysis, whereby the researcher uses grounded theory principles as well as some 
background theory (Birks and Mills 2011). The background theories can then be 
further developed during data analysis. In relation to this study, it did not follow a 
pure grounded theory approach; however, some techniques of grounded theory have 
been used (e.g. constant comparison method). 
The main method chosen to analyse qualitative data in this study was thematic 
analysis using a framework analysis approach (see section 5.9.1). Framework analysis 
is a structured approach to thematic analysis of qualitative data developed by Ritchie 
and Spencer (1994). It was explicitly designed to generate findings relevant to practice 
and policy (Ritchie and Spencer 1994). This fits in very well with the current study 
design, in terms of findings being relevant to (future) design of SAS emergency care as 
well as general diabetes care. Framework analysis also offered a structured approach 
to develop models of illness behaviour (the HEBC model, see section 7.3 and the HEHS 
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network, see section 8.3). These models were generated from the data with reference 
to existing evidence. 
Additionally, framework analysis links in well with the interpretivist approach this 
study was following in terms of its constructionist ontological position. It is also very 
useful in addressing pre-specified questions (Furber 2010). Another benefit of 
framework analysis is its systematic and transparent approach to data analysis, giving 
people other than the primary researcher access to the analytic process (Ritchie et al. 
2003b). 
A major difference between framework analysis and grounded theory is that 
framework analysis preserves the integrity of individual participant’s accounts through 
a process of summarising and classifying data within a thematic framework, in contrast 
to the intentional ‘fragmentation’ of data during the analytic process when using 
grounded theory (Green and Thorogood 2009). Again, this feature of framework 
analysis underlines its relevance to this study, facilitating a clear and transparent 
approach during each step of data analysis.  
5.9.1 Stage 1: Analysis of qualitative data 
As highlighted above, the analysis of qualitative components of this study was guided 
by principles of framework analysis (Ritchie and Spencer 1994). The framework 
approach is very appropriate as the objectives of the investigation are set in advance 
and it offers a practical and systematic way of analysing large amounts of qualitative 
data (Pope et al. 2000).  
 
156 
 
The main stages of the framework approach to qualitative data analysis are:  
 Familiarisation (with all collected data)  
 Identification of a thematic coding framework  
 Indexing (i.e. applying the thematic framework to data)  
 Charting data according to their thematic reference (which includes some 
abstraction and synthesis of data)  
 Mapping and interpreting the data as a whole  
 
Familiarisation 
The first stage in framework analysis is familiarisation with all data. All interviews in 
this study were audio recorded and transcribed verbatim. After each interview, 
recordings were listened to and transcripts read several times in order to become 
closely familiar with the data and to gain an overview of the range and diversity of 
data (Ritchie and Spencer 1994). During this stage, a list of key ideas and emerging 
themes was developed (Ritchie et al. 2003b). 
Identification of a thematic coding framework 
Following the familiarisation stage, a thematic coding framework was identified (see 
Appendices 16 and 17). This was guided by key themes generated by reading through 
and coding five transcripts. The five transcripts were selected to ensure that a variety 
of participants’ experiences was included based on the following criteria: different age 
groups (n=1 aged 18-40, n=2 aged 41-60 and n=2 aged over 60), genders (n=3 female 
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and n=2 male), and participant groups (n=2 SAS and n=3 non-SAS). The initial thematic 
coding framework was cross checked with both my supervisors and further refined 
and developed through critical discussion (see Appendix 18). At this stage, coding was 
conducted manually, as it is suggested that this is sufficient to gain an overview of key 
themes (Arksey and Knight 1999).  
The development of the thematic coding framework was an iterative process, moving 
back and forth between the coding framework and the transcripts, continuously 
refining and revising the coding framework and re-coding the transcripts (see 
Appendix 18). At this stage, my supervisors were involved in co-coding and checking of 
data analysis.  
Indexing and charting data according to their thematic reference 
Once the thematic coding framework had been identified, it was applied 
systematically to the whole (qualitative) data. I used a qualitative analysis software 
package, Nvivo (Version 9) to facilitate this process. Following indexing, the data was 
re-arranged according to their thematic reference and charted to the appropriate part 
of the thematic framework (see Appendix 18). During this process, data was 
summarized, abstracted and synthesized (Pope et al. 2000). 
Mapping and interpreting the data as a whole 
Finally, the charts, abstracts and summaries were used to develop and refine concepts 
and to establish associations between themes (Pope et al. 2000). I followed a 
pragmatic approach, developing charts for selective themes (those of particular 
interest to the study). This helped to develop the hypoglycaemic episode balancing 
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continuum (HEBC; see section 7.3) and the hypoglycaemic episode help-seeking 
network (HEHS network; see section 8.3). The process of mapping and interpreting the 
data as a whole was informed by the research aims, research questions and by themes 
from the data. This was also beneficial as it allowed for looking at phenomena across 
individual cases.  
5.9.2 Stage 2: Analysis of quantitative data 
The quantitative data from the hypoglycaemia diary and the plotting of blood glucose 
values was entered into a quantitative analysis software package, SPSS (Version 19). 
Following this, the data set was checked for errors to ensure the accuracy of the data 
set, as suggested by Buckingham and Saunders (2004). This was done by double 
checking for errors and mistakes. 
Quantitative data was analysed using descriptive statistics. It investigated: 
 count of hypoglycaemic episodes, comparison across the SAS and non-SAS 
group 
 consistency in perceptions of hypoglycaemic episodes (correlating the lowest 
blood glucose level with recording of hypoglycaemic episodes) 
 perceived severity scores, comparison across the SAS and non-SAS group. 
5.9.3 Stage 3: Data integration 
Data integration is an important step in studies adopting mixed methods approaches 
(Kroll and Neri 2009). The process of triangulation is generally used to integrate 
qualitative and quantitative findings, and is known to increase validity of results and 
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provides a more complete picture to answer the research questions (Jones and Bugge 
2006; Doyle et al. 2009). Triangulation involves using multiple perspectives to address 
a set of research questions, as well as comparing results from qualitative and 
quantitative methods (Patton 2002). This study used the technique of triangulation to 
integrate all data, following the separate analysis of qualitative and quantitative 
elements.  
Data integration was carried out at the interpretation stage. Results from qualitative 
and quantitative data were compared across the two participant groups (SAS and non-
SAS participants, see section 9.2.1), as well as looking at particular themes (e.g. the 
issue of hypoglycaemia unawareness; see Hussein 2009). This study used a parallel 
analytic approach (Östlund et al.2011), and findings from quantitative data were used 
to inform findings from qualitative data. For example, socio-demographic factors 
identified from the quantitative data (see section 6.2) were used to help understand 
findings from the qualitative data (e.g. the issue of health literacy, see sections 7.4.4 
and 7.5). The quantitative data on participants’ blood glucose readings was used to 
inform findings from qualitative data; for example, it helped to investigate 
hypoglycaemia unawareness, an important phenomenon that can contribute to the 
use of emergency services (see sections 6.5.3 and 7.4.3). 
5.10 Summary 
This study employed a longitudinal, multiple data collection approach, to explore 
participants’ perspectives and experiences of recurrent hypoglycaemia over time. This 
chapter has provided an overview of methods chosen in this study, including details on 
study aims, research questions, sampling strategy and issues around access to 
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participants and recruitment. It has highlighted ethical considerations, phases of data 
collection and the approach chosen for data analysis.   
The following chapters present findings from the analysis of the semi-structured 
interviews, hypoglycaemia and blood glucose diaries and telephone interviews. 
Chapter 6 presents the demography of the sample, characteristics of participants who 
completed the hypoglycaemia and blood glucose diary and then focusses on results 
from the quantitative data. It points out a number of differences between the SAS and 
non-SAS participants. These are further picked up on and analysed in chapter 7 (see 
for example section 7.5).  
Chapter 7 focusses on findings in relation to participants’ experiences and perceptions 
of recurrent hypoglycaemic episodes. Chapter 8 includes findings about participants’ 
management of hypoglycaemic episodes within their overall diabetes care.  
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Chapter 6 - Study sample and comparison of diary results 
6.1 Introduction 
This chapter reports details about sample demography (section 6.2), including 
information about the sub-sample who completed the hypoglycaemia and blood 
glucose diary (section 6.3), and highlights possible differences between those who 
completed the diary and those who did not (section 6.4). It also considers similarities 
and differences between SAS and non-SAS participants in terms of numbers of 
hypoglycaemic episodes, perceived severity ratings and recording of hypoglycaemic 
episodes in the hypoglycaemia and blood glucose diary (section 6.5.1). 
All quotes from participants are marked with their participant ID number, which 
provides basic information about the participant. The first part of the ID number 
shows which group participants belong to: AS= Scottish Ambulance Service (SAS) group 
and NS= non-SAS group. The number following the group code indicates people’s age 
group: 1= 18 to 40 years, 2= 41 to 60 years and 3= over 60 years of age. The letters M 
or F stand for male or female, and the number at the end of each participant’s ID 
number is simply a count of participants, from 01 to 30. For example, NS1_M23 would 
be a male non-SAS participant, age group 1 with participant number 23. 
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6.2 Demography of the sample 
The following table reports on the demographic characteristics of the sample. 
Participants in sample (n=30) Frequency Percentage 
Group 
     Scottish Ambulance Service (SAS) 
     Non-Scottish Ambulance Service (non-SAS) 
 
13 
17 
 
43%  
57% 
Age 
     Mean (All participants) 
     Mean (Non-SAS) 
     Mean (SAS) 
     18-40 years 
     41-60 years 
     >60 years 
 
50 years 
44 years 
58 years 
11 
11 
8 
Range:  
21-82 years (SD=17.2) 
28-66 years (SD=13.87) 
21-82 years (SD=18.55) 
37% 
37% 
26% 
Gender 
     Male (6 SAS/8 non-SAS) 
     Female (7 SAS/9 non-SAS) 
 
14 
16 
 
47% 
53% 
Type of diabetes 
     Type 1 (9 SAS/15 non-SAS) 
     Type 2 (4 SAS/2 non-SAS) 
 
24 
6 
 
80% 
20% 
Duration of diabetes 
     Mean (All participants) 
     Mean (Non-Scottish Ambulance Service) 
     Mean (Scottish Ambulance Service) 
 
24 years 
21 years 
28 years 
Range: 
2-65 years (SD=16.0) 
2-51 years (SD=16.68) 
6-65 years (SD=15.39) 
Scottish Index of Multiple Deprivation 
(SIMD) Deprivation category 
     1 
     2 
     3 
     4 
     5 
Mean (All participants) 
Mean (Non-Scottish Ambulance Service) 
Mean (Scottish Ambulance Service) 
 
 
7 
4 
2 
7 
10 
3.3 
4 
2.4  
 
 
23% 
13% 
7% 
23% 
34% 
- 
- 
- 
Table 6.1: Demographic characteristics of the sample 
All participants in this study were diagnosed with either type 1 (80%) or type 2 (20%) 
diabetes and were treated with insulin. The method of insulin administration was 
either through insulin pump (n=3, all from within non-SAS group) or injection (n=27). It 
was expected that the majority of participants would be diagnosed with type 1 
diabetes as insulin therapy is the only treatment for type 1 diabetes (and being treated 
with insulin therapy was one of the inclusion criteria for this study). Treatment for 
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type 2 diabetes ranges from diet control and exercise, to oral diabetes medications 
and insulin therapy.  
Participants ranged in age from 21 to 82 years, with the mean age being 50 years. The 
mean age for SAS participants was 58 years, while it was 44 years in the non-SAS 
participant group. Slightly more females (53%) than males (47%) took part in the 
study. There were more non-SAS participants (57%) than SAS participants (43%). This 
was due to challenges in the recruitment of SAS participants (see section 5.5.4.2). 
Looking at the duration of diabetes for all participants, the mean was 24 years. SAS 
participants had a longer duration of diabetes (28 years), compared to non-SAS 
participants (21 years). 
The Scottish Index of Multiple Deprivation (SIMD) was used to assess participants’ 
socio-economic backgrounds. Deprivation categories are based on scores from seven 
domains (income, employment, education, housing, health, crime, and geographical 
access), and can be identified using people’s postcodes (The Scottish Government 
2009). This study used the SIMD quintile scores which range from 1 to 5 (1 being most 
deprived). There was a spread across all five deprivation categories among study 
participants; however, there was clustering of participants on both ends of the 
deprivation scores. For example, 57% of the sample belonged to deprivation category 
4 or 5 (very little deprivation), while 36% were in the deprivation categories 1 or 2 
(higher levels of deprivation). Interestingly, 14 of the 17 non-SAS participants were in 
deprivation categories 4 or 5, which is reflected in a mean score of 4. SAS participants 
tended to live in more deprived areas, with a mean deprivation score of 2.4. 
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6.3 Sub-sample who completed the hypoglycaemia and blood glucose 
diary  
Of the 30 participants who took part in the semi-structured face to face interviews, 
67% (n=20) completed at least two months’ worth of diary time. 11 participants (9 
non-SAS/2 SAS) completed the full six months of diary time. Looking at the two groups, 
71% of non-SAS participants took part in the diary stage, and 53% completed the 
hypoglycaemia and blood glucose diary for the full six months. In the SAS group, 62% 
of participants wrote some diary entries, but only 15% completed the full six months. 
Further details can be found in table 6.3 (see section 6.5.1). All participants who took 
part in the diary stage completed both hypoglycaemia and blood glucose diary during 
that time. Table 6.2 (see overleaf) shows an overview of missing data across all 
participants. 
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Table 6.2: Overview of missing data across all participants  
 
Participant ID N= days 
diary kept 
N= missing 
days pre 
diary* 
N= missing days 
within diary 
N= missing days 
post diary 
(drop-out)** 
NS2_F01 170 10 0 0 
NS2_F02 168 12 0 0 
NS1_F03 92 0 0 88 
NS2_M04 160 20 0 0 
NS3_F05 178 2 0 0 
NS1_F06 0 N/A N/A N/A 
NS1_M07 177 0 3 0 
NS1_F08 0 N/A N/A N/A 
AS1_F09 180 0 0 0 
NS3_F10 112 0 68 0 
AS1_M11 62 0 0 118 
NS1_F12 0 N/A N/A N/A 
AS2_F13 54 7 0 119 
AS3_M14 0 N/A N/A N/A 
NS2_M15 180 0 0 0 
NS1_M16 0 N/A N/A N/A 
NS3_M17 180 0 0 0 
NS1_M18 61 0 0 119 
NS2_M19 84 0 7 89 
AS3_M20 0 N/A N/A N/A  
NS2_F21 178 2 0 0 
AS1_F22 109 0 4 67 
NS1_M23 0 N/A N/A N/A 
AS3_F24 179 0 1 0 
AS2_M25 0 N/A N/A N/A 
AS3_F26 0 N/A N/A N/A 
AS2_M27 110 7 5 58 
AS2_M28 77 8 5 90 
AS3_F29 77 9 58 36 
AS2_F30 0 N/A N/A N/A   
*missing days pre diary indicates that the participant did not start diary on 1st of the month  
(Participants usually started the diary the day following the face to face interview) 
**missing days post diary indicates that the participant stopped writing any further diary entries and 
dropped out from the study 
 
6.4 Potential differences between participants who completed the 
diary and those who did not 
There were 10 participants (five in each group) who did not write any diary entry 
following the initial interview. It was difficult to establish the reasons why participants 
decided to drop out of the study after the initial interview. This was because during 
166 
 
follow-up telephone calls or emails, participants did not directly state that they wished 
to drop out of the study, instead they responded to reminders by saying that they 
would try to write some diary entries.  
Comparing the ages of participants who decided to drop out, it can be noted that the 
mean age of non-SAS participants leaving the study was 32 years (with a range from 28 
to 35 years), while it was 68 years in the SAS group (with a range from 51 to 82 years). 
Even though the mean age was higher in the SAS group (see section 6.2), this 
difference still seems remarkable. There are some possible explanations for this 
difference: non-SAS participants might have been too busy with work or family 
responsibilities to commit to writing the diary, and SAS participants might have had 
further health problems that could have made diary completion difficult. For example, 
one of the SAS participants (82 year old male) had a stroke a few weeks after the semi-
structured interview, which is why he dropped out of the study. 
6.5 Differences between SAS and non-SAS participants who completed 
the diary  
As one of the inclusion criteria was either having called out the ambulance service in 
the week preceding recruitment (SAS participants) or not having required the 
assistance of emergency services due to a hypoglycaemic episode in the three months 
prior to recruitment (non-SAS participants), a major difference between non-SAS and 
SAS participants was whether or not they required external help to deal with 
hypoglycaemic episodes. One of the non-SAS participants explained why he had never 
needed the ambulance service or A&E due to a hypoglycaemic episode: 
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I've never once been hospitalised or had to call an ambulance with my 
hypos because I know how to treat them now and I know when they’re 
going to start. (NS2_M19, face to face interview) 
 
Issues around needing external help are investigated in more detail in section 7.2.5. 
Further differences between SAS and non-SAS participants are discussed throughout 
the findings chapters (see for example section 7.5). 
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6.5.1 Frequency and perceived severity of hypoglycaemic episodes by participant group 
 Participant ID Age Years since 
diagnosis 
Group N=days 
diary kept 
N=number 
of hypos 
recorded 
N=times 
BG<4 mmol/l 
Percentage* Mean 
perceived 
severity 
1 NS1_F03 28 1.5 Non-SAS 92 17 20 85.00 4.31 
2 NS1_M18 24 10 Non-SAS  61 20 20 100.00 3.10 
3 NS1_M07 40 4 Non-SAS 177 31 53 58.49 4.03 
4 NS2_F01 54 51 Non-SAS 170 62 58 106.90 4.86 
5 NS2_F02 59 11 Non-SAS  168 18 18 100.00 3.11 
6 NS2_F21 45 19 Non-SAS  178 61 78 78.21 5.64 
7 NS2_M04 56 51 Non-SAS  160 52 58 89.66 1.91 
8 NS2_M15 43 26 Non-SAS  180 46 74 62.16 2.51 
9 NS2_M19 50 7 Non-SAS  84 5 4 125.00 7.40 
10 NS3_F05 66 51 Non-SAS  178 47 69 68.12 2.93 
11 NS3_F10 62 24 Non-SAS  112 17 15 113.33 2.06 
12 NS3_M17 64 6 Non-SAS  180 50 51 98.04 6.65 
 Mean 49 22 Non-SAS  145 35.5 43.17 82.23 4.04 
13 AS1_F09 40 27 SAS 180 13 62 20.97 4.23 
14 AS1_F22 21 7 SAS 109 2 23 8.70 3.00 
15 AS1_M11 34 15 SAS 62 1 5 20.00 5.00 
16 AS2_F13 58 35 SAS 54 1 5 20.00 8.00 
17 AS2_M27 53 17 SAS 110 5 27 18.52 5.00 
18 AS2_M28 58 41 SAS 77 1 27 3.70 Missing 
19 AS3_F24 78 65 SAS 179 9 48 18.75 5.00 
20 AS3_F29 70 30 SAS  77 0 23 .00 Missing  
 Mean 52 30 SAS 106 4 27.5 14.54 5.04 
*Percentage = Percentage of times BG below 4 mmol/l and a hypo was recorded 
Table 6.3: Overview of results from quantitative data 
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Table 6.3 (above) provides an overview of frequency and perceived severity of 
hypoglycaemic episodes by participant group. These are results from the sub-sample 
of participants (n=20) who completed the hypoglycaemia and blood glucose diary. The 
table shows that SAS participants who completed the diary were slightly older (mean 
age 52 years) than non-SAS participants (mean age 49 years), and had lived with 
diabetes for a longer time (mean duration= 30 years), compared to a mean of 22 years 
in the non-SAS group. 
In terms of time the diary was kept, it ranged from 54 to 180 days. Comparing the 
mean data for SAS and non-SAS participants, non-SAS participants kept the diary for a 
longer time (mean=145 days) than SAS participants (mean=106 days). Participants also 
varied in relation to diligence and accuracy in completing the blood glucose diaries. For 
example, one SAS participant (AS1_F22, who was pregnant when taking part in the 
study) completed her blood glucose diary very diligently, and interestingly, her blood 
glucose readings were always within the target she had been given by her diabetes 
specialist (see Appendix 14). This highlights that participants could be more motivated 
to maintain appropriate blood glucose levels when pregnant, or there could 
potentially be an issue of participants trying to portray themselves in terms of what 
they thought was more desirable (Adams et al. 1999; Fielding and Thomas 2008). 
There were considerable differences regarding the overall number of hypoglycaemic 
episodes that were recorded. Non-SAS participants recorded an average of 35.5 
hypoglycaemic episodes, while SAS participants only recorded an average of 4. These 
were the number of self-reported hypoglycaemic episodes. Taking into consideration 
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that on average SAS participants kept the diary for a shorter length of time, the 
difference between the two groups still seems striking.  
The differences between the two groups are further highlighted when results from the 
blood glucose diary are considered. The blood glucose diary allowed me to analyse 
blood glucose readings surrounding hypoglycaemic episodes. SPSS was used to get a 
frequency count of low blood glucose readings (BG<4 mmol/l), and found that non-SAS 
participants had a higher number of times when their actual blood glucose readings 
were below 4 mmol/l (mean= 43.17). However, when correlating the number of 
hypoglycaemic episodes that each participant recorded with the number of times a 
low blood glucose reading was taken, there were considerable differences between 
the SAS and non-SAS group.  
In the SAS group, participants only wrote an entry in the hypoglycaemia diary in 
14.54% of the cases when their blood glucose readings were below 4.0 mmol/l. This 
contrasts to 82.23% in the non-SAS group. Some of these differences can be explained 
with different levels of record-keeping: perhaps participants in the SAS group found it 
more challenging to take a note of every hypoglycaemic episode they experienced 
during the diary time. Another possible explanation could be different levels of health 
literacy (also see section 7.4.4), and maybe a better understanding about what a 
hypoglycaemic episode is in the non-SAS group. 
The differences between the SAS and non-SAS group in relation to recording of 
hypoglycaemic episodes when their blood glucose level was below 4.0 mmol/l may 
also have been influenced by hypoglycaemia unawareness (see section 6.5.3).  
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Overall, 18 hypoglycaemic episodes required SAS support during the study. These 
incidents were all reported by SAS participants. Given the comparatively short time 
SAS participants kept the hypoglycaemia and blood glucose diary and the potential for 
underreporting as a result of self-reported methodology (McGregor and Makkai 2003; 
Myers et al. 2007), these numbers are considerable. 
6.5.2 Severity of hypoglycaemic episodes 
Participants were asked to give a severity rating for each hypoglycaemic episode they 
recorded in the diary. The severity rating was purely subjective, as perceived by each 
individual. It was based on a 1 to 10 scale (10 being most severe). Mean scores ranged 
from 1.91 to 8.0. There was a slight difference in the mean scores for the two groups. 
Non-SAS participants gave a mean score of 4.04, while SAS participants perceived their 
hypoglycaemic episodes to be slightly more severe with a mean score of 5.04. There 
was more variation when comparing severity scores within each group; especially in 
the non-SAS group where scores ranged from 1.91 to 7.4. The variety of perceived 
severity scores were further considered when looking at results from the qualitative 
data, (see section 7.3/table 7.1), especially in relation to attitudes towards 
hypoglycaemic episodes.   
6.5.3 Possible hypoglycaemia unawareness 
The (low) percentage of times a hypoglycaemic episode was recorded in participants’ 
diaries when their blood glucose level was below 4.0 mmol/l highlights another 
possible phenomenon: hypoglycaemia unawareness. Despite having a blood glucose 
level below 4.0 mmol/l, some participants might not have recognised that they were 
having a hypoglycaemic episode due to a lack of symptoms. Hypoglycaemia 
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unawareness is associated with a higher risk of experiencing severe hypoglycaemic 
episodes (Gerich 2000). This could be a particular problem in the SAS group, and might 
explain why the percentage of recorded hypoglycaemic episodes when the blood 
glucose level was below 4.0 mmol/l was so low. The results from the qualitative data 
further helped explain possible differences relating to hypoglycaemia unawareness 
between the SAS and the non-SAS group (see sections 7.4.3 and 7.5). 
6.6 Summary 
This chapter presented details of sample demography (section 6.2), as well as 
information relating to the sub-sample who completed the hypoglycaemia and blood 
glucose diary (section 6.3). SAS participants tended to live in more deprived areas and 
have had diabetes for longer than non-SAS participants.  
The results from the quantitative data have shown some differences between the SAS 
and non-SAS participants. For example, non-SAS participants recorded more 
hypoglycaemic episodes compared to SAS participants. This could in part be due to 
higher levels of hypoglycaemia unawareness in the SAS group (see section 6.5.3). In 
terms of perceived severity scores, SAS participants rated their hypoglycaemic 
episodes slightly more severe than non-SAS participants (section 6.5.2). Further 
differences between the two groups were explored as they occurred in the qualitative 
analysis and are discussed in the following chapters (see for example section 7.5). 
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Chapter 7 - Participants’ experiences and perceptions of 
recurrent hypoglycaemic episodes: Re-conceptualisations of 
balancing the risks 
7.1 Introduction 
This chapter focusses on participants’ experiences and perceptions of recurrent 
hypoglycaemic episodes and the impact hypoglycaemic episodes can have on their 
everyday life. It is structured into four sections. 
The first describes how the variation and unpredictability of hypoglycaemic episodes 
can affect participants (section 7.2). This includes worries about hypoglycaemic 
episodes happening (section 7.2.1), as well as difficulties such as feeling confused 
when participants were experiencing hypoglycaemic episodes (see section 7.2.3). It 
highlights that there can be a lack of association between blood glucose levels and 
symptoms participants experience, both on an individual level as well as across 
participants (section 7.2.4). This could have potential implications for clinical practice, 
for example, recommendations given to patients. It may be useful to include 
information that hypoglycaemia unawareness can affect people at various times and 
that blood glucose levels can fail to predict onset of hypoglycaemic episodes (see 
section 9.5.1). 
The second section presents the ‘hypoglycaemic episode balancing continuum’ (HEBC; 
section 7.3) which has been developed based on the findings of this thesis. The HEBC is 
a framework for understanding how participants adopted different stances towards 
hypoglycaemia, and that they varied in the way they balanced risks of long-term 
complications, the immediate impact of hypoglycaemic episodes and achieving 
174 
 
appropriate diabetes control. For example, the HEBC demonstrates that those 
participants who had a fearful perception of hypoglycaemia tended to keep a higher 
blood glucose level in an attempt to avoid hypoglycaemic episodes happening.  
The third section highlights participants’ individual explanations for recurrent 
hypoglycaemic episodes (section 7.4). This included participants’ awareness of the 
factors contributing to hypoglycaemic episodes, underlining the importance of health 
literacy. Findings show that participants’ understanding of the factors that can cause 
hypoglycaemic episodes varied considerably. 
The fourth and final section of this chapter presents the differences between 
participant groups. Findings show that SAS participants tended to experience more 
severe hypoglycaemic episodes, compared to non-SAS participants. One contributing 
factor was that they seemed to be less able to manage hypoglycaemia unawareness 
(section 7.5). 
7.2 Variation and unpredictability of hypoglycaemic episodes 
The following sections highlight various issues that were identified in relation to the 
variation and unpredictability of hypoglycaemic episodes participants experienced. For 
example, participants’ fears and worries about hypoglycaemia: this seemed to vary 
between different participants (section 7.2.1). In relation to the unpredictability of 
hypoglycaemic episodes, findings also showed participants’ feelings of being confused 
and not in control when experiencing a hypoglycaemic episode (sections 7.2.2 and 
7.2.3).  
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A surprising finding was the lack of association between blood glucose level and 
symptoms experienced: individuals spoke about experiencing symptoms of 
hypoglycaemia at various blood glucose levels. There was no consistency of symptoms 
at particular blood glucose levels. In fact, sometimes participants were still able to 
solve a difficult puzzle at very low blood glucose levels, while at other times they 
would struggle to even treat their hypoglycaemic episode at exactly the same blood 
glucose level, (see section 7.2.4). 
There was variation relating to participants’ experiences of needing external help 
(section 7.2.5). Major differences were evident between SAS and non-SAS participants: 
seeking external help was a lot more prominent in the SAS group, and this help was 
more often provided by the ambulance service.  Requiring external help also seemed 
to be associated with hypoglycaemia unawareness. 
7.2.1 “Hypos are scary”: fears and worries about hypoglycaemia 
Fears and worries about hypoglycaemia were mentioned by many participants. This 
included both fear when hypoglycaemic episodes actually occurred, as well as worries 
about potential hypoglycaemic episodes happening. 
When you start having all the hypos it’s quite scary. (NS1_F06, 
telephone interview) 
 
I get very impatient if I can’t have something to eat, not only because I 
know that I’m quite low [referring to blood glucose], but because I’m 
scared stiff that I’m going to go too low and I’m out. (NS3_M17, face to 
face interview) 
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I’ve never collapsed or anything, but I know that that can happen and 
that’s a hugely worrying thing to live with. (NS2_F02, face to face 
interview) 
 
For some participants, fear of hypoglycaemic episodes influenced their diabetes self-
management, resulting in them keeping a higher blood glucose level in order to avoid 
hypoglycaemic episodes happening (also see section 8.2.7.3). The following quote 
illustrates the dilemma of a female non-SAS participant who was very frightened of 
hypoglycaemic episodes. 
Some of the reasons why I stopped taking my insulin was because I was 
scared of hypos – I know it sounds really, really daft, but because of the 
way they make me feel, I'm scared to take too much insulin if it’s going 
to bring on a hypo, and sometimes that makes my blood go high. So I 
can't win [laugh]! (NS1_F12, face to face interview) 
 
One SAS participant spoke about experiencing a severe hypoglycaemic episode while 
travelling to another country. She described her anxiety of whether someone would 
know how to treat hypoglycaemic episodes and help her, and whether she would be 
able to explain that she had diabetes, and was experiencing a hypoglycaemic episode. 
She stated: 
It’s scary, hypos are scary in the fact that you feel vulnerable […] it’s the 
feeling of not feeling safe, that’s scary. (AS1_F09, face to face interview) 
 
Another SAS participant explained her fear and confusion when she needed external 
help due to a severe hypoglycaemic episode: 
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I just get scared when the paramedics are standing there, am I coming 
or am I going? […] I just don’t know what I’m doing. (AS2_F30, face to 
face interview) 
 
A number of participants also mentioned experiencing depression/low mood as a 
result of the burden of managing diabetes and hypoglycaemic episodes. The following 
participant explained how experiencing hypoglycaemic episodes and managing 
diabetes brought on depression. 
I know it sounds a daft thing but with the hypos and the diabetes, right, 
that’s what’s causing my depression as well. But a lot of people don’t 
realise this and it’s hard to try and get over to people, right, that 
depression is linked with diabetes now. […] it does get you down and 
that’s why I'm now on 40mg of anti-depressants a day as well now, 
right, because you do… don’t get me wrong when I first got diagnosed 
with diabetes, right, at one point I was getting suicidal. (NS2_M19, face 
to face interview) 
 
One of the SAS participants described how experiencing a hypoglycaemic episode in 
the morning can impact on the rest of the day causing her to feel depressed. 
If I experience a hypo in the morning, say, like I won't do anything for 
the rest of the day because I know that it’s going to be like that.  It’s 
going to go up and down all day, and if I do go out I’ll just take my sugar 
gels with me, but I don’t like going out if I know that my blood sugar’s 
been low in the morning… it puts a downer on it, I know that’s… they say 
don’t let it do that but it does.  You can't help it, it makes you feel all 
down and depressed when it goes like that. (AS1_F22, face to face 
interview) 
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This section has underlined the huge strain hypoglycaemic episodes can have on 
people’s life: feeling scared when hypoglycaemic episodes are actually happening, as 
well as worrying about potential hypoglycaemic episodes occurring at any point in 
time. For some participants, the experience of hypoglycaemic episodes and the 
demands of managing diabetes can cause feelings of depression. This could have a 
knock-on effect on their diabetes management; for example, trying to avoid 
hypoglycaemic episodes (also see section 8.2.1). 
7.2.2  “Not being in control”: issues around losing control 
When describing their experiences of recurrent hypoglycaemic episodes, participants 
often expressed the wish to be in control, to be able to take care of themselves. 
Hypoglycaemic episodes are sometimes perceived as a threat to achieving this, 
especially when help from another person becomes necessary. The following quote 
highlights that the feeling of losing control seemed to be associated with increased 
fears and worries about hypoglycaemia. 
“When you start having all the hypos it’s quite scary, just because you 
almost lose control, you know, you always want to be in control but 
you're almost losing control then.” (NS1_F06, telephone interview) 
 
The following participant reflected about the concept of (not) being in control in light 
of her experience of hypoglycaemic episodes over time.   
“You become conscious of the fact that you are not in control [when 
having a hypoglycaemic episode], it’s not that I’m a control freak, but 
it’s just I like to be in control of what I’m doing, I don’t mind about 
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anybody else, but that would be a serious loss for me.” (NS2_F01, face 
to face interview) 
  
Another participant described a conflict when a situation arose where external help 
was required, but she was reluctant to accept any help. This underlined her strong 
desire to be independent and ‘in control’. 
“I think it’s hard because that’s when you're feeling your most confused 
[refers to situation when blood glucose level is very low] and you don’t 
want anyone else taking control over you, well I probably wouldn’t like 
that anyway, you know, that’s part of the problem is that you don’t 
want any help.” (NS2_F21, face to face interview) 
 
Participants’ fear of losing control appeared to be a major concern in relation to how 
hypoglycaemic episodes disrupted their everyday lives, as well as the impact this could 
have on their ability to treat hypoglycaemic episodes themselves effectively. 
Interestingly, the issue of losing control was not just about physical control, but 
perhaps more importantly mental capacity: experiencing hypoglycaemic episodes 
could impact on people’s mental ability, as illustrated below. 
“Hypos are not nice things to have, it’s a horrible, horrible feeling. Apart 
from feeling drained and tired, it’s this business of not being in control; 
your mind isn't working the way it should and that bothers me, that 
really worries me.  You lose your rationale on things and you start to 
think ‘am I confused, am I thinking straight, what should I be doing?’” 
(NS3_F10, face to face interview) 
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7.2.3 “I’m so confused by them”: issues around confusion and struggles 
A number of participants viewed hypoglycaemic episodes as a major challenge in the 
management of diabetes. Some participants seemed to generally struggle to manage 
hypoglycaemic episodes. Participants also reported feeling confused and sometimes 
finding it challenging to treat hypoglycaemic episodes. Such confusion was a major 
factor that can impact on treatment, e.g. cause a delay in taking appropriate action or 
necessitate external help. Another important factor was people’s attitude towards 
diabetes and hypoglycaemic episodes. The following quote highlights one participant’s 
struggle: 
It’s an on-going battle every day in the big war that you never win! 
That’s what it feels like […] it’s very hard work, it’s quite exhausting and 
you feel like your whole life is just sort of taken over by it, although it 
isn’t, but that’s just… everything that you do is sort of impacted by it. 
(NS1_F08, face to face interview) 
 
Some participants reported that hypoglycaemic episodes can cause confusion, which 
can interfere with treatment. The following participant spoke about situations when 
she felt so confused that she ‘forgot’ what she was about to do, or how to treat the 
hypoglycaemic episode: 
Now I'm so confused by them [i.e. hypoglycaemic episodes] I don’t… I 
know once or twice I've even sat thinking ‘there’s something I really 
need to do, I must do it but I've no idea what it is?’ (NS2_F01, telephone 
interview) 
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I was just a bit confused, obviously because I was having a hypo! 
(NS1_M07, telephone interview) 
 
One SAS participant recalled a severe hypoglycaemic episode where she lost 
consciousness: 
I woke up and it’s like all confused and everything, it’s like didn’t know 
what was happening.  See when I woke up the last time with the 
ambulance here, I woke up and I thought I was actually just dreaming 
because the ambulance was there and I was like ‘what’s going on?’ 
(AS1_F22, face to face interview) 
 
This highlights an important problem in the treatment of hypoglycaemic episodes: 
when people get confused, external help may become necessary. This help is often 
provided by family members or friends, and in more severe cases the ambulance may 
be called. In situations when the individual is confused, the ability of the person’s 
support network to identify, help treat or call out an ambulance is vital. Section 8.2.7.4 
takes a closer look at the role of people’s support network. 
7.2.4 “No rhyme nor reason”: the lack of association of blood glucose 
levels and symptoms of hypoglycaemia 
Several participants spoke about discrepancies between their blood glucose level and 
the symptoms they experienced. For example, some of the non-SAS participants could 
feel ‘perfectly normal’ even though their blood glucose level was very low. The 
following quotes illustrate this: 
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I can still be doing a Sudoku diabolical puzzle at 1.8 and I'm still okay!  
But the other thing is I have different feelings; I can be 1.8/1.9/2 and I'm 
feeling okay, but sometimes at 3.4 I think ‘wait a minute, I need sugar 
here…’ So it varies and I just can't put rhyme nor reason to that. 
(NS2_M04, face to face interview) 
 
I've checked my blood and I've been 1.6 [mmol/l].  I'm completely 
normal […], I've been socialising with folk and it’s all fine, […] but there’s 
none of the symptoms, but also at the same time I can be 4.5 [mmol/l] 
and all the symptoms are all over the place. (NS1_M23, face to face 
interview) 
 
The above quotes illustrate that there were variations in relation to when symptoms 
of hypoglycaemia were felt. Some participants reported the absence of symptoms in 
situations when their blood glucose level would be classed as hypoglycaemic (below 
4.0 mmol/l, see section 2.7). But participants also reported that they could feel 
symptoms when their blood glucose level was well above 4.0 mmol/l. The following 
participant confirmed this: 
I can feel as though I’m having a hypo and my blood sugar is still over 5 
[mmol/l]. (NS2_F01, face to face interview) 
 
Several SAS participants described similar experiences. Interestingly, the experience in 
the SAS group appeared to be mainly related to low blood glucose levels where 
participants did not experience any symptoms, which is also known as hypoglycaemia 
unawareness, (see section 2.9).  This may suggest that hypoglycaemia unawareness is 
a more prominent problem in the SAS group, compared to the non-SAS group. Results 
183 
 
from the quantitative data (see sections 6.5.1 and 6.5.3) also confirmed that 
hypoglycaemia unawareness appeared to be a major problem in the SAS group. 
See sometimes I test and say I'm 2.6 [mmol/l] and I'm perfectly alright, 
I'm not hypo [..] other times at two point something I probably would be 
hypo, so it doesn’t always happen at the same level as far as I'm aware. 
(AS3_F24, face to face interview) 
 
I’ll check my blood and see what it is, and I might look at it and say ‘oh 
it’s a two point something’ and I still feel normal, I feel okay, I'm not 
going to fall down, I don’t feel any different, but maybe ten minutes 
later or even less than that you could just fall down, but this is you just 
finding out cause you’ve checked your blood. (AS2_M25, face to face 
interview) 
 
These quotes highlight that the lack of association between blood glucose levels and 
symptoms of hypoglycaemia is strongly associated with hypoglycaemia unawareness. 
The above quote illustrates that the participant’s sense of balance was not affected at 
a specific blood glucose level. However, a short time later he found himself in a 
situation where his sense of balance was affected and he was then likely to require 
external help. A similar experience is reflected in the following quote by a female SAS 
participant: 
There’s been a time when I check my sugars and I'm conscious and 
they're down at 1.2, and then another time they’ll be at 1.6 and the 
paramedics are having to bring me round. I can't explain that. (AS1_F09, 
face to face interview) 
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Another important aspect of the issue of lack of association of blood glucose levels and 
symptoms of hypoglycaemia is a potential conflict between participants’ responses to 
certain blood glucose levels (in terms of symptoms of hypoglycaemia) and health 
professionals’ recommendations. For example, one SAS participant described his 
experience of having a severe hypoglycaemic episode while in hospital. Before the 
hypoglycaemic episode became severe, he had felt symptoms and called for a nurse 
asking for glucose. However, no action was taken and the participant ended up 
unconscious. 
I was in the hospital, and during the night I felt I wasn’t right, you know, 
so I pressed the buzzer and one of the nurses came up and she said 
‘what’s the matter?’ and I had my own check for my sugar and I said ‘my 
sugar is 4.6’, ‘oh...’ she said ‘…that’s alright yet’ I said ‘but it’s not alright 
with me, my sugar is not alright at 4.6, it’s dangerous, it can go right 
over the edge very quick’. But anyway, she never bothered and it was 
only when they were going off the shift this other nurse had to get blood 
off me or something off me, and she couldn’t waken me up and she 
couldn’t get nothing in my mouth. I was away; I was away into a coma.  
Finally they got sugar into me, this stuff, you know, it’s Glucogel aye, 
and they managed to get that into me and they finally got me round, 
but it was a dangerous situation. (AS3_M14, face to face interview) 
 
7.2.4.1 Gradual versus quick onset hypoglycaemic episodes 
Participants’ accounts of various hypoglycaemic episodes showed one important 
difference between these episodes: how a particular hypoglycaemic episode started 
and at what point it was noticed. For example, one of the non-SAS participants 
(NS1_M16) distinguished quick onset and gradual onset hypoglycaemic episodes. 
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Quick onset hypoglycaemic episodes 
He explained that the quick onset hypoglycaemic episodes were much more 
noticeable because the symptoms were stronger and more present. 
If it [BG level] rapidly drops down then that to me is much more 
noticeable.  So, for example, if you over-bolus [i.e. take too much insulin] 
for a meal and it comes crashing down very rapidly then you really 
notice that, so it sort of depends on the speed, the rate of descent as it 
were, that makes how noticeable it is and how strong the symptoms are 
I think. (NS1_M16, face to face interview) 
 
One of the SAS participants described how his hypoglycaemic episodes can happen so 
quickly that it was very challenging for him to treat the hypoglycaemic episode on 
time.  
I've been at the point where I'm going below four going into a hypo, and 
I say to myself ‘right, I'm going into a hypo here’ and say to myself ‘right 
I need to take something quick’ but there are some points that it just 
drops… fast I don’t know, I know I'm going into it but…I've not got time 
to react sort of thing. (AS1_M11, face to face interview) 
 
While both participants referred to their hypoglycaemic episode happening rapidly, 
the non-SAS participant talked about having strong symptoms. He made no mention of 
not being able to treat himself. However, the SAS participant’s account of a quick 
onset hypoglycaemic episode provided details about difficulties in treatment due to 
the short time available ‘to react’ before the hypoglycaemic episode got worse. This 
highlights a potential link to hypoglycaemia unawareness. The reason the above SAS 
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participant talked about a short time available to treat himself could be an absence of 
early warning signs. 
Gradual onset hypoglycaemic episodes 
According to some participants, ‘gradual onset’ hypoglycaemic episodes tended to 
come on when the person was sedentary (i.e. working on the computer, watching TV). 
These hypoglycaemic episodes were much less noticeable until the blood glucose level 
had dropped further. The following quote refers to a situation where the participant 
was playing a computer game: 
Your blood glucose might just trickle down whilst you're doing that 
[playing computer game] and you might get quite low really without 
noticing, so you might sort of… might get up from doing that or 
whatever and you think ‘mmm, better check’ and you don’t feel too bad 
but you might be sort of, you know, down in the low threes. (NS1_M16, 
face to face interview) 
 
Another participant described a similar scenario when he watched TV. The absence of 
early symptoms caused him to worry. 
If I've just been sitting watching TV for instance, and I then decide to go 
to bed, I always take my blood sugar before I go to bed anyway, and it 
can often be low enough which suggests to me I'm actually having a 
hypo, but because I'm not doing anything, just sitting and watching telly, 
I don’t have the symptoms.  So that’s quite worrying I think […] It [blood 
glucose level] can be down as low as 2.5 which is really dangerously low 
in a way, isn't it? (NS3_M17, telephone interview) 
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There might be an association between what participants referred to as gradual onset 
hypoglycaemic episodes and hypoglycaemia unawareness. In fact, the ‘gradual onset’ 
could be a misinterpretation of a lack of warning signs/early symptoms. 
7.2.5 “It happens just like that”: the experience of needing external help 
Some participants talked about situations where they needed external help to get out 
of a hypoglycaemic episode. This issue was mentioned by all SAS participants, and 
mostly external help was provided by Scottish Ambulance Service paramedics. One of 
the SAS participants spoke about his experience of recurrent hypoglycaemic episodes 
when he needed the paramedics frequently. 
At some points I was taking two and three a day, that’s how bad things 
had got. […] the biggest majority of them have been where the 
paramedics have been out and had to bring me back, blood sugars 
below zero… below 1.1 and all that, this is how bad it had got. You get 
the paramedic out in the morning and get them back out at night time 
again. (AS2_M25, face to face interview) 
 
Needing external help seemed to be associated with hypoglycaemia unawareness, 
which has been identified as a contributing factor for severe hypoglycaemic episodes 
(Frier 2007a; Clarke et al. 1995). For example, some participants mentioned that their 
hypoglycaemic episodes come on quickly leaving them little time to identify the 
hypoglycaemic episode and treat themselves. This is one of the characteristics of 
hypoglycaemia unawareness, that is, the absence of early warning signs (Briscoe and 
Davis 2006; Frier 2007a). The following quotes illustrate where participants needed 
external help because of hypoglycaemia unawareness. 
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Lately it has been, what, about three times hasn’t it I've been into the… 
with the ambulance, you know.  It [hypos] just happens just like that and 
if you're not onto it right away you're in trouble. (AS3_M14, face to face 
interview) 
 
The last couple of times it’s happened, I've actually been sleeping and I 
haven't known anything about it until the paramedics woke me up. 
(AS2_M27, face to face interview) 
 
In comparison to SAS participants, non-SAS participants spoke about the theme of 
needing external help much less. In fact, none of the non-SAS participants needed 
ambulance service care during the study. When they did need external help, this was 
often provided by family, friends or colleagues. SAS participants also referred to their 
support network, e.g. one participant’s daughter either phoned or visited him on a 
daily basis to make sure he was alright. However, SAS participants tended to have 
more hypoglycaemic episodes where external help was required from the ambulance 
service rather than other sources. This suggests that their hypoglycaemic episodes 
may differ in speed of onset and severity, such that their immediate support network 
may not be able to respond, (also see section 8.3). The role of people’s support 
network is further discussed in section 8.2.7.4. 
7.2.6 Severity of hypoglycaemic episodes  
The extent to which hypoglycaemic episodes impact on participants’ everyday life 
depends on the severity, as well as response (whether treatment was taken quickly) 
and how long recovery takes, (see section 8.2.6). There was considerable variation 
regarding the severity of hypoglycaemic episodes participants experienced. For 
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example, for many non-SAS participants, hypoglycaemic episodes were a ‘minor 
inconvenience’ that they usually treated themselves.  
It is an interruption, but it’s not a major thing really for me with my 
lifestyle.  I know how to get over it, know how to deal with it, I do that 
quickly as I can and move on. So it’s not a huge thing for me really, a 
nuisance though, I get annoyed [laugh]! (NS3_F10, face to face 
interview) 
 
When hypoglycaemic episodes were more severe, the impact on participants’ 
everyday life was a lot more far reaching. For example, one 82 year old SAS participant 
who experienced a severe hypoglycaemic episode had to spend two weeks in hospital 
following the event. 
I got the ambulance right away and they took me straight into hospital, 
you know, and I was in there for a fortnight. (AS3_M14, face to face 
interview) 
 
Comparing the two groups, SAS participants tended to have more severe 
hypoglycaemic episodes. This was based on severe hypoglycaemic episodes being 
defined as requiring external help to effect treatment (DCCT 1997). In terms of 
participants’ perceived severity scores, there was only a slight difference in the mean 
scores for the two participant groups, (see sections 6.5.1 and 6.5.2). Non-SAS 
participants gave a slightly lower score compared to SAS participants. It is important to 
note that perceived severity and actual severity (based on symptoms, blood glucose 
reading, and whether external help was required) can differ greatly. 
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For example, one of the non-SAS participants (NS3_F05) recorded a perceived severity 
score of 5 when her blood glucose reading was 3.1 mmol/l, while she judged the 
severity as 2 when her blood glucose reading was 2.9 mmol/l on another occasion. 
When asked about this variation during a follow-up telephone interview, she stated 
that the difference in perceived severity was a result of how she felt during each 
hypoglycaemic episode. This experience was shared by many participants. 
7.2.7 The longitudinal impact of recurrent hypoglycaemic episodes 
This section looks at the longitudinal impact of recurrent hypoglycaemic episodes. It 
highlights changes over time in relation to participants’ experiences of hypoglycaemic 
episodes. Many participants spoke about technological improvements relating to 
diabetes treatment, for example, better blood glucose monitoring using a precise 
blood glucose monitoring machine rather than urine test strips and a colour chart. The 
following participant explained how she used urine tests to monitor her blood glucose 
level over fifty years ago when she was first diagnosed with diabetes. 
The testing was with gathering urine, putting five drops into a test tube, 
adding five drops clean water, putting in a tablet which then went 
[fizzing sound] and then looking and you were left with a colour, and if it 
was blue that meant you were okay […] but you didn’t really have any 
indication, there were no blood glucose tests. (NS3_F05, face to face 
interview) 
 
The experience of another participant illustrates that there has been considerable 
development and improvement relating to blood glucose monitoring. He described 
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how his blood glucose monitor would even recommend whether he should eat some 
carbohydrates. 
The blood testing kit I've got is a great wee gizmo because it actually… 
it’s one of the new systems, it actually… I've pre-programmed it with 
some settings and stuff so it takes in my insulin to carbohydrate ratios, 
so I do a blood test, it tells me what it is and then it’ll recommend the 
amount of carbohydrate to take. (NS1_M23, face to face interview) 
 
While these improvements in blood glucose monitoring may help to precisely 
determine an individual’s blood glucose level, and therefore classify whether the 
person is experiencing a hypoglycaemic episode, challenges to identify and treat 
hypoglycaemic episodes remain, (see sections 7.2.3 and 7.2.4). 
The following section focusses particularly on changes relating to frequency, severity 
and symptoms of hypoglycaemic episodes. A number of participants identified 
changes relating to their symptoms of hypoglycaemia. The changes in symptoms were 
often associated with hypoglycaemia unawareness, which in turn was linked to 
frequency and severity of hypoglycaemic episodes.  
Frequency 
In terms of frequency of hypoglycaemic episodes, participants reported changes 
relating to both an increase as well as a decrease in hypoglycaemic episodes. The issue 
of changes in frequency was mentioned by both SAS and non-SAS participants, 
however only very few non-SAS participants spoke about this issue. Compared to SAS 
participants, the non-SAS participants that did identify changes in frequency stated 
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that they were experiencing less hypoglycaemic episodes than previously. This 
decreased frequency of hypoglycaemic episodes was associated with better diabetes 
control, which was a result of better health education and learning from experience. 
I'm more aware of it now then there’s maybe… I probably think I had 
more hypos five years ago because I was taking higher amounts of 
insulin, whereas I don’t think I'm having as many and I know how to deal 
with them now more than what I did five years ago.  Whereas before I 
was just in a bit of denial about it all, and it’s just helped being more 
regulated, sort of, in the past couple of years about things, so I know 
what’s going to happen and if I get one I can explain it, whereas back 
then I probably couldn’t explain what was happening. (NS1_F08, face to 
face interview) 
 
In contrast, all SAS participants who mentioned changes in frequency concluded that 
they were experiencing more hypoglycaemic episodes than previously. Common 
reasons for this were a reduced ability to control diabetes (related to age/co-
morbidities), hypoglycaemia unawareness and duration of diabetes. Interestingly, 
looking at the age groups of participants who mentioned changes in frequency, all 
non-SAS participants were younger than 40 years (age group 1), while all SAS 
participants were older than 40 years (age groups 2 and 3). 
One SAS service participant explained that recently he was experiencing more 
hypoglycaemic episodes. He suggested that these might be associated with his 
inability to recognise them on time: “I seem to be having more hypos. It’s probably 
because I'm not detecting the signs soon enough” (AS2_M28, face to face interview). 
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According to a 78 year old female SAS participant, the increased frequency of 
hypoglycaemic episodes was caused by a long duration of diabetes and hypoglycaemia 
unawareness: 
I might have had more since I retired, erm… maybe that’s because of the 
length of time I've had diabetes, I don’t… I think you get less warning the 
longer you have it.  Less warning of a hypo. (AS3_F24, face to face 
interview) 
 
Another SAS participant linked the increase in hypoglycaemic episodes she 
experienced to the type of insulin she had been prescribed. During the interview, she 
mentioned challenges of changing to new types of insulin.  The challenges related to 
different levels of effectiveness, i.e. faster impact on blood glucose level. 
See I never used to get, I never used to get as many [hypos] as that. 
INT: So do you think anything has changed at all? 
RES: Aye definitely that Actrapid, it’s definitely down to that, mm hmm. 
(AS2_F13, face to face interview) 
 
Severity  
Changes in severity of hypoglycaemic episodes were closely linked to changes in 
symptoms. Interestingly, it was an absence of early symptoms that could lead to more 
severe hypoglycaemic episodes, resulting from hypoglycaemia unawareness, (also see 
section 2.9). 
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Those participants that did talk about a change in severity stated that their 
hypoglycaemic episodes had become more severe. One feature of this was a quicker 
onset of the hypoglycaemic episode, as described by the participant below. 
When I was younger, I could feel a hypo coming on when I was out in the 
garden, and I had time to walk into the kitchen and get something to 
eat. I wouldn’t actually risk doing that now. They are much quicker than 
that [now], and using that kind of energy could well be what pushed it 
too far. (NS2_F01, face to face interview) 
 
The wife of an 82 year old SAS participant confirmed the challenge of a quicker onset 
of hypoglycaemic episodes in the context of changes over time. 
Well when you were younger… it never seemed to come onto you as fast 
as it does now.  It seems as if it comes upon you faster now than what it 
did then, you know, you seem as if your body could take it on better 
than it could now, you know. (Wife of AS3_M14, face to face interview) 
 
Another aspect that was identified in relation to an increased severity was that 
recovery might take longer. 
When I do have a hypo they are worse now.  Like, it takes me longer to 
come out of it, whereas before it used to be just… a wee, like, ten 
minutes and I’d feel fine kind of thing. (NS1_F12, face to face interview) 
 
Symptoms 
In terms of symptoms, the most reported change was an increase in hypoglycaemia 
unawareness, that is, on the one hand, loss of early warning signs, and on the other 
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hand, a quicker onset of hypoglycaemic episodes. Both of these contributed to more 
severe hypoglycaemic episodes.  
The following participant spoke about losing her warning signs over time. She also 
described how she did not feel any symptoms of hypoglycaemia when she was 
pregnant. 
When I used to be able to feel it was like two-ish [refers to blood 
glucose] and that’s when I was, like, getting really tingly lips and stuff 
like that, that’s when I knew it was really down low.  The lowest I've… 
when I've actually been pregnant, the lowest I've been is, like, 1.5 I think 
it was, it was really low, but I didn’t have any warning with that one, it 
was quite low and not to get warning. (AS1_F22, face to face interview) 
 
One of the non-SAS participants reported a change in symptoms being caused by the 
type of insulin, which gave her less symptoms when her blood glucose level was low, 
as well as a quicker onset of hypoglycaemic episodes. 
The new insulins, the human insulins make the reactions a little bit less 
and much quicker, so you haven’t got a lot of time to muck about, you 
know finding is this high, is this low, is this whatever. So I generally, if 
I’m feeling odd at all, I’ll test my blood, sometimes I’m testing about 10 
times a day, but it’s just to be sure, you’ve got the blood glucose 
monitoring equipment, it’s silly to guess when you don’t need to. 
(NS2_F01, face to face interview) 
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7.3 The hypoglycaemic episode balancing continuum (HEBC) 
A number of participants referred in one way or another to managing diabetes as 
being a ‘balancing act’, which involved maintaining an appropriate blood glucose level, 
in order to avoid complications relating to a low or high blood glucose level. One 
participant described how she tried to keep her blood glucose levels balanced: 
You know, you feel split between two things: you want to get your blood 
glucose, your HbA1C, you want to get that down but you don’t want to 
get it so down that it’s giving you more hypos, so my HbA1C has been 
running round about seven, up to eight at one point, but it’s back down 
to about seven just now.  I would rather it was a bit lower but on the 
other hand if it was I’d have more hypos.  So it’s just that balancing act 
that you’ve got to do. (NS2_F02, face to face interview) 
 
Another factor that was identified in terms of the balancing act was weight 
management, as highlighted by the following participant. He explained that he had to 
make a decision about how he could balance achieving a ‘good’ HbA1c reading while 
avoiding hypoglycaemic episodes and putting on weight.  
I did improve slightly the last time [referring to HbA1c result] but at the 
expense of having a lot of hypos, so my average was lower but I was 
having a lot of hypos for it and having a lot of hypos meant I was eating 
more carb rich foods/sugary foods to bring myself back up so I put on 
weight.  So the trade-off was a lower HbA1c level but more hypos and I 
was getting fat!  So I sort of decided to accept that my blood levels can 
be around the eight mark, I would rather it was running around that 
level which isn't too bad than I was getting really unhealthily fat and 
having a lot of hypos. (NS2_M15, face to face interview) 
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Another participant mentioned that exercise influenced the balance of keeping an 
appropriate blood glucose level. He stated that he needed to eat (more) to treat his 
hypoglycaemic episodes, and then do more exercise/physical activity to help with 
weight management. 
My coping strategy [for hypos] tends to be eat; then it also means that 
I'm always worried that I'm eating too much, putting on weight or any 
of those kind of things, so it’s the balancing act which is why I tend to 
run quite a lot for fitness because that means that I can eat whenever I 
want [laugh] and not put on too much weight. (NS1_M07, face to face 
interview) 
 
Examining the data around the issue of ‘balancing act’ more closely showed some 
patterns in relation to how people balance the various risks surrounding diabetes 
management (e.g. short-term and long-term complications). Participants seemed to 
take different views about the hypoglycaemic episodes they experienced. Depending 
on what attitude people adopted, this could have various implications on their 
diabetes self-management. For example, some people may try to avoid hypoglycaemic 
episodes if these episodes were perceived as very negative (“I wouldn’t like to take 
another one [i.e. hypoglycaemic episode]. That was terrible.” AS3_F29), while others 
aimed to avoid long-term complications by keeping a very strict blood glucose control 
(“I would rather have a hypo than go blind!” NS1_M07). 
On the basis of these findings, I have developed the concept of a hypoglycaemic 
episode balancing continuum (HEBC). The HEBC is a framework for understanding how 
participants adopted different stances towards hypoglycaemia, and that they varied in 
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the way they balanced risks of long-term complications, the immediate impact of 
hypoglycaemic episodes and achieving appropriate diabetes control. It helps to explain 
how participants balanced risks of having (more) hypoglycaemic episodes when 
keeping a strictly controlled blood glucose level, as against reducing the number of 
hypoglycaemic episodes by keeping a higher blood glucose level and increasing their 
risk of experiencing long-term complications in the future. 
The hypoglycaemic episode balancing continuum was based on the assumption that 
people possess self-care agency, which is defined as the human ability to engage in 
self-care (Orem 2001). In the context of this study, self-care agency means that people 
make a conscious decision about how they view hypoglycaemic episodes and the 
possibility of long-term complications, and how these short (i.e. hypoglycaemic 
episodes) and long-term complications are prioritised. Another aspect of self-care 
agency is people’s ability to influence their condition and to make decisions regarding 
their diabetes self-management (e.g. adjusting the doses of insulin they are taking, 
regularly monitoring their blood glucose level and discussing treatment options with 
health professionals).  
Another assumption was that people have a certain level of health literacy and 
awareness about long-term complications. According to Ratzan and Parker (2000), 
health literacy is "the degree to which individuals have the capacity to obtain, process, 
and understand basic information and services needed to make appropriate health 
decisions" (as quoted in Nielsen-Bohlman et al. 2004:32). While this definition includes 
both an understanding of health information as well as health services, for the 
purpose of this study, the term ‘health literacy’ is used to capture people’s 
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understanding of health information as well as their health knowledge. This includes 
different types of knowledge: lay knowledge, experiential knowledge and medical 
knowledge. Lay knowledge is understood as knowledge passed on by non- 
professionals through narratives (Popay et al. 1998), experiential knowledge is 
individual knowledge learned through personal experience (Storkerson 2009) and 
medical knowledge is defined as knowledge of medical information. This can be 
obtained through health professionals, textbooks or the internet (Seale 2001). 
 
 
Figure 7.1: Hypoglycaemic episode balancing continuum (HEBC) 
 
It is important to note that the HEBC is a continuum and that participants can move 
along the continuum based on their experiences and perception of the risks of 
hypoglycaemia and long-term complications at any given time. Among the study 
participants, there were different management approaches towards hypoglycaemic 
episodes. People differed in the attitude they adopted towards having a 
hypoglycaemic episode: some people accepted hypoglycaemic episodes as a normal 
 
Individual keeps more 
balanced blood glucose 
level, aims to balance 
risks of hypoglycaemia 
and LT complications 
(Group B) 
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part of living with diabetes (=not fearful), while other people felt very fearful about 
experiencing hypoglycaemic episodes (=fearful). The classification whether a person 
was ‘fearful’ or ‘not fearful’ was made based on participants’ accounts in the 
interviews and diaries (see table 7.2 overleaf). Similarly, the classification into 
‘concerned’ or ‘not concerned’ about long-term complications (LT) was also based on 
evidence from the interviews and diaries. Examples from the data are given in the 
discussion of the different groups.  
As shown in table 7.1 below, participants’ perceived severity scores varied a lot. 
Participants’ perceived severity scores may be associated with their attitude to 
hypoglycaemic episodes (fearful or not fearful). Table 7.1 shows that there was a 
tendency for higher perceived severity scores in group C, while lower scores tended to 
be in group A. 
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1 11 4.86 2 3 3.11 3 6 4.31 
4 10 1.91 9 10 4.23 6* 4-5 N/A 
5 11-12 2.93 15 12 2.51 8* 10-12 N/A 
7 9 4.03 17 8-9 6.65 10 3 2.06 
16
* 
4-5 N/A 18 10 3.10 11 2.5 5.00 
21 13 5.64 20* 5 N/A 12 6 N/A 
26
* 
8 N/A 23* 6 N/A 13 2-3 8.00 
28 9 N/A 24 8 5.00 14* 2-3 N/A 
   25* 30 N/A 19 1 7.40 
   27 7 5.00 22 6 3.00 
      29 8 N/A 
      30* 4-5 N/A  
*Did not write any hypoglycaemia/blood glucose diary, number based on information 
provided during recruitment and interview 
Table 7.1: Number of self-reported hypoglycaemic episodes 
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In order to determine whether participants had ‘many’ or ‘few’ hypoglycaemic 
episodes, data from the hypoglycaemia and blood glucose diary was used. The number 
of hypoglycaemic episodes was counted as self-reported hypoglycaemic episodes in 
the hypoglycaemia diary, as well as number of times participants recorded a blood 
glucose level below 4.0 mmol/l. This is the commonly accepted threshold for 
hypoglycaemia (JRCALC 2006; Diabetes UK 2008). The number of times participants 
recorded a low (below 4.0 mmol/l) blood glucose level was only added to the overall 
number of hypoglycaemic episodes if the individual did not write an entry in the 
hypoglycaemia diary for that day. The number of hypoglycaemic episodes people 
recorded varied considerably, ranging from one to thirty per month. The cut-off point 
for classifying whether someone had many hypoglycaemic episodes was set at five. 
This was because experiencing five or more hypoglycaemic episodes per month meant 
that the person had more than one hypoglycaemic episode a week, which was 
considered ‘many’ hypoglycaemic episodes for the purpose of classifying frequency of 
hypoglycaemic episodes. Where participants did not write any entries in the 
hypoglycaemia diary (due to dropping out of the study), evidence from the interviews 
was used. 
There were some anomalies within group A and group C. Participant 8 reported 
considerably more hypoglycaemic episodes compared to other participants in group C, 
while participant 16 reported much less hypoglycaemic episodes than other 
participants in group A. The number of self-reported hypoglycaemic episodes for both 
participant 8 and participant 16 were based on verbal reporting in interviews, which 
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might over- or underestimate the number of hypoglycaemic episodes people 
experienced.  
Table 7.2 (see overleaf) shows an overview of HEBC groups within the sample. 
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HEBC 
group 
Participant 
group 
Participant 
number 
Gender Age Fearful Not fearful Many hypogly-
caemic episodes 
Few hypogly-
caemic episodes 
Concern LT Not concern LT 
A Non-SAS 1 F 54  X X  X  
A Non-SAS 5 F 66  X X  X  
A Non-SAS 7 M 40  X X   X  
A Non-SAS 4 M 56  X X  X  
A Non-SAS 16 M 34  X   X X  
A Non-SAS 21 F 45  X  X   X  
A SAS 26 F 73  X  X  X   
A SAS 28 M 58  X  X   X   
B-1 Non-SAS 2 F 59 X   X X  
B-1 Non-SAS 17 M 64 X  X  X  
B-2 Non-SAS 15 M 43  X  X   X 
B-2 Non-SAS 18 M 24  X  X   X 
B-2 Non-SAS 23 M 35  X X   X 
B-1 SAS 9 F 40 X  X   X  
B-1 SAS 20 M 79 X   X   X   
B-1 SAS 24 F 78 X   X   X   
B-2 SAS 27 M 53  X  X    X  
C-B Non-SAS 8 F 35 X  X   X 
C-B SAS 22 F 21 X   X    X 
C-B SAS 30 F 57 X    X X   
C Non-SAS 3 F 28 X  X   X 
C Non-SAS 6 F 29 X   X  X 
C Non-SAS 10 F 62 X   X  X 
C Non-SAS 12 F 28 X  X   X 
C Non-SAS 19 M 50 X    X   X  
C SAS 11 M 34 X   X  X 
C SAS 13 F 58 X   X  X 
C SAS 14 M 82 X    X   X 
C SAS 29 F 70 X   X    X  
* SAS 25 M 51  X X    X 
*low self-care agency  
Table 7.2: Overview of HEBC groups within the sample
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People’s views of hypoglycaemic episodes appeared to relate directly to how they 
prioritised risks of having long-term complications in the future versus the immediate 
impact a hypoglycaemic episode can have on everyday life. In terms of the HEBC, I 
have categorised the sample into three groups. It is important to note that the HEBC is 
a continuum and that participants can move along the continuum based on their 
experiences and perception of the risks of hypoglycaemia and long-term complications 
at any given time. 
Group A: People who are in group A experienced many hypoglycaemic episodes. They 
were not very scared of hypoglycaemic episodes and accepted them as a normal part 
of living with diabetes.  People in this group expressed a high level of concern about 
having potential long-term complications, and tried as much as possible to keep a low 
blood glucose level (sometimes even lower than the recommended target set by 
health professionals). Having a high blood glucose level was associated with physical 
discomfort/feeling unwell. They accepted having more hypoglycaemic episodes, if this 
reduced the (perceived) risk of long-term complications.  
Hypoglycaemia unawareness was more common in this group than in group B or C. 
Frequent previous hypoglycaemic episodes and a strict glycaemic control have been 
identified as risk factors for hypoglycaemia unawareness (Amiel 1994; DCCT 1997). 
Some quotes from people in group A are: 
To me, a hypo is going to happen as naturally as getting up and going to 
bed again, you know, it just happens. (NS2_F01, face to face interview) 
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I always tend to err on the side of having a hypo and bulk up with sweets 
rather than taking less insulin and running high on my glucose, because I 
would rather have a hypo than go blind! (NS1_M07, face to face 
interview) 
 
I think it’s more the higher blood sugars that I would be more concerned 
about.  No… yeah as I said, I think that I need to have some hypos, not 
that I need to have some, but it shows that I'm on the right track and 
managing my blood sugar. (NS2_F21, face to face interview) 
 
I get more upset about having high blood sugars than I do about having 
low blood sugar, I think the low blood sugar’s easy to alter and to 
rectify, whereas a high blood sugar you're toiling. (NS3_F05, face to face 
interview) 
Group B: People in group B were aware of the risks of both having recurrent 
hypoglycaemic episodes as well as the potential for long-term complications when 
keeping a high blood glucose level. They tried to balance risks by aiming for a ‘good’ 
HbA1c without increasing the number of hypoglycaemic episodes they had. In relation 
to the HEBC, people in group B could be fearful of both, hypoglycaemic episodes and 
long-term complications (group B-1). Another possible combination for group B was 
that people were fearful of neither hypoglycaemic episodes, nor concerned about 
long-term complications (group B-2). 
Quotes from people in group B: 
You feel split between two things: you want to get your blood glucose, 
your HbA1C, you want to get that down but you don’t want to get it so 
down that it’s giving you more hypos, so my HbA1C has been running 
round about seven, up to eight at one point, but it’s back down to about 
206 
 
seven just now.  I would rather it was a bit lower but on the other hand if 
it was I’d have more hypos.  So it’s just that balancing act that you’ve 
got to do. (NS2_F02, face to face interview) 
 
You do worry about the long-term effects but then the short-term effects 
will affect you right now, so yes you do worry about that, yes.  It’s just 
always a balancing act. (AS1_F09, face to face interview) 
 
Group C: People who were in group C were very fearful of hypoglycaemic episodes 
and tried to avoid them ‘at all costs’. They tended to run a higher blood glucose level 
(and thus have higher HbA1c readings). By keeping a high blood glucose level, they 
decreased the risk of having (recurrent) hypoglycaemic episodes, while increasing the 
risk of having long-term complications. People in this group had lower rates of 
hypoglycaemia unawareness. 
Quotes from people in group C: 
They always show 5.8 on the meters as being the paragon, you know, 
and I think ‘well, if I was at 5.8 all the time I would be on the verge of a 
hypo constantly’ […] I couldn’t live like that day in/day out, I wouldn’t 
want to.  That is just not a good life experience [laugh], so I avoid that I 
suppose, although I try as hard as I can.  If I could keep my sugar levels 
about seven or eight I’d be happy with that, never mind the 5.8, seven or 
eight or even… anything below ten, but unfortunately I don’t even do 
that a lot of the time, but I would never want to be so low that I would 
be risking, constantly risking a hypo. (NS3_F10, face to face interview) 
 
I don’t have the best control and I'm the first to admit that I like getting 
on a wee bit higher because I would rather avoid hypos if I can.  I feel if 
my blood sugar’s better controlled getting a hypo is almost guaranteed 
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and they’ll be more frequent and they’ll be more often and I almost 
think ‘well, are they going to get worse?’ (NS1_F06, telephone interview) 
People could experience hypoglycaemic episodes no matter at what point on the HEBC 
they were. However, hypoglycaemic episodes appeared to happen a lot more 
frequently in group A. People could move between groups depending on how they 
viewed hypoglycaemic episodes at any given time. A major aspect that influenced 
people’s attitude towards hypoglycaemic episodes was their experience of the same. 
For example, when a person experienced a severe hypoglycaemic episode impacting 
hugely on their everyday life, this could cause a shift on the HEBC from group A (less 
fearful) to group B or even group C (fearful). 
The first time I had one [i.e. hypoglycaemic episode] I thought I was 
dying, right, until I realised it was a hypo. (NS2_M19, face to face 
interview, group C) 
 
It’s quite scary because when you start shaking and going cold but 
you're sweating sort of thing and it’s quite scary. (AS1_M11, face to face 
interview, group C) 
 
It was not just the actual experience of hypoglycaemic episodes that could influence 
people’s attitude, but also their awareness about what might happen if they had a 
severe hypoglycaemic episode, as highlighted in the following quote. 
I've never collapsed or anything but I know that that can happen and 
that’s a hugely worrying thing to live with. (NS2_F02, face to face 
interview, group B-1) 
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Another important factor that may influence people’s balancing of priorities was the 
occurrence of long-term complications. For example, where a person used to keep a 
high blood glucose level due to fear of hypoglycaemia, when retinopathy or early signs 
of neuropathy were diagnosed, this could trigger a shift in priorities and move towards 
a more balanced approach (group B). The following participant explained why she 
preferred to keep a higher blood glucose level than recommended. She also stated 
that when her average blood glucose readings were ‘bad’ or when there was 
indication of a long-term complication starting, that would make her think again. 
I do worry about the complications that you can have with diabetes, not 
constantly, and I often think that’s why I don’t stick with my control as 
well as I should because it’s always way into the future rather than 
something immediate, you know, if it was something that as soon as you 
did the wrong thing you got an immediate reaction, that would be more 
inclined to me to say ‘well I'm not going to do that again’ you know, […] 
So there’s nothing immediate but each time you get a bad report [i.e. 
high HbA1c result] or some complication that seems to be starting or 
something like that, it does pull you up and you do worry about it. 
(NS3_F10, face to face interview, group C) 
 
There were some examples in the data (participants 8 and 22), where people had 
moved from group C to group B. In both cases, it was related to pregnancy, either the 
desire to become pregnant (participant 8), or the participant getting pregnant 
(participant 22). It is important to note that health professionals emphasise the target 
of keeping blood glucose levels within a tight range when planning for a baby or when 
pregnant (Mulholland et al. 2007; Mersereau et al. 2011). This clearly had influenced 
both participants to keep their blood glucose level more controlled. 
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A similar shift can theoretically happen from group A to group B. When people 
experience more severe hypoglycaemic episodes this might cause a change in their 
attitude towards having hypoglycaemic episodes. In turn, they might alter their 
behaviour resulting in keeping a higher blood glucose level in order to avoid (severe) 
hypoglycaemic episodes. In terms of the HEBC, people then move from group A to 
group B or even group C. However, there were no examples for a move from group A 
to group B in the data. 
7.4 Participants’ individual explanations for recurrent hypoglycaemic 
episodes 
Participants offered various explanations for the hypoglycaemic episodes they 
experienced, ranging from an imbalance of insulin and carbohydrate intake, to 
exercise, alcohol consumption and even the weather. In some cases participants were 
not able to explain what caused a specific hypoglycaemic episode. This could either be 
due to multiple factors being involved that made it difficult to identify a single reason, 
or people’s lack of understanding about what influenced their blood glucose level to 
drop. The following quotes illustrate the complexities surrounding people’s blood 
glucose control: 
It’s a very difficult balance, really is and the more you go into it, 
sometimes the worse it gets because it isn't analysable totally, it just 
isn't.  It’s subject to all sorts of vagaries.  You know, when you start 
saying that things like stress or worry or… depression or anything like 
that starts to affect you as well, it’s very difficult to… it’s bad enough if it 
was only food and understanding your intake and everything, that is 
complex enough, but when you start to, you know, exercise and all the 
other things that are going on in your body, and then of course you get a 
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cold or any illness, that has a different impact again. So it’s extremely 
difficult, well I find it so anyway [laugh]! (NS3_F10, face to face 
interview) 
 
This participant had an awareness of factors that could influence her blood glucose 
level (e.g. food intake, exercise, stress or an illness). However, she expressed difficulty 
in identifying the exact reason for a particular hypoglycaemic episode and keeping 
everything in balance. The following participant took explanations for hypoglycaemic 
episodes a step further, stating that complexities around social interaction as well as 
the weather influenced her blood glucose level. She felt that she had no control over 
many factors that influenced her blood glucose level.  
Every single day is different and everything that goes on around you 24 
hours a day, 7 days a week affects your sugars.  The weather affects 
your sugars, people affect your sugars, the situation you're in affects 
your sugars, driving, every single thing you do and the people you come 
into contact with affect your sugars.  You have no control over the 
majority of it. (AS1_F09, face to face interview) 
 
In contrast to the above participant, other participants believed that they could 
control their diabetes. For example, one of them, who had lived with diabetes for 51 
years, claimed that he was in control of his diabetes. 
My philosophy is that I control my diabetes, not diabetes controls me 
and that has held me in good stead for many, many years. (NS2_M04, 
face to face interview) 
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Issues around control in relation to hypoglycaemic episodes have also been discussed 
in section 7.2.2. 
7.4.1 Imbalance of insulin taken and carbohydrate intake 
Some participants showed a very clear understanding of how the amount and type of 
insulin they injected affected their blood glucose level, depending on their 
carbohydrate intake. When completing the hypoglycaemia diary, participants cited 
reasons for their hypoglycaemic episodes such as “missed lunch” (AS1_M11), “not 
eating enough” (AS2_M27), “high blood sugar before dinner and too much insulin 
taken to compensate” (NS1_M07), “overdid insulin at lunch” (NS2_F21). This shows 
that many participants had awareness of the key factors that could contribute to their 
blood glucose level going high or low (e.g. insulin dose, carbohydrate intake). 
Many participants understood that on the one hand, the insulin they injected could 
cause a hypoglycaemic episode if their carbohydrate intake was not proportionate to 
the amount of insulin taken. On the other hand, their blood glucose level could go high 
if the amount of insulin was not sufficient for the amount of carbohydrate intake. 
7.4.2 Exercise/activity 
Many participants spoke about the impact exercise or activity could have on their 
blood glucose level: it could reduce it quite substantially and thereby trigger a 
hypoglycaemic episode. 
If I exercise in the evening, I mean we have a wee exercise machine in 
the house and if I use that then I'm guaranteed to have a hypo during 
the night. (NS1_F06, Telephone interview) 
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If I've been for a run and I've taken too much NovoRapid in the morning, 
gone for a run at lunchtime, then that can obviously trigger a hypo 
because there’s too much insulin in your system. (NS1_M07, face to face 
interview) 
Similar to the participant above, another participant also described how a combination 
of exercise and taking insulin caused him to have hypoglycaemic episodes. As he was 
able to identify the problem, he made some slight adjustments in relation to the 
timing of taking his insulin injection. 
I tend to find I have hypos if I exercise when I've got insulin in my system.  
If I have my lunch, an injection for my lunch, and then I go for a walk, 
instantly I'm needing to have glucose tablets; it seems to be a problem, 
so now if I'm doing that, we go out to lunch, we have the walk and then I 
inject. So I've learned to sort of move things around a wee bit. 
(NS2_M15, face to face interview) 
 
In comparison to the non-SAS group, SAS participants spoke about the impact of 
exercise/activity much less; only half of the SAS participants did mention situations 
where exercise/activity brought down their blood glucose level. Fewer SAS 
participants reporting about the effects of exercise/activity may suggest either a lack 
of awareness or less active lifestyles. One of the SAS participants explained the impact 
gardening had on his blood glucose level: 
If you're doing something… exerting yourself, it could go faster, you 
know, to a hypo.  When I used to be up in the garden and doing the 
garden, I used to be digging the garden, I used to have to leave it in 
there and come down and everything was going black in front of my 
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eyes, you know, by the time I got into the house, you know. (AS3_M14, 
face to face interview) 
 
7.4.3 Hypoglycaemia unawareness 
Hypoglycaemia unawareness seemed to affect many participants at some point in 
their life. While hypoglycaemia unawareness can be a contributing factor for severe 
hypoglycaemia (Frier 2007a), in many cases, recurrent mild hypoglycaemia went 
unnoticed, unless a blood glucose test was carried out. In terms of awareness of 
hypoglycaemia unawareness, participants varied considerably. Some participants 
concluded that, if they did not have any symptoms and their blood glucose reading 
was below 4.0 mmol/l, they did not have a hypoglycaemic episode. When prompted 
for reasons/explanations for a low blood glucose reading, some participants could not 
see any reason why their blood glucose reading was low. As illustrated by the quotes 
below, hypoglycaemia unawareness also brought with it a level of unpredictability. 
I haven’t got a clue. I just hope that it does not go any lower than that. 
(AS3_F29, telephone interview) 
 
I don’t get any warning with the hypos, it just shoots me and that’s it, 
that’s it. (AS2_M25, face to face interview) 
 
No, there’s not always rhyme or reason and that’s frustrating, that’s 
really annoying, […] and that makes it worse. (NS3_F10, telephone 
interview) 
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Other participants were more aware about hypoglycaemia unawareness: they knew 
that hypoglycaemia unawareness meant a loss of early warning signs which 
necessitated closer monitoring of blood glucose levels. 
Over the last few years […] I certainly think that my awareness of hypos 
has deteriorated hugely, because I used to be very aware, and it didn’t 
stop me in anyway. Now I am wholeheartedly reliant on my blood 
glucose monitoring. (NS2_F01, face to face interview) 
 
I’ve got hypoglycaemia unawareness. (NS3_F05, face to face interview) 
 
The quote above shows that the participant treated hypoglycaemia unawareness like 
having another diagnosis. This may legitimise behaviours that might normally not be 
acceptable, especially in relation to feeling in control, (also see section 7.2.2). If 
participants had been told by health professionals that they ‘had’ hypoglycaemia 
unawareness, this could offer them an explanation/’excuse’ for situations when they 
were not able to control a hypoglycaemic episode.  
Interestingly, there was a noticeable variation of people’s response to hypoglycaemia 
unawareness. Some participants (like NS2_F01, see above) would monitor their blood 
glucose level more closely, others would try and be prepared in case a hypoglycaemic 
episode occurred, (see section 8.2.2), and some participants simply accepted that they 
may experience hypoglycaemic episodes without prior warning signs and that they 
would require external help. The latter view was more common where people did not 
have a clear understanding of the concept of ‘hypoglycaemia unawareness’. This was 
characteristic of the SAS group.  
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While hypoglycaemia unawareness was common in both groups, the knowledge of 
hypoglycaemia unawareness was much higher in the non-SAS group compared to the 
SAS group. This could have potential implications for diabetes management in the SAS 
group: experiencing hypoglycaemia unawareness over a period of (many) years 
increases the likelihood of having severe hypoglycaemic episodes (Gerich 2000; 
Briscoe and Davis 2006; Frier 2008). The issue of knowledge of hypoglycaemia 
unawareness is further discussed in section 9.3.1.  
7.4.4 Health literacy 
Participants’ individual explanations of recurrent hypoglycaemic episodes seemed to 
be associated to their diabetes health literacy: that is, how much they knew about the 
various factors that could influence their blood glucose level and how these 
interrelated. One participant spoke about learning how the liver’s activity could 
influence her blood glucose level: 
I have only just recently learned that there’s an impact on hypos from 
your liver’s activity too, and apparently when you go hypo, whether you 
take sugar or not, your liver will release some [glucose] in natural state 
of affairs, but what I didn’t know was that it will actually take some back 
too, later, to put back in its store, so you can have a hypo because of 
that. I had no idea about that. (NS2_F01, face to face interview) 
 
For many participants, learning about how to live with their diabetes and manage 
hypoglycaemic episodes was an on-going process. 
I’m learning every day with diabetes. (NS1_F03, face to face interview) 
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Some participants took time to study and learn about their condition in order to be 
better informed. There were also some circumstances in which participants described 
having to develop their own knowledge, when other sources of health information 
only took them so far. 
I then got loads of books out the library and went on the internet and 
such like, and learnt what foods were bad for me and what were good 
for me and what I shouldn’t eat and what I could eat and really that was 
fine until my next worry was going to a restaurant and judging what I 
could eat there. (NS3_M17, face to face interview) 
 
Most participants got some information about managing diabetes when they were 
diagnosed, either directly through conversations with their doctor or diabetes nurse, 
or indirectly in the form of information leaflets. 
They [i.e. health professionals] give you all these wee pamphlets, like, 
the one they’ve given me, the wee things is showing you where you take 
one jag in the morning, as soon as you get out your bed you take this jag 
and this one keeps your blood sugars all kind of levelled out. (AS2_M25, 
face to face interview) 
 
In terms of sources of information about diabetes management, these ranged from 
family members/friends who also had diabetes, to reading books, the internet, taking 
part in education courses to discussions with health professionals and reading 
information leaflets provided by the GP or hospital. Comparing health literacy 
between the SAS and non-SAS group, the non-SAS group were generally more 
knowledgeable about their condition and its management, or described more 
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information seeking activities. For example, almost half of the participants in the non-
SAS group reported having completed a structured education course (e.g. DAFNE ‘dose 
adjustment for normal eating’; DAFNE online 2010; Owen and Woodward 2012), while 
none of the participants in the SAS group had taken part in such a course.  
As highlighted above, the amount of diabetes education participants had received 
varied. General diabetes education is currently delivered on a one-to-one basis within 
primary care, where written material is also available. This includes diabetes education 
leaflets on various aspects of living with and managing diabetes, e.g. exercises, 
hypoglycaemia, coping with illness, diabetes and alcohol, driving and employment, 
diabetes and travel, etc. (NHS Forth Valley 2009). 
There are recommendations that every individual diagnosed with diabetes should be 
offered to take part in structured diabetes education (NICE 2003; The Scottish 
Government 2010). However, this target may not always be achieved and it is also left 
to the individual to decide whether or not to engage in any educational activities. 
7.5 Differences between SAS and non-SAS participants 
Participants’ individual explanations for hypoglycaemic episodes reveal a great deal 
about people’s understanding of their condition and their health literacy. The previous 
sections (7.4.1 – 7.4.4) have highlighted that there were various differences between 
SAS and non-SAS participants in relation to individual explanations for recurrent 
hypoglycaemic episodes. While most participants had a basic understanding about the 
requirement to balance the amount of insulin taken with the carbohydrate intake 
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(section 7.4.1), differences between the two groups became apparent when looking at 
participants’ health literacy (section 7.4.4).  
Health literacy captures people’s understanding/knowledge about diabetes 
management, as well as factors that contribute to occurrence of hypoglycaemic 
episodes (Schillinger et al. 2002; Powell et al. 2007). Participants’ diabetes health 
literacy influenced their knowledge about the impact exercise/physical activity can 
have on their blood glucose level (section 7.4.2), as well as awareness about 
hypoglycaemia unawareness (section 7.4.3). In terms of explaining hypoglycaemic 
episodes and achieving appropriate self-management responses, participants’ 
diabetes health literacy was key. Section 7.4.4 has shown that non-SAS participants 
were generally more knowledgeable about their condition and its management, 
resulting in a better awareness of hypoglycaemia unawareness (section 7.4.3). This 
could have been a result of non-SAS participants being younger than SAS participants, 
and likely to be more computer literate (Poynton 2005; Choi and DiNitto 2013). 
Another factor that may have influenced people’s health literacy and knowledge about 
their condition is their socio-economic background. SAS participants tended to live in 
more deprived areas compared to non-SAS participants (see section 6.2), which may 
have contributed to lower levels of health literacy (Brown et al.2003). 
This chapter has highlighted a number of differences between SAS and non-SAS 
participants in relation to participants’ experiences of recurrent hypoglycaemic 
episodes and impact on everyday life. While issues with confusion (section 7.2.3) and 
fear of hypoglycaemia (section 7.2.1) were common in both groups, there were some 
differences with regards to how people balanced risks of experiencing hypoglycaemic 
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episodes and having long-term complications in the future (section 7.3). In terms of 
the HEBC, the overview of groups within the sample (table 7.2) has shown that there 
was a spread of HEBC groups across both participant groups. However, in comparison 
to SAS participants, there were slightly more non-SAS participants in group A. This may 
suggest that non-SAS participants were more aware of the risks of long-term 
complications, or more concerned about them. 
The issue of lack of association between blood glucose levels and symptoms 
experienced (section 7.2.4) has emphasised that participants experienced symptoms 
of hypoglycaemia at different blood glucose levels. Sometimes participants reported 
experiencing no symptoms despite a low blood glucose level. Comparing the two study 
groups, the experience in the SAS group appeared to be mainly related to low blood 
glucose levels where participants did not experience any symptoms, which is also 
known as hypoglycaemia unawareness (section 2.9).  This suggests that hypoglycaemia 
unawareness was more common in the SAS group. In fact, results from the 
quantitative data (see sections 6.5.1 and 6.5.3) confirmed that hypoglycaemia 
unawareness appeared to be a major problem in the SAS group.  
All SAS participants mentioned the issue of needing external help (section 7.2.5). In 
most cases, external help was provided by SAS paramedics. It is important to note that 
needing external help was associated with hypoglycaemia unawareness (see previous 
paragraph). In comparison to SAS participants, non-SAS participants spoke about the 
issue of needing external help much less. In fact, none of the non-SAS participants 
needed help provided by the SAS during the study. When they did need external help, 
this was often provided by family, friends or colleagues.  
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In terms of severity of hypoglycaemic episodes (section 7.2.6), there were some 
differences between SAS and non-SAS participants. For many non-SAS participants, 
hypoglycaemic episodes were a ‘minor inconvenience’ that they usually treated 
themselves, while SAS participants tended to have more severe hypoglycaemic 
episodes. This was based on severe hypoglycaemic episodes being defined as requiring 
external help to effect treatment (DCCT 1997). A factor that may have contributed to 
SAS participants experiencing more severe hypoglycaemic episodes is duration of 
diabetes (see section 6.2). There is evidence to suggest that a longer duration of 
diabetes is associated with more severe hypoglycaemia (Briscoe and Davis 2006; 
Graveling and Frier 2009). In terms of participants’ perceived severity scores, there 
was only a slight difference in the mean scores for the two groups (see sections 6.5.1 
and 6.5.2). Non-SAS participants gave a slightly lower score compared to SAS 
participants. It is important to note that perceived severity and actual severity (based 
on symptoms, blood glucose reading, and whether external help was required) can 
differ greatly.  
7.6 Summary 
The findings reported in this chapter relate to participants’ experiences and 
perceptions of recurrent hypoglycaemic episodes, as well as impact on everyday life. 
They particularly highlighted that it is the variation and unpredictability of 
hypoglycaemic episodes that impact on participants’ everyday life and present a major 
challenge in diabetes self-management. Many participants described struggling with 
confusion and the feeling of losing control when hypoglycaemic episodes occurred. 
However, it was not only the actual hypoglycaemic episode affecting participants’ 
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everyday life, but also fears and worries about possible hypoglycaemic episodes 
happening (section 7.2.1).  
The findings presented in this chapter also highlighted the problem of hypoglycaemia 
unawareness, which was associated with the lack of association between blood 
glucose levels and symptoms experienced (see section 7.2.4). Many participants spoke 
about situations where their blood glucose level was below 4.0 mmol/l (the threshold 
for hypoglycaemia), without experiencing any symptoms. Hypoglycaemia unawareness 
also appeared to be linked to needing external help (section 7.2.5). The issue of 
needing external help was more prominent in the SAS group. 
The section on the longitudinal impact of recurrent hypoglycaemic episodes identified 
changes relating to frequency, severity and symptoms of hypoglycaemic episodes 
(section 7.2.7). It was noted that only SAS participants described an increase in 
frequency of hypoglycaemic episodes. This was mainly associated with a reduced 
ability to control diabetes, hypoglycaemia unawareness and duration of diabetes.  
A number of participants reported changes in symptoms (less early warning signs) 
relating to increased hypoglycaemia unawareness (section 7.2.7). This was associated 
with frequency and severity of previous hypoglycaemic episodes. Frequent previous 
hypoglycaemic episodes have been identified as a contributing factor for 
hypoglycaemia unawareness, while hypoglycaemia unawareness could cause more 
severe hypoglycaemic episodes (Amiel 1994; Gerich 2000; Briscoe and Davis 2006; 
Frier 2007a). 
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This chapter introduced the concept of a hypoglycaemic episode balancing continuum 
(HEBC), which conceptualised how participants took different stances towards 
hypoglycaemia. The HEBC explained how participants balanced the risk of long-term 
complications, immediate impact of hypoglycaemic episodes and achieving 
appropriate blood glucose control, depending on their fears in relation to 
hypoglycaemic episodes and long-term complications (section 7.3). It found that the 
focus of participants’ fear determined where they sat on the HEBC. The continuum has 
demonstrated that those who exhibited fear of hypoglycaemia would be more likely to 
keep a higher blood glucose level in an attempt to avoid hypoglycaemic episodes 
happening, or to reduce the number of hypoglycaemic episodes they experienced. 
Those who did not express a similar degree of fear were more likely to keep their 
blood glucose level within a lower range, and were more likely to be concerned about 
long-term complications.  
The findings reported in this chapter have shown that participants’ individual 
explanations for recurrent hypoglycaemic episodes ranged from an imbalance of 
insulin taken and carbohydrate intake, to the effects of exercise and the impact of 
hypoglycaemia unawareness. While most participants showed a basic understanding 
about the requirement to balance the amount of insulin taken with the carbohydrate 
intake (section 7.4.1), differences between the two groups were apparent when 
looking at health literacy (section 7.4.4). Non-SAS participants tended to be more 
knowledgeable about their condition and its management compared to SAS 
participants, resulting in a better awareness of hypoglycaemia unawareness (section 
7.4.3).  
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This chapter also presented differences between SAS and non-SAS participants 
(section 7.5). For example, findings showed that SAS participants tended to experience 
more severe hypoglycaemic episodes, and consequently required external help more 
often. It is important to note that needing external help was associated with 
hypoglycaemia unawareness, especially when the individual did not have much 
knowledge about the phenomenon. While both groups experienced hypoglycaemia 
unawareness, it appeared to be a more serious problem in the SAS group. Non-SAS 
participants seemed to be more knowledgeable about hypoglycaemia unawareness 
and better prepared in case a hypoglycaemic episode occurred. This contributed to 
non-SAS participants being able to better manage hypoglycaemia unawareness.  
The following chapter focusses on participants’ strategies to manage hypoglycaemic 
episodes (section 8.2), as well as participants’ coping strategies (section 8.2.7). It also 
introduces the hypoglycaemic episode help-seeking network (HEHS network), which 
helps to identify the agents involved in the management of participants’ 
hypoglycaemic episodes (section 8.3). 
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Chapter 8 - Managing hypoglycaemic episodes within 
diabetes care 
8.1 Introduction 
This chapter focusses on the management of hypoglycaemic episodes within diabetes 
care. It presents findings about participants’ strategies to manage hypoglycaemic 
episodes in the context of their everyday lives (section 8.2). This includes issues 
around always being prepared (section 8.2.2), managing daily life with diabetes 
(section 8.2.3) and recovery from hypoglycaemic episodes (8.2.6). This chapter also 
gives an overview of participants’ coping strategies (section 8.2.7), for example the 
tendency to avoid hypoglycaemic episodes by keeping high blood glucose levels 
(section 8.2.7.3). This is an important finding as it highlights the dangers associated 
with avoiding hypoglycaemic episodes by altering self-management strategies; that is, 
an increased risk of experiencing long-term complications in the future. 
Another coping strategy participants adopted was denying that they were 
experiencing a hypoglycaemic episode. This included both self-denial and denial 
towards others (section 8.2.7.2). This strategy might be risky as it could lead to a delay 
in treatment, which might cause the hypoglycaemic episode to get worse, thus 
increasing the likelihood of needing external help. 
Most hypoglycaemic episodes were managed by the individual without requiring any 
external help. However, participants’ ability to self-care differed and deficits occurred, 
resulting in participants being more likely to need involvement of others 
(family/friends; see section 8.2.7.4). When the capacity of others to help broke down, 
participants’ were more likely to need SAS emergency care. In order to explain how 
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hypoglycaemic episodes are managed, this chapter presents the hypoglycaemic 
episode help-seeking network (HEHS network), which has been developed from the 
data collected in this study (section 8.3). It helps to identify the various agents 
involved in helping to treat hypoglycaemic episodes. The  HEHS network illustrates 
agents who manage hypoglycaemic episodes, and also points out other factors that 
can be involved in the management of hypoglycaemic episodes, for example, 
hypoglycaemia unawareness, health literacy and the participant’s or their support 
network’s ability to identify and treat hypoglycaemic episodes. 
8.2 The management of diabetes and hypoglycaemic episodes 
The following sections report findings in relation to participants’ strategies to manage 
hypoglycaemic episodes in the context of diabetes self-management, as well as 
participants’ overall coping strategies (section 8.2.7). For example, hypoglycaemic 
episodes can have a huge impact on diabetes self-management, potentially resulting in 
poorer diabetes control caused by deliberate attempts to avoid hypoglycaemic 
episodes (section 8.2.7.3). 
Participants’ strategies to manage daily life with diabetes (section 8.2.3) and recovery 
from hypoglycaemic episodes (8.2.6) were also explored. Findings showed that some 
participants tended to avoid certain situations/tasks, and were especially concerned 
about keeping an appropriate blood glucose level while driving. Additionally, some 
participants admitted restricting exercise (on their own) or avoiding going out due to 
fear of hypoglycaemic episodes. 
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Findings also showed that the risk of having a hypoglycaemic episode caused some 
participants to try and always ‘be prepared’ (see section 8.2.2). One aspect of 
participants’ preparations was to make sure food or glucose tablets were within easy 
reach in case a hypoglycaemic episode occurred. Another aspect was always carrying 
diabetes ‘equipment’ and medications (e.g. blood glucose monitor, insulin pens) to 
monitor the blood glucose level and keep it within an appropriate range. 
8.2.1 Hypoglycaemia and diabetes self-management 
Diabetes self-management requires the individual to make decisions regarding his/her 
diabetes care on a daily basis. This includes dosage and timing of insulin injections, 
monitoring blood glucose levels, carbohydrate intake and exercise. Participants varied 
in their approaches towards diabetes self-management. For example, many 
participants adjusted their insulin dosage based on blood glucose levels, while others 
just followed recommendations given by their diabetes specialist. The following 
participant described how he adjusted the amount of insulin he took based on his 
blood glucose reading. 
It [i.e. blood glucose level] goes up and down, aye well if I get high blood 
sugars I’ll take a wee bit extra insulin, sometimes I’ve seen me maybe 
after I've had the injection I'm supposed to have for that day, the last 
one at night, I've seen me coming in at night and maybe taking maybe 
another ten units or something just to bring my blood down because I've 
had it maybe away up at maybe 35 and all that.  I know when it’s as bad 
as that I need to get my insulin to come back down, so I’ll just be lying 
on the couch and waiting for my blood to start to come down and 
eventually it’ll come down anyway and that maybe followed by a hypo, 
don’t know. (SAS participant, AS2_M25) 
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A female non-SAS participant explained how she worked out how much insulin to take. 
She showed a good understanding that taking more insulin could bring down her 
blood glucose level to a more controlled level; however, she was also aware that an 
increased amount of insulin could lead to (more) hypoglycaemic episodes occurring. 
I will sometimes change my Lantus, my night time insulin, if I'm not 
getting good results in the morning.  In fact I did that just last night 
because I sort of looked back over the last week and I thought ‘these 
morning results are creeping up a wee bit so it’s time to notch up the 
night time Lantus’ so I did that just last night, just going up a couple of 
units and whether that’s going to result in a few more hypos after the 
next couple of days I’ll just have to wait and see, but if it did then I’ll put 
it back down again. (NS2_F02, face to face interview) 
 
As the main responsibility of diabetes self-management lies with the individual, the 
individual has to make decisions and take action to manage diabetes. Sometimes an 
individual’s decision can diverge from health professionals’ recommendations as 
shown in the quote below. The participant admitted that he ‘worked out’ what 
amount of insulin was most acceptable for his individual diabetes control. 
Actually when I go to the clinic and they say to adjust my insulin, and I 
try it for a few days and I'm not happy with it, I tend to revert to what I 
was on before, I'm a bit stubborn like that [laugh]! […] Sometimes the 
doctor tells you to do something and it really doesn’t work for you, so 
you have to work things out for yourself a little bit as well. (NS2_M15, 
face to face interview) 
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Hypoglycaemic episodes potentially impact on participants’ diabetes self-management 
in two ways. First, adjusting the amount of insulin taken and/or carbohydrates 
consumed in order to avoid a hypoglycaemic episode (also see section 8.2.7.3); that is, 
before a hypoglycaemic episode occurs, and second, making changes in relation to 
insulin/carbohydrate intake following a hypoglycaemic episode. This is illustrated by 
the following quote: 
If I’ve had a hypo, I will eat more and cut my insulin down a wee bit, but 
not too much, and that seems to work for me. (NS1_F03, face to face 
interview) 
 
Generally, adjustments in diabetes self-management were aimed at reducing/avoiding 
hypoglycaemic episodes. However, as the hypoglycaemic episode balancing 
continuum (see section 7.3) has illustrated that some participants seemed more 
concerned about long-term complications, and would therefore accept more 
hypoglycaemic episodes happening as a result of keeping a lower blood glucose level. 
Some participants tended to monitor their blood glucose level more closely following a 
hypoglycaemic episode. One non-SAS participant described how she would check her 
blood glucose level more often after she has experienced a hypoglycaemic episode 
because she did not get any warning signs if she experienced another hypoglycaemic 
episode in such a situation. 
You check your blood every couple of hours, you’ve got no choice, 
there’s no other way of doing it. (NS2_F01, Telephone interview) 
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8.2.2  “Covering all bases”: participants’ strategies to prepare for 
potential hypoglycaemic episodes 
Many participants mentioned strategies to prepare for potential hypoglycaemic 
episodes. Preparations ranged from making sure food/glucose tablets were available 
in case a hypoglycaemic episode occurred, to carrying blood glucose monitors and 
planning ahead (e.g. timing of meals/snacks, exercise). The following quotes show the 
strategies some participants adopted in preparation for future hypoglycaemic 
episodes. 
If I was going to do something, like supposing I was going to go for a 
long walk, say 10/12 mile walk for instance, then I would make sure I 
had plenty of food, I would make sure I had my glucose meter with me. 
(NS3_M17, face to face interview) 
 
I've got everything I could possibly need for my diabetes all in the one 
bag and I've got to carry this about with me all the time.[…] I have a 
replica kit in the car as well, right in the glove compartment which has a 
blood machine, glucose tablets, gluco stop, right, it has everything in 
there so that if I forget to take that one with me, I've always got one in 
the car, there’s always a kit in my wife’s car, right, and there’s a kit in 
my wife’s handbag, right, so we’re covering all bases, right, in the case 
of emergency. (NS2_M19, face to face interview) 
 
One of the SAS participants spoke about going away (e.g. travelling) less because of 
the preparation required and the inconvenience of carrying all her diabetes related 
equipment with her, e.g. blood glucose monitor, insulin pens, something sweet to eat, 
etc. She described how she would worry about keeping her insulin cool, and that she 
felt more confident to look after her diabetes when she was at home. 
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It [having diabetes] restricts you from quite a lot I think. […] what if 
there’s a hold up with the traffic and all this, you know, [laugh] oh dear! 
(AS2_F13, face to face interview) 
 
Interestingly, all non-SAS participants made reference to the issue of ‘being prepared’ 
(as highlighted in above quotes), while some of the SAS participants did not mention 
anything about being prepared at all. This suggests that there could be differences 
between the two groups in relation to diabetes self-care and being prepared for 
potential hypoglycaemic episodes.  
8.2.3 “You’ve got to watch”: managing daily life with diabetes 
Many participants described managing diabetes as a balancing act (see section 7.3). 
The need to balance requirements to manage diabetes with everyday demands is 
further explored in this section. Two particular scenarios have been identified from 
participants’ accounts: one, participants’ tendency to avoid certain situations/tasks, 
and two, managing diabetes/keeping an appropriate blood glucose level while driving.  
A number of participants mentioned situations they preferred to avoid because of the 
risk of having a hypoglycaemic episode. For example, one non-SAS participant spoke 
about not going cycling on his own since he was diagnosed with diabetes. 
If you're on a bike, you know, your blood glucose can pretty quickly drop 
and, you know, if you're ten miles from home or 15 miles from home 
then it’s a bit unnerving if you're down a country road where there’s no 
one around. (NS1_M16, face to face interview) 
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Another participant recalled that he had missed many classes at university: 
This year my diabetes hasn’t been that good, well my bloods haven't 
been that good and I even missed, I’d say, 85% of my tutorials and about 
50% or 60% of my lectures because my blood sugars have been down 
low and I've just not had the energy to do anything. (NS2_M19, face to 
face interview) 
 
Some participants described that they did not go out at all because of fear of having a 
hypoglycaemic episode while out. This was often coupled with concern that people 
around would not understand what a hypoglycaemic episode was, and would 
therefore not be able to offer any help. 
I probably prefer to stay at home in case I went out and I took a more 
serious one [i.e. hypoglycaemic episode] sort of thing, eh.  But I don’t 
know because, like, if I do go out, see trying to explain hypos to people 
sitting in your company sort of thing they don’t really understand. 
(AS1_M11, face to face interview) 
 
One SAS participant (70 year old female) even avoided going to her regular diabetes 
check-up because of long walks within the hospital to get to the diabetes clinic. She 
also felt discouraged by the fast pace many doctors used to walk from the patient 
waiting room to the consultation room. 
You think it’s a marathon they're running’ and you're trying to keep up 
with them’, I says ‘no I'm not doing that anymore, because it knocks you 
all to pot’ see and you’ve got to watch, ken what I mean, you’ve got to 
watch. (AS3_F29, face to face interview) 
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In terms of driving, participants found that keeping a good balance for their blood 
glucose level was vitally important. Even though participants were aware that keeping 
their blood glucose level within a tight range would be the target, there seemed to be 
a shift towards keeping a higher blood glucose level when driving in order to minimise 
the risk of having a hypoglycaemic episode. 
If I'm doing a lot of driving on a long journey, I must admit I tend to let 
my blood glucose run a bit high, I’d rather have it a bit high than a bit 
low. (NS2_F02, face to face interview) 
 
8.2.4 Dealing with hypoglycaemic episodes 
Many participants had identified particular foods/drinks to treat hypoglycaemic 
episodes (e.g. Lucozade, glucose tablets, sweets), which they tried to keep handy in 
case a hypoglycaemic episode occurred. For example, one SAS participant talked about 
keeping sweets close to her bed so she did not have to get up to get treatment when 
she experienced hypoglycaemic episodes during the night. 
Well my bedroom, right next to my bed I've got a bedside cabinet, it’s 
like a snack bar actually, and I used to get the really easy to… they 
actually melt in your mouth, I find them really quick, you know, the fruit 
jellies you get? And they're soft and they're coated with sugar, so they're 
easy to swallow, aye. (AS2_F13, face to face interview) 
 
Another SAS participant described how he would always wake up during the night 
when his blood glucose level was low. He would then carry out a blood glucose test 
and eat some food or have a sugary drink to treat the hypoglycaemic episode. 
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Say I felt not too well during the night, I would say ‘my sugar’s getting 
low’, so I’d take my sugar level and all of a sudden I see it maybe 
dropped to 4.5 and I say ‘aha aha, sugar!’ or a drink of something or 
other or something to eat, a biscuit, something like that.  And then I’ll 
wait a wee while until I see it going back up the scale again, then I say 
‘right, that’ll do me till morning now’ you know. (AS3_M14, face to face 
interview) 
 
One of the non-SAS participants spoke about his treatment strategy when he 
identified a hypoglycaemic episode coming on. His treatment approach was in stages, 
starting with glucose tablets or a sugary drink, followed by a sandwich if he did not 
begin to feel better. A final measure would be taking a glucagon injection. 
Glucose tablets are the first line of defence along with maybe a bit of 
fruit or a can of Coke or a Mars Bar, right, that’s what I take.  If that 
doesn’t work and there is a sandwich, right, get all that inside me so it’s 
giving me slow release energy and then if that doesn’t work it’s hit the 
deck and glucose dope [laugh]! (NS2_M19, face to face interview) 
 
This section has shown that many participants had an initial strategy for treating 
hypoglycaemic episodes, which was often carried out by the individual.  
8.2.5  The issue of overcompensation  
An aspect closely linked to avoidance of hypoglycaemic episodes was 
overcompensation when a hypoglycaemic episode occurred. A number of participants 
described how they would take more sugary foods/drinks than strictly necessary to 
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treat a hypoglycaemic episode. For example, the following participant spoke about 
taking more glucose rich foods than necessary to treat the hypoglycaemic episode. 
Once I get a taste of chocolate or something sweet, I tend… when I'm 
having a hypo, I tend to want more.  I think that’s fairly common, you 
have this desperate need for something sweet, you just want to stuff 
your face with something sweet and you overdo it, you know, you take 
far more than you actually need [laugh]! (NS3_F10, face to face 
interview) 
 
A younger male participant confirmed the same challenge when treating his 
hypoglycaemic episodes, referring to it as ‘carbohydrate rage’. He also explained how 
he learned to control food intake better when he was experiencing a hypoglycaemic 
episode. 
The huge difficulty with a hypo is that in… regulating it once you know 
that you're having one is that you overshoot because it’s an unpleasant 
thing to have, it’s not nice, you know, so what you tend to do is to get it 
over and done with as quickly as possible, shove as much stuff down 
your gob as you can and you tend to overshoot, […]and before you know 
it you're up at 15/16, you know, 20 minutes later which is tiring […] 
What I've learnt to do now is to take a measured amount […] and live 
with it in the meantime, try not to do that sort of carbohydrate rage! 
(NS1_M16, face to face interview) 
 
Some participants also made reference to food tasting different or better when they 
were having a hypoglycaemic episode, which added to the challenge of 
overcompensation. 
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I could eat food that I really don’t like when I'm hypo and they’d taste 
absolutely amazing.  It’s really strange, although I’ll know when I'm 
eating it that I really don’t like this and then I’ll try it and go ‘oh that 
tastes absolutely amazing, why do I not like this, I’ll have some more of 
this!’ (NS1_M23, face to face interview) 
 
Interestingly, it was only non-SAS participants who referred to overcompensation. This 
suggests that either SAS participants did not experience this challenge, or non-SAS 
participants were more aware of it. 
The following sections describe findings relating to recovery from hypoglycaemic 
episodes, as well as coping strategies. For example, section 8.2.6 highlights that the 
time required for participants’ recovery from hypoglycaemic episodes and the impact 
hypoglycaemic episodes had on participants’ everyday life varied. 
8.2.6 Recovering from hypoglycaemic episodes 
Participants’ experiences of recovering from hypoglycaemic episodes varied in relation 
to the impact a hypoglycaemic episode could have on how they felt for the rest of the 
day and even the following days. Some participants said that they got ‘back to normal’ 
within a short time after the hypoglycaemic episode, while others described longer 
lasting effects. The following quotes illustrate the variety of participants’ experiences: 
Sometimes if I’ve had a hypo, the rest of the day is a washout, so it can 
just wipe your day out, you just feel rubbish, you feel weak and you can’t 
be bothered with things. (NS2_F01, face to face interview) 
 
After hypos, your body feels exhausted and you just want to sleep. 
(AS1_F09, face to face interview) 
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I would be back compos mentis within five minutes at the most. 
(NS2_M04, face to face interview) 
 
I feel like I've maybe ran a marathon or something like that […] that 
[hypo] was very scary that day because it probably took me about two 
days to recover from that, I just felt so awful and I felt emotionally 
drained and quite depressed. (NS1_F08, face to face interview) 
 
The above quotes highlight that the impact of hypoglycaemic episodes on participants’ 
everyday life can go beyond the actual occurrence of the hypoglycaemic episode; it 
can have an effect for up to a couple of days following the hypoglycaemic episode. The 
severity of hypoglycaemic episodes influenced recovery time and to what extent the 
hypoglycaemic episode impacted on the person’s everyday life. For example, if 
participants had experienced a ‘bad hypo’ they may have injured themselves from 
falling due to the impact the hypoglycaemic episode had on their sense of balance.  
I've actually injured myself falling out of bed and I've had carpet burns, 
in fact I've still got one I got about a month ago, should've seen the size 
of it, it was a great big, big carpet… […] I've actually hurt my back on 
furniture too and knocked furniture over, lamps – bedside lamps and 
things… I've fallen onto the floor, you know, from my bed. (AS2_M28, 
face to face interview) 
 
I remember the hypo just came on all of a sudden and I just remember 
falling and hurting my arm and having to go to A&E because I thought 
I’d fractured it and that’s because I had a hypo. (NS1_F08, face to face 
interview) 
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Participants from both groups mentioned injuries that occurred during a 
hypoglycaemic episode; however, compared to non-SAS participants, the theme was 
more prominent in the SAS group. This highlights that SAS participants seemed to 
experience more severe hypoglycaemic episodes compared to non-SAS participants. 
8.2.7 Coping strategies 
This section describes various coping strategies that participants adopted in response 
to hypoglycaemic episodes. Coping strategies included accepting hypoglycaemic 
episodes as a normal part of living with diabetes (‘positive attitude’; see section 
8.2.7.1), and denying that one is having a hypoglycaemic episode, particularly in the 
presence of others (section 8.2.7.2). Avoidance of hypoglycaemic episodes (section 
8.2.7.3) and building and educating a support network (section 8.2.7.4) were also 
identified as coping strategies. 
8.2.7.1 Positive attitude/acceptance 
A number of participants adopted a positive attitude about their hypoglycaemic 
episodes, accepting them as a normal part of living with diabetes. One of the non-SAS 
participants compared treating hypoglycaemic episodes to blowing her nose when she 
had a cold: “You’ve got a hanky in your pocket and you blow your nose, the world 
doesn’t stop while you do it“ (NS2_F01, face to face interview). She went on to 
describe a situation where she easily and quickly treated a hypoglycaemic episode 
without anyone around her noticing: 
If I was sitting round an office table, at a meeting, no-one else knew I 
had a hypo, I would- well, maybe they did, maybe they noticed I was 
eating glucose, but other than that, nothing happened, you just- I dealt 
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with it, they weren’t aware, they didn’t need to be aware anyway and 
life went on. That’s how diabetics do treat hypos, they are not the major 
event that in medicine they are. They are just, they are a routine thing. 
(NS2_F01, face to face interview) 
 
Another non-SAS participant shared a similar perspective. She claimed that she found 
it easy to treat hypoglycaemic episodes and get back to normal. 
To me it’s [i.e a hypo] not a very big risk because it’s so easily remedied 
and so, you know, I don’t make a big deal of it.  I know that some people 
feel very unwell when they have a hypo but I'm lucky I just… okay I hit 
the pits and then I bounce up again, so no, not a problem. (NS3_F05, 
face to face interview) 
 
An interesting aspect of the coping strategy of ‘acceptance‘ was discussed by a non-
SAS participant who said that he liked the fact that he could eat (more) food when 
having a hypoglycaemic episode. 
I quite like being hypo sometimes because it means I get to eat food, I 
quite like eating food [laugh] I don’t deliberately make myself hypo but 
if I do go hypo I always think ‘excellent, another chance to eat food’ so I 
do! […] I don’t think it’s a real issue that I am having lower blood levels 
now and again. (NS1_M23, face to face interview) 
 
The issue of having a positive attitude was more common in the non-SAS group. There 
were only a few SAS participants who made reference to this theme. The following SAS 
participant described how he kept a positive attitude. 
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I'm of the attitude that I control it, it doesn’t control me.  Obviously I 
watch what I'm eating and things like that but if I fancy a chocolate 
biscuit or something I just have one, you know.  But I go through all the 
standard stuff, you know, like, eating sensible and just watch what I'm 
doing you know, but it’s just a way of life now, I don’t think about it. 
(AS2_M27, face to face interview) 
8.2.7.2 Denial 
Some participants admitted that they tended to deny they were having a 
hypoglycaemic episode. This could potentially be problematic as it may lead to a delay 
in treatment, which could cause the hypoglycaemic episode to get worse. External 
help may then become necessary. Denying that one is having a hypoglycaemic episode 
could be associated with viewing the occurrence of hypoglycaemic episodes as failure 
to keep a ‘good’ blood glucose balance. Therefore, people may be reluctant to admit 
they are having a hypoglycaemic episode, especially in the presence of others. This 
perceived ‘embarrassment’ could be made worse if people around identified the 
hypoglycaemic episode before the individual did (see second quote). 
You tend to deny you’re having a hypo, you deny it oh gosh yes. 
(AS1_F09, face to face interview) 
 
The guys who were playing [golf] with me they always knew before I do 
because I was very resistant to taking advice and taking help, obstinate 
in fact was probably the best term I could use!  So I didn’t even listen to 
them and the 12th hole at the golf course is a lot of sand dunes on it and 
I used to go up and down the sand dunes in my own little dream world 
carrying my golf bag [laugh]. (NS2_M04, face to face interview) 
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The next quote highlights that some participants may even deny they are having a 
hypoglycaemic episode to themselves. The participant described how he sometimes 
ignored (early) symptoms of hypoglycaemia, and thereby risked going into a severe 
hypoglycaemic episode that would require external help. 
I think it’s really a case of all my life I've turned and said ‘right, if 
something doesn’t bother me I don’t bother it’ and maybe when I'm 
going fuzzy I'm ignoring it… (AS3_M20, face to face interview) 
 
8.2.7.3 Avoidance 
Hypoglycaemic episodes were associated with a host of challenges and negative 
emotions, (see sections 7.2.1 and 7.2.2). It was therefore not surprising that many 
participants spoke about trying to avoid hypoglycaemic episodes by keeping a high 
blood glucose level. Avoidance could manifest itself following a particular 
hypoglycaemic episode (see quotes below) or be a general coping strategy in the 
person’s diabetes self-management.  
I think once you’ve had one [i.e. hypo], you are doing everything you can 
to avoid another one. I think they make me run my blood glucose levels 
much higher than they need to be. (NS2_F01, face to face interview) 
 
I probably just let me blood sugars run a bit high over the weekend and 
probably for the next couple of weeks just because my body was 
drained, just to stop it happening again because it really frightened me. 
(NS1_F08, telephone interview) 
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There seemed to be an association between fear of hypoglycaemic episodes and 
participants’ avoidance of these episodes. This is explored in more detail in section 7.3. 
Other situations where people tried to avoid hypoglycaemic episodes were when they 
were driving (see section 8.2.3) or when they had an important task to do (e.g. 
interview/meeting, leading in a ceremony or presentation). For example, one of the 
non-SAS participants spoke about keeping her blood glucose level higher in order to 
avoid a hypoglycaemic episode happening during interviews she was conducting for 
her work. 
I would eat more than strictly necessary because having a hypo in the 
middle of an interview is not very clever. (NS3_F05, face to face 
interview) 
While this avoidance behaviour can help people cope by reducing the number of 
hypoglycaemic episodes occurring, it may have a negative impact on diabetes control. 
The way people tried to avoid hypoglycaemic episodes happening was by keeping a 
higher blood glucose level, which could have negative implications in relation to long-
term complications (Williams and Pickup 2004; American Diabetes Association 2012). 
For example, one of the non-SAS participants, who lived on a farm, tried to avoid 
having hypoglycaemic episodes as a way of coping with the everyday demands of 
living and helping out on the farm. 
I live on a farm so you're quite busy and the thought of having a hypo 
when you’ve got lots to do it kind of… it makes you run that wee bit 
higher because, you know, you're trying to avoid having hypos. 
(NS1_F06, telephone interview)  
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8.2.7.4 Support network 
Many participants took an active role in building a support network by identifying 
people they trusted and educating them about diabetes and what to do when a 
hypoglycaemic emergency occurred. In fact, all participants had at least one person 
(family member, friend, etc.) who supported them with diabetes management. The 
support ranged from being actively involved in the participant’s daily diabetes 
management (e.g. giving injections, taking blood glucose readings), to being prepared 
to help when this was required (e.g. during hypoglycaemic episodes). 
Sometimes a very competent member of the support network could intervene and 
provide support when a hypoglycaemic emergency happened, and thereby not call out 
emergency services. For example, the husband of one non-SAS participant was 
confident and competent to treat a hypoglycaemic emergency without calling the 
ambulance. 
He was actually very very good at dealing with hypos, in fact he was 
very laid back about it […] he got some sugar and mixed it in orange 
juice and he just sat me down on the couch and he poured it down my 
throat and I was- I came to wearing a tea towel, lots of orange juice, 
because he had just poured it and- and he’d walk away, in the kitchen 
and he started peeling spuds or something, and just left me to come 
round. And I think a lot of people would have panicked and called for an 
ambulance, but he just thought, ‘no no, I’ve dealt with that, once she 
gets that sugar in her system, she will be ok’ (NS2_F01, face to face 
interview) 
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However, as has been highlighted in section 7.2.3, when people got confused, external 
help may become necessary. In this context, participants’ support network did not 
only play an important role in helping to treat hypoglycaemic episodes, they could also 
help with identifying when the individual was having a hypoglycaemic episode before 
the individual recognised it. This was of particular importance where the person was 
affected by hypoglycaemia unawareness.  
Some participants described how people close to them were sometimes able to 
identify a hypoglycaemic episode before they recognised it themselves.  
My daughter and my wife, they know I'm going to have a hypo because 
my wife will say to me ‘you're going to have a hypo’ and I went ‘how 
d'you know?’ she said ‘you’ve gone grey’.  She says ‘your face colour’s 
just changed, you’ve gone grey so I’ll go and make you a sandwich just 
now’. (NS2_M19) 
However, some participants admitted that they did not always accept another 
person’s opinion identifying their hypoglycaemic episode, and might delay taking food 
or glucose (see ‘being discredited by others’, section 9.3.1). 
Somebody might say to me ‘You're not looking very… or you're not 
speaking whatever’ and I’d probably be feeling alright but they would 
notice it before me and try to tell me, ‘Are you sure you're okay, you 
know, you're going pale or whatever?’ you know, and I would be 
stubborn and say ‘I'm feeling fine, what are you talking about!’ (SAS 
participant, AS2_M28) 
 
If I'm with friends they're very good at spotting that I'm needing sugar 
and they’ll say… and I ask them afterwards ‘how did you know I was 
needing sugar?’ ‘well because your eyes were different’ you know, 
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something changes in my face [laugh] and, erm, if I'm good I’ll obey 
them and take something… which I usually do when I'm told firmly to 
take it. But you can be argumentative as well.  It just changes your brain 
somehow or other. (SAS participant, AS3_F24) 
 
These quotes show that participants’ struggles to manage hypoglycaemic episodes did 
not only refer to themselves but extended to their interpersonal relationships. While a 
good support network was important, it might conflict with people’s desire to remain 
independent. 
8.3 The hypoglycaemic episode help-seeking network (HEHS network)  
A closer look at how participants’ managed hypoglycaemic episodes in the context of 
their everyday life showed a pattern. This pattern provides a number of options in 
relation to what roles various agents play in controlling hypoglycaemic episodes, and 
whether external help is required. Data showed that the following agents could 
potentially play a key part in the management of a hypoglycaemic episode:  
1) The individual, that is the person experiencing the hypoglycaemic episode 
2) Their carer or immediate family member(s) 
3) A member of the individual’s wider support network, and/or 
4) Ambulance clinician(s) or paramedic(s).  
In order to explain the relationship between severity of a hypoglycaemic episode, and 
the role of the agents identified, I have developed the hypoglycaemic episode help-
seeking network (HEHS network; see figure 8.1 below). The HEHS network describes 
the key people/agents involved and the role they play in the management and control 
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of an individual’s hypoglycaemic episode. There are four options in the HEHS network; 
each option is named according to the agent involved. 
 
Figure 8.1: A visual representation of the hypoglycaemic episode help-seeking 
network (HEHS network) 
 
The HEHS network helps to identify whether an individual is able to control their 
hypoglycaemic episodes and at what point external help is required. It shows options 
that are available in managing hypoglycaemic episodes. The HEHS network is based on 
the assumption that better control is achieved when the individual is able to manage 
the hypoglycaemic episode. Another assumption is that the higher the option number 
of the agent/network who controls a hypoglycaemic episode, the more severe it tends 
to be.  
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Option 1: The individual  
This option presents a situation when the individuals are able to identify and control 
their hypoglycaemic episodes without requiring any external help. As highlighted 
previously (section 8.2.4), many participants developed strategies to deal with their 
hypoglycaemic episodes (e.g. keeping food/sugary snacks/drinks close by). In option 1, 
the individual could take, for example, a sugary drink/snack or food to treat their 
hypoglycaemic episode, and is able to recover from the hypoglycaemic episode 
without help from any other person. There were many examples in the hypoglycaemia 
diary of when individuals were able to identify and treat their hypoglycaemic episodes 
(also see table 8.1).  
I treated myself with sweets and fruit juice followed with 2 chocolate 
digestives. (NS1_M07, hypoglycaemia diary) 
 
I treated myself, had a cup of coffee with 2 sugars + chocolate biscuit. 
(NS2_M04, hypoglycaemia diary) 
 
I looked after myself, took 100ml Lucozade, then lunch. (NS3_F05, 
hypoglycaemia diary) 
 
An important factor that determined whether a hypoglycaemic episode could be 
controlled at option 1 (i.e. by the individual experiencing it) was the impact of 
hypoglycaemia unawareness. When people are affected by hypoglycaemia 
unawareness, they may not recognise that they are having a hypoglycaemic episode 
until it reaches a severe stage (see section 7.4.3). At that point, people are much more 
likely to need external help.  
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Option 2: Help from a family member or carer was required 
In some instances, participants were supported by a partner/family member or carer 
in order to treat hypoglycaemic episodes. The following are examples of when 
participants were assisted by a partner or family member to treat a hypoglycaemic 
episode. 
My partner made me toast as I was worried that I was going to pass out. 
(NS3_M17, hypoglycaemia diary) 
 
I needed my wife’s assistance to make a snack. My daughter also 
assisted with glucose tabs + sugary drink. (NS2_M19, hypoglycaemia 
diary)  
 
Participants’ hypoglycaemia diaries suggest that option 2 may be a result of people 
delaying to treat the hypoglycaemic episode, or worrying about the hypoglycaemic 
episode getting worse (see table 8.1). 
Option 3: Help was provided by a member of the wider support network 
Option 3 of the HEHS network is indicated when help was provided by a member of 
the wider support network including friends, colleagues and neighbours. For example, 
a 78 year old female SAS participant recorded a hypoglycaemic episode where she lost 
her balance, but was able to phone a friend to help her treat the episode. 
I fell on the floor and could not get up. Eventually I rolled over to phone 
and managed to contact my friend. Just could not reach glucose. She 
gave me the Lucozade while I was able to drink. (AS3_F24, 
hypoglycaemia diary) 
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The following is an example where help from both a family member (the participant’s 
mother, option 2) as well as help from a member of the wider support network (a 
neighbour, option 3) was required: 
I came down for breakfast, I vaguely remember coming down the stairs 
and then the next thing I remember I'm waking up on the couch… 
apparently I’d got down, made my cereal, went through to the dining 
room, sat down and apparently just collapsed off onto the floor and 
then my mum tried to give me a Glucagon injection but I was fighting 
her off so she had to… so she ran out into the street in her dressing 
gown and there was a neighbour getting into his car for work and she 
said ‘can you come and help me I need you to hold my son down while I 
give an injection bla, bla, bla’ so I’d some bloke sitting on me while I got 
my injection and that kind of stopped me fighting everyone off, and then 
they managed to get me onto the couch where I think I effectively just 
either was knocked out or just fell asleep. (NS1_M23, face to face 
interview) 
 
Option 4: Help was provided by ambulance clinician(s)/paramedic(s) 
In option 4, people required emergency assistance to treat a hypoglycaemic episode. 
In many situations when emergency assistance was required, it involved actions of 
other agents/people from various options in the HEHS network. For example, a family 
member might help by calling the ambulance, and then the ambulance service 
provided treatment. Another example was one female SAS participant who described 
a situation where people around noticed that she needed help (option 3), then her 
father arrived and called the ambulance (option 2), and finally, the ambulance arrived 
and provided treatment (option 4).  
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I had to rush out to an interview and then onto another one at last 
minute. I got lost and was panicking, had got myself in a terrible state. 
People noticed me and dad had arrived and phoned paramedics. 
(AS1_F09, hypoglycaemia diary) 
 
Another SAS participant required external help to treat a hypoglycaemic episode while 
out sweeping leaves at work. Initially, motorists saw him and called an ambulance 
(option 3), and then eventually the ambulance and a doctor from a nearby health 
centre arrived and treated the hypoglycaemic episode (option 4). 
There was one time when I was out on City Road, motorists saw me, I’d 
slipped on wet leaves and I was sort of on my back and I was kicking 
about, and some motorists saw me and someone obviously called an 
ambulance, I don’t know who it was, but one of the doctors from across 
in the health centre at the City Road came down to see me too, but I was 
okay, I came round. (AS2_M28, face to face interview) 
 
The individual’s or their support network’s ability to identify and treat hypoglycaemic 
episodes on time (i.e. before the hypoglycaemic episode worsened and could no 
longer be controlled by the individual or their support network) also influenced 
whether the individual was able to control their hypoglycaemic episodes.  
Good diabetes control means the individual is able to control the hypoglycaemic 
episode  
In a situation where the individual is able to identify and treat a hypoglycaemic 
episode on time, better control is achieved without needing external help (option 1 of 
the HEHS network). This is because external help takes more time to arrive; therefore 
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it is more likely for the hypoglycaemic episode to get worse in such a situation. One 
non-SAS participant described a tricky situation where he was driving and he felt a 
hypoglycaemic episode coming on. He was able to identify that he was experiencing a 
hypoglycaemic episode; however, he did not have anything with him to treat the 
episode. He then decided to keep driving to the nearest place where he could get 
some glucose rich food or drink, rather than stopping the car and waiting for external 
help to arrive.  
There was an incident when I couldn’t… I was about half an hour before I 
could eat something, and then I got the cold sweat and the shakes and 
all those kind of things quite badly and I just had to sit for a while and 
wait until they all calmed down.  That was about a month ago and I was 
in the car and just didn’t have anything, I had to wait until I could get to 
a garage. [..] I was driving, so yes I am aware that that is dangerous, but 
the traffic was very slow and I didn’t have any choice.  I had the option 
of keep on going or pull over and wait until however long it would take 
for someone to come and help me and I thought that would just be too 
bad. (NS1_M07, face to face interview) 
 
There was a two-way association between severity of hypoglycaemic episode and 
needing external help: when the individual with diabetes needed external help, the 
hypoglycaemic episode was likely to be severe. On the other hand, as the person 
perceived they needed external help, there was a delay in treatment (e.g. from calling 
the ambulance until it arrived at the scene) which meant the hypoglycaemic episode 
was likely to worsen before it was treated. Mechanic (1995) has suggested that people 
are more likely to seek external help when symptoms interfere with their ability to 
carry out everyday activities (see help-seeking theory, section 4.6). In terms of study 
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data, when participants experienced a severe hypoglycaemic episode, they required 
external help, as symptoms did not only interfere with their ability to carry out 
everyday activities, but also with the ability to treat the hypoglycaemic episode 
themselves (also see sections 7.2.3 and 7.2.6). 
The HEHS network does not represent a linear sequence of when the various agents 
may be involved in the management of hypoglycaemic episodes; rather, it illustrates 
who could be involved at different points, and what options were exemplified in the 
study. For example, in some instances help was provided by paramedics, without 
anyone being involved at option 2 or 3.  
The following table presents data that was used to develop the HEHS network. It was 
extracted from participants’ hypoglycaemia diary entries.   
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Table 8.1: Extract of hypoglycaemia diary data used to develop the HEHS network 
 
 
Participant Diary data (Did you treat yourself?) Control option 
NS2_F01 Treated myself. Always have glucose in pocket. Then 
got Lucozade from car. Then tested BG. Then ate, and 
ate and ate until I felt back in control. 
1 
NS2_F01 Yes, ate glucose sweets (about 13g CHO)  
Treated myself and returned to sleep.  
1 
NS1_F03 Treated self  
Yes, can of juice, chocolate  
1 
NS1_M07 Treated myself  1 
AS1_F09 Yes. I got up and drank Lucozade.  
I was given a sweet drink + then I took another myself. 
No ambulance called. 
1 
NS3_F10 Yes, treated myself. 2 pieces of white chocolate. Didn’t 
get up.  
1 
AS1_M11 
 
Yes, I treated myself.  
Treated myself with fiancée present & no ambulance 
needed   
1, 2 
AS3_F24 Treated myself - drank Lucozade.  1 
NS1_M07 My wife made me tea although I was capable of doing 
it.  
2 
AS1_F09 I did at first, but kept delaying myself, so needed 
father’s help. No service was called  
2 
NS3_F10 I didn’t treat myself as I was cooking dinner at the time 
& thought I could last until dinner was ready.  
My husband got me some sweets.  
2 
NS3_M17 Partner made me toast as I was worried that I was going 
to pass out. Treated by myself & partner  
2, 1 
NS2_M19 I needed my wife’s assistance to make a snack. My 
daughter also assisted with glucose tabs + sugary drink.  
2 
AS2_M27 Mother, 2 Glucogel + Jelly babies, ambulance service 
was not called.  
2 
AS2_M27 Mother called ambulance, paramedics came.  2, 4 
AS2_M27  
 
Mother treated me.  No ambulance was called.  2 
NS3_F10  Bit of a panic – vending machine not working – had to 
go to another floor to get Mars bar. Running out of 
time; colleagues were on hand to help  
3 
AS3_F24 
 
Neighbour heard me – needed someone. She gave me 
the Lucozade while I was able to drink.  
3 
AS3_F24 
 
The other bowlers got the emergency Lucozade out of 
the Bowling Club fridge & gave me a drink. 
3 
AS1_F09 
 
People noticed me, dad had arrived & phoned 
paramedics. 
2, 3, 4 
AS1_F22 I couldn’t get up, midwife helped [participant was 
pregnant]. 
4 
AS3_F24  Neighbour heard me. She called ambulance. 3, 4 
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8.4 Summary 
The findings presented in this chapter emphasised different ways in which 
hypoglycaemic episodes affected participants’ diabetes self-management and 
everyday life, for example, preparations for potential hypoglycaemic episodes (e.g. 
always having food/glucose tablets available, carrying a blood glucose monitor) and 
recovery from hypoglycaemic episodes. Some participants admitted that they tended 
to avoid certain tasks or social situations due to worries about a (severe) 
hypoglycaemic episode happening. This ranged from never exercising alone to not 
travelling or going out, (see section 8.2.3). 
The chapter also pointed out the potential impact hypoglycaemic episodes can have 
on participants’ diabetes self-management. One of the major ways in which 
hypoglycaemic episodes can influence diabetes self-management was in shifting 
participants’ self-management strategies towards keeping a higher blood glucose level 
aimed at avoiding hypoglycaemic episodes; thereby increasing their risk of having 
long-term complications in the future. On a day to day basis, participants tended to 
adopt various strategies to deal with hypoglycaemic episodes, e.g. keeping sugary 
foods within easy reach, (section 8.2.2).  
The avoidance of hypoglycaemic episodes was not just an issue in the day to day 
management of diabetes, but also a coping strategy adopted by many participants. 
Participants admitted to intentionally altering their diabetes treatment, aiming to keep 
a higher blood glucose level in order to avoid hypoglycaemic episodes happening, 
(section 8.2.7.3). This could have a devastating effect on their risk of experiencing 
long-term complications. 
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Some participants adopted a positive attitude to cope with hypoglycaemic episodes, 
and accepted these episodes as normal part of living with diabetes. They also claimed 
that it was easy to treat hypoglycaemic episodes, (section 8.2.7.1). This attitude was 
more common in the non-SAS group.   
Another coping strategy was that some participants tended to deny that they were 
having a hypoglycaemic episode. This included self-denial as well as denial towards 
others, (section 8.2.7.2). This strategy might be risky as it could lead to a delay in 
treatment, which might cause the hypoglycaemic episode to get worse. Section 8.2.7.4 
has highlighted the importance of a support network, whose members can not only 
help with treatment of hypoglycaemic episodes, but crucially help identify the onset of 
hypoglycaemic episodes and thereby support people affected by hypoglycaemia 
unawareness. However, when individuals tried to deny that they were having a 
hypoglycaemic episode, accepting help from members of their support network might 
be challenging. 
The HEHS network (section 8.3) captured the various agents that may be involved in 
the management of hypoglycaemic episodes. It helped to identify the various options 
available to control hypoglycaemic episodes and at what point external help was 
required. While participants developed strategies to deal with hypoglycaemic episodes 
as they happened (section 8.2), they sometimes required help from their support 
network or the ambulance service.  
According to the HEHS network, when people were not able to control their 
hypoglycaemic episodes, they required alternative options (options 2, 3 and/or 4), 
thus needing external help. This was usually the case when hypoglycaemic episodes 
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were more severe. The HEHS network suggested that good diabetes control can only 
be achieved when individuals were able to manage their hypoglycaemic episodes, 
without needing external help.    
The next chapter provides an overview of study findings and discusses these findings 
with reference to the wider literature and theory. It also highlights strengths and 
limitations of this study. Finally, it discusses implications for clinical practice and 
further research. 
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Chapter 9 - Discussion 
9.1  Introduction 
This chapter presents a summary of study findings (section 9.2), and discusses these 
findings with reference to the wider literature (section 9.3). It also examines which 
theories (see chapter 4) may be helpful in understanding the study findings. In terms 
of theoretical positioning, this study is a piece of applied health research which has 
been informed by a number of sociological theories. 
The chapter further reflects on strengths and weaknesses of this study, for example, 
limitations regarding study design, sampling, and the potential influence of the 
researcher on data generation.  Finally, implications for clinical practice and further 
research are considered. 
9.2   Summary of study findings 
This study investigated participants’ experiences and individual explanations of 
recurrent hypoglycaemic episodes. It found that hypoglycaemic episodes can have a 
wide ranging impact on participants’ everyday life. It was not only the actual 
hypoglycaemic episode that affected participants’ everyday life, but also fears and 
worries about future hypoglycaemic episodes, the preparations that people engaged 
in to manage potential hypoglycaemic episodes, and the process of recovery, (see 
section 8.2.6). 
The study found that hypoglycaemia unawareness was a major problem for many 
participants living with diabetes. Hypoglycaemia unawareness appeared to be linked 
with the likelihood of needing external help, (section 7.2.5). While participants in both 
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groups experienced hypoglycaemia unawareness, a key difference was how 
participants managed it. SAS participants tended to be less aware and less 
knowledgeable about hypoglycaemia unawareness, resulting in more severe 
hypoglycaemic episodes. Consequently, they were more reliant on external help from 
both the ambulance service, as well as their support network (section 7.5).   
Findings of this study call for a re-conceptualisation of the previously recognised 
‘balancing act’ of managing diabetes and hypoglycaemic episodes. This study has 
introduced the concept of a hypoglycaemic episode balancing continuum (HEBC) 
which enables a deeper understanding of the factors involved in this balancing act: it 
demonstrates that people balance the various risks differently, depending on whether 
they prioritise their fear of hypoglycaemia over fear of long-term complications, 
(section 7.3). Participants’ position on the continuum directly affects their 
management strategies for hypoglycaemic episodes, for example, some participants 
actively avoided hypoglycaemic episodes more than others.  
This thesis found that fear of hypoglycaemic episodes governed some participants’ 
management of diabetes, but for others, the fear of long-term complications was 
greater. The focus of people’s fear determined where they sat on the HEBC. The 
continuum demonstrates that those who exhibited fear of hypoglycaemia would be 
more likely to keep a higher blood glucose level in an attempt to avoid hypoglycaemic 
episodes happening, or to reduce the number of hypoglycaemic episodes they 
experienced. Those who did not express a similar degree of fear were more likely to 
keep their blood glucose level within a lower range, and were more likely to be 
concerned about long-term complications. However, there were times when avoiding 
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hypoglycaemic episodes was necessary to engage in activities (e.g. driving, physical 
exercise). Some participants used avoidance of hypoglycaemic episodes as a 
temporary coping strategy, while other participants adopted avoidance of 
hypoglycaemic episodes as a permanent coping strategy (see section 9.3.1).  
In order to illustrate how hypoglycaemic episodes are managed, this thesis has 
developed the hypoglycaemic episode help-seeking network (HEHS network) from 
the data, which helped to identify the various agents involved in helping to treat 
hypoglycaemic episodes (e.g. the individual with diabetes, their carer/family members, 
members of their wider support network, and ambulance service 
paramedics/clinicians; section 8.3). The HEHS network suggests that while many 
participants tried to deal with hypoglycaemic episodes as they happened, they 
sometimes required help from their support network or the ambulance service. It has 
illustrated the nature of involvement of the various agents in the management of 
hypoglycaemic episodes, and why/when they were likely to be involved.  
The HEHS network shows that the severity of each hypoglycaemic episode influenced 
whether external help was required, and that the most severe episodes were likely to 
be treated by the ambulance service. Another important factor that influenced which 
agent was involved in the management of the hypoglycaemic episode was the 
individual’s or their support network’s ability to identify and treat hypoglycaemic 
episodes on time. This ability was affected by participants’ knowledge about their 
diabetes and their capacity for its management. When this capacity has been 
exceeded, e.g. through hypoglycaemia unawareness, then participants were more 
likely to require SAS involvement.  
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9.2.1 Differences and similarities between the SAS and non-SAS group 
Both the SAS and the non-SAS group experienced hypoglycaemia unawareness, 
however, it was more common and appeared to be more problematic in the SAS 
group. One important aspect was people’s response to hypoglycaemia unawareness, 
which seemed to differ in the two groups. For example, non-SAS participants tended 
to be more prepared (e.g. having food/glucose tablets available; see section 8.2.2) in 
case a hypoglycaemic episode occurred. This was particularly important when an 
individual was affected by hypoglycaemia unawareness, as it caused hypoglycaemic 
episodes to come on a lot more quickly and severely, leaving the person little time to 
identify and treat the episode. 
Another major factor in managing hypoglycaemia unawareness was awareness about 
the phenomenon itself. This is where participants’ health literacy is key; that is a good 
understanding about what hypoglycaemia unawareness is, what causes it and how it 
can be addressed. Non-SAS participants tended to be more knowledgeable about their 
condition and its management than SAS participants, resulting in a better awareness 
of the potential to develop hypoglycaemia unawareness, (see sections 6.5.3 and 
7.4.3). A good awareness of hypoglycaemia unawareness can contribute to better 
management of it (e.g. being prepared, checking blood glucose level more regularly), 
or even help to reduce hypoglycaemia unawareness by altering diabetes medications 
(Frier 2007a). The differences between the two groups may be a reflection of the non-
SAS study sample being mainly recruited through Diabetes UK, a population that could 
represent a group more willing to learn about their diabetes and to take active control 
of their self-care.  
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A number of differences between SAS and non-SAS participants have been identified 
in relation to socio-demographic factors (see section 6.2). For example, SAS 
participants were older and tended to live in more deprived areas compared to non-
SAS participants. These factors may have contributed to lower levels of health literacy 
in the SAS group, which in turn affected participants’ ability to manage hypoglycaemia 
unawareness (see section 7.4.3). 
Hypoglycaemia unawareness is a known risk factor for severe hypoglycaemia, and 
poor management of hypoglycaemia unawareness makes the situation worse (Clarke 
et al. 1995, Frier 2007a). As highlighted above, SAS participants’ experiences and 
descriptions of hypoglycaemic episodes would indicate a greater tendency towards 
hypoglycaemia unawareness compared to non-SAS participants. SAS participants also 
appeared to be less able to manage hypoglycaemia unawareness. This may help to 
explain why SAS participants experienced more severe hypoglycaemic episodes where 
they were unable to treat the episode themselves, and thus required external help, 
(see section 7.2.5). In contrast, none of the non-SAS participants needed help provided 
by the ambulance service during the study. They rarely required any help, but when 
they did, this was often provided by family, friends or colleagues. 
In terms of severity of hypoglycaemic episodes (section 7.2.6), there were some 
differences between SAS and non-SAS participants. For many non-SAS participants, 
hypoglycaemic episodes were a ‘minor inconvenience’ that they usually treated 
themselves, while SAS participants tended to have more severe hypoglycaemic 
episodes. This was based on severe hypoglycaemic episodes being defined as requiring 
external help to effect treatment (DCCT 1997). In terms of participants’ perceived 
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severity scores for individual hypoglycaemic episodes, there was only a slight 
difference in the mean scores for the two groups, (see sections 6.5.1 and 6.5.2). Non-
SAS participants gave a slightly lower score compared to SAS participants. It is 
important to note that perceived severity and actual severity (based on symptoms, 
blood glucose reading, and whether external help was required) can differ greatly.  
Another aspect of severity was the occurrence of injuries happening during a 
hypoglycaemic episode, as mentioned in section 8.2.6. When comparing the two study 
groups, injuries were more common in the SAS group. This further underlines that SAS 
participants seemed to experience more severe hypoglycaemic episodes compared to 
non-SAS participants. 
9.3 Discussion of study findings with reference to the wider literature 
and theory 
9.3.1   Study findings with reference to wider literature and theory 
Wide ranging impact of hypoglycaemic episodes 
Frier (2008) and Barnett et al. (2010) concur with the study finding that hypoglycaemic 
episodes can have a wide ranging impact on participants’ everyday life, including 
travel, driving, physical activities, employment and relationships. The aspect of fears 
and worries about hypoglycaemia has also been well documented (Currie et al. 2006; 
Wild et al. 2007; Tierney et al. 2008; Belendez and Hernandez-Mijares 2009; 
Hanberger et al. 2009). The study adds to this understanding of people’s experiences 
of hypoglycaemic episodes and how these episodes affect people’s everyday life, 
ranging from preparations for potential hypoglycaemic episodes happening, and issues 
around being confused and not in control when experiencing a hypoglycaemic episode 
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to recovery from hypoglycaemic episodes. The findings highlight an important problem 
in the treatment of hypoglycaemic episodes: when participants get confused, they 
may not be able to initiate treatment on time, and external help may become 
necessary. The issue of confusion is also confirmed in the literature (Diebel 1999; 
Banks 2005). 
One aspect this study adds to knowledge of the impact of diabetes on everyday life is 
the issue of being prepared for potential hypoglycaemic episodes happening, (see 
section 8.2.2). The degree of preparedness has been found to be one of the 
differences between the SAS and non-SAS group, which could be a key difference in 
whether external help was required. A qualitative study involving six participants with 
type 2 diabetes in Singapore also highlighted that being prepared for potential 
hypoglycaemic episodes reduces the fear and anxiety associated with hypoglycaemia, 
and helps to recover from hypoglycaemic episodes more quickly (Tan et al. 2012b). 
This study found that hypoglycaemic episodes can impact on participants’ everyday 
life beyond the actual episode, and that full recovery from hypoglycaemic episodes 
can sometimes take a few days. Participants spoke about feeling exhausted and 
depressed after experiencing a hypoglycaemic episode, especially if the episode was 
perceived as severe, (section 8.2.6). This is referred to as ‘post-hypoglycaemic 
syndrome’ in the literature (Costea et al. 1993).  
In chapter 4, it was suggested that Charmaz’ (1983) concept of the impact on identity 
and sense of self may be relevant for this study. For example, Charmaz points out that 
people may be discredited by others due to their chronic condition. This study found 
that both SAS and non-SAS participants sometimes tended to deny they were 
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experiencing a hypoglycaemic episode, (section 8.2.7.2). This could be due to people 
not wanting to be discredited by others, or to be viewed as not capable of managing 
their diabetes and hypoglycaemic episodes, (also see section 8.2.7.4).  
Another aspect of Charmaz’ concept is ‘living a restricted life’ to accommodate the 
chronic condition or to avoid embarrassment. Study findings have highlighted that 
some participants preferred to avoid certain situations because of the risk of having a 
hypoglycaemic episode, for example, going out or exercising on their own, (see section 
8.2.3).  
The issue of ‘being a burden to others’ (Charmaz 1983) relates to the finding that 
participants may lose control when experiencing a hypoglycaemic episode. In such 
situations, people rely on others to help them treat the hypoglycaemic episode. 
According to Charmaz (1983), all these aspects (i.e. being discredited, living a 
restricted life, being a burden to others) can lead to a loss of self (section 4.9). This 
may impact on people’s identity and sense of self. 
Impact of hypoglycaemia unawareness and importance of health literacy 
This study has identified hypoglycaemia unawareness as a key factor that can impact 
on the management of hypoglycaemic episodes. For example, when participants did 
not experience any early symptoms of hypoglycaemia, this left them at risk of both, 
not being able to identify an impending hypoglycaemic episode, as well as a higher 
chance for the hypoglycaemic episode to get to the severe stage (also see Gerich 2000; 
Briscoe and Davis 2006). The wider literature confirms that hypoglycaemia 
unawareness is a problem that affects many people with diabetes. According to Frier 
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(2007a), a reduction or gradual loss of warning signs (i.e. mild symptoms) affects about 
25% of all people treated with insulin, rising to almost 50% after 25 years or more of 
insulin-treated diabetes (Pramming et al. 1991). Høi-Hansen et al. (2005) used a 
continuous blood glucose monitoring system to investigate unrecognised 
hypoglycaemic episodes. They found that over six days, 90% of 29 participants with 
type 1 diabetes experienced at least one occasion where their blood glucose level was 
within a hypoglycaemic range, while only 15% experienced symptoms. 
While the problem of hypoglycaemia unawareness has been widely acknowledged in 
the literature (Clarke et al. 1995; Gerich 2000; Briscoe and Davis 2006; Frier 2007a; 
Hayes 2008; Gibson 2009; Cove 2011; Elliott and Heller 2011), it is the response to 
hypoglycaemia unawareness that can be a key difference in how people cope and 
whether they require external help (Rogers et al. 2012). One of the factors that 
influenced participants’ response to hypoglycaemia unawareness was their knowledge 
about the phenomenon itself (also see Tan et al. 2012a). For example, non-SAS 
participants tended to be better prepared in case a hypoglycaemic episode occurred. 
They also seemed to be more knowledgeable about their condition and its 
management, resulting in a better awareness and understanding of hypoglycaemia 
unawareness (section 9.2.1). 
The importance of health education and health literacy to achieve good diabetes 
control has been emphasised in the wider literature (Schillinger et al. 2002; Murata et 
al. 2004; Powell et al. 2007; Protheroe et al. 2008; Longo et al. 2010; Stiles 2011). For 
example, Lawton et al. (2013) carried out a longitudinal qualitative study involving 30 
participants with type 1 diabetes, who had recently taken part in a DAFNE education 
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course (DAFNE online 2010). They focussed specifically on self-treatment of 
hypoglycaemic episodes, and found that education plays a key role in establishing 
appropriate treatment strategies.  
However, the key role health literacy plays in participants’ explanations for 
hypoglycaemic episodes is something this study adds. This is especially important in 
addressing the issue of hypoglycaemia unawareness. This study found that a good 
understanding about what hypoglycaemia unawareness is, what causes it, and how it 
can be addressed can contribute to a more appropriate response and better 
management of hypoglycaemia unawareness (sections 7.4.3 and 7.4.4).  
One of the theories that is potentially relevant for this study is help-seeking theory 
(Mechanic 1966; Zola 1973; Mechanic 1968; Mechanic 1995). A central element of 
help-seeking theory is perception, recognition and interpretation of symptoms. This 
can be applied to the study findings, which have highlighted that experience and 
appropriate interpretation of symptoms are key in identifying and treating 
hypoglycaemic episodes. For example, where people were affected by hypoglycaemia 
unawareness, they did not experience any symptoms at the onset of hypoglycaemic 
episodes. This absence of symptoms removed any opportunity for self-care or active 
help-seeking, as there was no indication/detection of an impending hypoglycaemic 
episode at that stage. 
In terms of Zola’s help-seeking model (1973), some of the triggers that can cause an 
individual to seek help/take remedial action (see section 4.6, figure 4.1) apply to the 
study findings. For example, perceived interference with work, social or leisure 
activities; findings confirm that when symptoms of hypoglycaemic episodes interfered 
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with participants’ everyday activities, they were more likely to seek help or to treat 
themselves via self-management strategies. Closely related to the interference with 
everyday activities is what Mechanic (1968) called ‘tolerance for the symptoms’. This 
tolerance describes people’s ability to accommodate symptoms before they take 
action to treat the hypoglycaemic episode (i.e. treat themselves or seek help). Study 
findings have shown that there were certain situations in which participants could not 
afford to accommodate symptoms, e.g. when driving or during an important meeting, 
(see section 8.2.3). In such situations, participants tended to pre-empt the symptoms 
with self-management strategies, which might be counterintuitive to good healthcare 
practice. 
According to Zola’s model (1973), help-seeking does not only relate to lay referral (i.e. 
help and advice from family members/carers or friends) and medical help, but it 
includes self-medication. This is particularly relevant for this study, as participants 
often treated themselves when they experienced hypoglycaemic episodes.  
Mechanic (1995) suggests that people’s perception of their health status influences 
their responses to symptoms. Study findings have shown that it is not just people’s 
perception of their health status; rather, it is their perception of their condition (for 
example, do they believe diabetes is controllable/not controllable) and ability to 
manage hypoglycaemic episodes, that influences people’s responses to symptoms. 
This ability determines whether people seek external help. Additionally, sometimes 
symptoms are not recognised and the biomedical indicators are not always reliable to 
identify hypoglycaemic episodes (see section 7.2.4).  
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In relation to social construction of illness (Mechanic 1968; Conrad and Barker 2010), 
study findings have highlighted that participants relied on their experiential knowledge 
as opposed to medical definitions of what constitutes a hypoglycaemic episode (see 
section 7.2.4). Even though diabetes and hypoglycaemia are biomedical conditions 
(Williams and Pickup 2004), participants placed more importance on how they felt and 
how hypoglycaemia impacted on their everyday life (see section 8.2.4). This has 
potential implications for clinical practice (see section 9.5.1). 
The hypoglycaemic episode balancing continuum (HEBC) 
This study, like others (Callaghan and Williams 1994; Shiu and Wong 2002; Campbell et 
al. 2003; Vermeire et al. 2003; Debono and Cachia 2007; Moser et al. 2008; Wu et al. 
2011) found that participants described managing diabetes as being a ‘balancing act’, 
which involves maintaining an appropriate blood glucose level, in order to avoid 
complications relating to a low or high blood glucose level. This included reducing the 
risk of long-term complications whilst at the same time striving to avoid short-term 
complications (e.g. hypoglycaemic episodes), and maintaining a good quality of life.  
According to Nafees et al. (2006), people often place a higher priority on the 
immediate effects of treatment/short-term complications as opposed to long-term 
complications at some point in the future. Some people may alter their diabetes self-
management in order to avoid experiencing hypoglycaemic episodes, due to fear of 
hypoglycaemia (Wu et al. 2011; Tan et al. 2012a). This is captured in group C of the 
hypoglycaemic episode balancing continuum (HEBC), as presented in chapter 7. People 
who are in group C tended to be fearful of hypoglycaemic episodes and tried to avoid 
them by keeping a higher blood glucose level. In the short term, this decreased their 
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risk of experiencing hypoglycaemic episodes; however, in the long run, it increased 
their risk of having long-term complications. Avoidance of hypoglycaemia has also 
been identified as a coping strategy, (see section 8.2.7.3). 
In terms of balancing priorities, this study adds a more differentiated understanding of 
approaches people adopted. Many authors have focussed on measuring people’s fear 
of hypoglycaemia using a quantitative scale (Choe et al. 2001; Vermeire et al. 2003; 
Nafees et al. 2006; Tierney et al. 2008; Anderbro et al. 2010); however, they did not 
consider how this related to people’s actual diabetes management, or their concern 
about long-term complications. The HEBC explains the relationship of people’s 
perception of hypoglycaemic episodes (e.g. fearful of hypoglycaemic episodes/not 
fearful), occurrence of hypoglycaemic episodes, blood glucose control and attitude 
towards long-term complications. It clarifies that people adopt various positions 
towards hypoglycaemic episodes, based on their experiences and understanding of 
hypoglycaemic episodes, as well as long-term complications. Therefore, the HEBC may 
offer explanations for differences in self-care processes. 
For example, some participants accepted experiencing more hypoglycaemic episodes 
as a result of strict glycaemic control, in order to reduce the risk of having long-term 
complications in the future (group A on the HEBC). According to Rogers et al. (2012), 
people’s fear of long-term complications/high blood glucose contributes to low 
concern about hypoglycaemia unawareness. Even though Rogers and colleagues 
focussed on hypoglycaemia unawareness, their findings are relevant to the HEBC, as 
they illustrate that a significant fear and anxiety of high blood glucose levels and long-
term complications can reduce people’s concern about hypoglycaemia.  
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The HEBC has also illustrated how some participants took a more balanced approach 
in managing risks of long-term and short-term complications. This could either be a 
result of them being fearful of both, hypoglycaemic episodes as well as long-term 
complications (group B-1), or not being fearful of either and thus not altering their 
diabetes self-management strategy (group B-2). 
The HEBC is an example of people making decisions about their diabetes self-
management in the context of their everyday lives, and also illustrates where people’s 
priorities can change, thus drawing on sociological thinking. When hypoglycaemia 
impacted on participants’ social life or their ability to ‘function normally’ especially 
when in an important situation (e.g. driving, meeting), they tended to adopt strategies 
to avoid hypoglycaemic episodes (see section 8.2.7.3). 
A qualitative study carried out by Wu et al. (2011) confirmed that people vary in 
relation to how they balance risks of short-term and long-term complications. Wu et 
al. (2011) interviewed 17 people diagnosed with type 1 or type 2 diabetes in Taiwan, 
and found that participants balanced the risks of experiencing hypoglycaemia and 
having long-term complications in the future, depending on their perception of the 
threat of hypoglycaemia. They concluded that “regardless of which approach they 
used to maintain glucose levels, participants recognised the potential risks of 
hypoglycaemia and hyperglycaemia, while recognising this experience as living with a 
constant shadow of dilemma” (p.2281). 
Murphy and Kinmonth (1995) conducted a qualitative study using in-depth interviews 
with 46 participants who were diagnosed with type 2 diabetes. They confirmed that 
participants varied in relation to how they balanced the various risks, and classified 
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participants into two categories: Those concentrating on avoiding symptoms and 
those focussing to avoid long-term complications. While Murphy and Kinmonth (1995) 
did not specifically focus on hypoglycaemia, their findings are relevant to the HEBC, as 
they demonstrate that people living with diabetes vary in how they view diabetes and 
how they balance the risk of short-term symptoms and avoiding long-term 
complications. 
Self-care and the hypoglycaemic episode help-seeking (HEHS) network 
Orem’s theory of self-care (1991; 1995) could explain participants’ abilities to perform 
self-care actions; as well as situations when people are not able to meet self-care 
demand, they would require external help (e.g. during a severe hypoglycaemic 
episode). According to Orem (1959), self-care is a necessity to maintain life and health.   
Therefore, the need for self-care action can be viewed as a basic human need. Masters 
(2011) claims that every individual has the ability to perform self-care and take 
responsibility for their health. People with diabetes have to carry out a variety of self-
care actions (e.g. monitor blood glucose level, inject the appropriate amount of insulin 
at regular intervals, etc.) to cope with their condition, and to maintain life. However, 
there is the possibility that some people living with a chronic condition may have a 
limited ability to perform self-care actions, and may require external help. 
The HEHS network (section 8.3) illustrates the above interplay, and shows when 
people are able to carry out self-care actions, and when they would require external 
help, as well as the various agents that could be involved in managing hypoglycaemic 
episodes. According to the HEHS network, better control (self-care agency) is achieved 
when individuals are able to identify and control their hypoglycaemic episodes without 
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requiring any external help (option 1 in the HEHS network). When people are not able 
to manage their hypoglycaemic episodes themselves (i.e. meet self-care requisites), 
external help would be required (options 2, 3 and 4 in the HEHS network). This can be 
considered a self-care deficit, (see section 4.10). Self-care deficit can be caused by 
hypoglycaemia unawareness or the person’s lack of knowledge about their condition 
and its management.   
In relation to hypoglycaemia unawareness, little knowledge about the phenomenon 
itself (see section 7.4.3) could mean that people were not able to respond to 
hypoglycaemia unawareness appropriately; that is, they were not able to meet their 
self-care demand. The inability to carry out diabetes self-care actions (e.g. blood 
glucose monitoring, responding to early warning signs/symptoms of hypoglycaemia, 
being prepared for possible hypoglycaemic episodes, etc.) could also imply a self-care 
deficit. People who have a self-care deficit usually require external help to meet self-
care demand. This was more prominent within the SAS group and explains why more 
people within this group repeatedly needed external help/emergency services. Orem’s 
theory therefore helps to explain how people with diabetes are required to carry out 
self-care actions in order to lead a normal life (‘maintain life and health’) and navigate 
the complexities of managing a long-term condition. It shows that when people living 
with diabetes have a self-care deficit, needing external help is inevitable.  
Avoidance of hypoglycaemic episodes 
This study has shown that avoidance of hypoglycaemic episodes is a coping strategy 
many participants adopted at various times. Given many negative experiences 
associated with the experience of hypoglycaemic episodes (e.g. feelings of losing 
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control, anger and anxiety) and the potential for embarrassment when having a 
hypoglycaemic episode in a public place, it is not surprising that people tried to avoid 
experiencing hypoglycaemic episodes by altering their self-management activities, 
resulting in a higher blood glucose level (Callaghan and Williams 1994; Rajaram 1997; 
Green et al. 2000; Everett 2001; Di Battista 2009; Fidler et al. 2011; Sutton and 
Chapman-Novakofski 2011; Tan et al. 2012a).  
This study contributes to a more differentiated understanding of people’s avoidance 
behaviour, going beyond avoidance simply as a response to fear of hypoglycaemia 
(Irvine et al. 1992; Costea et al. 1993; Shiu and Wong 2000; Leiter et al. 2005; Fidler et 
al. 2011). The study found that some participants adopted avoidance of hypoglycaemic 
episodes as an overall approach to diabetes self-management, which can be 
considered a permanent coping strategy. This was often a general trait which may 
develop in response to fear of hypoglycaemia. In terms of the HEBC, people adopting 
avoidance of hypoglycaemic episodes as a permanent coping strategy would likely be 
in group C.  
However, some participants tried to avoid hypoglycaemic episodes only in specific 
situations (e.g. when driving, during an important task/meeting); that is, using it as a 
temporary coping strategy. Participants who adopted avoidance of hypoglycaemic 
episodes as a temporary coping strategy would likely be in group A or group B of the 
HEBC. They tended to be more concerned about experiencing long-term 
complications, and would therefore only try to avoid hypoglycaemic episodes as an 
exception. 
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It is important to note the difference as the former approach (i.e. avoidance as a 
permanent coping strategy) could potentially be more damaging to diabetes control. 
When avoidance of hypoglycaemic episodes is adopted as a permanent coping 
strategy, people aim for a higher blood glucose level on a permanent basis resulting in 
an increased risk of suffering from long-term complications (Watkins 2003; American 
Diabetes Association 2012). 
9.3.2   Advancement of theory 
Mechanic’s help-seeking theory (Mechanic 1966; Mechanic 1968; Mechanic 1995), 
which proposes that illness behaviour is based on perception, recognition and 
interpretation of symptoms, was useful to explain participants’ variations in response 
to symptoms of hypoglycaemia. The study findings have also highlighted that 
experience and appropriate interpretation of symptoms were key in identifying and 
treating hypoglycaemic episodes. However, Mechanic’s (1995) assumption that the 
patient takes a decision to seek help, and then actively seeks help underlines a 
limitation of help-seeking theory (Mechanic 1966; Mechanic 1968; Mechanic 1995) for 
chronic conditions such as diabetes. It does not clearly address the different roles 
which an individual can play in the help-seeking process; for example, taking action to 
seek help, delegating action to seek help or not seeking any help/not being able to 
seek help. 
This study has shown that in relation to participants’ experiences of hypoglycaemic 
episodes, help-seeking was not always an active process participants engaged in; in 
other words, participants were not always able to make a decision to seek help. For 
example, participants might not be able to seek help when they experienced a severe 
274 
 
hypoglycaemic episode (due to confusion or even unconsciousness). In such situations, 
they relied on others to recognise and either help them treat the hypoglycaemic 
episode or call emergency services. It can be argued therefore, that people may not 
always seek help when they need help. In such cases, help-seeking can be seen as a 
transferred responsibility. 
While Mechanic (1968) underlines that people's responses to illness situations can be 
influenced by their social environment, which is referred to as the ‘social construction 
of illness’ (Conrad and Barker 2010), he also states that little is known “about how 
people use their friends and acquaintances in attempting to cope with distress” 
(Mechanic 1968:135). According to Mechanic (1968), the main focus of help-seeking 
activity lies with the individual; however, Mechanic also acknowledges that ‘others’ 
can be involved in the interpretation of symptoms and advise that medical help should 
be sought. Though Mechanic addresses other people’s involvement in the decision-
making stage, he says less about whether others can seek help on the person’s behalf, 
for example, in situations when people are not able to seek help themselves 
(Mechanic 1968; Mechanic 1995). This study has demonstrated that other people can 
play a significant role in seeking or providing help in the context of treating 
hypoglycaemic episodes. 
Also, Mechanic (1995) assumes that people understand the signs and symptoms of 
their condition, emphasising the importance of recognition and interpretation of 
symptoms. This ability requires people to have adequate knowledge and awareness 
about their condition. However, findings have shown that participants did not always 
have sufficient knowledge to make sense of their symptoms (section 7.4.4), and that 
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confusion could be a symptom that may complicate an appropriate response, (section 
7.2.3). This indicates that people may need more support to engage in appropriate 
help-seeking activities, and to deal with hypoglycaemia unawareness. 
Zola (1973) describes that ‘sanctioning by others’ who advise on medical help being 
sought can be a trigger that may cause the individual to seek help. This could only be 
applied to this study to some extent. While study findings highlight that ‘others’ play 
an important role in the help-seeking process, they do not just advise on seeking help, 
but often take an active part in seeking help by either calling the emergency services 
or providing assistance in treating the hypoglycaemic episode. However, some 
participants tended to deny they were experiencing a hypoglycaemic episode and 
openly rejected advice by others, (section 8.2.7.2), which could lead to a delay in 
seeking help until the hypoglycaemic episode worsened or participants lost control, 
(section 7.2.2). This could make ‘sanctioning by others’ more challenging, as 
participants did not want others to recognise that they were having a hypoglycaemic 
episode. When others did recognise that the person was experiencing a hypoglycaemic 
episode, a loss of face or challenge of the person’s experiential knowledge may occur. 
Therefore, help-seeking theory may need to be expanded to accommodate illnesses 
such as diabetes; in particular, addressing that the individual may not always be the 
key player in the help-seeking process.  
Orem’s theory (1995) was useful to explain people’s ability to carry out self-care 
actions. When a person was not able to carry out self-care actions (i.e. had self-care 
deficits), the help of healthcare professionals would become necessary. Orem (1991) 
defined self-care as “the practice of activities that individuals initiate and perform on 
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their own behalf in maintaining life, health and well-being” (p.117). Therefore, Orem 
(1992) emphasises the ability of the individual to perform self-care and take 
responsibility for their health (Masters 2011). However, this study has illustrated that 
in the context of diabetes self-care, it may be useful to consider the role of the 
individual’s support network, as it can play a vital part in the management of diabetes 
and hypoglycaemic episodes, and was a link in the process leading to increased use of 
emergency services.  
The HEHS network (section 8.3) incorporates other agents who may provide help, for 
example, family members and the wider support network. Findings have also shown 
that while participants developed strategies to deal with hypoglycaemic episodes as 
they happened (section 8.2); they sometimes required help from their support 
network or the ambulance service. The agents who may provide help bring with them 
their own capacity to support the patient, as well as deficits when they are no longer 
able to offer help.   
Therefore, this study adds to Orem’s self-care theory in relation to the involvement of 
various agents in the management of hypoglycaemic episodes, particularly the role of 
the individual's support network and family members. Thus, Orem’s theory of self-care 
may need to be expanded to include the important role that ‘other agents’ may play in 
the management of chronic conditions such as diabetes. 
9.4 Strengths and limitations of this study 
This study attempted to investigate participants’ experiences, possible individual 
explanations and management of recurrent hypoglycaemic episodes over time. 
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A longitudinal design combining qualitative semi-structured interviews with blood 
glucose and hypoglycaemia diaries was employed to obtain a rich and in-depth 
understanding of participants’ experiences of recurrent hypoglycaemic episodes. The 
longitudinal approach allowed prospective data collection, giving an insight into ‘real’ 
hypoglycaemic episodes as they happened (Polit and Beck 2003). A longitudinal 
approach is considered particularly useful for a study using multiple methods as it can 
help to gain a more accurate picture of the phenomena under investigation (Mingione 
1999). As well as the longitudinal approach, multiple methods research is an important 
approach for combining qualitative and quantitative findings, and thus provides a 
fuller overall account, which may not have been achieved using one approach alone 
(Bryman 2007).  
A key strength of the longitudinal approach is that it facilitated the investigation of a 
variety of hypoglycaemic episodes. This enabled analysis within individual participants, 
which was very relevant to investigate the lack of association of blood glucose levels 
and symptoms of hypoglycaemia (see section 7.2.4). The longitudinal aspect of the 
study also helped to explore what happened in-between, in the run-up to, as well as 
following different hypoglycaemic episodes. The longitudinal approach allowed an 
insight into participants’ everyday life experiences of hypoglycaemia. For example, it 
helped to explore participants’ strategies to prepare for potential hypoglycaemic 
episodes (see section 8.2.2), as well as the impact of recovery (see section 8.2.6). 
The longitudinal approach was particularly useful to investigate differences between 
various hypoglycaemic episodes, and factors that influenced whether participants 
needed external help. Thus, it helped to develop the HEHS network (see section 8.3). 
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Qualitative semi-structured interviews provided a good understanding of participants’ 
experiences and explanations for recurrent hypoglycaemic episodes. The qualitative 
approach helped to explore people’s attitude towards hypoglycaemic episodes (e.g. 
whether they were fearful or not fearful) in relation to people’s experiences of 
hypoglycaemic episodes and their overall diabetes management. 
Limitations of study design 
A number of limitations were identified in relation to the blood glucose diary. Some of 
the lowest recorded blood glucose readings may not have been the lowest in the day, 
due to the fact that some participants did not check/record their blood glucose level 
during a hypoglycaemic episode. This means there is a potential for missing data 
around the hypoglycaemic episode.  
Another limitation of the blood glucose diary was the absence of time when the blood 
glucose reading was taken. This made it impossible to analyse the results from the 
blood glucose diary within their time sequence, to establish whether a reading was 
taken before or after a meal, and to investigate issues around a potential rise or fall in 
blood glucose level preceding or following a hypoglycaemic episode. While it was 
possible to compare results from the blood glucose diary with recording of 
hypoglycaemic episodes (as recorded in the hypoglycaemia diary), it was not possible 
to establish whether high blood glucose readings occurred before or after a 
hypoglycaemic episode. These limitations regarding the blood glucose diary meant 
that interpretation was limited. 
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The decision not to include the time the participants took a test of their blood glucose 
level in the blood glucose diary was taken following consideration of burden on 
participants, and whether this would have added any value to the study. It was 
thought that, on an aggregate level, knowing all the different times of day of blood 
glucose readings across participants would not have yielded much, given that 
participants also recorded blood glucose readings during and following each 
hypoglycaemic episode in the hypoglycaemia diary. However, the incompleteness of 
blood glucose readings in hypoglycaemia diaries might have been mitigated had the 
timing of daily blood glucose readings been available. Future studies of hypoglycaemia 
may benefit from the use of technologies that test and record blood glucose readings 
more accurately. 
In terms of the hypoglycaemia diary, recording of hypoglycaemic episodes was 
subjective. Participants made the decision as to what they regarded as a 
hypoglycaemic episode and whether to record it in the diary. This may have 
introduced bias and the potential for missing data. However, one strength of using 
both the blood glucose and hypoglycaemia diary was that it allowed a comparison of 
the days hypoglycaemic episodes were recorded with data from the blood glucose 
diary. It was therefore possible to investigate whether participants recorded a 
hypoglycaemic episode when their blood glucose level was below 4.0 mmol/l, which is 
the accepted threshold for hypoglycaemic episodes (JRCALC 2006; Diabetes UK 2008).  
Limitations of sample 
There were a number of limitations in relation to sampling (Groger et al. 1999). For 
example, the non-SAS participants might not be entirely representative of people who 
280 
 
do not use emergency services. There might also have been differences between those 
SAS patients who took part and those who refused to take part. Unfortunately, it was 
not possible to investigate differences between those SAS patients who took part and 
those who did not. The experiences of recurrent hypoglycaemic episodes of those SAS 
patients who did not take part in this study may have been different from the 
experiences of those SAS patients who agreed to take part in the study. 
One of the inclusion criteria was experience of at least one hypoglycaemic episode a 
month (based on self-report). However, during recruitment participants did not always 
know how many hypoglycaemic episodes they had experienced. This was because 
many participants did not keep a record of their hypoglycaemic episodes, and people’s 
understanding about what constituted a hypoglycaemic episode varied. For example, 
some participants differentiated between low blood glucose events (less severe) and 
hypoglycaemic episodes (more severe). During recruitment, many participants 
appeared to underestimate the number of hypoglycaemic episodes they experienced 
(compared to the results from the hypoglycaemia diary). This highlights the limitations 
of participant recall and advantage of prospective data collection. 
This study only included people who resided in the central belt of Scotland, who might 
have different views and experiences of hypoglycaemic episodes compared to people 
who live outwith the region, and in more rural settings where other issues may 
become more important. 
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Limitations of study method 
A major limitation in using a longitudinal approach was the issue of attrition; that is 
participants deciding to drop-out of the study at different time points (Polit and Beck 
2012). The main concern with attrition is that those who stay in the study may differ in 
important aspects from those who decide to leave the study (Bryman 2008), hence 
impacting on the representativeness of the sample and validity of study findings 
(Ruspini 2000; Polit and Beck 2012). It is therefore important to address this by 
identifying any differences between participants who leave the study and those who 
stay in the study. While it was not possible to establish the exact reasons why some 
participants decided to leave the study after the initial interview, it was noted that 
non-SAS participants who left the study were much younger than SAS participants who 
left the study, (section 6.4). Possible explanations for this were that non-SAS 
participants might have been too busy with work or family responsibilities, while SAS 
participants might have had additional health problems that could have made diary 
completion challenging. It is unlikely that the participants who left the study were 
different in important aspects from those participants who stayed in the study.  
Further consideration was given to the time lag between data collection points, as a 
longer time lag can contribute to attrition (Robson 2011). In this study, data collection 
was on-going during the six month follow-up phase, and I kept in regular contact with 
participants. In order to make study participation as straightforward and easy as 
possible, participants were provided with clear information about the study and given 
the opportunity to ask questions both before and during the study. Despite these 
attempts to minimise attrition rates, some attrition was inevitable due to the 
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longitudinal approach and the requirement for participants’ on-going involvement in 
the study (Ruspini 2000). In total, ten participants decided to leave the study after 
completing the semi-structured interview (5 non-SAS/5 SAS), and a further eight 
participants dropped out during the diary phase (3 non-SAS/5 SAS). 
It is important to acknowledge the impact the researcher might have on the research 
process: the personality, gender, behaviour and background of the researcher does 
not only influence the way rapport is created with participants, but also the responses 
given during the interviews and in the diary (Robson 2011). During the recruitment 
stage of the study, my gender and nationality (non-native English speaker) might have 
influenced people’s willingness to take part in the study. However, this may be a 
theoretical issue rather than an actual problem that was found in the study; it was not 
raised as an issue by any participant, though they may have been reluctant to raise 
such issues directly. 
The longitudinal nature of the study meant that I had repeated contact with 
participants during the course of the study. While this was vital for developing a good 
rapport with participants, it may have influenced the responses and motivation to 
participate in the study. Participants may have been steered towards giving answers 
they anticipate the interviewer wants to hear, rather than expressing their views and 
perceptions freely (Fielding and Thomas 2008). Additionally, participants may have 
given responses they perceive as socially desirable in order to present themselves in a 
favourable light. This includes providing responses that make their condition appear 
better or worse than it actually is (Adams et al. 1999). These limitations may have 
been a potential threat to objectivity and validity of the study. However, due to the 
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longitudinal design of this study, I spoke to participants several times, which gave me 
the opportunity to check whether there were any discrepancies.  
Using a self-completed diary increased the potential for missing data, as well as 
inaccuracies in reporting (Bryman 2008). For example, participants’ level of diligence in 
recording blood glucose readings may have varied. However, it allowed for prospective 
collection of data, minimising the impact of participant recall, and revealed how 
participants wanted to portray themselves in terms of self-image/self-care (Richardson 
1994), see Appendix 14 for some examples. The fact that the diaries were structured 
helped to limit the level of bias.  
Another factor that may have influenced participants’ responses is the way in which 
interviews and diaries were introduced. Participants required sufficient information 
about the study and what participation involved in order to make an informed decision 
about their willingness to participate. However, the information provided has to be 
carefully selected to minimise the level of bias in participants’ reporting. Another 
dimension of this is that participants may want to be perceived as ‘good patients’ and 
rational beings (Locker 1981; Jadad et al. 2003). I chose not to provide a pre-set 
definition of hypoglycaemia, and instead explored participants’ views as to what 
constitutes a hypoglycaemic episode, from their individual perspectives. 
The interviews and diaries may have revealed that some participants’ self-care 
activities or diabetes control were either problematic or inappropriate. I 
acknowledged the limitation of my role as a researcher, and only referred participants 
to seek medical advice and help when they expressed concern.  
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9.5 Conclusion and recommendations 
This thesis has made a unique and original contribution to knowledge with regard to 
people’s experiences and individual explanations of hypoglycaemic episodes. In 
particular, the study design made it possible to compare the experiences of people 
who had recently used emergency services with those who had not done so. 
A key contribution of this study to knowledge is the development of the 
hypoglycaemic episode balancing continuum (HEBC), which enables a deeper 
understanding of the factors involved when an individual balances the risks associated 
with their diabetes and hypoglycaemia. The HEBC helps to explain how people’s 
priority setting is placed in relation to their risks of hypoglycaemia and long-term 
complications, and how this can impact on their diabetes self-management (see 
section 7.3). 
9.5.1   Implications for clinical practice 
Study findings have shown that participants’ experiences of hypoglycaemic episodes 
varied; specifically that there was a lack of association of blood glucose levels and 
symptoms of hypoglycaemia. For example, participants could feel fine even though 
their blood glucose level was very low, or they could experience symptoms of 
hypoglycaemia when their blood glucose level was above the threshold for 
hypoglycaemia (section 2.7). It seems important that such variations are included in 
information given to patients. 
Findings from this study have implications for clinical practice. For example, looking at 
hypoglycaemia unawareness, this study has shown that current understanding may fail 
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to take account of participants’ real experiences, which show hypoglycaemia 
unawareness to be a fluid phenomenon that can affect people at various times. Blood 
glucose levels can also fail to predict onset of hypoglycaemic episodes. Clinical practice 
mainly focusses on blood glucose monitoring to detect and manage hypoglycaemic 
episodes (Watkins et al. 2003). This may not be helpful from participants’ perspectives. 
This study has shown that some participants placed more importance on how they felt 
(i.e. whether they had symptoms and how disruptive these symptoms were) rather 
than on a number that represented their blood glucose level (section 7.2.4). 
This study also found that people can be affected by hypoglycaemia unawareness at 
certain times, while they may not be affected at other times; that is, sometimes they 
did experience early warning signs, and at other times they did not (see sections 7.2.4 
and 7.2.4.1). This may be useful in terms of patient education, especially when (new) 
patients are given information about hypoglycaemia unawareness.  
Findings confirm the burden associated with managing diabetes to prevent or avoid 
hypoglycaemic episodes. However, they also highlight the unpredictability of 
hypoglycaemic episodes where ‘visual’ blood glucose levels are an unreliable predictor 
of symptoms. Current advice by healthcare professionals may need to take this into 
account.  
Study findings have highlighted that avoidance of hypoglycaemic episodes was a 
coping strategy that participants adopted on either a temporary or more permanent 
basis. This may contribute to a deterioration in glycaemic control (De Galan et al. 
2006), and thus could be an important issue to address in clinical practice. The HEBC 
has potential for use in clinical practice, as it could help health professionals explore 
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how patients feel about hypoglycaemic episodes and how they place their priorities in 
relation to risk of hypoglycaemia and risk of long-term complications. The HEBC could 
also help to identify those at greater risk of hypoglycaemic episodes and those at 
greater risk of long-term complications, and to target advice more specifically to these 
patient groups. Thus, study findings have underlined that clinical practice needs to 
take into consideration patients’ individual self-management strategies. 
This study found that due to a long duration of living with diabetes, some participants 
experienced less symptoms of hypoglycaemia (i.e. an increased risk of hypoglycaemia 
unawareness) and more severe hypoglycaemic episodes (see section 7.2.7). 
Healthcare professionals may need to consider this when providing advice and 
information to patients who have lived with diabetes for a long time. 
As highlighted in section 7.4.4, non-SAS participants appeared to be more 
knowledgeable about their diabetes and its management compared to SAS 
participants, resulting in a better awareness of hypoglycaemia unawareness (section 
7.4.3). In this regard, it may be beneficial to invite people contacting the SAS to take 
part in a structured education course/refresher class. The SIGN guideline for the 
management of diabetes also recommends that people experiencing difficulties with 
hypoglycaemia should be offered to take part in structured education programmes 
(SIGN 2010).  
To reduce the use of emergency services, more attention has to be paid to 
hypoglycaemia unawareness and better advice provided about the condition. For 
example, it could be recommended that patients take part in a structured education 
programme, such as hypoglycaemia anticipation, awareness and treatment training 
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(HAATT; Cox et al. 2004). Also, more education should be provided for family 
members/carers, given the crucial role they play in the management of diabetes and 
hypoglycaemic episodes, and being a link in the process leading to increased use of 
emergency services (Sutton and Chapman-Novakofski 2011).  
Another potential way to reduce the use of emergency services is the increased 
monitoring of blood glucose levels, which has been identified as a strategy to manage 
hypoglycaemia unawareness (Graveling and Frier 2010). The development and use of 
new technologies to measure blood glucose and provide early feedback might also be 
helpful. 
9.5.2   Implications for further research 
The study findings have highlighted that carers/family members play an important role 
in supporting the person with diabetes. This is particularly the case when the person is 
unable to identify and treat a hypoglycaemic episode (e.g. due to hypoglycaemia 
unawareness). This study only included carers/family members when this was 
requested by the participant (see section 5.5.3). Overall, five carers/family members 
took part in the face to face interviews. It would be beneficial to carry out further 
research that focusses more on the role of carers/family members in supporting 
people experiencing (recurrent) hypoglycaemic episodes. This would also need to 
explore carer knowledge in more detail to better understand their role in helping to 
manage hypoglycaemic episodes.  
This study found that there may be a link between people’s knowledge about their 
diabetes and its care, and their ability to manage hypoglycaemia unawareness. While 
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the qualitative approach this study adopted was useful to gain an in-depth account of 
participants’ experiences, a quantitative approach could measure people’s level of 
diabetes health literacy, and investigate how this relates to hypoglycaemia 
unawareness.  
Preparation for potential hypoglycaemic episodes happening (section 8.2.2) was a key 
difference between the two participant groups, and one of the factors that influenced 
whether external help would be needed. Further research could develop an 
intervention for people who are less prepared for potential hypoglycaemic episodes. 
Further research could develop the HEBC into a useful ‘screening tool’ for healthcare 
professionals to help identify where patients sit in terms of prioritising risks of 
hypoglycaemia and long-term complications to be able to tailor help to individuals. 
This could be in the form of a questionnaire. 
The HEBC has suggested that there may be a link between people’s fear of 
hypoglycaemia, fear of long-term complications and diabetes self-management. 
Further quantitative research could investigate any correlations between these 
factors. 
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Appendices 
Appendix 1: Participant Information 
Sheet (non-SAS) 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
This information sheet explains the purpose of the  
study and clearly outlines what participation will involve. 
 
Version 1.8, June 2011 
  
1. Study title 
‘Participants’ experiences of hypoglycaemia and diabetes’  
 
2. Invitation 
You are being invited to take part in a research study.  Before you decide, it is 
important for you to understand why the research is being done and what it will involve.  
Please take time to read the following information carefully and discuss it with others if 
you wish.  Please ask the researcher if there is anything that is not clear or if you would 
like more information.  Take time to decide whether or not you wish to take part.  
Thank you for reading this. 
 
3. What is the purpose of the study? 
The purpose of this research study is to find out about participants’ views and 
experiences of recurrent hypos. 
 
The research questions will be about:  
 What are participants’ individual explanations for having recurrent hypos?  
 What coping strategies do participants adopt to deal with recurrent hypos? 
 How (if at all) do recurrent hypos influence diabetes self-management? 
 What is the impact of hypos on your family and wider social network? 
 How do hypos affect the everyday life of people with diabetes? 
 Are there any changes over time? What influences these? Are there any 
differences between various hypos? 
 
The study is being carried out between July 2011 and July 2012.   
 
4. Why have I been chosen? 
We have given you this information sheet as you may fit our study criteria.  Study 
participants should be diagnosed with type 1 or type 2 diabetes and treated with 
insulin. You should experience at least one hypo in a month. We are looking for people 
who are over 16 years of age and living in the central belt of Scotland.   
 
If you decide to opt-in, please speak to the researcher who sent you this information 
sheet.  We wish to recruit 48 individuals in total and all those opting in who fit the 
criteria will be recruited on a ‘first come, first served’ basis.  You may be asked to go 
on a reserve list in case people who have already agreed to take part leave the study 
in future. 
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5. Do I have to take part? 
No, participation in this study is completely voluntary. It is up to you to decide whether 
or not to take part.  If you do decide to take part, the researcher will set up a time and 
place for you to meet for an interview.  At the time of interview you will be asked to sign 
two copies of a consent form and given one of the copies to keep. If you decide to take 
part you are still free to withdraw at any time, without giving a reason and without your 
medical care or legal rights being affected. 
 
6. What will happen to me if I take part? 
Participation in the study is in three parts:   
1. If you decide to take part, a suitable date, time and location for an interview will be 
agreed with the researcher. After giving your consent, you will be interviewed at the 
arranged time and place with the interview lasting for approximately one hour.  The 
interview will be based around a series of key questions relating to the study topic.  
Your interview will be audio recorded and notes will be taken from the recording.   
2. At the interview you will be shown how to use a ‘hypoglycaemia and blood glucose 
diary’ and asked to use this diary to record your hypos and blood glucose values 
for a period of six months.   
3. During the diary time, the researcher will stay in regular contact and arrange to 
interview you by telephone monthly. This interview will further explore your 
experiences during the time of keeping the diary. It will last around 10 minutes.  
 
All data collected will be analysed and the findings will be used to help to answer the 
research questions.   
 
7. What do I have to do? 
You have to decide whether you wish to take part in this study. If you do, simply fill in 
the ‘Participants’ Details’ Form enclosed and return to the researcher. We will then set 
up a suitable time, date and location to be interviewed.  
 
8. What are the possible risks and disadvantages of taking part? 
There are no medical risks involved in taking part in this study.   
 
9. What are the possible benefits of taking part? 
By taking part you are helping to provide information that will give the researchers a 
better understanding of the experiences of hypos of people living with diabetes.  A 
researcher will feed back the findings of the research to you following this study and 
offer you a summary of the findings.  A copy of the full report will be available upon 
request.   
 
10. Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  You will be identified by an ID number and any information 
about you will have your name and address removed so that you cannot be recognised 
from it.  Only the researchers will have access to the data collected in this study.  The 
research report will include a summary of the type of people (e.g. type 1 diabetes, 
male, 40-60 years old) interviewed and descriptors will be used carefully within the 
report in relation to participants, ensuring anonymity is maintained.   
 
11. What will happen to the results of the research study? 
This study is being undertaken by Theresa Ikegwuonu as part of her PhD. The results 
of the study will be published in her PhD thesis and other publications. Participants will 
not be identified.  A summary of the findings will be offered to you following completion 
of this study.    
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12. Who is organising and funding the study? 
The study is being organised by the researcher as part of her PhD based at the 
Nursing, Midwifery and Allied Health Professions’ Research Unit (NMAHP RU) at the 
University of Stirling, funded by the University of Stirling, NMAHP Research Unit and 
the Scottish Ambulance Service. 
 
13. Who has reviewed the study? 
The study has been approved by the University of Stirling’s Department of Nursing and 
Midwifery Ethics Committee. 
 
14. Contact for further information 
Theresa Ikegwuonu 
NMAHP Research Unit 
Iris Murdoch Building 
University of Stirling 
Stirling, FK9 4LA 
Tel: 01786 466 341 
Email: ti1@stir.ac.uk  
 
This study is supervised by:  
Dr Edward Duncan 
NMAHP Research Unit 
University of Stirling 
Tel: 01786 466 286 
Email: Edward.duncan@stir.ac.uk 
 
15. What if something goes wrong? 
If you would like to speak to someone who knows about this study who is an 
independent advisor, please contact: 
 
Professor William Lauder             
Head of School of Nursing, Midwifery and Health 
University of Stirling 
Tel: 01786 466 345 
Email: William.lauder@stir.ac.uk 
 
If you have any concerns about your diabetes or your health and emotional well-being, 
please contact your GP in the first instance. You may also contact: 
Diabetes UK (Scotland) Helpline 0845 120 2960 or www.diabetes.org.uk 
Breathing Space 0800 83 85 87 or www.breathingspacescotland.co.uk 
 
 
 
Study participants will be given a copy of this information sheet and a signed 
consent form to keep. 
 
 
THANK YOU IN ADVANCE FOR TAKING PART IN THIS STUDY. 
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Appendix 2: Participant Information 
Sheet (SAS) 
 
                     
This information sheet explains the purpose of the study and 
clearly outlines what participation will involve. 
 
Version 1.8, 6th July 2011 
  
1. Study title 
‘Participants’ experiences of hypoglycaemia and diabetes’  
 
2. Invitation 
My name is Theresa Ikegwuonu and I am undertaking a PhD at the University of 
Stirling. I am required to undertake a project as part of my course and invite you to take 
part in the following study. However, before you decide to do so, I need to be sure that 
you understand firstly why I am doing it, and secondly what it would involve if you 
agreed. I am therefore providing you with the following information. Please read it 
carefully and be sure to ask any questions you might have and, if you want, discuss it 
with others including your friends and family. I will do my best to explain the project to 
you and provide you with any further information you may ask for now or later. 
 
3. What is the purpose of the study? 
The purpose of this research study is to find out about participants’ views and 
experiences of recurrent hypos. 
 
The research questions will be about:  
 What are participants’ individual explanations for having recurrent hypos?  
 What coping strategies do participants adopt to deal with recurrent hypos? 
 How (if at all) do recurrent hypos influence diabetes self-management? 
 What is the impact of hypos on your family and wider social network? 
 How do hypos affect the everyday life of people with diabetes? 
 Are there any changes over time? What influences these? Are there any 
differences between various hypos? 
 
The study is being carried out between July 2011 and July 2012.   
 
4. Why have I been chosen? 
You are being invited to take part in this research study as you have recently 
experienced a hypoglycaemic emergency involving the Scottish Ambulance Service 
and may fit our study criteria.  Study participants should be diagnosed with type 1 or 
type 2 diabetes and treated with insulin. You should experience at least one hypo in a 
month. We are looking for people who are over 18 years of age and living in the central 
belt of Scotland.  
 
You have been sent this information sheet as agreed during a telephone call with the 
researcher. If you decide to opt-in, either speak to the researcher (Theresa Ikegwuonu, 
see contact details below), or complete and return the enclosed card in the pre-paid 
envelope provided.  We wish to recruit 24 individuals in total and all those opting in 
who fit the criteria will be recruited on a ‘first come, first served’ basis.  You may be 
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asked to go on a reserve list in case people who have already agreed to take part 
leave the study in future. 
 
5. Do I have to take part? 
No, participation in this study is completely voluntary. It is up to you to decide whether 
or not to take part.  If you do decide to take part, the researcher will set up a time and 
place for you to meet for an interview.  At the time of interview you will be asked to sign 
two copies of a consent form and given one of the copies to keep. If you decide to take 
part you are still free to withdraw at any time, without giving a reason and without your 
medical care or legal rights being affected.    
                                                                                                                    
You are able to have someone else present with you during the interview (e.g. partner, 
family member, carer), if you wish. 
 
6. What will happen to me if I take part? 
Participation in the study is in three parts:   
1. If you decide to take part, a suitable date, time and location for an interview will be 
agreed with the researcher. After giving your consent, you will be interviewed at the 
arranged time and place with the interview lasting for approximately one hour.  The 
interview will be based around a series of key questions relating to the study topic.  
Your interview will be audio recorded and notes will be taken from the recording.   
2. At the interview you will be shown how to use a ‘hypoglycaemia and blood glucose 
diary’ and asked to use this diary to record your hypos and blood glucose values 
for a period of six months.   
3. During the diary time, the researcher will stay in regular contact and arrange to 
interview you by telephone monthly. This interview will further explore your 
experiences during the time of keeping the diary. It will last around 10 minutes. 
 
All data collected will be analysed and the findings will be used to help to answer the 
research questions.   
 
7. What do I have to do? 
You have to decide whether you wish to take part in this study. If you do, simply return 
the enclosed card or contact the researcher (Theresa Ikegwuonu, see contact details 
below). We will then set up a suitable time, date and location to be interviewed.  
 
8. What are the possible risks and disadvantages of taking part? 
There are no medical risks involved in taking part in this study.   
 
9. What are the possible benefits of taking part? 
By taking part you are helping to provide information that will give the researchers a 
better understanding of the experiences of hypos of people living with diabetes.  A 
researcher will feed back the findings of the research to you following this study and 
offer you a summary of the findings.  A copy of the full report will be available upon 
request.   
 
10.  Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  The only occasion on which this may be breached is when 
the researcher has concerns for your safety or the safety of others. In the unlikely 
situation that this would arise, we would first inform you that we would for ethical and 
moral reasons be required to contact an appropriate authority. 
 
You will be allocated a study number and any information about you will have your 
name and address removed so that you cannot be identified from it.  Only the 
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researchers will have access to the data collected in this study.  The research report 
will include a summary of the type of people (e.g. type 1 diabetes, male, 40-60 years 
old) interviewed and descriptors will be used carefully within the report in relation to 
participants, ensuring anonymity is maintained. Digital recordings of the interviews will 
be securely stored and erased on completion of the study. Anonymised paper 
transcripts will be held securely for a period of 10 years, in accordance with good 
research practice guidelines. If you wish, you may request a copy of any of your 
transcripts held. 
 
With your permission, we will inform your GP of your participation in the study. 
 
11. What will happen to the results of the research study? 
This study is being undertaken by Theresa Ikegwuonu as part of her PhD. The results 
of the study will be published in her PhD thesis and other publications. Direct quotes 
may be used; however, participants will not be identified.  A summary of the findings 
will be offered to you following completion of this study.    
 
12. Who is organising and funding the study? 
The study is being organised by the researcher as part of her PhD based at the 
Nursing, Midwifery and Allied Health Professions’ Research Unit (NMAHP RU) at the 
University of Stirling, funded by the University of Stirling, NMAHP Research Unit and 
the Scottish Ambulance Service. 
 
13. Who has reviewed the study? 
The study has been reviewed by a NHS Research Ethics Committee, which has 
responsibility for scrutinising proposals for medical research on humans. In this case, 
the reviewing Committee was the Fife & Forth Valley Research Ethics Committee who 
have raised no objections from the point of view of medical ethics. 
 
14. Contact for further information 
Theresa Ikegwuonu 
NMAHP Research Unit 
Iris Murdoch Building 
University of Stirling 
Stirling, FK9 4LA 
Tel: 01786 466 341 
Email: ti1@stir.ac.uk  
 
This study is supervised by:  
Dr Edward Duncan 
NMAHP Research Unit 
University of Stirling 
Tel: 01786 466 286 
Email: Edward.duncan@stir.ac.uk 
 
15. What if something goes wrong? 
If you would like to speak to someone who knows about this study who is an 
independent advisor, please contact: 
Professor William Lauder             
Head of School of Nursing, Midwifery and Health 
University of Stirling 
Tel: 01786 466 345 
Email: William.lauder@stir.ac.uk 
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If you have any concerns about your diabetes or your health and emotional well-being, 
please contact your GP in the first instance. You may also contact: 
Diabetes UK (Scotland) Helpline 0845 120 2960 or www.diabetes.org.uk 
Breathing Space 0800 83 85 87 or www.breathingspacescotland.co.uk 
 
Study participants will be given a copy of this information sheet                                       
and a signed consent form to keep. 
 
THANK YOU FOR TAKING THE TIME TO READ THIS INFORMATION SHEET             
AND FOR CONSIDERING TAKING PART. 
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Appendix 3: Participant Information 
Sheet (Carers and family members) 
This information sheet explains the purpose of the study and 
clearly outlines what participation will involve. 
 
Version 1.0, 6th July 2011 
  
1. Study title 
‘Participants’ experiences of hypoglycaemia and diabetes’  
 
2. Invitation 
My name is Theresa Ikegwuonu and I am undertaking a PhD at the University of 
Stirling. I am required to undertake a project as part of my course and invite you to take 
part in the following study. However, before you decide to do so, I need to be sure that 
you understand firstly why I am doing it, and secondly what it would involve if you 
agreed. I am therefore providing you with the following information. Please read it 
carefully and be sure to ask any questions you might have and, if you want, discuss it 
with others including your friends and family. I will do my best to explain the project to 
you and provide you with any further information you may ask for now or later. 
 
3. What is the purpose of the study? 
The purpose of this research study is to find out about participants’ views and 
experiences of recurrent hypos. 
 
The research questions will be about:  
 What are participants’ individual explanations for having recurrent hypos?  
 What coping strategies do participants adopt to deal with recurrent hypos? 
 How (if at all) do recurrent hypos influence diabetes self-management? 
 What is the impact of hypos on your family and wider social network? 
 How do hypos affect the everyday life of people with diabetes? 
 Are there any changes over time? What influences these? Are there any 
differences between various hypos? 
 
The study is being carried out between July 2011 and July 2012.   
 
4. Why have I been chosen? 
You are being invited to take part in this research study as your partner/family member 
or the person you care for has requested that you be present when we speak to them 
about their hypoglycaemic episodes. They have been asked to take part because they 
have recently experienced a hypoglycaemic emergency involving the Scottish 
Ambulance Service and may fit our study criteria.   
 
5. Do I have to take part? 
No, participation in this study is completely voluntary. The decision to participate in the 
study will initially lie with your family member/the person you care for with diabetes. We 
will arrange any interviews with them and they should inform you of these dates and 
times if they still want you to be present. If you decide to take part you are still free to 
withdraw at any time, without giving a reason and without your legal rights being 
affected.                           
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6. What will happen to me if I take part? 
You and the person you care for will be interviewed together for approximately one 
hour. You will be asked to sign two copies of a consent form prior to the interview, and 
you will be given one of the copies to keep. The interview will be based around a series 
of key questions relating to the study topic.  Your interview will be audio recorded and 
notes will be taken from the recording.   
 
All data collected will be analysed and the findings will be used to help answer the 
research questions.  
  
7. What are the possible risks and disadvantages of taking part? 
There are no medical risks involved in taking part in this study.   
 
8. What are the possible benefits of taking part? 
By taking part you are helping to provide information that will give the researchers a 
better understanding of the experiences of hypos of people living with diabetes.  A 
researcher will feed back the findings of the research to you following this study and 
offer you a summary of the findings.  A copy of the full report will be available upon 
request.   
 
9. Will my taking part in the study be kept confidential? 
All information which is collected about you during the course of the research will be 
kept strictly confidential.  The only occasion on which this may be breached is when 
the researcher has concerns for your safety or the safety of others. In the unlikely 
situation that this would arise, we would first inform you that we would for ethical and 
moral reasons be required to contact an appropriate authority. 
 
You will be allocated a study number and any information about you will have your 
name and address removed so that you cannot be identified from it.  Only the 
researchers will have access to the data collected in this study.  The research report 
will include a summary of the type of people (e.g. type 1 diabetes, male, 40-60 years 
old) interviewed and descriptors will be used carefully within the report in relation to 
participants, ensuring anonymity is maintained. Digital recordings of the interviews will 
be securely stored and erased on completion of the study. Anonymised paper 
transcripts will be held securely for a period of 10 years, in accordance with good 
research practice guidelines. If you wish, you may request a copy of any of your 
transcripts held. 
 
10. What will happen to the results of the research study? 
This study is being undertaken by Theresa Ikegwuonu as part of her PhD. The results 
of the study will be published in her PhD thesis and other publications. Direct quotes 
may be used; however, participants will not be identified.  A summary of the findings 
will be offered to you following completion of this study.    
 
11. Who is organising and funding the study? 
The study is being organised by the researcher as part of her PhD based at the 
Nursing, Midwifery and Allied Health Professions’ Research Unit (NMAHP RU) at the 
University of Stirling, funded by the University of Stirling, NMAHP Research Unit and 
the Scottish Ambulance Service. 
 
12. Who has reviewed the study? 
The study has been reviewed by a NHS Research Ethics Committee, which has 
responsibility for scrutinising proposals for medical research on humans. In this case, 
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the reviewing Committee was the Fife & Forth Valley Research Ethics Committee who 
have raised no objections from the point of view of medical ethics. 
 
13. Contact for further information 
Theresa Ikegwuonu 
NMAHP Research Unit 
Iris Murdoch Building 
University of Stirling 
Stirling, FK9 4LA 
Tel: 01786 466 341 
Email: ti1@stir.ac.uk  
 
This study is supervised by:  
Dr Edward Duncan 
NMAHP Research Unit 
University of Stirling 
Tel: 01786 466 286 
Email: Edward.duncan@stir.ac.uk 
 
14. What if something goes wrong? 
If you would like to speak to someone who knows about this study who is an 
independent advisor, please contact: 
Professor William Lauder             
Head of School of Nursing, Midwifery and Health  
University of Stirling 
Tel: 01786 466 345 
Email: William.lauder@stir.ac.uk 
 
If you have any concerns about your diabetes or your health and emotional well-being, 
please contact your GP in the first instance. You may also contact: 
Diabetes UK (Scotland) Helpline 0845 120 2960 or www.diabetes.org.uk 
Breathing Space 0800 83 85 87 or www.breathingspacescotland.co.uk 
 
Study participants will be given a copy of this information sheet                                       
and a signed consent form to keep. 
 
THANK YOU FOR TAKING THE TIME TO READ THIS INFORMATION SHEET             
AND FOR CONSIDERING TAKING PART. 
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Appendix 4: Consent Form                   
(Non-SAS participants) 
 
Participants’ experiences of  
Hypoglycaemia and diabetes 
 
 
Name of Researcher:   
Theresa Ikegwuonu 
Tel. 01786 466 341 
Email: ti1@stir.ac.uk 
 
    Please initial box 
 
1.  I confirm that I have read and understand the information sheet version 1.8  
dated June 2011 for the above study and have had the opportunity to ask           
questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw  
at any time, without giving any reason, without my medical care or legal rights  
being affected.  
 
3. I understand that this form will be kept separately from any other information  
that I provide and will be stored in a locked drawer for the researcher’s use  
only and will not be shared with anyone else. 
 
4. I agree to take part in the above study.  
 
5. I agree that an audio record of my participation can be made. 
 
6. I give permission for the information I provide to be used for research purposes 
(including reports, publications and presentations) with strict preservation  
of anonymity. I understand that direct quotes from my interviews may be used, 
but I will not be identified through them. 
 
7. I understand that any information I provide will be treated in the strictest  
confidence. The information will be held securely for ten years and will only  
be available to the researcher. The information will be destroyed after this time.
      
 
           
Name of Participant             Date       Signature 
 
 
   
Name of Person taking consent            Date       Signature 
 
 
When completed, 1 copy for participant; 1 copy for researcher 
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Appendix 5: Consent Form                    
(SAS participants) 
 
Participants’ experiences of  
Hypoglycaemia and diabetes 
 
 
Name of Researcher:   
Theresa Ikegwuonu 
Tel. 01786 466 341 
Email: ti1@stir.ac.uk 
    
Please initial box 
 
1.  I confirm that I have read and understand the information sheet version 1.8  
dated 6th July 2011 for the above study and have had the opportunity to  
ask questions. 
 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care 
or legal rights being affected.  
 
 
3. I agree to my GP and diabetes health worker being informed of my  
participation in this study. 
 
My GP’s contact details are:________________________________________ 
 
_______________________________________________________________ 
 
 
4. I understand that this form will be kept separately from any other 
information that I provide and will be stored in a locked drawer for the 
researcher’s use only and will not be shared with anyone else. 
 
 
5. I agree that an audio record of my participation can be made. I understand  
that the recording will be securely stored and erased on completion of the  
study. Transcriptions will be anonymised with personal and place names  
removed.  
 
6. I give permission for the information I provide to be used for research purposes 
(including reports, publications and presentations) with strict preservation of  
anonymity. I understand that direct quotes from my interviews may be used, 
but I will not be identified through them. 
 
7. I understand that any information I provide will be treated in the strictest 
confidence. The information (interview transcripts and diaries) will be held  
securely for ten years and will only be available to the research team.  
The information will be destroyed after this time.  
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8. I agree to take part in the above study.      
 
 
 
           
Name of Participant             Date       Signature 
 
 
   
Name of Person taking consent            Date       Signature 
  
 
When completed, 1 copy for participant; 1 copy for researcher 
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Appendix 6: Consent Form                    
(SAS carers/family members) 
 
Participants’ experiences of  
Hypoglycaemia and diabetes 
 
 
Name of Researcher:   
Theresa Ikegwuonu 
Tel. 01786 466 341 
Email: ti1@stir.ac.uk 
   
Please initial box 
 
 
 I confirm that I am attending an interview for the above study at the request of                     
___________________________ (insert participant’s name).  
 
 
 
1.  I confirm that I have read and understand the information sheet version 1.0  
dated 6th July 2011 for the above study and have had the opportunity to  
ask questions. 
 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without legal rights  
being affected.  
 
 
3. I understand that this form will be kept separately from any other 
information that I provide and will be stored in a locked drawer for the 
researcher’s use only and will not be shared with anyone else. 
 
 
4. I agree that an audio record of my participation can be made. I understand  
that the recording will be securely stored and erased on completion of the  
study. Transcriptions will be anonymised with personal and place names  
removed.  
 
 
5. I give permission for the information I provide to be used for research purposes 
(including reports, publications and presentations) with strict preservation of  
anonymity. I understand that direct quotes from my interviews may be used, 
but I will not be identified through them. 
 
 
6. I understand that any information I provide will be treated in the strictest 
confidence. The information (interview transcripts and diaries) will be held  
securely for ten years and will only be available to the research team.  
The information will be destroyed after this time.  
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7. I agree to take part in the above study.      
 
 
 
           
Name of Participant             Date       Signature 
 
 
   
Name of Person taking consent            Date       Signature 
  
 
When completed, 1 copy for participant (carer/family member); 1 copy for researcher 
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Appendix 7: Telephone Protocol (SAS recruitment) 
 
Part 1: to get the target individual on phone 
 
Researcher: Hello, can I speak to X please? 
C: May I ask who is calling? 
Researcher: My name is Theresa Ikegwuonu, and I’m calling from the University of Stirling 
regarding a study of diabetes. 
C: Why do you want to speak to X? 
Researcher: I believe X is in a position to help with our study. I just want to ask X’s permission 
to send out study information, but I can’t do this without getting his/her permission first. 
C: How did you get his/her phone number? 
Researcher: X has been identified through a previous contact with health services as someone 
who could help with our study. 
 
If X is not available: 
Researcher: Can I call back later or leave my contact details for X to contact me? 
 
If we don’t hear anything back within 2-3 days, we would call back. 
No more than 2 attempts to contact someone will be made. 
 
Part 2: Speaking to the target individual 
 
Researcher: Can I please just check I’m speaking to the right person? (verify name, age/DOB) 
My name is Theresa Ikegwuonu, and I’m calling from the University of Stirling. I am currently 
working on a project with the Scottish Ambulance Service, and I’m very interested in diabetes 
and hypoglycaemia. I would like to find out about people’s experiences of hypos, and to see if 
anything can be done to help people cope with hypoglycaemia over time.  
 
The reason I’m contacting you is because I understand you have recently contacted the 
ambulance service due to a hypoglycaemic emergency. 
At this stage, I just want to ask if you are willing to receive further information about the 
study, and if I can send you an information pack? 
If you read the information and want to take part, all you need to do is to return the enclosed 
postcard, or to send me an email or give me a call. 
 
Would you be willing to receive this information? 
If yes  Where should I send the information pack to? (confirm address) 
If no  Thanks very much for your time. Sorry to have bothered you about this. 
 
If the person asks for further information, the researcher will briefly explain what participation 
in the study will involve (e.g. taking part in a one to one interview, keeping a hypoglycaemia 
and blood glucose diary and taking part in brief follow-up telephone interviews). It will be 
made clear that the reason for the telephone call is just to check whether the person is willing 
to receive further information about the study.  
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Appendix 8: Letter for SAS Participants 
 
Date 
 
 
 
Dear Participant, 
 
 
 
Re:  Study about people’s experiences of hypos and diabetes 
 
 
 
Following our recent chat over the phone, I am pleased to enclose some further 
information about the study “Experiences of Hypoglycaemia and Diabetes” 
(Participant Information Sheet and consent forms). 
  
Please note that you do not need to sign the consent forms at this stage, we would 
have time to do that before the interview. 
 
If you are interested to participate, could you fill in the form (‘Participants’ details’) 
and return it to me by fax or post (in the pre-paid envelope provided)? 
 
If you’ve got any questions about the study, please do not hesitate to contact me 
(email/phone/post). 
  
Looking forward to hearing from you! 
  
Best regards, 
Theresa 
  
Theresa Ikegwuonu 
PhD Research Student 
NMAHP Research Unit 
Iris Murdoch Building 
University of Stirling 
STIRLING,FK9 4LA 
email: ti1@stir.ac.uk 
Phone: 01786 466 341 
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Appendix 9: Participant’s Details Form 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
           Research Study 
“Participants’ Experiences of 
Hypoglycaemia and Diabetes” 
 
 
Participant’s details 
 
 
Name: ________________________________________________________________ 
 
Address:_______________________________________________________________ 
 
Age/DOB:______________________________________________________________ 
 
Phone Number:_________________________________________________________ 
 
Email:_________________________________________________________________ 
 
 
Additional information 
 
Type of diabetes: _______________________________________________________ 
 
Diagnosed since: ________________________________________________________ 
 
Treatment: ____________________________________________________________ 
 
How often do you have hypos?  ___________________________________________ 
 
Did you ever call the emergency services/ambulance as a result of a hypo? If yes, when 
was the last time you contacted them? ______________________________________
  
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
 
Please return this form to Theresa Ikegwuonu by email (ti1@stir.ac.uk) or post: NMAHP 
Research Unit, Iris Murdoch Building, University of Stirling, Stirling, FK9 4LA
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Appendix 10: Hypoglycaemia Study Project Flyer 
 
An investigation of people’s experiences of 
hypoglycaemia and diabetes. 
 
 
Volunteers wanted… 
 
Would you be willing to take part in the above 
research study? 
 
 
We are very interested in finding out about people’s views and 
experiences of having hypos, and the impact hypos have on 
everyday life.  Participation will include a one-to-one interview, 
keeping a blood glucose diary and taking part in brief follow-up 
telephone interviews. Interested?  
We would like to involve people who: 
 
 Are over 18 years of age 
 Are treated with insulin 
 Normally have at least 1 hypo every month 
 Have not used the emergency services (due to their 
hypoglycaemia) in the last 3 months  
 
For more information, please contact: 
Theresa Ikegwuonu 
Tel. 01786 466 341 or email: ti1@stir.ac.uk  
NMAHP Research Unit, University of Stirling, FK9 4LA  
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Appendix 11: Letter to participant’s GP 
Date 
 
 
Dear Dr …, 
 
 
Ref:  Study Investigating Patients’ Experiences of Hypoglycaemia and Diabetes 
 
 
 
Re: (Patient’s name, DOB, address) 
 
We are undertaking a research study which aims to investigate patients’ experiences 
of/and possible explanations for recurrent hypoglycaemia over time. The study is 
being funded by the Scottish Ambulance Service and the University of Stirling, and is 
being undertaken as part of a PhD at the University of Stirling.  The study has been 
given Research Ethics Approval by the Fife & Forth Valley Research Ethics Committee 
(11/AL/0330).  
 
As part of this study we contact patients with diabetes who have recently required 
ambulance service assistance for a hypoglycaemic emergency.  Patients are invited to 
take part in face to face interviews, keep a hypoglycaemia and blood glucose diary for 
a period of six months, and take part in brief follow-up telephone interviews.  
  
As the above patient’s General Practitioner we are informing you they have agreed to 
take part in this study.  Consent was given by the patient prior to sending you this 
letter.  
 
If you have any further questions, please do not hesitate to contact me, or my 
supervisor Dr. Edward Duncan (Tel. 01786 46 6286). 
 
 
 
Kind regards 
 
 
 
Theresa Ikegwuonu (PhD Research Student) 
Tel. 01786 46 6341 
Email. Theresa.ikegwuonu@stir.ac.uk  
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Appendix 12: Interview Topic Guide 
 
Tell me about living with diabetes. What is it like?  
How long have you been diagnosed? 
 
Tell me about your experiences with hypos (hypoglycaemia). 
Do you remember your worst hypo? Could you tell me about it? 
(Do you know...) What level do you go hypo at? 
 
Do you ever experience hypos in the night/during sleep? 
What did you do the day before? 
 
How do you know when you are about to have a hypo?  
( Hypoglycaemia unawareness) 
What happens after you’ve had a hypo? 
How does your body feel? 
 
 
Do hypos affect your daily activities? 
Driving...? 
 
Do you have any particular strategies to deal with hypos? 
 
 
How (if at all) do hypos influence your family and  
friends? 
Do you talk about hypos with your family and friends? 
How do you educate them? (support network) 
 
Do hypos influence your social life? Going out? 
 
What about work? Do hypos influence your work life? 
 
 
For many people with diabetes, hypos are not  
just a one-off event, but can happen quite regularly. 
In your opinion, what are the reasons for repeat hypos?  
Are there any differences between hypos? 
 
 
If you think about the last 5 years (or the time since  
you had diabetes), do you think that anything  
(relating to diabetes/hypos) has changed at all? 
 
Do you think that anything might change in the future? 
 
RQ1&RQ3: hypo 
experience + 
change over time 
RQ1a: impact on everyday life 
RQ2a: Coping strategies 
RQ1b: impact on 
social network 
RQ1&RQ2: 
experience& individual 
explanations of 
recurrent hypos 
RQ3: change 
over time 
General hypo experience 
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Do you think hypos influence your diabetes management? 
 
 
------------------------------------------------------------------- 
Is there anything else you wish to tell me?  
 
Thank you very much for sharing your thoughts  
and for your openness. 
 
(END OF INTERVIEW) 
 
RQ= research question 
 
 
 
 
 
 
 
 
 
 
 
 
 
RQ2b: diabetes 
self-management 
Conclusion 
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Appendix 13: Example Page from the Hypoglycaemia Diary 
Hypo Diary 
   Name: NS2_F01 
Date & time of 
hypo 
Where were you? How long did hypo 
last? 
BG value (if recorded) 
(during hypo) (after hypo) 
24/08/2011 
3.10pm 
Kitchen 40 mins 3.6 11.3 
Who was around? 
 
Alone 
What were you doing? 
 
Housework 
Number of days since last 
hypo? 
<1 
 
What do you think might have caused this hypo? 
 
Activity?   Low BG at lunchtime not adequately covered. 
What symptoms did you have?  
 
Shaky, poor concentration, confusion 
Aware something was wrong, but struggled to 
remember what to do. 
 
From your perspective, how bad was the hypo? 
(on a scale of 1-10, with 10 being very bad) 
 
4 
Did you treat yourself? Did you need someone’s assistance (if so, please give relationship (e.g. 
wife/husband, friend, sister)? Was the ambulance service called? 
 
Sorted it myself 
 
Treatment of hypo? (e.g. glucose tablets, sweets, glucagon injection) 
 
Lucozade, then biscuit 
Any other comments? 
 
Didn’t feel any early warnings, and was busy, so wasn’t watching for them. 
 
Please be as open as you can, remember all entries are strictly confidential. 
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Appendix 14: Example Pages from the Blood Glucose Diary 
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Appendix 15: Telephone Interview Topic Guide 
 
----------------------------------------------------------------------------- 
 
How did you get on with your diary?  
Was this period quite normal for you in terms of hypos? Any more, less? 
 
The following questions were used to discuss an example of a hypoglycaemic episode 
that occurred during the diary time: 
 
What led up to the hypoglycaemic event? 
What could have been done differently? (before/during/after event) 
 
What happened during the hypoglycaemic event? 
How severe was it? How bad (on the scale of 1-10) would it have to be before you 
would seek external help? 
 
How did you cope? 
 
Did you change anything after this hypoglycaemic episode? 
 
Is there anything else you wish to tell me (relating to your experience of 
hypoglycaemia)?  
 
Anything you noticed by keeping the diary? Any new insights? 
 
Do you have any questions? 
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Appendix 16: Mind map of initial themes 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
  
Variation of BG  
symptoms 
By self By others 
Explanations 
Hypo unaware 
Too much 
insulin 
Activity/sport/stress 
Weather 
Alcohol 
None/’out of the 
blue’/can’t work out 
Lack of knowledge/ understanding 
Hypo 
Experiences 
Control 
Impact everyday life 
Confusion 
Inconvenience/interruption 
Blame/guilt 
Struggle  
(“not again”) 
Monitor BG 
Chronic condition ‘you 
never get a day off’ 
Recovery time 
Always being 
prepared 
Balance/negotiate: get good 
HbA1c while avoiding hypos 
Other people - worry 
CoT Hypos 
 Severity 
Frequency Symptoms 
Trust BG reading 
Trust feeling/ 
physical symptoms 
Evidence/knowledge 
doesn’t match experience 
 
Self-care 
Positive/pro-active 
Negative 
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Treatment (of hypo) 
Food “Everything 
tastes so good when 
I’m hypo.” 
Glucose 
tablet/drink 
Glucagon injection 
Over-compensation 
Coping 
Acceptance/positive 
attitude, “It’s part of living 
with diabetes” 
Avoidance 
Learning to balance 
Humour Denying/playing down 
level of threat to health 
and well-being 
Change over 
time (CoT) Change over 
time (CoT)  
 
Other people with 
diabetes 
Support Network 
Friends/Neighbours 
Family 
339 
 
Appendix 17: Thematic Coding Framework 
COPING (COP)      HYPO EXPERIENCES (HE) 
 COP – Avoid hypo    HE- Acceptance  
COP – CoT     HE- blame n guilt 
COP – Denial      Blame by others 
COP – humour      Blame guilt self 
COP – positive attitude    HE- Confusion  
COP – learning to balance    HE- Control   
       HE- CoT 
EXPLANATIONS (EXPL)       CoT- frequency 
 Expl- Activity       CoT- severity 
Expl- Alcohol      CoT- symptoms 
Expl- Hypo unaware    HE- Fear  
Expl- injection sites    HE- hypos cluster 
Expl- natural drop in BG    HE- night 
Expl- None     HE- struggle 
No- Evidence no match experience  HE- Symptoms 
No- lack understanding   HE-  Variation of BG- sympt exp 
Expl- too much insulin     Variat- feelings 
Expl- Weather or temperature     Variat- trust BG 
         
HYPO TREATMENT (HT)     SUPPORT NETWORK 
 HT- CoT         
 HT- Food 
 HT- Glucagon Inject     
 HT- Glucose 
 HT- Over-Compensation 
         
IMPACT EVERYDAY LIFE (IEL)  
 IEL- always prepared 
 IEL- avoid social situations 
 IEL- balance 
 IEL- change job-career 
 IEL- inconvenience 
 IEL- monitor BG 
 IEL- never off  
 IEL- other people worry 
 IEL- recovery time 
 IEL- self-care 
  Self-care- pos 
  Self-care- neg  
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Appendix 18: Revised Thematic Coding Framework 
 
COPING (COP)      HYPO EXPERIENCES (HE) 
 COP - Avoid hypo     HE- Acceptance  
COP – CoT     HE- blame n guilt 
COP – Denial      Blame by others 
COP – humour      Blame guilt self 
COP - positive attitude    HE- Confusion  
COP- learning to balance    HE- Control   
      HE- CoT 
EXPLANATIONS (EXPL)       CoT- frequency 
 Expl- Activity       CoT- severity 
Expl- Alcohol      CoT- symptoms 
Expl- Hypo unaware    HE- Depression (new code)  
Expl- injection sites    HE- External Help (new code) 
Expl- natural drop in BG    HE- Fear 
Expl- None     HE- hypos cluster 
No- Evidence no match experience  HE- injury (new code) 
No- lack understanding   HE- night 
Expl- too much insulin    HE- struggle 
Expl- Weather or temperature   HE- Symptoms  
       HE-  Variation of BG- sympt exp 
HEALTH EDUCATION/HEALTH LITERACY (new code)   Variat- feelings 
        Variat- trust BG    
HYPO TREATMENT (HT)          
 HT- CoT      SUPPORT NETWORK   
 HT- Food 
 HT- Glucagon Inject     
 HT- Glucose 
 HT- Over-Compensation 
 
 
IMPACT EVERYDAY LIFE (IEL)  
 IEL- always prepared 
 IEL- avoid social situations 
 IEL- balance 
 IEL- change job-career 
 IEL- inconvenience 
 IEL- monitor BG 
 IEL- never off 
 IEL- other people worry 
 IEL- recovery time 
 IEL- self-care 
  Self-care- pos 
  Self-care- neg  
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Appendix 19: Extract of summary chart for themes used to 
develop the HEBC 
Extract of summary chart for themes used to develop the Hypoglycaemic Episode 
Balancing Continuum (HEBC) 
Participant Theme: Fear of hypoglycaemia Theme: Perception of long-term 
complications 
NS1_M07 “I always tend to err on the side 
of having a hypo and bulk up 
with sweets rather than taking 
less insulin and running high on 
my glucose.” (p.10) – does not 
express any fearful attitude 
towards hypoglycaemic episodes 
“I would rather have a hypo than go 
blind.” (p.10) – he is very concerned 
about long-term complications 
AS1_F09 “It’s scary; hypos are scary in the 
fact that you feel vulnerable.” 
(p.1) 
 
“You do worry about the long-term 
effects but then the short-term 
effects will affect you right now. It’s 
just always a balancing act.” (p.13) 
NS2_F02 
 
“I've never collapsed or anything 
but I know that that can happen 
and that’s a hugely worrying 
thing to live with.” (p.1) 
“You feel split between two things: 
you want to get your blood glucose, 
your HbA1C, you want to get that 
down [to avoid long-term 
complications], but you don’t want 
to get it so down that it’s giving you 
more hypos […] it’s just that 
balancing act you’ve got to do.” 
(p.2) 
NS3_F10 “If I was constantly just going 
below the five and feeling a hypo 
coming on, I couldn’t live like 
that day in/day out, I wouldn’t 
want to.  That is just not a good 
life experience.” (p.13) 
 
“I do worry about the complications 
that you can have with diabetes […] 
but it is always way into the future 
rather than something immediate 
[…] each time you get a bad report 
or some complication that seems to 
be starting, […] you do worry about 
it.” (p.12) 
NS3_M17 “I get very impatient if I can’t 
have something to eat [when 
experiencing a hypoglycaemic 
episode], because I’m scared 
stiff that I’m going to go too low 
and I’m out.” (p.5) 
“I don’t think GPs and medics 
realise the worry that patients have 
of getting the [long-term] side 
effects, you know, like your 
retinopathy or neuropathy or 
anything like that, I really don’t 
think they realise that.” (p.2) 
AS3_F29 “I wouldn’t like to take another 
hypo. That was terrible.” (p.2) 
Did not express any concern about 
long-term complications. 
 
 
342 
 
Appendix 20: University of Stirling/School of Nursing Midwifery 
and Health Research Ethics Committee Approval 
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Appendix 21: NHS Research Ethics Committee Approval 
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Appendix 22: Scottish Ambulance Service R&D Approval 
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